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Abstract 
 
Introduction 
 
Melanoma is one of the most common human malignancies. Yet, it is often thought 
of as a disease of adulthood rather than one affecting children and young people. 
Although melanoma is rare in children, the incidence is rising in adolescents and 
young adults. Despite improvements in survival rates for young people, there is 
no evidence around the experiences of young people and their family/significant 
of living with this disease. 
 
Method 
 
A qualitative study underpinned by Interpretive Phenomenological Analysis was 
conducted using a novel multiperspective design to explore the experiences of 
young people and their family/significant other living with malignant melanoma in 
Scotland.  Five young people were purposively sampled from three Scottish 
National Health Service Boards based on the treatment location. Each young 
person and a nominated family member/significant other were interviewed (n=10) 
either individually (n=4) or as a dyad (n=6). Semi-structured interviews were 
conducted, and, with the participant’s consent, interview data were audio-recorded 
and transcribed verbatim and analysed. This identified key themes which were 
then clustered into four dominant super-ordinate themes and the findings distilled 
into an overarching metanarrative. 
 
Findings 
 
The metanarrative ‘Life Interrupted' was the core conceptual thread woven 
throughout the findings. It represents the interconnections and interrelationships 
between the four identified super-ordinate themes that encapsulated the 
experience of young people living with malignant melanoma and that of their 
family/significant other: (1) ‘Is it Serious’, (2) ‘Too Much too Young’, (3) ‘Not the 
Same’, and (4) ‘Time to Live’. 
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Conclusion 
 
Being able to recognise and seek support in diagnosing malignant melanoma was 
challenging for young people and their families/significant other with limited 
physical, emotional or social support, often resulting in feelings of isolation. To 
overcome this lack of support and isolation, it is recommended that the care of 
young people and their families/significant other is seamless, and that clear links 
are established between services. Improvements to their journey can be made by 
focussing and addressing the experiences of young people and their 
family/significant other identified through this study. 
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Prologue 
 
“The truth is of course that what one calls the interruptions are precisely 
one’s real life.” 
C. S. Lewis, in a letter to his first and closest friend Arthur Greaves 
on 20th December 1943 (Lewis, 2008 p.97). 
 
I am Wendy McInally, a nurse, educator and researcher with over 25 years’ 
experience in the United Kingdom and internationally. I first encountered 
Malignant Melanoma (MM) professionally in my role as a paediatric oncology 
nurse. After moving into a Higher Education role at Edinburgh Napier University 
(ENU), my new academic purpose was to develop cancer education throughout 
the pre-and-post graduate curriculum. Throughout my earlier career, I have 
always worked with children, teenagers and young people from the ages of 0 to 
25 years of age, either within the settings of a specialist children’s hospital or in 
the community outreach services. At the outset of this study, my initial assumption 
was that a MM diagnosis would be a catastrophic, life-ending event with no hope 
for this fatal disease. As my literature review progressed, it became clear that there 
had been no significant research into the experiences of an MM diagnosis within 
the TYA population, or their family, worldwide. MM is an under-explored type of 
cancer, particularly in terms of the lived experience. I was also interested in 
exploring this experience so that young people and their families/significant other 
living with MM could receive the same levels of recognition, support and treatment 
as other patients with cancer.  
 
Current literature amongst young people is focused on particular Lymphomas, 
Central Nervous System (CNS) tumours and Leukaemia. In addition to this, 
discussing my research with other healthcare professionals further challenged my 
initial assumptions that MM in young people mostly resulted in poor outcomes. For 
example, as a paediatric specialist oncology nurse, I had attended a conference 
in Brisbane, Australia, in 2001. I can still recall one of the main presentations 
regarding MM, this being one of the gravest cancers for Children and Young 
People (CYP). At this time, MM was not something that I had come across within 
my practice or personally. In addition to this at the 2017 AYA Global Accord 
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international cancer conference, I met a young Australian man who been 
diagnosed as a child with MM but who had survived to reach the age of 26, was 
disease-free and was full of optimistic plans for his future. This one-to-one 
discussion fundamentally challenged my entrenched initial assumption that MM 
was a catastrophic, life-ending event. 
 
My interest in MM unexpectedly arose in 1998 when my younger brother was first 
diagnosed at the age of 31 with Stage 2B MM. Subsequently, he was treated and 
supported through his MM experience, and a clinical trial for a new drug treatment, 
until his premature death of Stage 4 MM in May 2003 at the age of 36, leaving a 
3-year-old child and young wife. In this particular instance, prolonged unprotected 
childhood and adolescent exposure to the sun was thought to be the primary 
cause of the disease. As an immediate family member, I experienced and endured 
the emotional roller coaster and feeling of helplessness that all families go through 
when a loved one is diagnosed with cancer. This experience helped me form a 
deep understanding of the challenges and difficulties faced by TYA and their 
families. Cancer does affect the immediate family, and this is also extended to 
other family members and friends. I can still recall the day I received the call from 
the GP in London. I was living with my brother and his wife at the time, and I 
received the telephone call to ask if he could go to the surgery immediately. The 
mole which had been excised the week previous had come back 'cancerous'. As 
they were on holiday, I had to wait another week before he returned. From there 
on in he received treatment and surgery to remove lymph nodes as the cancer 
had spread from the top of his left thigh to his groin area. This was in 1998, and 
by 2003 he was dead. Ironically it was the GP who had excised the mole who 
certified his death on the morning of the 11th May when he died. 
 
My personal experience as a family member shaped this study and was the main 
justification for wanting to explore this area of care. However, I became aware of 
the increase in this disease within the UK and the imparity of the services available 
for young people and their families/significant other living with this disease. This 
study has captured the voices of both the young person and their family/significant 
other and how it impacts on the whole family/significant other. 
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Chapter 1 
 
1.1 Introduction 
 
Malignant Melanoma (MM) remains one of the most prevalent cancers in young 
people worldwide. The reported incidence continues to rise, despite global 
advances in cancer treatments, management and public awareness over the last 
50 years (Hajdarevic, Rasmussen & Hornsten, 2014; McNally et al., 2014; World 
Health Organisation (WHO) 2019). This sustained upward global trend in the 
incidence of MM highlights the timeliness and importance of understanding the 
particular needs and experiences of this unique population.   
 
This study explored the specific experiences of the young people and their 
family/significant other living with MM as they wrestled with its early indications 
and symptoms and how the diagnosis ultimately affected their lives. Over the next 
five sections, this Chapter introduces the unique characteristics of the young 
people, the age group definitions and terminology associated with describing this 
population. The background and incidence of MM in young people is explored 
globally, across the United Kingdom (UK) and within the Scottish healthcare 
system. The models of available care, including care transitions, are also 
considered. Specific evidence of the needs of young people with MM is scarce, 
but the demands for knowledge and understanding about the disease within this 
population are increasing, reflecting the changes in the global incidence of the 
disease. Consistent with the qualitative research tradition, my position as the 
researcher is explained within the Chapter. My prior assumptions, highlighted in 
the prologue, were fully considered within the overall context of the study. This 
approach sets the scene for the subsequent development of the research aim and 
questions. The final section of the Chapter outlines the full structure of the thesis.   
 
1.2 Adolescents, Young Adults, Teenagers and Young People  
 
Adolescents and Young Adults (AYA) are a unique group in society, perched on 
the cusp of no longer being a child but not yet fully an adult with all the 
independence and responsibilities this brings (Gibson, 2018; Smith, Davies, 
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Wright, Chapman & Whiteson, 2007; Smith, Mooney, Cable & Taylor, 2016). This 
transition is a momentous time and important life event in the developmental 
trajectory of AYAs. During this period, the young person is moving from 
dependence to independence (Arnett, 2000).  
 
The WHO (2019) defines 'Adolescents' as individuals in the 10 to 19 years’ age 
bracket and 'Youth' as the 15 to 24 years’ age bracket. However, in other parts of 
the world, there is no apparent consensus on what constitutes a ‘Young Adult'. For 
example, in the United States of America (USA), the term 'Young Adult ' extends 
to the age of 39 years (Zebrack, Kent, Keegan, Kato & Smith, 2014). In England 
and Scotland AYA are considered to be within the age bracket of 15 to 24 years 
of age (National Institute for Health and Care Excellence (NICE), 2005; Scottish 
Government, 2016). 
 
There is considerable confusion within the available literature on what terminology 
should be used to describe AYA. The idea of a young adult entering their 
adolescent years and demonstrating behaviours and attitudes that were not 
common in childhood or to the general adult population first appeared in the early 
1900s. G. Stanley Hall (1904) first pioneered the discovery of the 'adolescent', 
presenting a definition of adolescence and establishing the ‘normal and ‘ideal’ 
behaviours that characterised the developmental phase for this age group (Arnett, 
2006). Hall's definition of adolescence initiated the idea of research into 'youth' 
and their behaviours, habits, and requirements. From his research, Hall suggested 
that the transition phase between childhood and adulthood was a time of 
‘becoming’, when the fixed period of being a child came to a natural end through 
the emotional, physical and physiological growth into the adult state.  
 
Adolescence has long been defined as a liminal zone (James 1986), a clearly 
marked space between childhood and adulthood (Arnett, 2006; Jaskulska & 
Mickiewcz, 2015; Janusz & Walkiewicz, 2018). This space is marked by a series 
of transitions that denote the movement from childhood to adulthood, from being 
dependent in childhood through to independence in adulthood (Marris, Morgan & 
Stark, 2011; Valentine, 2003). Valentine (2003) described this period for young 
people as one marked by a series of ‘boundary crossings'. Importantly, these 
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boundaries are not merely imposed by adults but are in a constant state of flux 
and change, subject to repeated re-negotiation between the adolescent and the 
adult. The concept of liminality describes the time when people are on the 
threshold of entering a new phase in their life, having left the earlier one behind. 
This was first introduced by Charles-Arnold Kurr Van Gennep (1873-1957), a 
French-German-Dutch ethnographer. Gennep remains famous for his study of the 
rituals associated with ‘the rites of passage' marking significant transitions in 
human lives, such as birth, puberty, adolescence, marriage, and death (Cheal 
1988, Van Gennep, 1960). His work continues to be a significant theoretical and 
research construct, as is shown throughout this thesis. Victor Turner (1920-1983), 
a British interpretive anthropologist, builds upon Van Gennep’s work and suggests 
adolescence is a ‘rites of passage’ and a transitional phase where the person is 
in a “state of progressive movement” to “becoming” a new self (Turner, 1964, 
p.46). In describing the transitional phase around adolescence, the term 
“teenager” is one of the more unusual inventions of the 20th century.  
 
During the 1940s American publications began to use the word "teenager" to 
describe young people between the ages of 14 and 18 years (Savage, 2007). 
However, as a descriptor, the term ‘teenager' did not gain any widespread 
recognition or acceptance until the mid-1950s (Weller, 2006) when the confluence 
of three trends in education, economics, and technology allowed today's idea of 
the teenager to form. Compulsory education to the age of 15 in the UK provided 
young people with a place to build a separate culture outside the watchful eye of 
family. Rapid economic growth in the post-war years provided an income, either 
earned or taken from their parents. The growing use of technology in society at 
this time, combined with a reduction in the statutory working week, led to a 
dramatic increase in the time available for leisure (Savage, 2007; Valentine, 2003; 
Weller, 2006).  
 
As a life stage, adolescence is marked by a rapid phase of significant physical 
change, along with development in cognitive, psychological and social behaviours. 
For the young person, this can be a time of emotional turmoil, rapid physical 
development, and a time of growing self-awareness (Chisholm, Hough & Soanes, 
2018). Understanding this evolving sense of self-awareness and individuality in 
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the young adult is essential if healthcare providers are to treat serious illness in a 
suitable and flexible way that recognises each young adult's specific needs. 
 
For the purposes of this thesis, and reflecting the participant age group, the term 
‘Young People' (YP) is used as the consistent collective term rather than AYA 
(Adolescents and Young Adults), TYA (Teenagers and Young Adults), or YA 
(Young Adults). I refer to the age group as YP as the participants in this study 
were 16 years and over at the time of interview. According to Scottish Law, a child 
is defined as a person less than 16 years of age (Scottish Government, 2014). 
This definition is reflected in the current Scottish Government policy as set out in 
the Cancer Plan for Children and Young People aged 0 to 25 years (Scottish 
Government, 2016). Perhaps most importantly and tellingly of all, the YP 
participating in the study used the term ‘young’ or ‘young person’ rather than 
‘child,’ ‘adolescent’ or ‘teenager’ to describe themselves and as such this seemed 
the most natural and appropriate term to use when representing their voice and 
experiences. The term ‘family member’ was used to refer to parents and 
commonly used by the YP in the study. ‘Significant other’ was used as a catch-all 
term to refer to the life-partner of one participant within the study.  
 
1.3 Young People with Cancer Worldwide 
 
The most recently reported figures from 2012 reveal that approximately 1,048,821 
YP are diagnosed with some form of invasive cancer each year (Ries et al., 2017; 
GLOBOCAN, 2019). Within the UK, the incidence of cancer in YP is relatively rare 
but has shown a progressive rise from 14.4 cases per 100,000 of the population 
for those aged between 15 to 19 years and 22.6 cases per 100,000 of the 
population for those aged between 20 to 24 years. Cancer is the second most 
frequent reason for death in YP aged 15 to 24 years, accounting for 11% of all 
deaths (Birch et al., 2008; Kelly, Pearce & Mulhall, 2004).  
 
More recent analysis from the UK, based on data extracted from the Information 
Services Division in Scotland (ISD), the Office for National Statistics in England, 
the Northern Ireland Cancer Registry and the Welsh Cancer Intelligence and 
Surveillance Unit, confirm that less than 1% of all new cancers diagnosed each 
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year are identified between the age of 15 to 24 years of age (Cancer Research 
United Kingdom (CRUK), 2019a).  
 
Consequently, there are approximately 2,200 new cases of cancer reported in YP 
between the ages of 15 to 24 years of age in the UK each year (Children’s Cancer 
and Leukaemia Group (CCLG) 2019, CRUK, 2019a). This compares to 1,600 new 
cases reported in children aged 0 to 14 years. Young people present with a 
spectrum of cancer types that are different from those affecting children and older 
adults. According to the ISD (2019), the most common diagnoses reported in YP 
across Scotland were carcinomas (21%), lymphomas (18%); and melanomas and 
skin cancers (16%). 
 
Over the past 20 years, cancer care has improved for YP across the UK due to 
advances in medicine and advanced nursing practice alongside more focused 
policy (Department of Health (DoH), 2007; NICE 2005; Scottish Government, 
2016). In Scotland, around 180 YP, aged 16 to 24 years, are diagnosed with some 
form of cancer each year (ISD, 2019), compared to approximately 130 children 
aged 0 to 15 years diagnosed with cancer (Scottish Government, 2016). With 
general cancer survival rates now exceeding 80%, there is a growing population 
of YP living with and beyond their cancer diagnosis and treatment, including 
approximately 14 YP living with an MM diagnosis each year.  
 
1.3.1 Models of Care for Young People with Cancer 
 
Young people with cancer experience a wide variety of different treatment and 
care processes and the needs of the family/significant other cannot be separated 
from that of the YP (Gibson & Soanes, 2008; Davies, Kelly & Hannigan, 2018; 
Morgan, 2018). The UK has been at the forefront of developing YPs services, 
where there have been several political drivers for change. The first driver for 
change was the Platt Report (1959) that drew attention to the specific needs of YP 
in hospital. The Platt Report commissioned by the UK Ministry of Health and 
formally titled ‘The Welfare of Sick Children in Hospital', investigated the care of 
children in hospital and highlighted that children should be treated separately from 
adults. The committee, chaired by Sir Harry Platt, found that hospitals were 
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miserable places for children, where they were expected to conform to ward 
routines, not allowed to play; where to lie quietly was the accepted norm, and 
where, under no circumstances, were the parents allowed to visit outside the 
declared visiting hours. Despite the pioneering ideas of this early literature around 
caring for children in hospital and the role of the family, it would take many years 
before the revolutionary ideas contained within the report would be put into 
practice in the UK and in many other Western countries. By the early 1980s, 
changes began occurring rapidly with a new generation of doctors and nurses 
sympathetic to the main recommendations of the report (Taylor, Muller, Wattley & 
Harris, 1999; Morgan, 2018).  
 
The development of the Teenagers and Young Adults (TYA) care concept was 
first introduced into the UK during the early 1990s by the Middlesex Hospital in 
London, England with the specific purpose of meeting the distinct care needs of 
TYAs with cancer (Gibson et al., 2012; Morgan, as cited in Olsen & Smith, 2018). 
The DoH commissioned Calman-Hine (1995) report and outlined radical reform of 
the UK's cancer services to improve outcomes and reduce inequalities in NHS 
cancer care. This included how services for TYAs should be further expanded to 
include an environment staffed with suitably trained and qualified healthcare 
professionals (McInally & Willis, 2017; Smith et al.,  2007). The Teenager Cancer 
Trust (TCT) charity has since taken the lead in driving these specialist services 
forward. Since that time, NICE (2005) and the Scottish Government (2016) has 
been instrumental in steering professionals in the care of TYAs with cancer. 
However, as these services have become more established, there has been a 
notable disparity in the definitions applied to the TYA group. For example, in 
England, TYA cancer care for YP aged 15 to 18 years with cancer must be referred 
to a Principal Treatment Centre (PTC). For those aged between 19 to 24 years, 
there is some choice available regarding their preferred treatment location, but the 
rest of the UK has yet to follow this lead (NICE, 2005). 
 
Currently, there are 28 TCT units spread across the UK, and as seen in Figure 
1.1, 23 are located in England, one in Wales and no current provision in Northern 
Ireland and four in Scotland. The UK is the only country currently to have such 
models of care for TYA, although work is currently being explored regarding TYA 
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units within some states of the USA (Teen Cancer America, Simon Davies, 2019). 
The number of YP diagnosed with cancer each year across England is 
approximately 2,600 (CRUK, 2019a). In Wales, 104 YP are diagnosed with cancer 
each year on average. The Cardiff children's hospital, opened in 2009, has a 
designated cancer service for children and young people as well as a TCT unit for 
YP aged 14 to 25 years. In Northern Ireland, the number of YP diagnosed with 
cancer each year is approximately 80 (CRUK, 2019a). The PTC in Belfast has two 
beds for teenagers, and young people and the acceptable range variation is from 
13 to 20 years.  
 
Figure 1.1 UK Teenage Cancer Trust Locations 
 
Scotland has four TCT units, and the TYA age range is generally recognised as 
people between the ages of 16 to 24 (Scottish Government, 2016). It is 
fundamental to the patient's treatment and recovery experience that care is 
provided in a suitable, age-appropriate setting (NICE, 2005; Scottish Government, 
2016). Many YP with cancer are not being treated within a setting appropriate for 
their age (NICE 2005), especially young people with MM. Many of these patients 
are also not considered for entry into clinical trials (Hollis & Hooker, 2009), which 
ultimately impacts on their overall cancer survival and recovery from the disease. 
It is important that as patients mature into adulthood, care pathways are clearly 
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defined (Maher & McConnell, 2011). These should consider the individual age, 
cancer type and the future risks of late effects from treatment as well as the 
personal needs of the young person and their family (DoH, 2007).  
 
Comparing different international models of healthcare for YP is made more 
difficult by the differences in age group definitions. For example, in the USA, some 
individual State Healthcare Services extend the TYA age categorisation to 39 
years of age (Zebrack et al., 2014). Despite varying definitions across the UK and 
globally, the fundamental strength of a TYA care model is that the patient can 
mature through their illness, developing coping strategies and a sense of self-
worth and belief (Al Omari & Wynaden, 2014; Trevino et al., 2012). Supplying 
holistic care requires healthcare professionals to be highly trained, experienced 
and knowledgeable about the needs of this unique patient group and that of their 
family. This is a challenge within the UK as training and education for doctors, 
nurses and other healthcare professionals is subdivided into childhood and adult 
specialisms (Gibson et al., 2012). As a group, YP are often misunderstood by 
healthcare professionals due to a lack of both healthcare expertise and experience 
that recognises the age of the patient, the biology of the disease and the 
availability of clinical trials (Fern et al., 2013a). While striving for independence, 
autonomy and making decisions that affect their care, the young person is also, at 
times, dependent on their families (Soanes & Gibson, 2018; Trevino et al., 2012). 
 
Caring for YP with cancer and their families requires a range of specific 
knowledge, skills, and experience to deliver these often-complex care regimes, 
both within the hospital and community environment (NICE,  2005). Policy reviews 
in cancer care across the UK have tried to ensure a single service throughout the 
treatment journey (Scottish Government, 2016; DoH, 2007). Initial cancer 
diagnoses are typically made at the appropriate PTC, situated within the local 
hospital. Delivery of treatment is dependent on the agreed treatment protocol and 
the needs of the patient and family, but generally takes place within either the 
Shared Care Centre (SCC) (a unit located within the hospital) or the home 
environment (Gibson & Soanes, 2008). Agreed treatment protocols available in 
the UK include the introduction of intensive multi-agent chemotherapy, combined 
with radiotherapy, surgery, bone marrow transplant and a recent addition is 
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immunotherapies (CCLG, 2019). These treatments meet and follow all necessary 
national and international standards (Gibson & Soanes, 2008; NICE, 2005). 
 
Young people aged 16 to 24 years, with any type of cancer are a vulnerable group 
of patients with unique medical and psychosocial needs who are less likely to 
access optimal cancer services than any other group of patients (Gibson et al., 
2012; NICE, 2005; Whelan, Dolbear, Mak, Møller & Davies, 2007). Providing 
national cancer services for YP is a particularly complex and challenging area of 
care requiring new clinical collaborations that straddle existing site-specific 
practice models, including paediatric, TCT units and adult services (Smith et al., 
2016). 
 
1.3.2 Transition of Care 
 
Transition is an essential part of the cancer journey for each young patient, yet not 
all hospital services offer this (McInally & Cruickshank, 2013; Weston, Soanes, 
Chisholm, & Wiseman, 2018). The literature defines transition as “the purposeful, 
planned movement of AYA with chronic physical and medical conditions from 
child-centred to adult-orientated health care systems and should be a planned and 
regularly reviewed, to ensure a smooth transition to adult services” (Blum et al., 
1993 p.2; Royal College of Physicians Edinburgh, 2008). This group of patients 
has been described as the ‘lost tribe,’ implicitly acknowledging there are no clear 
pathways of care in place as they transition from children’s to adult services within 
the cancer journey (Kelly & Gibson, 2008). Transition is therefore crucial for the 
YP with cancer, from the child to adult services and must be seen as a critical part 
of the cancer experience. 
 
As YP transition to adult services, they are moving into a more independent and 
responsible phase of their lives and are encouraged to take responsibility for their 
own health care. It is crucial to empower these YP to make decisions about their 
health care, yet there is no transparent approach which may impact on their ability 
to achieve this (Davies, Kelly & Hannigan, 2015). McCann, Kerney & Wengström 
(2014) established that TYA require appropriate ‘readiness’ for transition to be 
effective. To allow for this preparation, healthcare professionals must strive to 
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ensure that the planning and preparation for this transition are communicated well 
before the actual transition occurs. A vital element of this success is for all health 
and social care professionals to work collaboratively together across children's 
and adult services. It should be recognised that an individual young person may 
find this emotionally and psychologically difficult and that further research 
regarding these specific challenges is required.  
 
The majority of adult cancer care, in comparison to children's services, is delivered 
on a speciality focused basis, such as neurology or haematology. Young People 
report experiencing adult services as fraught with many difficulties and challenges, 
such as not being able to have a parent/carer stay overnight and restricted visiting 
during the day (Kelly & Gibson, 2008). Consequently, many patients and their 
families may have difficult transition experiences that negatively impacts on this 
crucial phase in their lives. For the transition of these patients with cancer to be 
seamless, healthcare professionals caring for this patient group and their families 
require a sound knowledge and understanding of the needs (Aldiss et al., 2015). 
This supports healthcare professionals to care appropriately and deliver a positive 
transition experience to the adult services. 
 
1.3.3 The Family  
 
The concept of family and what is commonly recognised as a family unit has 
evolved over the years. The term, ‘nuclear family’, coined in 1947, consisted of 
two biological parents with dependent children (Whyte, 1997). Today the family 
unit is more diverse, and society has changed since the 1940s (Whyte, 1997), the 
term ‘household' now encapsulates the larger family unit. Cancer in YP is a family 
disease that affects not only the child or YP but the whole family (Grinyer, 2007). 
As the young person grows and develops into an independent individual, they are 
encouraged to take responsibility for decisions about their own healthcare (Davies 
et al., 2018). In part, this is dependent upon the age, stage, and severity of their 
disease. Although it is important to empower YP to make these decisions, there is 
little research on, or indeed clarity about, decision-making, their ability to take this 
responsibility or the impact these decisions have on the individual and their family 
(Davies et al., 2015; Wicks & Mitchell, 2010). This is important as the experience 
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of cancer can often occur at a time when YP are in the process of developing their 
early adult life plans (Taylor, Pearce, Gibson, Fern & Whelan, 2013). The 
diagnosis and subsequent treatment for cancer at this juncture may significantly 
impact their lives. In addition, a diagnosis of cancer at this time may add to the 
stressors associated with a ‘normal' transition from child to young person and 
young person to adulthood as well as the impact on their relationships, quality of 
life and psychological wellbeing, amongst other components of their lives. 
 
The needs of the family cannot be separated from the child or YP during this 
period. Feedback from children, YP and cancer charities has highlighted that they 
need support, space and a forum to discuss these issues (Cancer and Leukaemia 
in Childhood (CLIC) Sargent 2019; TCT, 2019). To ensure YP and their 
family/significant other receive timely information and support to empower them to 
make these decisions, further research into their specific needs and experiences 
to be undertaken (Davies et al., 2015). 
 
The Family Centred Care (FCC) approach lies at the centre of children and young 
people's nursing within the UK (Darbyshire,1994; Franck & Callery, 2004; 
Coleman, Smith & Bradshaw, 2003, Shields, 2015). The FCC approach directly 
supports the current view that involvement of the family is essential to the 
compassionate healthcare of children and young people (Fawcett, 2011). 
However, unclear conceptual definitions and inconsistent implementation remain 
despite FCC principles being encouraged since the publication of the Platt report 
in 1959. The concept of children and young people's nursing has deep roots within 
this model where healthcare professionals strive to work in partnership by 
negotiating the care where and when appropriate. This approach, however, differs 
for YP who may not be cared for within a children's hospital and therefore, 
experience a ‘person-centred' approach to care (Kvale & Bondevik, 2008). This 
FCC approach becomes problematic in the TCT and adult services where the care 
is focused on the patient being empowered to take responsibility for their own 
health care and does not always include a role for the family. For example, within 
the children's service, the parents/family are encouraged to stay with their child 
and often make decisions together in recognition of the crucial role that the family 
plays in supporting and caring for the YP throughout their treatment journey. 
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Changes in the care delivery for individuals with cancer to one which promotes an 
FCC model where independence and self-awareness are encouraged and 
necessary may be problematic for some patients and their family (Hokkanen, 
Eriksson, Ahonen & Salantera, 2004; Wicks & Mitchell, 2010). In dealing with the 
practicalities of supporting YP with cancer, families often express that it is “not 
clear who is in the driving seat” (Stuart Lawtie Conference, Mrs. Lawtie, 2016) 
when making treatment-related decisions. Services that are tailored to meet the 
individual needs of the young person and their family are necessary. The next 
section discusses YP and MM and is the focus of this study.  
 
1.4 Young People with Malignant Melanoma 
 
The incidence of MM is increasing globally and is affecting YP (CRUK, 2019b; 
Melanoma UK, 2019; McNally et al., 2014; Ferlay, et al., 2015). During the last 
decade, MM was rare in YP, with around 2% of all melanomas occurring in those 
aged less than 20 years (Bader, Li, Olmstead, Strickman & Green, 1985). Current 
evidence suggests that an MM diagnosed early can help ensure a positive 
prognosis and a healthy outcome (DoH, 2007; Scottish Government, 2016). Yet, 
if not diagnosed and treated with alacrity, the outcome can be fatal. Despite 
advances in MM treatments that have driven improved survival rates, the 
incidence of the disease continues to increase in several countries, due to a 
combination of factors such as UV exposure, familial traits such as hair and skin 
colour and other societal factors (Ali, Yousaf & Larkin, 2013). Young people are at 
risk, and these factors need to be taken seriously in the future (Kyle, Forbat & 
Hubbard, 2012).  
 
There is considerable variation in the incidence of MM between countries (McNally 
et al., 2014; Ali et al., 2013). Rates of MM have seen a marked increase in YP 
who reside in developed countries (Downing et al., 2006, Purdue et al., 2006). 
This trend is attributed to variations in racial skin phenotype, as well as differences 
in sun exposure around the world. In the USA, for example, 98.2% of cases are 
reported amongst white-skinned individuals (Ali et al., 2013). According to a study 
by Mitis et al.,  (2015), MM is the second most usual form of cancer for people 
aged 15 to 29 years in the USA and the third most common cancer for young 
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adults aged between 25 to 29 years of age in the UK. In the UK it is estimated that 
almost twice as many females (n=153) than males (n=73) are diagnosed with MM 
annually (CRUK, 2019b).  
 
1.4.1 Young People with Malignant Melanoma in Scotland 
 
Rates of MM are climbing, and Scotland has above average incidence when 
compared to the UK (Kyle, et al., 2014). Although more often diagnosed in older 
people, it is increasingly affecting the younger population with annual diagnosis 
rates growing (ISD, 2019). In 2019, new statistics revealed that MM is the third 
most prevalent cancer amongst young people in Scotland with 14 young people 
aged 15 to 24 years diagnosed with the disease each year (ISD, 2019). The 
situation in England is very similar, where MM is now the fourth most common 
cancer amongst young people (National Cancer Registration and Analysis 
Service, 2018).  
 
In Scotland, of the 180 YP aged between 16 to 24 years diagnosed with some 
type of cancer each year, on average 14 YP, some 8%, are diagnosed with MM 
(Scottish Government, 2016; ISD, 2019). In 2017, there were no children under 
the age of 15 years, three YP between 15 to 19 years and 12 YP between 20 to 
24 years were diagnosed with MM (ISD, 2019). The number of cases per year is 
higher within the 25 to 39-year-old age groups. In particular, young females are 
more at risk than young males. Survival rates in Scotland have risen by 21% over 
the past 20 years, from 64% in the period 1983 to 1997 to 85% in the years 2003 
to 2007 (ISD, 2010; Kyle et al., 2014). Today MM is now the third most common 
cancer in the YP age group in Scotland (CRUK, 2019b; ISD, 2019). The current 
documented survival rate for YP diagnosed with MM is 95% (ISD, 2019), if the 
diagnosis is made sufficiently early in the life cycle of the disease to allow effective 
treatments and interventions to be introduced. Figure 1.2 charts the 
Melanoma/skin cancer incidence and mortality for YP living in Scotland between 
1990 and 2014.  
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Figure 1.2: Melanoma Cancer Incidence and Mortality 
  
 
 
The growing incidence of MM in Scotland is primarily due to several factors 
specific to Scotland's population, including environmental, societal and cultural 
conditions along with some genetic predisposition to the disease (Scottish 
Government, 2018). The combination of these factors presents a unique 
opportunity to understand better how YP and their families/significant other in a 
modern and sophisticated society cope with an MM diagnosis and how their lives 
are lived thereafter.  
 
Young people are at a greater risk of MM than previous generations (Kyle et al., 
2014) as today's media and ‘celebrity' culture set ever-increasing body image 
expectations and demands. All media channels, particularly social media, 
bombard YP with images of tanned and thin people enjoying a lifestyle that is 
unattainable for the vast majority of the population. This pressure to be seen as 
beautiful and tanned poses a direct risk to the future health of YP if they succumb 
to these lifestyle pressures and expose themselves to harmful UV light. This 
pressure also extends to alcohol consumption, diet, exercise and other behaviours 
(Murray & Turner, 2004). 
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1.4.2 Epidemiology and Diagnosis of Melanoma 
 
There are three main types of Melanoma skin cancer, basal cell carcinoma (BCC), 
squamous cell carcinoma (SCC) and cutaneous melanoma (CM). Although BCC 
and SCC are the most common, CM is highly malignant and requires an early 
diagnosis to prevent infiltration of the disease (McNally et al., 2014). There are a 
number of factors known to contribute to this disease, such as lack of awareness 
around the dangers of UV exposure, light skin colour, blonde or red hair, number 
of moles, family history, and of course actual excess exposure to ultraviolet (UV) 
radiation, particularly in childhood (Basta, James, Craft & McNally, 2011; Bader et 
al., 1985; McNally et al., 2014). 
 
Although MM is more often diagnosed in older people, it increasingly affects YP. 
Malignant Melanoma has five main stages, ranging from Stage 0 to Stage IV. The 
categorisation, or staging, provides a standard way of describing the cancer, 
assisting healthcare professionals to discuss, treat and manage the disease in a 
consistent manner (Ali et al., 2013). 
 
The stages and the general expected UK adult survival rates for each stage are 
noted below. However, it is worth noting that survival rate data for the various 
individual stages are not yet routinely available in the UK due to inconsistencies 
in the data collection (CRUK, 2019b). 
 
• Stage 0. Refers to melanoma in situ, meaning the melanoma cells are found 
only in the outer layer of skin or epidermis. This stage of melanoma is unlikely 
to spread to other parts of the body. The expected general survival rate for 
Stage 0 is 100%. 
 
• Stage I. The primary melanoma is still only in the skin and is very thin. Stage I 
is divided into two subgroups, IA or IB, depending on the thickness of the 
melanoma. The expected general survival rate for Stage I is almost 100%. 
 
• Stage II. Stage II melanoma is thicker than Stage I, extending through the 
epidermis and further into the dermis, the dense inner layer of the skin. There 
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is a higher risk of spreading to other parts of the body. Stage II is divided into 
three subgroups—A, B, or C. The expected general survival rate for Stage II is 
between 80 – 90%.  
 
• Stage III. This stage describes melanoma that has spread locally or through 
the lymphatic system to a regional lymph node. Stage III is divided into four 
subgroups—A, B, C, or D. The expected general survival rate for Stage III is 
greater than 50%.  
 
• Stage IV. This final stage describes melanoma that has spread through the 
bloodstream to other parts of the body, such as distant locations on the skin or 
soft tissue, distant lymph nodes, or other organs like the lung, liver, brain, bone, 
or gastrointestinal tract. The expected general survival rate for Stage IV is 
between 10 and 25%. 
 
Figure 1.3 illustrates the differences between each stage. The most important 
prognostic feature for YP with MM is the thickness of the primary tumour at 
diagnosis, and this determines the stage of the disease. The staging 
categorisation helps clarify the stage of disease for patients and healthcare 
professionals. 
 
Figure 1.3: The Five Stages of Melanoma 
 
 Image source: Jaworek-Korjakowska, & Kleczek (2018) 
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1.4.3 Management of Malignant Melanoma 
 
Historically MM was seen as intractable and untreatable, whereas today, it is 
revealing its molecular weaknesses (Levy et al., 2018). Advances in clinical 
research mean that MM patients can now expect positive outcomes and a good 
quality of life (Hajdarevic et al., 2014; Weller, 2006). Curative treatment, however, 
is dependent on early diagnosis and the stage of the disease at the time of 
diagnosis, with the specific treatment dependent upon the stage of the disease 
(Office of National Statistics, 2016; Walter, Humphrys, Tso, Johnson & Cohn, 
2010).  
 
Young people with suspicious lesions are initially referred for further assessment 
by their GP or local dermatologist (CRUK, 2019b). There is little evidence or 
guidance on the treatment and management of YP with this specific disease. 
Children in Scotland under 16 years of age will typically be treated within the CYP 
services, whereas YP, aged over 16 years, will be seen within an adult service 
(Scottish Government, 2016). Young people do not always have access to 
specialist cancer services due to the treatment journey for melanoma being 
different from other forms of cancer. Most of the management for YP and their 
family/significant other is provided through outpatient appointments, depending on 
the stage of the disease. For all cases, treatment is usually a wide excision of the 
primary tumour with clear margins around the mole with no cancer cells evident. 
However, the definition of what represents a suitable clear margin and whether 
regional lymph nodes are affected and removed during surgical treatment is 
subject to extensive debate in the medical profession (CRUK, 2019b). Adjuvant 
therapy such as immunotherapy may be used as an additional treatment to 
supplement the primary excision for high-risk patients, but there is no standard 
practice in this area of care. Medical oncologists are trialling immunotherapy, 
which is expected to help substantial numbers of patients, but the best timing for 
this type of intervention has not been determined (O’Reilly et al., 2019). Systemic 
treatment is used in palliative and end of life care along with radiotherapy, 
especially for patients with metastatic disease (Levy et al., 2018). Some YP 
experience disease recurrence, undergo multiple surgeries and attend clinics for 
many years (Bird, Coleman & Danson, 2015). 
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In addition, the successful management of MM depends on the approach to care 
delivery. Recognition of early symptoms to ensure prompt diagnosis and treatment 
is crucial (Zebrack et al., 2014). Delivery depends on regular reviews of services 
and the identification of relevant treatment protocols and pathways in combination 
with a trained workforce to meet demand. This is a fundamental requirement so 
that YP and their family/significant other can be supported and prepared for their 
future. In Scotland, the cancer strategy focusses on enhancing multidisciplinary 
working across health and social care to ensure that YP receive care tailored to 
their needs (Scottish Government, 2016). 
 
1.4.4 Government Policy in Caring for Young People with Malignant 
Melanoma 
 
Government policy towards caring for YP with MM differs across the devolved 
nations of the UK. Healthcare policy in England and Wales dictates that the ideal 
treatment and care experience should be delivered from specialist centres and 
supported by other services that are age-appropriate (NICE, 20015; 2005; Smith 
et al., 2016; Taylor et al., 2013). However, there is limited evidence to suggest 
what is meant by ‘age-appropriate care' and what this offers in comparison to other 
services for YP. ‘Age appropriate care' and specialist services are not readily 
available for all YP with cancer across the world or indeed within the UK due to 
different devolved health care systems, resources and priorities (Birch et al.,  
2013; Pearce, 2009). There is also a need to address what happens in practice 
from the YPs’ perspective and what information they receive about services for 
ongoing care and support (Taylor, Whelan, Gibson, Morgan & Fern, 2018). In 
England, ‘BRIGHTLIGHT’ has explored whether specialist services for TYA 
delivered any tangible difference to the YPs' treatment experience (Taylor et al., 
2015). At the time of writing, the BRIGHTLIGHT research has yet to publish its 
final report. However, interim findings indicate that ‘age-appropriate care’ for YP 
is essential but depends upon a range of interdependent factors for its successful 
and sustained implementation and not all YP have access to these specialist 
services. The findings suggest that the benefits of ‘age-appropriate care’ can be 
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applied to many healthcare services, not just cancer (Lea et al., 2018). The 
publication of the final report is awaited with interest.  
 
Currently, the Government in Northern Ireland has no policy in place but is in the 
process of preparing and reviewing specific guidelines for children and young 
people (CYP) with cancer (Cancer Focus Northern Ireland, 2019). In Scotland, 
Government policy is set out in the Cancer Plan for Children and Young People 
and aims to ensure that CYP between 0 to 25 years diagnosed with cancer have 
equal access to the best possible care and treatment as early as possible (Scottish 
Government 2016). The Managed Service Network (MSN) for CYP with Cancer 
has been charged with delivering this vision (Scottish Government, 2016). It is 
important that, as YP mature into adulthood, early diagnosis and defined care 
pathways are established. These pathways should consider the individual age, 
cancer type and the future risks of late effects from treatment as well as the 
personal needs of the young person and their family. The key driver to the policy 
is for CYP to be given the right diagnosis, the right treatment by the right team 
within the right place (Scottish Government, 2016). Within Scotland, it is 
recommended that each multi-disciplinary team has a Skin Cancer Clinical Nurse 
Specialist (CNS) whose role is to support patients and their families through the 
journey (Scottish Intercollegiate Guidelines Network, 146 2017). However, this 
policy is for adults only and does not apply to YP with MM. 
 
A national review of services for CYP has provided an impetus for change in what 
has become a high priority area for the UK and Scottish Government and national 
charities such as the TCT, Macmillan and CLIC Sargent (Scottish Government 
2016, NICE, 2005). Research has shown that after a cancer diagnosis YP are at 
significant risk of developing later life complications such as physical, emotional, 
and psychological trauma following their cancer treatment (Grinyer, 2007). 
 
When considering skin cancer in Scotland, the key messages from the 
Government around the risks from UV exposure have changed. The most recent 
guidance on excessive sun exposure should be followed, but it is now recognised 
that some exposure to natural sunlight is essential to prevent a lack of Vitamin D 
in the general population (The Scientific Advisory Committee on Nutrition (SACN), 
 __________________________________________________________________________ 
20 
 
Scottish Government, 2019). Sunlight is necessary for the human body to produce 
vitamin D to prevent the onset of physical complications such as rickets in small 
children and osteoporosis in late adulthood. The Scottish Government (2019b) 
has recommended that everyone in Scotland have between 10–15 minutes of 
unprotected exposure to the sun each day. Sunscreen once applied to the skin, 
blocks vitamin D synthesis. Remaining in the sun for prolonged periods without 
the protection of sunscreen increases the risk of skin cancer, and Government 
advice on this remains unchanged (Kyle et al., 2014; Scottish Government, 
2019b). 
 
1.4.5 Research Rationale  
 
Malignant Melanoma is an important disease within this age group, and 
awareness of the dangers of UV exposure is essential in addition to early 
diagnosis and care management within age-appropriate specialist services 
(Murray & Edgar, 2012). The YPs' experience of cancer is often at a time when 
they are in the process of developing their early adult life plans and are at a 
fundamental crossroads in their life. This study is concerned with the personal and 
relational impact an MM diagnosis can bring to YP and their families/significant 
other living in Scotland. As this disease continues to rise within YP in Scotland, 
treatment pathways and policy is changing. There is now a need to understand 
how YP and their families /significant other live with this disease. The fundamental 
purpose of the study was to gain an understanding and find meaning from the 
lived experience of each participant, as this is a poorly understood area of care. 
Understanding the impact on the individual sense of self and that of their 
family/significant other is critical if healthcare professionals are to deliver more 
appropriate care and support for young people with this disease in the future. 
 
1.5 Position of the Researcher  
 
The experience of living with MM is poorly understood with no international or 
national research focussing on the experiences of YP living with an MM diagnosis 
(McInally, 2018). This is also true for the experiences the families/significant other 
share with the young person endeavouring to cope with the disease. Reflexive 
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engagement with the available literature, detailed supervisory debates and 
interviews with the participants themselves allowed new understandings to 
emerge. The research revealed that some people positively embrace the 
challenges that an MM diagnosis can bring and regard overcoming the disease as 
a life-affirming event, encouraging them to live their lives to the fullest possible 
potential and not take life for granted. The personal value of this experience was 
the exposure, challenge, and changing of my own previously entrenched 
assumptions. This experience, and looking back on my reflexive notes, helped me 
become more aware of these assumptions and how deeply entrenched they were. 
  
As the research progressed, it was important to guard against any elements of 
personal or professional bias creeping into the study. Although cognisant that my 
own experiences would help build empathy when meeting the young participants 
and their family/significant other, I proactively worked to minimise the risk of any 
undue influence affecting the outcome of this study. 
 
Initially, I viewed the available healthcare structures through the prism of a 
specialist child health nurse, and not as the researcher. However, engaging with 
the literature, discussions with my supervisory team, reflexive diary reviews and 
attending a series of IPA workshops allowed me the opportunity to bring the 
personal voices and family experiences of the participant group to the front and 
centre of my research. My own experience of MM, as a family member, helped 
shape this study and was the primary motivation for wanting to explore this area 
of care. Although there is minimal research around YP with MM, there is equally 
limited research around the experiences of the families/significant other who must 
share the emotional trials of MM in someone they love. As this thesis developed 
and progressed, I was able to explore, challenge and revise my original 
assumption, as detailed in the Prologue, that every MM diagnosis in a young 
person led to an early death.  
 
1.6 Structure of the Thesis 
 
This thesis presents the results of an Interpretative Phenomenological Analysis 
(IPA) exploration into the lived experiences of YP diagnosed with MM and their 
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life-changing journey dealing with the unique challenges of this cancer during a 
time of transition into adulthood. The qualitative approach adopted, hermeneutic 
phenomenology and specifically the IPA allowed for the study participants to 
reflect upon their experience of living with MM (Smith, 2010). The participants core 
narratives help to articulate the meaning of their experience and the influential role 
played by the family/significant other in the MM journey. Literature was scarce 
about YP with MM, their lived experience and the impact this has on their 
immediate support mechanisms, such as their family/significant other. The impact 
on their immediate family/significant other is an essential dimension in their 
journey experience and as such, was a prominent consideration in this study.  
 
Chapter 2 presents a review of the literature on YPs' experiences of MM and 
general cancers affecting this age group and summarises the current state of 
knowledge and understanding. The research strategies used to inform the 
narrative review are outlined within the Chapter. Based on the identified gaps in 
the current understanding of YP with MM, the literature review concludes with a 
rationale for this study. 
  
Chapter 3 begins by stating the research aim and associated research questions 
that were developed from the literature reviews. It then discusses the research 
methodology and methods, along with the ethical considerations of the study. 
Throughout, I critically review and discuss the theoretical basis for the research 
design and approach and then explain the choices made in completing this study. 
Within this Chapter, I outline my efforts to achieve a deeper understanding of the 
participants' lived experiences through the phenomenological, hermeneutic and 
idiographic approaches of IPA.  
 
Chapter 4 presents the findings from the study under the four super-ordinate and 
12 sub-themes with extracts from relevant individual or dyad interviews to support 
the findings and the rigorous analysis, ensuring credibility and trustworthiness 
throughout. These findings lay the foundations for the metanarrative ‘Life 
Interrupted’ which is the core conceptual thread which is discussed further in 
Chapter 5.  
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Chapter 5 revisits the research aim and questions before discussing the core 
conceptual thread, the ‘Life Interrupted’ metanarrative. The main findings are 
illustrated through a conceptual representation and embedded within the four 
superordinate themes. These are then critically discussed and evaluated, 
exploring the meaning, importance and relevance of my research to theory and 
practice. In concluding this Chapter, I discuss my study’s original contributions to 
the broader body of knowledge, the strengths and limitations of the research, 
before highlighting and summarising my recommendations for future research, 
practice and policy. Finally, I present my overall conclusions from this research. 
 
I end with an epilogue that bookends this thesis, highlighting my journey 
throughout, what I have learnt from undertaking this study and plans for future 
research. 
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Chapter 2 – Literature Review 
 
2.1 Introduction  
 
Chapter 1 outlined the context of the study, and positioned MM as a disease in YP 
which was rare during the 1970s but is increasing more rapidly than any other 
cancer in the UK. Scotland has an above average incidence when compared to 
the rest of the UK (Kyle et al., 2014; CRUK, 2019b, McNally et al., 2014) with no 
survivorship programme or long-term planning in place. Currently, the majority of 
YP are managed within the surgical skin/plastic department of their most 
conveniently located NHS Hospital with minimal contact with the UK's specialist 
cancer services. This Chapter aims to explore the existing literature and to 
understand what is currently known about the experiences of YP living with MM 
and those others most affected by this disease such as the immediate family 
(parents/carers, siblings and extended family members) and significant others (life 
partners, boy/girlfriend, close friends). These individual YP are still transitioning 
into adulthood and often require support and guidance from the family/significant 
other. From personal experience, as indicated in the prologue, cancer affects the 
whole family and significant others, including partners, loved ones and friends. 
Consequently, it was decided to include others within the young person's journey 
of living with MM.  
 
Two separate literature reviews are presented in four distinct parts. Firstly, I set 
out the search strategy used to identify papers focused on the experiences of 
young adults with MM. As the initial search failed to identify any literature explicitly 
focused on the experiences of young adults/people with MM, the second literature 
review was widened to include young adult’s/peoples experiences of all cancers. 
Secondly, I discuss an existing meta-synthesis study which supports the second 
review. Thirdly, the search strategy used to identify papers for the second broader 
search and the literature, which focused on YPs experiences of cancer. Finally, I 
present an in-depth discussion of the papers for this narrative synthesis and 
review the overarching themes and subthemes that were identified around young 
adult's experiences of cancer and those of their family. This positions my study 
within the body of existing theoretical knowledge and research, and identify the 
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contribution my study makes to advancing the current state of understanding 
within research, practice and policy. 
 
A sound understanding of the experience and specific care requirements of young 
adults with this disease, along with that of their family/significant other, is important 
if health and social care professionals are to base their future care plans on 
reliable and robust evidence. The focus of this study was to explore the lived MM 
experiences of YP and their family/significant other. Consequently, a qualitative 
research methodology was selected as the most appropriate way of exploring the 
lived experiences in a profound and meaningful way. 
 
The role of the literature review in qualitative research has been widely debated. 
Some authors suggest that the literature review is best completed after data 
collection, with the grounded theory approach being one example of this (Polit & 
Beck, 2010). The rationale behind this view stipulates that an in-depth knowledge 
of the literature may limit the researcher's openness to new ideas. A possible 
consequence may be that the researcher becomes 'boxed-in' and unable to 
identify or accept challenges to their pre-conceived ideas and positions. 
Alternatively, a review of the literature prior to data collection offers the researcher 
the opportunity to fully explore what is known about the topic, identify gaps in that 
knowledge or understanding by reviewing the previous research and then provide 
an underpinning rationale for the study (Parahoo, 2014). Additionally, the literature 
review helps to contextualise and define the theoretical basis of the study.  
 
Most qualitative methodologies reject formulating hypotheses before the research 
and instead promote an open inductive approach. This approach also helps 
identify any gaps in the researcher's knowledge and influences the methodology 
chosen to answer the specific research question(s). For these reasons, a literature 
review was undertaken before commencing the study. From the outset, it was 
clear there was a lack of research and evidence-based practice concerned with 
young adults with MM and those others affected by the disease. 
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2.2 Literature Review Approach  
 
For the purposes of this Chapter narrative, integrative and systematic reviews 
were considered. As I was specifically concerned with the experiences of YP with 
cancer and of those affected by the disease, a narrative review was considered 
appropriate to identify only qualitative empirical papers. An integrative review 
considers both quantitative and qualitative research using different designs within 
the research process. In contrast, a systematic review brings together all 
quantitative research, and often utilises a common design, such as randomised 
controlled trails. Both integrative and systematic reviews were inappropriate 
(Grove, Burns & Gray, 2013) as these did not fit with my overall thesis and 
questions around MM. In addition, neither reviews matched with my stated 
inclusion and exclusion criteria. Ultimately, both approaches were disregarded as 
inappropriate for my literature review and not pertinent to the overall research aim 
and questions. 
 
Qualitative research studies have become popular in healthcare, and have gained 
widespread acceptance within academic journals. Qualitative research focuses on 
the meaning and experience where quantitative research is scientific (Polit & Beck, 
2010). These types of studies are designed to facilitate the collection of rich data 
in a non-threatening way (Bryman, 2008; Polit & Beck, 2010). Standard research 
methods adopted include individual interviews or focus groups where each 
participant can openly discuss their experiences or perceptions in a safe and non-
judgemental environment.  
 
Coughlan, Cronin & Ryan (2013) suggest a focused narrative review is a useful 
approach to providing a comprehensive overview of the literature while retaining 
many of the features of the systematic review approach. A systematic approach 
ensured my narrative review remained focused through specifying the exact 
parameters used in selecting the research papers for inclusion. The narrative 
review provided an overview of the current state of knowledge on the area of 
interest for the thesis and identifies areas for further study which subsequently 
informed the development of the overall aim and research questions which guided 
the study. The narrative review, informed by a meta-synthesis (Taylor et al., 2013) 
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was congruent with a rigorous, detailed and thorough examination of the available 
published literature. This approach considered the stated inclusion and exclusion 
criteria which are essential steps within this type of review. A narrative review 
seeks to ‘summarise, explain and interpret evidence on a particular topic or 
question' using the qualitative evidence (Green, Johnson & Adams, 2006 p45). 
This was deemed as the most suitable type of review for this research. 
 
2.2.1 Search Strategy 
 
My review of the literature was carried out systematically between February 2015 
and December 2017 using a range of databases, including MEDLINE, Cumulative 
Index to Nursing & Allied Health (CINAHL) and PsycINFO. As the research 
question was not solely about nursing, PsyclINFO was included as an important 
resource when seeking YPs experiences as discussed in Chapter 1 section 1.4.5. 
In current practice, YP with cancer are cared for by several healthcare 
professionals, and it was therefore essential that all healthcare databases were 
included to capture all the various disciplines involved and not just nurses and the 
question focused on YPs experiences.  
 
Review Question 
 
Initially, the review question was: “What are the experiences of living with 
malignant melanoma for young adults and their family?”  
 
A copy of the Medline search is shown in Table 2.1. Medline is the primary 
database providing full text for over 1,400 journals indexed within healthcare. 
Searches were conducted with the support of an expert Information Support 
Advisor through the Higher Educational Institution (HEI) Library, EBSCO database 
and catalogue. 
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Table 2.1: Medline Research Parameters 
# Query Results 
S8 S1 AND S5 
Limiters - Date of Publication: 20000101-20171231; English 
Language; Human; Clinical Queries: Qualitative - Best Balance  
40 
S7 S1 AND S5 
Limiters - Date of Publication: 20000101-20171231; English 
Language; Human  
311 
S6 S1 AND S5 628 
S5 S2 OR S3 OR S4 786,475 
S4 TI (child* or adolesc* or teenage* or young adult*) 784,110 
S3 MM "Adolescent+" 5,518 
S2 MM "Young Adult" 84 
S1 (MM "Melanoma+") or "malignant melanoma*" 72,481 
 
The search strategy used the following main terms to capture the largest number 
of relevant articles: 
• disease ('skin neoplasm'; 'malignant melanoma');  
• age ('child'; 'teenager'; ‘young adult’);  
• relationships ('family');  
• study design ('qualitative'); and  
• focus ('experience').  
 
MeSH terms were used as appropriate. Boolean operators 'AND' and ‘OR' and 
wildcards were used to ensure maximum inclusion. In addition to database 
searches, experts who have written extensively within children and YP's cancer 
care were searched by hand to provide any additional papers that may have been 
missed. For example, Professor Faith Gibson and Dr Rachel Taylor, from the UK, 
Dr Roberta Woodgate from Canada and Professor Zack Zebrack from the USA. 
These are all well-known authors within this specialist field of practice. This activity 
identified no additional papers.  
 
Study types included 
 
All qualitative peer-reviewed primary research were included in the initial review. 
Papers relevant for inclusion needed to feature terms such as teenagers and/or 
young adults, or wildcard variations of other terms such as adolescent, YP, 
adolescent and YP (AYA) or teenager and young adult (TYA) in the title. This 
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approach was adopted early in the search process to narrow down the number of 
papers that were identified by the research.  
 
Papers were deemed to be eligible for inclusion if published between February 
2000 and December 2017. These specific dates are significant as qualitative 
research methodologies have become more widely conducted, recognised and 
published within healthcare over the past 15 years (Parahoo, 2014). Only research 
papers that were written in English were included.  
 
Internationally, and particularly in the USA and Canada, people are recognised as 
a young person/adult up to the age of 39 years (Miedema, Easley & Hamilton, 
2006; Zebrack et al., 2014). In order to be inclusive and not to omit any potential 
studies given the differences in this age group, all studies that included this upper 
age bracket were included. Young adults with cancer have also been given 
increasing recognition as having ‘different needs' and as advances in treatment 
and models of care have evolved over the past 20 years (Taylor et al., 2013). 
Before these advances, the experiences of YP dealing with a cancer diagnosis is 
likely to have been very different from today's evidence-based approach (Taylor 
et al., 2013).  
 
Study types excluded 
 
This review did not include children aged under 12 years or young adults over 39 
years. All studies that included young adults in the study but not in the research 
title were excluded. Studies that focused on YP with non-malignant cancers, other 
chronic illnesses, cognitive impairment and/or learning disability were also 
excluded. The study also excluded YP who had completed a course of treatment 
and had required no further interventions or disease recurrence in the past five 
years. There is a vast amount of literature around survivorship of cancer; however, 
this research was interested in the experiences of living with the disease and not 
the survivorship. All other types of research, editorials and policy were excluded, 
and the specific inclusion/exclusion criteria are shown in Table 2.2. 
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Table 2.2: Exclusion/Inclusion Criteria 
 Exclusion Criteria  Inclusion Criteria 
Age  < 12 to > 39 years  12 to 39 years 
Population Health Professionals, Nurse 
Doctor 
Young Adult, People, 
Teenagers Family 
Disease 
 
Non-malignant, cognitive 
impairment, cancer 
Malignant Melanoma  
Diagnosis  >5 years of diagnosis Within 5 years of being 
diagnosed 
Language Non-English English 
Publication date 
 
Papers prior to 2000 February 2000 to December 
2017 
Papers 
 
Quantitative 
Non-peer reviewed papers 
Expert opinion, review, meta-
analysis, systematic review  
Qualitative  
Peer-reviewed papers 
Primary research paper 
 
 
Participants/population 
 
There is a wide variation in categorisation and definitions used to describe this 
age group around the world, for example, teenagers, YP, young adults and 
adolescents, which was discussed in Chapter 1. I opted to use the term ‘young 
adults' to cover the population aged between 12 and 39 years of age who had 
been diagnosed with MM. This definition was then used within the literature review 
to capture the necessary age group to ensure no studies were missed (Fern et al., 
2013b, WHO 2019). 
 
Family members were also considered within the literature review as they play a 
significant role in the cancer journey, especially if YP are still living at home. 
However, as the age range was extensive in this literature review, extending from 
12 to 39 years, the inclusion of the family/significant other was not regarded as a 
compulsory factor for inclusion in my review. 
 
Results 
 
Initially, 100 articles were retrieved from the search (Medline n=50, CINAHL n=40 
and PsycINFO n=10). From these 100 articles, 7 were duplicates and removed. A 
total of 93 abstracts were scrutinised and all the articles required for this review 
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identified. No papers relating to the initial question were found for this review, as 
shown in Figure 2.1 (PRISMA). 
 
Figure 2.1: PRISMA 2009 Flow Diagram 
 
Reference: Moher, Liberati, Tetzlaff, Altman (2009) 
 
Figure 2.1 demonstrates that no international research papers reported the YP's 
experiences of MM or that of their family/significant other. Current research has 
tended to focus on the older patient with MM (Bird et al., 2015) and the 
experiences for YP living with other types of cancer such as Leukaemia and 
Lymphoma. As discussed in Chapter 1, Leukaemia and Lymphoma are more 
common than MM in the general population although the incidence of the disease 
is rising in this age group and there is a greater need for self-awareness and 
recognition of the early signs and symptoms of this disease. This increasing 
incidence of MM in this age group provides further justification for my thesis, 
participant group selection and the methodology chosen. 
 
With this in mind, the literature search was widened to include all of YP’s 
experiences of cancer. It was also the intention to include all cancers as the 
research papers may have included YP with MM in the data collection of these 
studies. On widening the search to include all cancers, a study by Taylor et al. 
Identification
Records identified through 
database searching. Medline = 40 
CINAHL = 50 PsycInfo = 10. (n = 
100)
Additional records identified 
through other sources 
(n =0)
Screening
Records after duplicates removed 
(n =93)
Records screened (n=93) Records excluded (n=92)
Eligibility
Full-text articles assessed for 
eligibility 
(n = 1)
Full-text articles excluded. 
Survivorship, benign cancers, age, 
(n =92) 
Included
Studies included in qualitative 
synthesis 
(n =0)
Studies included in quantitative 
synthesis (meta-analysis) 
(n = 0)
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(2013) was identified as having conducted the most recent review of YP's 
experiences of cancer. I have included the Taylor et al. (2013) paper separately 
as this has supported the development of the second literature review. 
 
2.3 The Earlier Meta-Synthesis Cancer Review 
 
Taylor et al. (2013) study highlighted the findings of a meta-synthesis of the 
literature from 1988 to 2010 and proposed a conceptual model of teenager and 
young adult experiences of cancer. This model has directly supported the 
development and research of the BRIGHTLIGHT study, which sought to gauge 
how specialist cancer services in England impact on patient outcomes and 
experiences (Taylor et al., 2015). The Taylor et al. (2013) meta-synthesis included 
papers that were both quantitative and qualitative, although only the qualitative 
papers were extrapolated. The meta-synthesis was concerned with YP between 
12 to 26 years of age. Taylor et al. (2013) study focused on individual cancers and 
did not consider the experiences of the family/significant other or the dynamic 
inter-relationships affected by the diagnosis. 
 
Taylor et al. (2013) systematically reviewed 17 international papers, of which 59% 
were assessed as being high-quality research, and none rated as poor (Cesario 
et al., 2002). The primary cancers included within the papers were Leukaemia, 
Hodgkin’s, Osteosarcoma and Ewing’s. None of the papers included YP with MM 
or reviewed individual cancer-specific experiences separately. Nine themes were 
identified, and these formed the basis for the conceptual model proposed. The 
model was refined by the BRIGHTLIGHT user group who identified that there were 
gaps in the care delivery that require further exploration (Fern et al., 2013b). This 
is illustrated in Figure 2.2. Three of the studies included in this review are included 
in my second review (Hedström, Skolin & von Essen, 2004; Kelly et al., 2004; 
Wicks & Mitchell, 2010) as they met my inclusion/exclusion criteria.  
 
Previous qualitative research has tended to study a range of different types of 
cancers in YP and their experiences, but there are strong arguments to suggest 
that there are unique aspects of different types of diseases/ cancers which none 
have focused on trying to understand. For example, the Taylor et al. (2013) review 
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has not explicitly sought to understand the experience of one type of cancer and 
what the impact has been for the young person and their family/significant other. 
 
Figure 2.2: Conceptual Model - Taylor et al. (2013) 
 
 
The model highlights areas of care that YP with cancer require to ensure their 
cancer experience is optimised. This study suggests that YPs psychological well-
being is often dependent on receiving information from healthcare professionals 
in order that they can be empowered to take care of themselves and to continue 
to act as independent individuals regardless of their disease. However, Taylor et 
al. (2013) also stress the importance of recognising early symptoms in order that 
prompt diagnosis and treatment is available throughout the cancer journey 
(Hedström et al., 2004; Kelly et al., 2004, Wicks & Mitchell, 2010). Interestingly 
‘social support’ as a mediator is included in the model but has not included the 
family/significant other as being important within the YP cancer journey, or the 
dynamic interrelationships.  
 
Taylor et al. (2013) identified that as YP progress from diagnosis through to 
treatment and survival, the place of care, such as a specialist children’s ward, 
Teenage Cancer Unit, or an adult ward, was an important consideration in their 
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overall cancer experience. Additionally, the delivery of care by suitably trained and 
experienced healthcare professionals plays a vital role in the cancer journey. 
Dedicated teenage and young adult cancer units were noted to have a series of 
additional benefits which outweighed the other treatment areas, in particular, the 
adult wards. Being with their peers, having access to healthcare professionals who 
were educated and trained to support YP all contributed to a better experience 
overall. There is recognition from the review that teenagers and young adults with 
cancer merit age-appropriate specialist care (Taylor et al., 2013) but the specific 
details of this remain unclear. However, outcomes associated with such specialist 
cancer care are not well defined (Fern et al., 2013b). Nevertheless, the Taylor et 
al. (2013) study has been the stepping-stone to exploring the YP's experience 
throughout the cancer journey. Through the development of their conceptual 
model, further research has taken place to examine the young person's 
experience and outcomes (Lea et al., 2018; Taylor et al., 2015). 
 
2.4 Search Strategy 
 
The paper by Taylor et al. (2013) supported the second review, and the literature 
search was widened to include all YP’s experiences of all cancers by including 
‘neoplasm' and ‘cancer' as there were no studies focused on YP’s experiences 
with MM. With this in mind, this second review aimed to address the following 
question: “What are the experiences of living with cancer for young adults and 
their family?”  
 
2.4.1 Types of Studies Included and Excluded 
 
The same search strategy was carried out as per Section 2.2 However, this search 
was broadened to include ‘neoplasm’ and ‘cancer’. A copy of the Medline search 
is seen in Table 2.3.  
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Table 2.3: Medline Search Strategy (EBSCO) September 2017 
# Query Results 
S19 S8 AND S16 
Limiters - Date of Publication: 20000101-20171231; 
Clinical Queries: Qualitative - Best Balance  
1,298 
S18 S8 AND S16 
Limiters - Date of Publication: 20000101-20171231  
3,576 
S17 S8 AND S16 5,169 
S16 S1 AND S7 294,070 
S15 S8 AND S12 
Limiters - Date of Publication: 20000101-20171231; 
Clinical Queries: Qualitative - Best Balance  
28 
S14 S8 AND S12 
Limiters - Date of Publication: 20000101-20171231  
113 
S13 S8 AND S12 148 
S12 S2 AND S7 11,939 
S11 S8 AND S9 
Limiters - Date of Publication: 20000101-20171231  
12 
S10 S8 AND S9 19 
S9 S3 AND S7 2,445 
S8 (MH "Family+") 272,752 
S7 S4 OR S5 OR S6 2,516,408 
S6 TI ( child* or adolesc* or teenage* or young adult*) 779,422 
S5 (MH "Adolescent") 1,788,294 
S4 (MH "Young Adult") 575,605 
S3 "malignant melanoma*" 25,137 
S2 (MH "Skin Neoplasms+") 110,482 
S1 (MH "Neoplasms+") 2,917,543 
 
Results 
 
Initially 3,016 articles were retrieved (Medline n=1298, CINAHL n=1632 and 
PsycINFO n=86). From the 3,016 papers, 151 were duplicates and therefore 
removed. 2,865 papers were screened with 121 abstracts being fully scrutinised 
for inclusion. Only 18 papers that met with the inclusion/exclusion criteria were 
included as per Figure 2.3, with the addition ‘cancer’ as the disease as opposed 
to MM. Endnote web was used to collect and file the finalised papers (Bryman, 
2008).  
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Figure 2.3: PRISMA 2009 Flow Diagram 
 
Reference: Moher et al. (2009) 
 
2.4.2 Quality Assessment 
 
Qualitative studies were assessed using the guidance framework provided by 
Popay et al. (2006). This was a useful vehicle for structuring a narrative review 
and increased transparency and rigour of the process. While there may be risks 
with over interpretation of study data, the framework supported the transparency 
and reproducibility of narrative review. An overview of the study characteristics is 
shown in Table 2.4.  
 
 
 
 
 
  
Identification
Records identified through 
database searching. Medline = 
1298 CINAHL = 1632 PsycInfo 
= 86. (n = 3017)
Additional records identified 
through other sources 
(n =0)
Screening
Records after duplicates 
removed 
(n =2866)
Records screened (n = 2866) Records excluded (n=2744)
Eligibility
Full-text articles assessed for 
eligibility 
(n = 122)
Full-text articles excluded. 
Survivorship, benign cancers, 
age, (n =104) 
Included
Studies included in qualitative 
synthesis 
(n = 18)
Studies included in quantitative 
synthesis (meta-analysis) 
(n = 0)
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Table 2.4: Characteristics of Reviewed Articles 
Author / 
Date 
Country Aims  Philosophy 
/ Theory 
Age Group 
/ Cancer 
Study Design / 
Data Collection 
Methods 
Al Omari, 
Wynaden, 
Al-Omari & 
Khatatbeh 
(2017) 
 
 
Jordan Explore - Coping 
Strategies of 
Jordanian 
Adolescents with 
Cancer: An IPA 
study 
IPA 13 to 18 years 
 
Leukaemia 
n=4, Hodgkin’s 
n=3 non-
Hodgkin’s n=3 
In-depth individual 
interview of YP who 
were receiving 
chemotherapy 
Al Omari & 
Wynaden 
(2014) 
 
Jordan Explore -The 
psychosocial 
experience of 
adolescents with 
haematological 
malignancies in 
Jordan; an IPA 
study 
IPA 13 to 17 years 
 
Leukaemia 
n=6, Hodgkin’s 
5, non-
Hodgkin’s n= 3 
Individual Semi-
structured 
interviews, 
interviewed twice in 
2 hospital settings 
six months after 
receiving a 
diagnosis 
Farjou et al. 
(2013) 
 
Canada Understanding the 
healthcare 
experiences of 
teenage cancer 
patients and 
survivors from 3 
paediatric hospitals  
Open-ended 
survey  
12 to 20 years 
 
Leukaemia n= 
82, Lymphoma 
n=37, sarcoma 
n=30, brain 
n=25 other 
n=26  
Open ended 
questionnaire 
 
3 parts to it  
Fern et al. 
(2013) 
UK The Art of Age-
Appropriate Care: 
Reflecting on a 
conceptual model of 
cancer experience 
for teenagers and 
young adults 
Qualitative 
Participatory 
Action 
13 to 25 years 
Male n=5 
Female n- 6 
Semi-structured 
peer to peer 
interviews, 
workshop 
Gibson et 
al. (2013) 
 
 
 
 
 
 
UK To describe how YP 
describe their 
prediagnosis cancer 
experience 
Interpretive 
using narrative 
inquiry 
16 to 24 years  
 
All solid 
tumours 
Ewing’s n= 7 
Osteosarcoma 
n=5, Hodgkin's 
n= 5, 
medulloblasto
ma n= 1 
neuroblastoma 
1, 
malignant 
peripheral 
nerve n=1, 
ovarian n=2, 
synovial 
sarcoma n=1, 
metastatic 
adenocarcino
ma of bowel 
n=1 
Semi-structured 
interviews 2-4 
months from 
diagnosis of a solid 
tumour. Case notes 
were also 
accessed. 
Hedström et 
al. (2004) 
 
Sweden  Distressing and 
positive 
experiences and 
important aspects of 
care for adolescents 
treated for cancer. 
Adolescent and 
nurse perceptions 
Cross-
sectional 
descriptive 
13 to 19 years 
 
Lymphoma 
n=8, 
Osteosarcoma 
n= 5, Ewing’s 
n=2, 
Leukaemia 
n=3, other 
Semi-structured 
interviews with an 
open-ended 
questionnaire 
YP and nurses. 
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solid tumours 
n= 5 
Hokkanen 
et al. (2004) 
 
Finland Exploring what 
adolescents with 
cancer experience 
of life and how it 
could be made 
easier 
Descriptive  13 to 18 years  
 
Leukaemia 
n=11, 
Hodgkin’s n = 
2, aplastic 
anaemia, non-
Hodgkin’s, 
brain and bone 
n=5 
n=2 unknown 
what they had. 
Focus groups 
attending cancer 
adjustment camp  
 
3 focus group of 7  
Kelly et al.  
(2004) 
 
 
UK Set out to provide 
insight into an 
adolescent cancer 
unit 
Ethnography 13 to 20 years  
 
 
Cancers not 
known 
 
Observation and in-
depth semi-
structured 
interviews with YP 
and parents 
Kumar & 
Schapira 
(2013) 
 
 
USA Examine how young 
adult cancer 
patients make 
sense of their 
experiences with 
cancer. 
Exploratory 18 to 30 years  
 
Ovarian n = 3, 
Hodgkin’s n= 
2, non-
Hodgkin’s n=1, 
Leukaemia 
n=3, 
melanoma 
n=1, breast 
n=1, 
endometrial 
n=1, 
ependymoma 
n=3 
Semi-structured 
interviews 
Kyngäs et 
al. (2001) 
 
 
Finland 
To describe the 
coping strategies 
and resources of 
YP with cancer 
None 16 to 22 years 
 
Cancer 
lymphatic 
system n=5, 
Thyroid n= 2 
Sarcoma n= 2 
Leukaemia 
n=2 ovarian 
n=1brain n=1 
granulocytoma
tous tumour 
n=1 
 
Interviews  
Miedema et 
al. (2006) 
 
 
 
 
 
 
 
Canada Young adults’ 
experiences with 
cancer 
None 
exploratory  
20 to 43 years 
of age, various 
cancers and 
stages through 
to survivorship 
Hodgkin’s n=5, 
Thyroid n= 2, 
breast cancer 
n=3,  
Synovial, 
melanoma, 
osteosarcoma, 
colorectal and 
fibrohistocyto
ma n=1  
Individual Semi-
Structured 
Interviews 
interviewed once 
 
Olsson, 
Jarfelt, 
Pergert & 
Enskär  
(2015) 
Sweden Identify the 
requirements and 
acknowledge what 
is relevant to 
teenagers and YP 
Exploratory 15 to 29 years  
 
 
Leukaemia 
n=12, 
Focus groups 
 
5 focus groups with 
15-18 years (paed 
unit) 
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 treated for cancer in 
Sweden 
Lymphoma n= 
11 sarcoma 
n=12, brain 
tumour n=2, 
Testicular n=5 
gynaecological 
n=2 
 
6 focus groups with 
19-29 years)  
Stegenga & 
Ward-Smith 
(2009) 
 
USA Explore the lived 
experience of being 
diagnosed with 
cancer from the 
perspective of the 
adolescent. 
Phenomenolo
gy 
12 to 17 years 
 
Cancer not 
known 
Semi-structured 
interviews 
Woodgate 
(2005) 
 
Canada Part of a more 
extensive study, this 
study, in particular, 
sought to 
understand the 
impact cancer and 
its symptoms had 
on the adolescents' 
sense of self. 
Longitudinal 12 to 18 years 
 
 
Leukaemia or 
lymphoma 
n=12  
Solid tumour 
n=3 
Semi-structured 
interviews moderate 
participant 
observation and 
focus groups with 
one group 4 males 
and 1 group 5 
females.  
Woodgate 
(2006)  
 
Canada  This paper explores 
the sources of 
social support that 
help YP get through 
their cancer 
experience.  
Longitudinal 12 to 18 years 
 
Same 
participants as 
above 
Open-ended 
interviews with 
follow-up questions 
and a focus group 
Wu, Chin, 
Hasse & 
Chen (2009) 
 
Twain To describe the 
essence of the 
coping experiences 
of Taiwanese 
adolescents with 
cancer. 
Phenomenolo
gy 
12 to 18 years 
 
Leukaemia 
n=6 
Brain n= 1, 
Neuroblastom
a n=1, 
Lymphoma 
n=1 
Osteosarcoma 
n=1 
Interviews  
Wicks & 
Mitchell 
(2010) 
 
New 
Zealand 
This study 
examined the 
adolescent cancer 
experience from the 
perspective YP. 
None 16 to 22 years 
 
Leukaemia 
n=3 
Lymphoma 
n=3 
Brain tumour 
n=1 
Bone tumour 
n=2 
Germ cell 
tumour n=1 
In-depth semi-
structured 
interviews 
Zebrack et 
al. (2014) 
USA To describe 
adolescent and 
young adult cancer 
medical care or 
experience with 
cancer 
Survey open-
ended 
questionnaire 
15-39 years 
 
 
Survey e-mailed 
 
2.4.3 Rigour 
 
The issue of quality in qualitative research has been debated over several years 
(Horsburgh, 2003; Rolfe, 2006). Qualitative research must address the issue of 
rigour if the study is to be judged trustworthy, credible and authentic (Rolfe, 2006; 
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Vivar, McQueen, Whyte & Armayor, 2007). Methodological rigour is, therefore, 
essential to produce high-quality research within this paradigm of research. There 
are a number of frameworks for assessing the quality of qualitative research. 
However, Rolfe (2006) suggests that there should be no rigid generic framework 
to establish rigour, as this has the potential to thwart the authenticity and creativity 
of the individual studies.  
 
In considering this, I have chosen to use Guba & Lincoln (1994)'s four concepts 
of rigour to assess qualitative methodologies and ensure their trustworthiness. 
These are credibility, transferability, dependability and confirmability. This 
framework was used to assess the quality of each of the individual papers 
identified in the literature review. To ensure the credibility of the review, the 
researcher evaluated available frameworks and discussed these with supervisors. 
The credibility of each of the papers was dependent on independent analysis, 
ethical approval, and whether the findings were clear. In order to ensure 
transferability, constant checking was completed through a rigorous review of the 
papers. The transferability of the literature review was completed by ensuring that 
the findings were current and that the reported results were trustworthy and 
credible. Dependability and confirmability are continuous, and this was carried out 
through a constant update of the literature and being reflexive at all stages of the 
process (Morrow, 2005). Despite the general shortage of relevant literature on 
MM, 17 empirical papers were retrieved for this review. 
 
2.5 Analysis of the Literature 
 
The review includes four studies from Canada, (n=4), three from the USA (n=3), 
three from the UK (n=3), two from Sweden (n=2), two from Finland (n=2), two from 
Jordan (n=2), one from Taiwan (n=1) and one from New Zealand (n=1). A range 
of qualitative designs were applied, four (n=4) used phenomenology with two 
(n=2) specifically selecting IPA. One used a cross-sectional survey design, (n=1), 
two, longitudinal exploratory design (n=2), one ethnography (n=1), and two 
narratives and descriptive (n=2). Two papers identified no design but used 
qualitative exploratory methods and one action research (n=1). Only one paper 
included the family in their data collection, although three (n=3) mentioned the 
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family as being important within the data analysis. The age range of the 
participants varied, but the majority were in the age categories outlined in Figure 
2.4. 
 
Figure 2.4: Participant Age Range and Study Type 
 
 
 
The Miedema et al. (2006) paper can be regarded as an outlier in terms of the age 
range. However, it was included as the vast majority of the 15 participants, some 
14 people, were aged under 39, which met my stated inclusion criteria. 
 
2.5.1 Synthesis of Findings 
 
Using an inductive approach, the Popay et al. (2006) narrative framework, a 
systematic research review tool, allowed for the critique of each paper and for the 
overall synthesised themes to be identified. There are many such tools available 
for critiquing literature, with varying degress of complexity. As my study utilised a 
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narrative review approach, the Popay et al. (2006) was the most useful in providing 
the necessary guidance and structure for my review. From each of the papers, the 
aim was to construct meaning from the narrative and illuminate an understanding. 
The researcher analysed and colour-coded the initial subthemes into a smaller 
number of the overarching themes. The themes reported in the identified studies 
are presented in Table 2.5 and are supported by relevant quotes reflecting the 
essence of each of the individual themes. The three main themes that emerged 
from the literature review are (1) being diagnosed with cancer, (2) uncertainty - 
holding on to life (3) gaps in care delivery.  
 
Table 2.5: Emerging Cancer Themes 
Study Sample Research 
Findings 
Overarching 
Themes From 
Study 
Sub-
Themes 
From 
Review 
Overarching 
Themes 
From 
Review 
Al Omari 
et al. 
(2017) 
10 YP 13 to 
18 years of 
age, 5 males, 
5 females 
 
To cope with the 
impact of cancer, 
coping strategies 
emerged. There 
were some cultural 
issues faced within 
this study and the 
female participants. 
  
Strengthening 
spiritual convictions 
 
Being optimistic 
and rebuilding hope 
 
Enhancing 
appearance 
 
Finding self again 
Loss of oneself 
 
Hope and fear 
 
 
 
Uncertainty – 
holding on to 
life 
 
 
 
 
 
Al Omari 
& 
Wynaden 
(2014) 
14 YP 13 to 
17 years, 9 
male 5 female 
Participants reported 
limited emotional and 
psychological 
support from family, 
friends and 
healthcare team. 
Separated from 
family, friends once 
hospitalised. 
Treatment generated 
uncertainty of the 
future. 
Being in the 
hospital, the 
changing self 
 
Fearing the 
unknown 
Loss of oneself 
 
Hope and fear 
Uncertainty – 
holding on to 
life 
Farjou et 
al. (2013) 
200 YP aged 
12 to 20 
years, 108 
male 92 
females 
 
 
89% answered Q1 
63% Q2, 69% Q3. 
This study was part 
of a more extensive 
teen-centred care 
study. Likes and 
dislikes were 
conceptualized into 
key themes. Support 
the shaping of future 
services for YP. 
Staff at the 
treatment centre 
itself 
 
The cancer care  
they received, 
The treatments 
centre itself 
 
Social activities 
 
Experience of 
healthcare 
delivery 
 
Age-
appropriate 
specialist 
services 
 
 
Gaps in the 
care delivery 
 
 
 
 
 
Fern et al. 
(2013b) 
11 YP aged 
13 to 25. 5 
male, 6 
female 
Built upon the 
conceptual model by 
Taylor et al. (2013) 
and identified areas 
of care that were 
deficient or 
unreported by YP 
experiencing cancer. 
Diagnosis period 
 
Levels of 
information 
provided 
 
YP involved in 
research 
Impact of 
diagnosis. 
 
Delay in 
diagnosis 
 
Being 
diagnosed 
with cancer 
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The diagnosis and 
information provided 
at this time was an 
important aspect of 
the cancer journey. 
 
 
Experience of 
healthcare 
delivery 
 
Age-
appropriate 
specialist 
services 
Gaps in the 
care delivery 
Gibson et 
al. (2013) 
24 YP, 16 to 
24 years, 14 
male 10 
female 
 
 
Perspectives of the 
impact of the 
symptoms on their 
lives and in general, 
how others played a 
significant part. 
Findings report of the 
time lag from first 
symptoms to 
diagnosis. Age plays 
a vital part in this 
group patient as they 
are seeking 
independence. 
The individual and 
nature of the 
symptoms 
 
Symptoms in 
relationship to other 
people 
 
Experiences of the 
generalist 
healthcare system  
 
Threshold points 
 
Specialist cancer 
care 
Delay in 
diagnosis 
 
 
Experience of 
healthcare 
delivery 
 
Age-
appropriate 
specialist 
services 
Being 
diagnosed 
with cancer 
 
 
Gaps in the 
care delivery 
 
 
 
 
 
 
 
 
Hedström,  
et al. 
(2004) 
23 YP 13 to 
19 years, 15 
male 8 female 
 
 
Findings indicate a 
range of positive and 
negative experiences 
related to the 
disease and 
treatment. Highlights 
the importance of 
information and the 
value of experienced 
staff that are 
competent in the 
care delivery. 
Being told the 
diagnosis 
 
Receiving 
chemotherapy 
 
Being admitted to 
the ward 
 
Important aspects 
of care 
 
Impact of 
diagnosis 
 
 
Experience of 
healthcare 
delivery 
 
Age-
appropriate 
specialist 
services 
Being 
diagnosed 
with cancer 
 
 
Gaps in the 
care delivery 
 
 
Hokkanen 
et al. 
(2004) 
20 YP 13 to 
18 years, 13 
female 7 male 
 
 
Findings from the 
study report cancer 
experience can affect 
the adolescent's 
relationship with the 
world around self. 
Relationships with 
families were 
affected by the 
disease. They also 
found it hard to be 
independent. 
Experiences of 
current life situation 
 
Future views 
 
 
Information 
received 
 
The need for 
additional 
information 
 
How life could be 
made easier 
Family and 
friends 
 
Experience of 
healthcare 
delivery 
 
Age-
appropriate 
specialist 
services 
 
Hope and fear 
Being 
diagnosed 
with cancer 
 
Gaps in the 
care delivery 
 
 
 
Uncertainty – 
holding on to 
life 
 
Kelly et al. 
(2004) 
10 YP 13 to 
20 years, 4 
male 6 female 
 
10 parents 9 
mothers 1 
father 
Findings provide an 
insight into one 
specific cancer unit 
in London. The 
culture of the unit 
emerged as pivotal in 
supporting YP with 
cancer and through 
the expertise within 
the unit itself.  
Cancer and the unit 
 
Changes over time 
Impact of 
diagnosis 
 
Loss of self 
 
Hope and fear  
 
Experience of 
healthcare 
delivery 
 
Age-
appropriate 
specialist 
services 
 Being 
diagnosed 
with cancer 
 
Uncertainty – 
holding on to 
life 
 
 
Gaps in the 
care delivery 
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Kumar & 
Schapira 
(2013) 
15 YP 18 to 
30 years, 7 
males  
8 females 
 
 
YP affected by the 
loss of physical 
control during and 
after treatment. 
Some found support 
from family and 
friends; others did 
not and felt isolated.  
Intrapersonal, 
interpersonal, role 
identity 
 
 
Family and 
friends 
 
Loss of self 
 
 
Being 
diagnosed 
with cancer 
 
Uncertainty – 
holding on to 
life 
 
 
Kyngäs et 
al. (2001)  
14 YP 16 to 
22 years of 
age, 6 male, 8 
females 
How YP coped with 
life and the coping 
strategies used.  
Three significant 
strategies identified 
social support, 
belief in recovery 
and getting back to 
normal life as soon 
as possible 
Impact of 
diagnosis 
 
Hope and fear  
 
 
Experience of 
healthcare 
delivery 
Being 
diagnosed 
with cancer 
 
Uncertainty – 
holding on to 
life 
 
Gaps in the 
care delivery 
Miedema 
et al. 
(2006) 
15 YP/adult 
20 to 43 
years, 6 male 
9 female 
 
The most important 
issue that emerged 
was that being young 
appeared to delay in 
diagnosis: patients or 
physician's inaction. 
 
 
 
Participant’s age 
contributed to a 
delay in diagnosis 
either inaction from 
themselves, 
parents or 
physician 
Delay in 
diagnosis 
 
Experience of 
healthcare 
delivery 
 
Age-
appropriate 
specialist 
services 
Being 
diagnosed 
with cancer 
 
Gaps in the 
care delivery 
Olsson et 
al. (2015)  
44 YP 15 to 
29 years, 16 
male and  
28 females 
 
 
The needs vary over 
time due to individual 
situations. HCPs 
need increased 
knowledge to care 
for this patient group. 
Special needs of this 
group are not being 
met in Sweden. 
Personal & 
professional 
integration 
 
Knowledge and 
participation,  
Age-appropriate 
care 
 
 Support 
Experience of 
healthcare 
delivery 
 
Age-
appropriate 
specialist 
services 
 
 
 
Gaps in the 
care delivery 
 
 
 
 
 
 
Stegenga 
& Ward-
Smith 
(2009) 
10 YP 12 to 
17 years, 1 
male 9 female 
Findings suggest a 
loss of normalcy 
having been 
diagnosed with 
cancer is immense. 
 
Peer support 
fundamental and 
may support the loss 
of normalcy. 
Loss of normalcy 
 
Gaining information 
 
Importance friends 
and their reactions 
 
Getting used to it, 
Giving back 
 
Family support 
Family and 
friends 
 
Experience of 
healthcare 
delivery 
 
Age-
appropriate 
specialist 
services 
 
Loss of self 
Being 
diagnosed 
 
Gaps in the 
care delivery 
 
 
 
 
Uncertainty – 
holding on to 
life 
Woodgate 
(2005) 
15 YP 12 to 
18 years, 8 
male 7 female  
 
 
Findings revealed 
that adolescents 
experience changes 
to their bodies 
because of 
symptoms and their 
increasing 
awareness of their 
body changing. 
HCPs to be in a 
position to recognise 
this and support 
where when 
necessary. 
Ways of being in 
the world 
 
Still pretty much 
same person, well 
almost 
 
Respond as same 
person, but treat 
me as special 
 
Loss of self Uncertainty – 
holding on to 
life 
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Woodgate 
(2006) 
15 YP 12 to 
18 years, 8 
male 7 female 
This study found that 
families, special 
friends and HCPs 
were the three 
central supportive 
relationships YP 
experience. Although 
supportive at times, a 
source of stress.  
Supportive 
relationships 
 
Being there 
 
Consequences of 
being there 
 
Family and 
friends 
Being 
diagnosed 
Wu , Chin, 
Hasse & 
Chen  
(2009) 
10 YP 12 to 
18 years, 6 
male 4 female 
 
 
Findings suggest that 
there were many 
challenges of having 
cancer, especially 
ones they could not 
control. YP also felt 
that they required 
having hope as a 
useful coping 
mechanism to enable 
them to keep going. 
Losing confidence  
 
Rebuilding hope 
Hope and fear  
 
 
Uncertainty – 
holding on to 
life 
Wicks & 
Mitchell 
(2010) 
6 male 4 
female 
 
 
Findings underline 
the need for effective 
communication, 
ongoing 
psychological 
support and service 
flexibility. 
Treatment issues 
 
Hospital facilities 
 
Information 
provision 
 
Physical effects of 
treatment 
 
Emotional effects 
 
Impact on 
developmental 
processes 
Impact of 
diagnosis 
 
Loss of self 
 
 
Experience of 
healthcare 
delivery 
 
Age-
appropriate 
specialist 
services 
Being 
diagnosed 
with cancer 
 
Uncertainty – 
holding on to 
life 
 
Gaps in the 
care delivery 
Zebrack et 
al. (2014) 
296 YP/adult 
15 to 39 
years, 192 
male 104 
female 
 
 
Findings contribute 
to a better 
understanding of the 
cancer treatment 
experience. 
Medical care 
domain 
 
Side effects and 
symptoms domain 
 
The psychological, 
spiritual domain 
 
Relationship 
domain 
 
Practical domain 
Hope and fear  
 
Loss of self 
 
Age-
appropriate 
specialist 
services 
 
Uncertainty - 
holding on to 
life 
 
 
Gaps in the 
care delivery 
 
These themes and subthemes are interrelated and summarised within Figure 2.5:  
 
• Theme 1 represents the beginning of the journey, being diagnosed with 
cancer.  
• Theme 2 denotes the uncertainty following the diagnosis and holding on to 
life.  
• Theme 3 is the gaps in the care delivery and highlights the parts of the 
cancer journey that were missing, for example,‘ specialist services’. 
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Figure 2.5: YP’s Cancer Journey 
 
 
 
While this figure has some similarities to the conceptual model developed by 
Taylor et al. (2013) as discussed in Section 2.3, there are fundamental aspects of 
the young person's psychosocial well-being that the review by Taylor et al. (2013) 
did not capture. It is also interesting to find that none of the literature from Taylor 
et al. (2013) or the researcher's second review explicitly discussed the 
experiences of a young person with MM. Young people experience the three 
themes identified at different times and stages of their disease and were unlikely 
to emerge in any chronological order.  
 
2.6 Being Diagnosed with Cancer  
 
While cancer is relatively uncommon in the general population of YP compared to 
adults, YP reported that receiving a cancer diagnosis was the most challenging 
part of the cancer journey. This experience was compounded by the need to wait 
for an appointment or starting their treatment. Being diagnosed with cancer was 
mentioned in ten of the studies (Fern et al., 2013b, Gibson et al., 2013, Hedström 
et al., 2004, Hokkanen et al., 2004, Kelly et al., 2004, Kumar & Schapira, 2013, 
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Miedema et al., 2006; Stegenga & Ward-Smith, 2009; Woodgate, 2006; Wicks & 
Mitchell, 2010) and each of these are critically discussed under the three 
subthemes. The three subthemes included: impact of diagnosis, delay in 
diagnosis and family and friends. These studies identified that the impact of a 
diagnosis combined with a delay in diagnosis was an integral part of the overall 
cancer experience and journey. Family and friends were also an important part of 
this journey, from diagnosis to living with cancer and beyond. Young people 
reported that it was their immediate family and friends that were important in facing 
the future as they had been involved from the beginning. 
 
2.6.1 Impact of Diagnosis 
 
Being diagnosed with cancer can impact profoundly on the young person's life 
(Fern et al., 2013; Hedström et al., 2004; Kelly et al., 2004; Kyngäs et al., 2001; 
Wicks & Mitchell, 2010). Fern et al. (2013b) aimed to refine the conceptual model, 
which was developed by Taylor et al. (2013) from a meta-synthesis. This study 
built upon the model, identifying areas of care that were deficient or underreported. 
Poor experiences of the journey to diagnosis were reported using action research 
with eleven YP (n=11) aged between 13 to 25 years in England. Although the 
paper states they involved YP who were cancer survivors, ten (n=10) YP were 
treated for cancer within the 5 years. This study was unique in that they trained 
the YP in research methods so they could be an active part of the study. These 
YP participated in peer to peer interviews, followed by a workshop. This research 
built upon the conceptual model as discussed as a bridge to this narrative review 
(Taylor et al., 2013). Although a small sample of YP from England, this study 
reported on the diagnosis period as being an important aspect of the cancer 
journey and the level of information received. Both the Fern et al. (2013b) and the 
Taylor et al. (2013) studies informed the survey development for a longitudinal 
cohort study examining patient experience and outcomes, which was part of the 
BRIGHTLIGHT study. 
 
Hedström et al. (2004) used a cross-sectional descriptive survey and undertook 
open-ended interviews with 23 YP with cancer and 21 nurses. This study was 
carried out in Sweden within paediatric units with YP, aged 13 to 19 years. This 
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study found a range of positive and negative experiences that individuals faced, 
such as being diagnosed, receiving chemotherapy, ward admission and other 
important aspects of the care delivery. This study, however, did not include YP 
being cared for within non-paediatric settings. This may be because there are no 
young adult cancer units in Europe.  
 
Similar findings to this study were reported by Kyngäs et al. (2001). This research 
involved 14 YP, aged 16 to 22 in Finland and aimed to define coping strategies 
and resources that YP with cancer require to support them at the time of diagnosis. 
Through their descriptive approach, they found that it was often how the diagnosis 
was delivered, often over the telephone and by a healthcare professional who did 
not know them. Often, the young adult would then have to wait days before they 
were seen and were left to worry about cancer and its possible impact on their life. 
As a result, YP felt unable to ask questions about their diagnosis or seek 
clarification around the nature of their disease. This was an important, but missing, 
part of the cancer journey for all YP. Another critical factor on which they reported 
was that healthcare professionals were unable to care for teenagers and young 
adults and were therefore unable to support them through the cancer journey. This 
had a negative impact on the overall cancer experience and heightened their fear 
and distress about the diagnosis and any further communication from the 
healthcare team (Hedström et al., 2004; Kyngäs et al., 2001). 
 
In addition to these studies, Kelly et al. (2004) set out to provide further insight into 
an adolescent cancer unit in England with 10 YP aged 13 to 22. Kelly et al. (2004) 
used an ethnographic approach to capture the experiences of YP on such a 
specialist unit and discusses the impact a diagnosis can have on the young 
person's life, that of their family and the healthcare professional. This paper was  
particularly pertinent to the UK, where specialist care has been provided for YP 
with cancer since the early 1990s. The study found that when a diagnosis is given, 
support from the family is essential, and the healthcare professional is necessary 
in order to try and work through the diagnosis and move forward within the cancer 
journey. As one young participant expressed “I don’t want to tell everybody, just 
some people and then I don’t want to talk about it”. This quote highlights the impact 
of a cancer diagnosis and that YP often need time to process this and be 
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supported to work through likely implications of the diagnosis. It was also 
interesting that the YP were selective of the people they wanted to interact with 
during this period of their lives. It was also common for YP to reject the initial 
diagnosis and fail to understand that this disease was now part of their life. The 
findings from this paper were significant when considering how a diagnosis should 
be delivered to the patient and by whom.  
 
Similar to Kelly et al. (2004) a further study by Wicks & Mitchell (2010) involving 
semi-structured interviews with 10 YP, aged 16 to 22 in New Zealand also found 
that there was a clear need for effective communication especially at the time of 
diagnosis. Any ongoing psychological support and service delivery needed to be 
flexible around the specific requirements of the patient. While receiving a cancer 
diagnosis was reported as mostly negative, the YP reported that having this 
information communicated to them by a trained and experienced healthcare 
professional with a positive attitude supported them both emotionally and 
psychologically. Both these studies have highlighted the need for effective 
communication at the time of diagnosis, which can lessen the impact of the cancer 
diagnosis. 
 
Much of the literature to date clearly suggests that how the initial diagnosis is 
delivered can have a profound impact on the overall cancer journey experience 
from that point forward (Gibson et al., 2013; Hedström et al., 2004; Hokkanen et 
al., 2004; Kelly et al., 2004; Kyngäs et al., 2001; Kumar & Schapira, 2013; 
Miedema et al., 2006; Stegenga & Ward-Smith, 2009; Woodgate, 2006; Wicks & 
Mitchell, 2010). The diagnostic period was described as traumatic, and life-
changing, and had an overall effect on YP’s lives. It was important to consider how 
this information is delivered, where it is given and by whom. The literature 
suggests that in order to provide effective communication, especially around 
diagnosis, this should be given by healthcare professionals who know and 
understand this patient group. The healthcare professional must also be someone 
who knows the young person and their family. As most of these studies were 
international, apart from two which were UK based (Gibson et al., 2013; Kelly et 
al., 2004), the models of care for YP were different across the globe. Most YP and 
their families felt that their lives had been turned upside down and would never be 
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the same again, and required support both psychologically and emotionally to 
cope with this experience and determine how best to move forward with their lives.  
 
2.6.2 Delay in Diagnosis 
 
A delay in diagnosis from the first symptoms was evident in two of the studies 
(Gibson et al., 2013; Miedema et al., 2006). This was seen as just as crucial to the 
cancer journey experience as the impact of the diagnosis. Gibson et al. (2013) 
narrative study involved 24 YP between the ages of 16 to 24 in England who told 
their stories about physical pain and alterations to their bodies. These YP did not 
connect these symptoms to anything being wrong, nor did they see the need to 
visit their General Practitioner (GP). For example, as one young person 
commented: "I thought I had just twisted it at a party” … (it being his leg) (Gibson 
et al., 2013 p.2587). However, this study reported that the experience of cancer 
can be worsened where there is diagnostic delay by the young person, their family 
or healthcare professional (Gibson et al., 2013).  
 
The Miedema et al. (2006) study interviewed 15 YP aged between 20 to 43 in New 
Brunswick, a province in Canada. Although the authors had one patient with 
melanoma in the study, their unique experiences were not evidenced by the study 
as it is not discussed in the paper. Both Gibson et al. (2013) and Miedema et al. 
(2006) found that the young person's age and stage of development appeared to 
contribute to delays in both the young person and the physician's inaction who did 
not always act on the seriousness of the health concern. For the young person, 
they did not understand the seriousness of symptoms, and it had not entered their 
mind that they would have ‘cancer'. For those physicians who did not see many 
cases of cancer in YP, this lack of experience often meant that no prompt action 
was taken. 
 
These studies illustrated that young adults being diagnosed with cancer need time 
to process this information and that the diagnosis is clearly and professionally 
communicated by healthcare professionals effectively and articulately, with the 
family present (Gibson et al., 2013, Miedema et al., 2006). The experience of a 
cancer diagnosis was the first step in the overall cancer journey and participants 
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were able to describe this vividly in the papers included within this sub-theme. The 
impact on the young person and those close to them is evident and that they 
require support. Both the young person and the physician need to be aware and 
recognise the symptoms presented and act on these, whether serious or not. This 
was an important consideration within the overall cancer experience if delays to 
diagnosis and treatment are to be avoided. 
 
2.6.3 Family and Friends 
 
Five studies highlighted that YP who are experiencing a diagnosis of cancer need 
their family and friends to support them through the cancer journey (Hokkanen et 
al., 2004; Kelly et al., 2004; Kumar & Schapira, 2013; Stegenga & Ward-Smith, 
2009; Woodgate, 2006). Within most of the five studies, there was an emphasis 
on maintaining normal family routines, while recognising the impact that cancer 
had on family and peer relationships. The descriptive study by Hokkanen et al. 
(2004) which involved 20 YP, aged 13 to 18 years in Finland, explored what YP's 
experience of cancer was and how this could be made more accessible. They 
undertook focus groups at a cancer adjustment camp, which was a camp where 
YP could receive support from other YP with cancer and have fun at the same 
time, through camp activities. This was an innovative way to collect data from this 
patient group and was the only study in this review which has collected the data 
in this way. As discussed in section 2.7.1 Kelly et al. (2004) highlight that the needs 
of the family, cannot be separated from that of the young person. Both YP and the 
family value information and support, which can be offered in a more structured 
way. For example, receiving communication that is clear and concise by a 
healthcare professional who knows them and in a way that can be understood.  
 
Although similar to Hokkanen et al. (2004) and Kelly et al. (2004), a study by 
Kumar & Schapira (2013) found that only some YP affected by their cancer 
received support from family and friends, while others felt isolated by the disease. 
Kumar & Schapira's (2013) study examined how young adult patients, aged 18 to 
30 years in the USA, made sense of their cancer experiences. It was interesting 
to find that from the 15 YP who were interviewed, many felt they could rely on 
family and friends to support them while having chemotherapy or with emotional 
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distress. Others, however, preferred “to take care of myself than wait for others” 
(Kumar & Schapira, 2013 p.1755). For those YP who experienced this, they turned 
to support groups at the treatment centre for support. YP appeared caught 
between two worlds; the world of childhood that they are outgrowing and 
adulthood, a world they are preparing for and aspiring to, but one that they have 
not yet fully reached. As apparent in this paper, some YP wanted to be 
independent and care for themselves without involving their families. This study 
highlighted that, although this experience was different for some, the YP found 
that they learnt a lot about themselves and how to care for themselves better. This 
impacted on their ability to take responsibility, especially at a time where a 
diagnosis is given and how this influenced their lives (Stegenga & Ward-Smith, 
2009, Woodgate, 2006). Stegenga & Ward-Smith (2009) discuss the loss of 
normalcy having been diagnosed with cancer, and that peer support is 
fundamental to the cancer experience. Adolescence was highlighted here as a 
dynamic developmental life stage and having the support of family and friends 
being a vital part of this. This was another study undertaken in the USA, although 
phenomenology was used to capture the experiences of ten YP aged 10 to 17 on 
receiving a cancer diagnosis.  
 
Similar to the paper by Stegenga & Ward-Smith (2009), Woodgate (2006) 
highlights the need for social support during the adolescence phase. This research 
undertook a longitudinal study interviewing 15 YP, aged 12 to 18 in Canada. This 
study found that families, special friends (friends whom they had known for a long 
time and had a special bond with), and healthcare professionals were the three 
main supportive relationships YP experience within the cancer journey. The family 
relationship was the most important to them and the one they most relied upon 
during treatment. The average age of the YP included in this study was younger 
than some of the other papers. This may have been a factor in the YP requiring 
support from their family and friends. Some YP relied on family and friends they 
were close too as it made them feel safe. As one participant reported ‘being there 
to hold my hand’ (Woodgate, 2006 p127) and “the only reason I have come 
through this far is because of them [family and friends]'” (Woodgate, 2006 
p127,125). Having the presence of another human being at a time where the 
young person is afraid supported them. They felt that having the human touch of 
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someone they could trust and rely upon helped them through the initial diagnosis 
and the treatment. 
 
Nevertheless, although supportive for some YP, this study also highlighted that 
family and friends were at times a source of stress for some others who did not 
have this special bond. This was because the YP experienced feelings of guilt with 
regards to family members always having to be there for them. Concerning friends, 
the YP often felt that they had let their friends down as they could not be there for 
them.  
 
This section focused on the impact of diagnosis, delay in diagnosis and the value 
of having family and friends. Being diagnosed with cancer can profoundly impact 
on YP's lives, their families and that of the healthcare professionals who are caring 
for them. In addition to the diagnosis, family and friends were seen as necessary 
for some YP who had developed individual bonds and relationships. However, this 
was not always seen as necessary for those who did not have a strong relationship 
with their family or friends. The ability of the young person to take individual 
responsibility for their healthcare was evident, although this is partly dependent 
upon the relationship and the age and stage of the young person. Healthcare 
professionals need to consider these findings when addressing the full care 
requirements and the needs of the individual patient and that of their family or 
friends. The following section explores YP's experiences of cancer, in particular, 
the uncertainty about their life and their future. 
 
2.7 Uncertainty – Holding on to Life 
 
The experience of cancer can often occur at a time when YP are in the process of 
developing their early adult life plans, transitioning from being a child to teenager 
and from teenager to young adult (Fern et al., 2013ab). Seven studies discuss that 
a cancer diagnosis can bring uncertainty and is often associated with hope, fear, 
and loss of self (Al Omari & Wynaden 2014; Al Omari et al., 2017; Hokkanen et 
al., 2004; Kelly et al., 2004; Kyngäs et al., 2001; Wu, Chin, Hasse & Chen,  2009; 
Zebrack et al., 2014). During this period, YP often found themselves trying to hold 
on to the life they had imagined. As the disease progresses beyond diagnosis, 
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and the impact of their treatment grows, YP experience physical, emotional and 
psychological change, often leading to hope, fear and a loss of self. Cancer 
brought many challenges which were out of their control. 
 
Nevertheless, having hope provided YP with a way to cope with cancer itself and 
allowed them to live their lives. This theme has been divided into two sub-themes, 
but as shown in Figure 2.5, they are interrelated in the overall cancer experience. 
These subthemes are hope and fear and loss of self.  
 
2.7.1 Hope and Fear 
 
The theme of hope and fear was present in seven of the studies. Young adults 
experienced fear of the unknown which was mainly due to feeling afraid of having 
cancer and not being able to cope with this (Al Omari & Wynaden, 2014; Al Omari 
et al., 2017; Hokkanen et al., 2004; Kelly et al., 2004; Kyngäs et al., 2001; Wu et 
al., 2009; Zebrack et al., 2014). These international studies were mainly 
concerned with young adults' experiences concerning hope which helped them to 
cope with their fears and enhanced their ability to cope with living with their cancer 
and treatment. Nevertheless, what was reported in these papers is that YP were 
not prepared for the treatment or the side effects. Some began to realise that they 
may even die sooner than they had previously expected and this preoccupied their 
thoughts, as one young participant expressed “the idea of death became dominant 
in my life, cancer is a killer” (Al Omari & Wynaden, 2014 p 4). These feelings were 
all-consuming and the fear of being alone and uncertainty about their future and 
became the main focus of their experience. Two of the studies by Al Omari & 
Wynaden (2014) and Al Omari et al. (2017) involved 10 to 14 young adults aged 
between 13 and 18. These studies were the only papers within this review that 
have both used IPA to explore the experiences of YP being treated for cancer 
within one of two specialist hospitals in Jordan. Interestingly, the studies were 
similar, although the 2017 study discusses the coping strategies, whereas the 
other 2014 study focused on psychological experiences.  
 
One of the coping strategies, ‘strengthening spiritual convictions', by Al Omari, et 
al. (2017) was that YP were Muslim and had a strong belief in Islam and adapted 
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these rituals to their daily life with cancer. This allowed these YP hope through 
their faith in that Allah (God) would help cure them of their cancer and support 
their suffering. This experience of coping through a belief in God is evident within 
two other studies (Kyngäs et al., 2001; Zebrack et al., 2014). Although Kyngäs et 
al. (2001) paper included AYAs who had endured > 5 years with cancer, the 
rationale was not initially apparent, so this paper was included to avoid missing 
any fundamental research. Other studies identified that prior to the confirmation of 
diagnosis YP need to have attained effective coping strategies in order to have 
gained an overall positive experience of cancer (Hokkanen et al., 2004; Kelly et 
al., 2004; Wu et al., 2009). Understanding YP's coping mechanisms can support 
the experiences they encounter. In a study by Wu et al. (2009), they interviewed 
ten YP aged between 12 to 18 in one paediatric haematology/oncology ward. 
Within their study, although YP experienced loss of confidence and became 
fearful, they also worked hard to rebuild a sense of hope, which would inevitably 
help them cope. As one young boy aged 12 expressed “I could not do what I 
wanted to do, but I had my life” (Wu et al., 2009 p2362). Key findings from this 
study were comparable to other studies by Woodgate (2005, 2006) who discussed 
YPs’ need for psychosocial support. Young people were grateful and happy to be 
alive, and that part of the recovery from the treatment and cancer meant a new 
beginning for them, even though they would ultimately be on a different path from 
the one that had previously been on (Hokkanen  et al., 2004; Kelly et al., 2004; 
Kyngäs et al., 2001).  
 
2.7.2 Loss of Self 
 
Eight studies highlighted how YP experience a sense of loss of self as their bodies 
dramatically changed from the chemotherapy, radiotherapy and surgery (Al Omari 
& Wynaden 2014; Al Omari et al., 2017; Kelly et al., 2004; Kumar & Schapira 2013; 
Stegenga & Ward-Smith 2009; Woodgate, 2005; Wicks & Mitchell, 2010; Zebrack 
et al., 2014). Within the cancer experience, YP reported that they often lost sight 
of themselves, physically their bodies changed and they no longer recognised the 
person they had become. These studies found that having cancer and the 
treatment which followed, affected their lives. For example, having the treatment 
meant that their hair would fall out, and they would become unrecognisable. The 
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loss of their hair affected body image and confidence for many females and being 
‘bald'. As one young participant explained, "I am a girl, and I like my hair, without 
my hair, my friends won't see me" while another expressed “When I lose my hair 
completely, I will cover my head” (Al Omari & Wynaden, 2017 p37, 38). These 
quotes highlight how the treatment can affect the overall experience and loss of 
self. This was interesting as Muslim women often have their head covered but do 
have the hijab off when with their female friends and husband/s. Although the loss 
of hair was an issue, loss of a body part (breast) or limb through amputation also 
had a dramatic effect on the cancer experience and loss of self. Body image plays 
a vital role here and was related to the young person's loss of themselves, the 
person they were to the person they had become. Loss of a limb impacted 
powerfully on the YP but also the family. Both felt that this was the hardest part of 
the cancer journey experience and having to adapt to a new life with often 
restricted mobility. This loss seemed to symbolise the destruction that cancer 
brings and the need to adapt to the new life (Kelly et al., 2004; Kumar & Schapira, 
2013).  
 
These physical changes to self also affected the YP psychologically. The concept 
of loss of self was related to the age group. This loss of self also connects to their 
identity, which was essential within YP as they transition from being a child to a 
YP, as discussed in Chapter 1. Within this period of transition, comes change and 
was often seen as the altered state of self (Kelly et al., 2004; Kumar & Schapira, 
2013; Stegenga & Ward-Smith, 2009; Woodgate, 2005; Wicks & Mitchell, 2010; 
Zebrack et al., 2014). Another study by Zebrack et al. (2014) utilised an open-
ended survey questionnaire to collect data from adolescents and young adults 
(AYAs) aged from 15 to 39 years in the USA. The open-ended survey helped the 
AYAs describe their experiences with the care they had received. Again, none of 
the 296 participants who undertook the survey had a diagnosis of MM. This was 
surprising considering the large sample size in this study and that MM is on the 
increase in the USA. Struggles were evident within this patient population, 
especially around efforts to establish a sense of self and maintain a sense of 
normalcy in their lives. From the sample, n=120 reported that “cancer sucks” and 
was very disruptive to their lives (Zebrack et al., 2014 p.5). This, in return, had an 
impact on their lives, emotionally, psychologically and physically. Several 
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indicated that they had lost jobs, lost friends, lost hair, lost motivation due to lack 
of energy and had struggled with alcohol and drugs. In essence, it was the loss of 
different aspects of their life that shaped the loss of sense of self. As this study 
sample has included an older age group, the loss of self may be different than in 
any of the other studies.  
 
The impact of cancer on the YP and their family has been emphasised in this 
section, with feelings of uncertainty being prominent within the cancer experience. 
With this uncertainty about the future, hope for recovery and life itself, and that the 
fear of having cancer subsides as they move through the cancer journey 
experience itself. Alongside this were the loss of self once the treatment 
commences and their physical and emotional state changes. This experience 
often occurred as they received treatment or surgery, which altered their bodies in 
ways that changed them. Participants felt that this body change affected the way 
they felt because of the way they now looked. Concerns about their body image 
made them feel anxious, less confident and worried about relationships with other 
people. The following section discusses the gaps in the care delivery; physical, 
psychological and emotional. 
 
2.8 Gaps in the Care Delivery 
 
Within nine of the studies there were certain aspects of the care delivery that were 
absent from the overall cancer experience, from the YP perspective (Farjou et al., 
2013; Fern et al., 2013b; Gibson et al., 2013; Hedström et al., 2004; Hokkanen  et 
al., 2004; Kelly et al., 2004; Kumar & Schapira 2013; Olsson et al., 2015; Wicks & 
Mitchell, 2010; Zebrack et al., 2014). Being cared for by knowledgeable and 
experienced healthcare professionals, was critical to the YP and their families, 
along with the care environment. Within this review, not all YP were cared for 
within a specialist young adult cancer unit; most were cared for within paediatric 
or adult wards. It was also clear that YP wanted healthcare professionals to 
discuss cancer with them rather than their parents or families and for this to be 
done in a clear and meaningful way that was appropriate for their age and stage 
of development. 
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2.8.1 Experience of Healthcare Delivery 
 
The delivery of high quality evidence-based care, by healthcare professionals who 
are knowledgeable and experienced within the cancer speciality and the 
immediate and long term implications a cancer diagnosis brings, was a 
fundamental requirement to the cancer journey experience (Farjou et al., 2013; 
Gibson et al., 2013; Hedström et al., 2004; Hokkanen et al., 2004; Kumar & 
Schapira 2013; Kelly et al., 2004; Kumar & Schapira 2013; Olsson et al., 2015; 
Stegenga & Ward-Smith 2009; Zebrack et al., 2014). These ten studies provide 
the need for information and support, leading up to and following a diagnosis of 
cancer. For example, YP reported that healthcare professional's attitudes and the 
way they communicated were often inappropriate. YP commented on how the 
Oncologist Consultants were quite stern “it’s like talking to a piece of cement” 
(Kumar & Schapira, 2013 p1756) and did not address them directly “I wish people 
talked to me rather than my parents” (Farjou et al., 2013 p 725). Both papers 
identified the importance of the delivery of communication by appropriately 
educated and trained staff which supported them in developing a trusting 
relationship with the specialist multidisciplinary team. According to other studies 
by Gibson et al. (2013) and Stegenga & Ward-Smith (2009) who support these 
findings, clear and focused information, education and advice should also be 
made available regarding all aspects of their care, such as diagnosis, 
chemotherapy, the side effects and what YP themselves choose to be involved in.  
 
One study, in particular, highlighted privatised healthcare, which was an issue for 
some (Zebrack et al., 2014). This study from the USA found that AYAs who 
received a cancer diagnosis and then went on to have treatment worried about 
their future and the financial implications due to unemployment or inadequate 
health insurance. Cancer often impacted on their employment and on the ability 
to work, which in return affected the cancer experience. YP worried about this and 
what their futures would hold once they began and had completed treatment. The 
lack of a universal healthcare system, as present in the UK, was problematic and 
worrying for the YP. This has been discussed in Chapter 1 under models of care. 
Overall AYAs within a privatised healthcare system were unable to integrate the 
cancer journey into their daily lives, nor did they have the insurance or finances to 
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support them through this journey. This was very distressing for most of the YP, 
and they sought solace through adopting coping strategies such as self-belief in 
‘getting better' which in return gave them hope (Kyngäs et al., 2001; Zebrack et 
al., 2014).  
 
2.8.2 Age-appropriate Specialist Care  
 
There is a tendency to view the ideal treatment and care experience as arising out 
of specialist services that are age-appropriate (Lea et al., 2018; NICE, 2006). This 
however, was not always readily available for all YP with cancer across the globe 
due to different healthcare systems and resources (Farjou et al., 2013; Gibson et 
al., 2013; Hedström et al., 2004; Hokkanen  et al., 2004; Kelly et al., 2004; 
Miedema et al., 2006; Olsson et al., 2015; Wicks & Mitchell, 2010; Zebrack et al., 
2014). Olsson et al. (2015) and Gibson et al. (2013) research focused on what YP 
experience in their treatment for cancer and what they require to support them 
through their journey.  
 
Olsson et al. (2015) paper specifically explored the experiences of teenagers and 
YP treated for cancer in Sweden. This study was undertaken in both child and 
adult hospitals as there are no young adult cancer units within Sweden. The focus 
was also within acute hospitals as opposed to community settings. The study 
included 44 participants, aged 15 to 29, through focus group participation. What 
is interesting regarding this paper was that the authors have separated the YP into 
two focus groups, one for those aged 14 to 18 years and a second for those 
between 19 and 29 years. The 14 to 18 years were treated within paediatric 
services, and the older age group were treated within the adult services. YP had 
a solid tumour or eukaemia, and none had MM. However, this study highlighted 
that YP required an age-appropriate environment which supported their physical 
and social needs. As one young participant expressed “there are only old people 
….so why was I there?” (participant 20 years) and "now we shall do some painting, 
and only the small children came out of the room, the teenagers stayed in their 
rooms" (participant 16 years) (Olsson et al., 2015 p 578). The study also found 
that these specific needs of having an age-appropriate environment and 
psychosocial support varied over time and throughout the cancer journey and 
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were unique to each person. It was clear from this study that these needs were 
not being met. They wanted the hospital interior to be different and equipped for 
YP and to be cared for within an area where there were people of their own age.  
 
A further study by Farjou et al. (2013) set out to understand the healthcare 
experiences of 200 YP through an open-ended questionnaire, within three 
paediatric hospitals in Canada. The YP were aged between 12 to 20, with 79 being 
actively treated and 121 were off treatment and being followed up regularly. This 
study found that the environment was important, especially the social interaction 
that teenagers require, and an environment that is comfortable for them and their 
families. It was clear from the literature that this type of environment would support 
their interaction with their peers. Again, unsurprisingly, this paper highlighted that 
not all countries provided care for teenagers or YP. Many are still being cared for 
within either the paediatric or adult environment. 
 
This theme demonstrated the there are gaps in the care delivery for YP with 
cancer and their families. Cancer care needs to be delivered in appropriate 
environments which are conducive to the age and stage of the young individual. 
The care delivery was necessary, and it was highlighted that this should be 
provided by knowledgeable and competent healthcare professionals and that 
specialist care is available for all YP. 
 
2.9 Summary and Conclusions 
 
The literature search was updated during September 2019 and revealed a further 
13 papers concerned with YP living with MM, and an additional 65 papers 
exploring how YP were living with cancer, but none met the inclusion/exclusion 
criteria. Consequently, these papers were categorised as irrelevant to my study 
because the majority were quantitative studies focusing on the needs of an adult 
population. There were two studies retrieved concerning adults with experiences 
of MM but neither included the family/significant other nor did these studies use 
an IPA approach (Bird et al., 2015 & Hajdarevic et al., 2014), or meet the inclusion 
criteria for my research. Other studies have selected more general MM research 
in the TYA population and have chosen to work within the quantitative 
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methodological paradigm or a mixture of both quantitative and qualitative 
approaches (Hubbard et al., 2018). Most of the literature regarding YPs 
experiences were concerned with all types of cancers without focusing on singular 
diseases. Some of the papers in the literature review were concerned with the 
family (n=2) however, this was not common, and none included the 
family/significant other. 
 
It is clear from existing literature that there was no international or national 
research focusing on the experiences of YP living with an MM diagnosis, nor any 
studies utilising an IPA methodology. This can also be said for the experiences of 
the families /significant other who share the journey with the young person. This 
review has identified the gap in knowledge regarding the dynamic relationship 
between the YP their  family/significant other and has provided an insight into the 
dearth of knowledge in one specific type of cancer. Current research has tended 
to focus on the experiences of YP living with other types of cancer, such as 
Leukaemia and Lymphoma, to the exclusion of MM. As the family/carer is vital 
within the cancer journey, they were also included. 
 
The Taylor et al. (2013) meta-synthesis was included to support the second 
literature review regarding YPs experiences of cancer. However, none of these 
studies included any YP with MM, nor did they include the family/significant other. 
The Taylor et al. (2013) review differed in that their inclusion/exclusion criteria 
included both types of research methodology, although they only used the 
qualitative material to develop their conceptual model. This model depicts the 
mediators and consequences of cancer care that impact on YPs quality of life after 
a diagnosis of cancer has been received. It was interesting to see that the model 
does include social support. However, the family/significant other were not central 
to this support nor seen as being important in the YP cancer journey and there 
was no consideration given to the dynamic interrelationships.  
 
A more extensive review of the literature of young adult's experiences of cancer 
found that there were critical aspects to the cancer experience: Theme 1 – cancer 
diagnosis, Theme 2 - the uncertainty this brought to their lives and the feeling that 
their lives were put on hold and Theme 3 - the gaps within the care delivery. This 
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review found 18 qualitative research papers focusing on YPs experiences of 
cancer. However, only two of the studies used IPA and four used 
phenomenologies to give the studies the depth and meaning of the lived 
experience. There was also a limited amount of research that involved both the 
young person with cancer and their families. Only one of the 18 papers included 
the family (and given the emphasis from the review on the importance of family 
and friends, this appears to be a significant omission from the research (Kelly et 
al., 2004). 
 
Much of the literature revealed that a cancer diagnosis has an impact on the 
overall experience of one’s life from that point onwards. (Gibson et al., 2013; 
Hedström et al., 2004; Hokkanen et al., 2004; Kelly et al., 2004; Kyngäs et al., 
2001; Kumar & Schapira 2013; Stegenga & Ward-Smith, 2009; Woodgate, 2006; 
Wicks & Mitchell, 2010). A key finding was that these studies all present the 
experiences of being diagnosed with cancer but the actual word ‘cancer’ was 
rarely used within the healthcare setting. It was not clear from the literature why 
the word ‘cancer’ was not used by the healthcare professional but needs 
consideration in how a cancer diagnosis is given, where and by whom. It was 
interesting in the paper by Miedema et al. (2006) that the delay in diagnosis may 
not affect the health outcome, which was contradictory to current evidence, as 
delay in diagnosis can be detrimental to the overall disease process, especially 
MM, and early intervention is essential (Gibson et al., 2013). It did, however, 
impact on the experience both psychologically and emotionally (Miedema et al., 
2006). Where YP are treated and cared for and by who needs careful 
consideration and the approach to how healthcare professionals communicate 
with YP was fundamental to the cancer experience. It was also suggested that YP 
and physicians need to be aware of the symptoms presented and be prepared to 
act on these whether serious or not. This was imperative within the cancer 
experience and this patient group in particular.  
 
The impact of cancer on the young person has been emphasised throughout the 
review, and it became clear that YP living with cancer experience uncertainty 
about their future. With this uncertainty, there was also hope for recovery and life 
itself. The fear of having cancer, and the reality that death may be pending, did 
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feature and quickly subsided as they moved through the cancer journey. 
Alongside this is the loss of themselves once the treatment commences and their 
physical and emotional state changes (Al Omari & Wynaden, 2014; Al Omari et 
al., 2017; Kelly et al., 2004; Kumar & Schapira, 2013; Stegenga & Ward-Smith, 
2009; Woodgate, 2005; Wicks & Mitchell, 2010; Zebrack et al., 2014). 
 
YP with cancer experience a wide variety of different treatments and care 
processes and the needs of the family cannot be separated from that of the young 
person with cancer. Both family and friends were significant others within the 
cancer experience. There was a tendency to view the ideal treatment and care 
experience as arising out of age-appropriate specialist services. However, this 
was not always readily available for all YP with cancer across the globe due to 
different healthcare systems and resources. Where and how the treatment and 
care are delivered by competent healthcare professionals, who are 
knowledgeable about the immediate and long-term implications of cancer 
therapies, was necessary. This was a fundamental requirement in order that YP 
and their families can be supported and prepared for whatever lies ahead.  
 
Existing literature documents that YP with different types of cancer experience a 
variety of care and treatment processes. It is not fully understood what YP and 
their families/significant other with MM experience, especially at a time in their 
lives when they are looking forward to what the future holds. More specifically, MM 
is an under-explored area, particularly in terms of the lived experience.  
 
There was no qualitative research that has focused on YP’s experiences of living 
with MM, or for their families/significant other, and this provided the rationale and 
justification for my study. Although a rare disease, it is increasing within YP, 
particularly within Scotland, and healthcare professionals will need to be prepared 
and equipped on how to care for this specific age group within a relational context. 
This is important as YP are often still living within the family home or with a loved 
one or friend/s. As I wanted to explore the experiences of what it meant for YP 
and their family/significant other living with MM, this novel qualitative approach 
fitted well with my research aims and questions. Further research on individual 
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cancers is required to understand the impact they have on YP and their 
family/significant other and their unique care requirements. 
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Chapter 3 - Methodology and Methods 
 
3.1 Introduction 
 
This Chapter begins by discussing the rationale and justification for selecting a 
qualitative IPA approach to explore the experiences of YP and their 
families/significant other living with MM, as opposed to other methodological 
approaches. The paradigms and the philosophical theory that supports IPA are 
discussed along with the epistemological and ontological underpinnings, and my 
own positionality and reflexivity within the selected methodology are presented. 
Following the methodology sections, the methods I used to conduct the research 
are also discussed.  
 
3.2 Research Focus  
 
In Chapter 2, the critical narrative review and discussion of the available literature 
confirmed the paucity of specific research concerned with the experiences of YP 
living with MM, and this study closes the identified gap. Moving beyond the YP 
experiences alone, I have gone further in considering the family/significant other 
within this journey and how this disease had affected the YP as well as their 
family/significant other. As the second literature review concerned the experiences 
of all cancers, I wanted to specifically research one type of cancer in considerable 
depth to determine if there were any other gaps when considering this population 
group as opposed to research clusters of many cancer types. Anecdotal evidence 
indicated that YP experiencing an MM journey were different from other YP with 
different types of cancers. In addition, I wanted to utilise a novel methodology that 
understands how these YP, and those that matter to them, make meaning from 
their experiences in real depth.  
 
In identifying and selecting an appropriate methodology, it was essential to 
consider the core research aims and the associated questions that would deliver 
the required richness and deep insights. As Newell & Burnard (2006) suggest, it 
is essential to avoid methodological choices that reflect the preferences of the 
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researcher and focus on suitable methodologies to answer the research questions 
noted in Table 3.1. 
 
Table 3.1: Research Aim and Questions 
Research Aim and Questions  
Aim: Explore the experiences of young people and their family/significant 
other living with MM within Scotland. 
Question 
1 
What are the experiences of young people and their family/significant other 
living with malignant melanoma? 
Question 
2 
What are young people and family/significant other experiences of the 
support and care they require or need? 
Question 
3 
What further support or improvements in care do young people and 
family/significant other identify? 
 
In contrast to positivism, where the researcher relies specifically on scientific 
evidence, is the constructivist approach, also known as the naturalistic inquiry 
(Guba & Lincoln, 1994) which proposes multiple realities that are dependent upon 
context. This approach is steeped in subjectivity and is associated with the 
qualitative research methodology. Qualitative studies are designed to collect rich 
data in a non-threatening way and ensure credibility and trustworthiness in 
attempting to answer questions around individual and group experiences and 
perceptions (Parahoo, 2014; 2006). The qualitative researcher endeavours to tell 
the story of an individual or group’s experiences or perceptions in their own words. 
Qualitative research focuses on narrative compared to quantitative research, 
which focuses on data, numbers and facts (Guba & Lincoln, 1994). Qualitative 
research logic can be challenging for those researchers more accustomed to the 
alternative deductive approach. Qualitative research employs an inductive 
approach where the researcher first collects data and then attempts to derive 
explanations from that data. Consequently, qualitative research tends to be more 
exploratory, seeking to provide insight into how individuals and groups understand 
their world (Polit & Beck, 2010). Various qualitative designs were critically 
considered against the research questions and in order to find the most 
appropriate approach. 
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3.3 Research Paradigms 
 
All researchers have their own individual views on what constitutes truth, 
knowledge and understanding. It is these views that often guide and inform how 
researchers frame the world around them. This is known as a paradigm and was 
defined by Schwandt (2001, p183-184) as a “shared world view that represents 
the beliefs and values in a discipline and that guides how problems are solved.”  
  
Research paradigms can be defined as sets of beliefs, conceptions and values 
concerning the nature of reality and knowledge construction held by a discipline, 
which inform the priorities for research and process of inquiry (Kuhn, 1970). 
Currently, within healthcare research, the leading paradigms may be considered 
as a positivist, constructivist/interpretive and critical social theory, the foundation 
respectively for quantitative and qualitative approaches (Parahoo, 2014). 
 
In selecting the most appropriate research paradigm to answer the research aims 
and questions, both quantitative and qualitative paradigms were considered. The 
quantitative research approach is heavily influenced by the traditional sciences 
and aims to objectively examine and map the relationships between known 
variables through empirical measurement and statistical analysis (Parahoo, 2014; 
2006). In contrast to the quantitative approach, qualitative research studies are 
popular, have gained widespread acceptance within healthcare over the years and 
are designed to ensure trustworthiness and permit rich data to be collected in a 
non-threatening way (Bryman, 2008). It was clear that a qualitative research 
approach would be more suited to answering research questions that focused on 
capturing and interpreting personal experiences. This conclusion was supported 
by the literature review in Chapter 2, which revealed that research studies 
exploring the experiences and personal impact of a major disease such as MM 
can bring mainly relied on the qualitative research paradigm with their emphasis 
on subjective experiences. According to Guba & Lincoln (1994), research 
paradigms can be characterised through their epistemological and ontological 
stance. 
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3.4 Research Methodologies Considered 
 
As discussed in Section 3.2, there is a knowledge gap in the literature around the 
experiences of YP and their family/significant other living with MM. Consequently, 
the following research designs were considered – mixed methods, case study and 
grounded theory. Mixed methodology has been criticised by some researchers 
who argue that the paradigms are often grounded in incompatible epistemological 
and ontological principles (Rolfe 2006, Silverman, 2006). The principal concern of 
epistemology has tended to be the philosophical exploration of propositional 
knowledge (Meleis, 1992) and considers addressing questions such as ‘how do I 
know what I know, and what counts as proof of what we know?' Ontology, 
however, explores the essence of things helping to grapple with the fundamentals 
of our questions, for example, 'what is nursing?’. Nevertheless, Bryman (2008) 
acknowledges this but suggests that quantitative and qualitative approaches can 
complement one another as they can deliver different types of knowledge to 
identify the evidence that the researcher was seeking to find. A mixed 
methodology, combining quantitative and qualitative methodologies, was 
considered for the research questions as this methodology has gained greater 
prominence and academic acknowledgement (Creswell, 2009).  
 
3.4.1 Mixed Methods  
 
In considering the mixed methodology approach, a survey design questionnaire 
with open and closed questions to investigate the participants’ experiences of 
living with MM was discussed. However, this approach would lead to copious 
amounts of data which would have been advantageous to the study but would not 
have addressed the initial research questions and the focus on people’s 
experiences with MM (Bryman 2008; Parahoo, 2014). Survey design is a popular 
method with social scientists, sociologists and increasingly amongst nursing 
research. This approach, according to Parahoo (2014; 2006), is cost and 
resource-effective as opposed to the qualitative interview. The use of a survey 
design was ultimately rejected due to the research questions and the small 
number of participants diagnosed with MM in Scotland, approximately 14 per year. 
Besides, the quantitative methodology predominantly utilises a deductive strategy 
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and the testing or confirming of theories, which incorporate practices of positivism 
and quantification (Polit & Beck, 2010). It would be difficult to quantify and 
measure the participants experience through closed and open-ended questions, 
as there may be too many variables to control (Parahoo, 2006). As such, the mixed 
methodology was disregarded. Nonetheless, as my research aims and questions 
finally evolved into ‘exploring the experiences of YP living with MM and their 
family/significant other’ this methodology approach was considered unsuitable for 
this study.  
 
3.4.2 Case Study 
 
The case study methodology is useful in helping the researcher explore the data 
in some detail within a specific context, most commonly restricted to a limited 
number of participants or small geographical location. Fundamentally, the case 
study approach permits the investigation and exploration of the current real-life 
phenomenon, such as transition, through the detailed analysis of a limited number 
of contextual events or conditions, and their relationships (Parahoo, 2014). Yin 
(1984 p23) describes the case study research method "as an empirical inquiry that 
investigates a contemporary phenomenon within its real-life context; when the 
boundaries between phenomenon and context are not evident; and in which 
multiple sources of evidence are used." The case study approach was disregarded 
due to the research focus on the YPs experience of living with MM and not 
investigating a contemporary real-life phenomenon. This real-life phenomenon 
would have been challenging to capture through a case study unless the specific 
methodology was adapted to follow an IPA approach. An example of this is seen 
within a single case study by Eatough & Shaw (2019) who present the 
understanding of the lifeworld for someone living with Parkinson’s disease. Due to 
the nature of my research aims, questions and interest, I was keen to include YP 
and their family/significant other from across Scotland rather than focusing on a 
single case study. 
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3.4.3 Grounded Theory 
 
Grounded theory was also considered to address the research questions. 
Grounded theory focuses on social processes and structures and was seen as a 
valid consideration. This approach is grounded in data collected from the 
individual participants, either through interview or by observation within the 
participant’s environment (Silverman, 2006). The grounded theory design was 
originally developed in the early 1960s by American sociologists Glaser & Strauss 
(1967), and later by Strauss & Corbin (1997). The philosophical basis 
predominantly is a symbolic interaction and pragmatism, utilised to investigate and 
explain human experiences, actions and interactions within the context of social-
psychological processes. The specific types of data discovered, generated or 
constructed depends on the grounded theory tradition followed by the researcher. 
It can be difficult to confidently predict the direction and duration of the study at 
the outset, due to the theoretical sampling and the process of constant comparison 
in data collection and analysis until theoretical saturation is achieved (Charmaz, 
2000). Time limitations precluded the use of a grounded theory approach, and as 
my study was to consider the individual experiences rather than wishing to 
generate models of theories to explain the phenomena, this design was 
disregarded. 
 
3.5 Phenomenology 
 
My earlier Masters Level research (McInally, Masters & Key, 2012) involved 
conducting a phenomenological study informed by critical theory, which provided 
a strong foundation for conducting qualitative research within the 
phenomenological paradigm. The experience of planning, designing and 
implementing this research programme positively shaped my knowledge and 
understanding of the value and robustness of the phenomenology methodology 
and for the type of research questions, it is suitable to address. 
 
Phenomenology is a philosophical approach to the study of experience. In life, 
phenomenology is concerned with the experience of being human and what 
matters along with what constitutes the world in which lived (Smith, Flowers & 
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Larkin, 2009). Phenomenological enquiry has two distinct approaches; descriptive 
and interpretative phenomenology (Smith et al., 2009). Interpretative 
phenomenology analysis has foundations in both and phenomenology is, 
therefore, the underpinning of IPA (Peat, Rodriguez & Smith, 2019). Healthcare 
professional researchers pursuing a qualitative approach to their research have 
gravitated towards different qualitative designs, including phenomenological 
methodology, perhaps to reflect the perceived holistic nature of their work.  
 
Descriptive phenomenology aims to describe the lived experience without giving 
meaning (Smith et al., 2009). The principal founder of phenomenology, Edmund 
Husserl (1859 – 1938), and the originator of descriptive phenomenology 
suggested that during data collection and analysis the researcher should ‘bracket’ 
or leave aside previous knowledge and investment to enable the phenomena to 
be illuminated as experienced. Husserl wanted to grasp the essence that makes 
possible an experience of any kind. Originally a mathematician, Husserl became 
disenchanted and disillusioned with the natural sciences as a means of studying 
human experience (McConnell-Henry, Chapman & Francis, 2009). Husserl 
opposed the view that empirical science was the sovereign arbiter of truth and saw 
phenomenology as a way of returning to and exploring the reality of life and living, 
of going 'back to the things themselves' (Tuohy, Cooney, Dowling, Murphy & 
Sixsmith, 2013). Crotty (1996) and Paley (2014) have criticised researchers for 
the use of Husserl phenomenology on the basis that many researchers have 
misunderstood Husserl’s original intentions. This position is based on the belief 
that very few researchers have directly referenced the original research 
conclusions of Husserl. Given that Husserl’s writing is in his native German, it is 
easy to understand why researchers have not fully accessed his research, even 
though his work has been translated into English. 
 
Husserl introduced the concept of the ‘lifeworld’, meaning the world as it is 
immediately experienced (Wilson, 2018), and claimed that the lifeworld was not 
readily accessible, as it constituted that which is taken for granted and those things 
which are common sense (and therefore go largely unnoticed) (Koch, 1995). Study 
of the lifeworld explores what an experience is like ‘pre-reflectively’, focusing on 
that which is experienced in the consciousness of the individual (Eatough & Shaw 
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2019; Smith et al.,  2009). It is prudent to explore some of the critical concepts of 
descriptive phenomenology, and how this has influenced my research, as a 
deeper understanding can serve to help illuminate the contrasting hermeneutic 
paradigm of Heidegger, and discussion of the concept of bracketing provides a 
rationale for the rejection of pure descriptive phenomenology in this study (Wilson, 
2018).  
 
The descriptive phenomenology concept was later challenged by Martin 
Heidegger (1989 - 1976), Merleau-Ponty (1908 – 1961) and Gadamer (1976) who 
suggested that to describe a lived experience fully, and an interpretative 
phenomenology researcher cannot extract themselves from the research and 
interpretations are made from our perceptions. The interpretation of an individual’s 
‘meaning-making’ is considered in light of the researcher’s perspective, at that 
specific time. According to Heidegger, researchers observe and empathise but 
view phenomena from their own perspective of being in the world; and the 
narrative is developed through interpretation (Peat et al., 2019). Heidegger’s 
seminal work Sein und Zeit (Being and Time) illustrates how he moved radically 
away from Husserl’s phenomenological approach (Earle, 2010; Heidegger, 1962). 
The term hermeneutic phenomenology is therefore attributed to Heidegger and is 
influenced by an ontological perspective concerned with the nature of “being in 
the world" or "Dasein" (Heidegger, 1962, p41). The process of bracketing provides 
epistemological information, rather than ontological, for example, one can know 
about a life event through description but to truly understand this life event 
meaning must be derived from this (Smith et al., 2009). Heidegger travelled from 
the epistemological emphasis of Husserl to an emphasis on the ontological 
perspective believing the outcome of phenomenological research should be 
understanding and meaning through interpretation rather than a purely descriptive 
science (Wilson, 2018). Heidegger disagreed with Husserl and subsequently 
criticised and rejected this notion of ‘bracketing’. Heidegger and other existential 
phenomenologists (LeVasseur, 2003), believed that understanding is never 
without presuppositions (Earle, 2010) and that understanding is already there, and 
cannot, nor should not, be divorced from our thinking.  
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Heidegger, similar to Gadamer (1976) rejects ‘bracketing’ by questioning whether 
preconceptions of the researcher may be truly set aside, through adopting an 
attitude of openness. Gadamer also acknowledges individuals as historical 
beings, bringing with them life experiences and belief’s which shape the meaning 
and understanding of new experiences within their lifeworld (Wilson, 2018). 
Phenomenology is concerned with an epistemological and ontological position 
whereby the researcher strives to explore the essence of what the individual feels 
is real, authentic and important. Researchers accept that each individual have 
different life experiences and that the truth can often be deceptive and subjective 
(Denzin & Lincoln, 2005; Rolfe, 2006). As different scholars employed divergent 
philosophies regarding phenomenology, various strands arose with differing 
epistemological and ontological perspectives. A phenomenological researcher, 
therefore, seeks to describe the meaning of the 'lived experiences' for several 
individuals regarding a certain phenomenon (Van Manen, 1990; Willig, 2011).  
 
When pursuing a phenomenological methodology, researchers must wrestle with 
a fundamental problem within the approach. Once the research findings are 
recorded and transcribed the original meanings may be lost or distorted by this 
process. This is a valid criticism and not one that is easily overcome. As discussed 
earlier, all researchers view the world around them through their own unique set 
of individual filters. In attempting to address this issue, some authors have referred 
to the original German texts to provide further insight and understanding of the 
approach (Fleming, Gaidys & Robb, 2003). However, Koch (1995, p174) has 
observed that “wrestling with obscure German texts” is not a primary objective of 
nursing researchers. Researchers are required to understand the philosophical 
underpinnings of the methodology to ensure the delivery of robust and accurate 
research.  
 
It was recognised at the beginning of this study that each participant would have 
a personal perspective to add, but due to the very nature of the study, there would 
potentially be common shared experiences (Smith et al., 2009). Conducted to 
generate knowledge, the study was to be inductive with a focus on what the 
participants say rather than quantification in the collection and analysis of data, 
further suggesting the qualitative paradigm and the phenomenological approach 
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(Bryman, 2008; Bloomberg & Volpe, 2008). In summary, this approach was pivotal 
in the selection of IPA as the primary research approach, which is rooted within 
the work of Husserl, Heidegger, and Gadamer, alongside other philosophers’ 
work.  
 
3.5.1 Epistemology and Ontology  
 
At its core, the IPA approach is concerned with an epistemological and ontological 
position. In IPA we may wish to treat people's experience as a lens for illuminating 
the broader meaning or consequences of an event or journey such as MM to 
understand its broader constitution, dynamics, or mechanisms (Larkin, Shaw & 
Flowers, 2019). A phenomenological researcher looks to accurately describe the 
meaning of the 'lived experiences' of several individuals regarding a particular 
phenomenon (Peat et al., 2019; Van Manen, 1990). Throughout the process, the 
researcher is required to suspend or disconnect their natural attitude, perceptions, 
beliefs and experiences to ensure objectivity and to fully understand the 
phenomena as it truly appears, which supports the Husserlian phenomenology. 
 
The epistemology of IPA is built around the interpretative inquiry of the narratives 
of the individual's lived experiences, and the research questions should focus on 
the understandings of these experiences and should be exploratory as opposed 
to explanatory questions (Smith et al., 2009). Considering the epistemological 
position and how it is defined, some suggest that it relates to the theory and nature 
of knowledge (Finlay & Ballinger, 2006) with others offering slightly differing 
definitions. It is proposed that epistemology relates to the claims or assumptions 
about how it is possible to gain knowledge (Blaikie, 2007) and should be identified 
with the goals of the research in mind. This ensures that these aims are achieved 
and demonstrate coherence and rigour in the study. Awareness of these 
philosophical concepts increases the quality of research and can contribute to the 
creativity of the researcher. 
 
Ontology is defined as the nature of reality. It explores the essence of things, 
helping us, for example, to understand the attributes of being a person and 
shedding some light on the questions we require answers to (Creswell, 2009). 
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Within the IPA approach and this study, where it is crucial to explore the 
experiences of living with such a disease and being in the world in which we live, 
the work by Heidegger also requires to be considered (McConnell-Henry et al., 
2009). Part of this reality, however, is different for each person and therefore it 
must be explicit as to how each phenomenon is viewed by the researcher, 
acknowledging that many biases and interpretations influence the research. At 
one end of the ontological continuum sits realism which assumes there is only one 
reality that is entirely independent of human subjectivity. At the other end of this 
continuum is relativism where there are multiple realities which are entirely 
dependent upon human subjectivity and interpretation (Braun & Clarke, 2013). My 
study aimed to align itself with the constructivist theoretical underpinnings which 
informed a relativist epistemological approach informed by an IPA methodology 
which suggests that the lifeworld consists of many individual realities which are 
influenced by our culture, society and the wider world we live in (Wilson, 2018).  
 
It is important to acknowledge at this point, that participants rely on somatics in 
that they tell the story of their experiences as they remember it, at the time, through 
their mind and body (Osborn & Smith, 2006; Smith & Osborn, 2007). For example, 
when the participants were describing their experiences, they could relate this to 
what was real and true for them at this time. They could refer to the shock and 
worry they had experienced in receiving bad news or the pain they had to bear 
from the surgery. This supports previous philosophers’ work including Husserl, 
Heidegger and Merleau-Ponty.  
 
3.5.2 Interpretative Phenomenological Analysis 
 
Interpretative Phenomenological Analysis was originally developed in 1995 by 
Johnathan Smith as a method to undertake experiential research in psychology, 
and has gained prominence across health and social sciences as a way to 
understand and interpret topics which are complex and emotionally laden, such 
as disease, chronic illness experiences (Peat et al., 2019). In essence, IPA 
consists of three central tenets - phenomenology, hermeneutics and idiography 
(Smith et al., 2009) as summarised in Figure 3.1.  
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Figure 3.1: The Three Influences of IPA 
 
 
Adapted from: Smith et al. (2009) 
 
 
In earlier sections within this Chapter, I have tried to provide a deeper 
understanding of the philosophical and methodological nuances of 
Phenomenology and IPA (Smith2009). The purpose of this research was to 
illuminate and steer the research to gain a deeper understanding of the 
experiences of YPs and family/significant others living with MM.  
 
Interpretative Phenomenology Analysis (IPA) aims to uncover what a lived 
experience means to the individual through a process of in-depth reflective inquiry 
(Smith et al., 2009). The interpretative phenomenological analysis draws on 
phenomenological thinking, with the purpose to return ‘to the things themselves’ 
(Smith et al., 2009 p168). However, IPA also acknowledges that we are each 
influenced by the worlds in which we live and the experiences we encounter. 
Therefore, IPA is an interpretative process between the researcher and 
1. Phenomenology
"to fully describe a lived experience"
Descriptive Phenomenology
To describe a lived experience without attepting to give 
meaning to it
Philosophical Influence
Husserl (1927): To 'bracket' or leave aside previous 
knowledge and investments in order to see phenomena as 
experienced.
Interpretative Phenomenology
Aim
To reveal and interpret implicit meaning in a lived 
experience.
Philosophical Influence
Heidegger (1962): Researchers cannot extract themselves 
from the research.
Merleau-Ponty (1962): Interpretations are made from our 
perspective
2. Double Hermeneutics
"the theory of interpretation"
Aim:
To provide surer foundations and processes for 
interpreting text.
Major Hermeneutics Theorists:
Heidegger (1962): Researchers bring theirn own 
preoccupation to the analysis.
Gadamer (1990): 'Fusion of horizons' between 
reseacher and participant.
3. Idiography
"Focus is on the individual"
Aim:
To concern oneself with the particular in 2 ways.
(1) 'With detail': thorough and systematic depth of 
anlaysis.
(2) From the perspective of particular people, in a 
particular context.
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researched, influenced predominantly by Heidegger's interpretive 
phenomenology, hermeneutics and idiography. Within IPA, it is typical for 
researchers to select a small homogenous sample to explore the shared 
perspectives on a single phenomenon of interest (Larkin, Shaw & Flowers, 2019). 
Undertaking an IPA approach, concerned with the epistemological and ontological 
theoretical underpinnings supported the aims and objectives of this study. Over 
time, the theoretical foundations of IPA are likely to be further refined and 
strengthened (Larkin et al., 2019). Smith et al. (2009), have suggested that the 
main strength of IPA as a research methodology lies in the detailed description of 
the interpretative analysis. 
 
3.5.3 Hermeneutics 
 
Following in the footsteps of Husserl, his student Martin Heidegger sought to 
further develop the underpinnings of the hermeneutics concept with his theory of 
interpretation. While IPA researchers view the participant as the experiential 
expert, they acknowledge that experience cannot be revealed. Instead, the 
process of rich engagement and interpretation involving both the researcher and 
researched is required for an understanding to be reached (Smith et al., 2009). 
This can be seen in Figure 3.2. 
 
Figure 3.2: Process of Understanding - PA+RU+REF=U 
 
Adapted from: Smith et al. (2009) 
1 2
4 3
Process 
of 
Understanding 
Researcher 
Understanding (RU)
Similar to the participant, however, the 
researcher is striving to make sense of 
what is being said or written. This 
involves close interpretative 
engagement. 
2
Reflexivity (REF)
The researcher is required to be aware 
of their own perceptions and be 
reflexive through out and follow the 
hermeneutic process. 
3
The Participant (PA)
The participant is engaged in the
interview and the telling of their story.
Drawing on their life-world to make
sense of their experiences of living with
MM.
1
Understanding (U)
Understanding is achieved by not
separating the researcher from the
research in order for full understanding
to be achieved.
4
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This engagement is commonly referred to as the double hermeneutic approach to 
analysis, whereby the researcher seeks to make sense of the participants making 
sense of their world (Wilson, 2018). To allow for this to occur, IPA researchers are 
required to engage with what is known as the hermeneutic circle. The hermeneutic 
circle can be thought of as an iterative process involving moving between the 
smaller units of meaning and the larger units of meaning, or between the parts 
and the whole of the investigated phenomena or lived experience. Table 3.2 
illustrates that each sentence and section of the transcription was subsequently 
examined to expose meaning and identify the experiences of each participant 
(Smith et al., 2009). 
 
Table 3.2: The Hermeneutic Circle 
The Part The Whole 
The single word The sentence in which the word is embedded 
The single extract The complete text 
The particular text The complete oeuvre 
The interview The research project 
The single episode The complete life 
 
It was clear that IPA was the most appropriate approach and directly informed the 
further development of the research questions, data collection methods and data 
analysis. Smith et al., (2009) discuss the similarities between IPA and social 
constructionism as the IPA methodology strives to reveal the lived experiences of 
the individual and determine the meaning and impact within their own life and that 
of their family/significant other. Gadamer (1976) argues that when 
analysing/interpreting the narrative, the researcher is trying to make sense of the 
text rather than the participant. This supports the work of Heidegger, hermeneutics 
and the challenges between the interpreter and the interpreted.  
 
3.5.4 Idiographic Approach 
 
The basic principles of IPA feature a hermeneutic and idiographic approach 
focusing on the particular, rather than the general. This approach demonstrates 
an understanding of how distinct groups make sense of specific phenomena in a 
 __________________________________________________________________________ 
79 
 
context (Smith et al., 2009). This IPA approach was necessary from the outset to 
achieve an “insider’s perspective” (Larkin & Griffiths, 2002, p.284) and to develop 
a deeper understanding of the lived MM experiences. It is therefore inductive, (by 
rejecting hypotheses) and the idiographic procedures of IPA help achieve the 
research aims and answer the questions. The focus of an IPA researcher is on 
idiographic inquiry, as compared to a nomothetic inquiry. This idiographic 
commitment has a two-level function. Firstly, the IPA aims to explore in detail the 
experiences of individual people in particular contexts. Secondly, from a 
methodological stance, the analysis is detailed and very intensive to present 
accounts of a small number of participants (Smith, 2017). In the findings, the 
narrative that is used to represent the whole group must always be traced back to 
the level of the individual. Larkin et al. (2019) posit that there must always be a 
balancing act between description and interpretation when conducting an IPA 
study.  
 
Within this research approach, I strived to be consistent and compatible with the 
hermeneutic and idiographic approach of IPA. The individual interviews, in 
contrast to the dyad interviews, presented a new multi-perspective approach that 
permitted rich data to be collected from both YP and their family/significant other 
(Larkin et al., 2019). Consequently, IPA can be viewed as idiographic as the 
individual’s experience and the meaning of that experience is of paramount 
importance. Researchers utilising the IPA approach endeavour to understand the 
participants trying to make sense of their world, with detailed analysis involving 
the linguistic, affective and physical being, which Smith & Osborn (2003, p51; 
2007) refer to as the “double hermeneutic”, allowing for deep interpretative 
analysis at the level of the individual.  
 
3.5.5 Positionality and Reflexivity in IPA 
 
It was clear from the initial planning stages, and from subsequent discussions with 
my supervisory team that IPA was a research methodology that appealed to me 
both professionally and personally. The impact of how a cancer diagnosis affects 
the individual life trajectory and that of their family/significant has always been of 
particular interest to me. Being a paediatric nurse through training in the early 
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1990s, family centred care has always been an important consideration for me 
and is enshrined within the philosophy of Child Health nursing (Darbyshire, 1994; 
Coyne, et al., 2016; Arnett, 2006).  
 
As identified in the Chapter 2 literature review, there is no national or international 
research focusing on the experiences of YP living with MM or the impact on the 
family/significant other. Within the IPA approach, identifying the researcher's 
positionality and being reflexive is essential, and the two are linked closely to the 
concept of ‘bracketing’ and ‘hermeneutics’ as discussed earlier in this Chapter. 
Within IPA, bracketing is recognised as not being entirely possible, nor should we 
want to use it within this methodology (Smith et al., 2009). Being transparent and 
reflective throughout the research process supported the participant’s own 
narrative and my understandings to ensure that the interpretations were grounded 
and authentic of the participant’s stories. It is important to stress here what the 
dialogue brings to the text and what the text brings to the researcher (Smith et al.,  
2009). I acknowledged the inevitability of biases and assumptions when 
conducting this research and kept a reflexive audio diary throughout. It is 
suggested that researchers using IPA reflect on how this shapes their research 
inquiries and, following Gadamer (1976), they aim to engage with them entirely for 
understanding which ultimately allows for the ‘fusion of horizons’. When this fusion 
occurs, there is an understanding concerning the researcher and the researched 
(Wilson, 2018).  
 
3.6 Methods  
 
The methods employed within the study are discussed within this Chapter in four 
parts to explain the analytical journey taken as well as providing a coherent and 
logical account of the data collection and data interpretation methods in keeping 
with an IPA approach. Firstly, participant selection and recruitment criteria are 
discussed, along with the ethical considerations required and ethical approvals 
pertinent to this study explored. Secondly, the data collection methods are 
examined in some detail, analysing the congruence to the methodology. Thirdly, 
a number of the theoretical approaches to qualitative data analysis are examined, 
before a reasoned argument for the approach used in analysing the data is 
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presented. The work of Smith et al. (2009) underpins this overall approach. Lastly, 
the steps taken to ensure credibility and rigour during the analysis process are 
made explicit following Yardley’s (2000) four broad principles for assessing quality 
in qualitative research thus strengthening the personal trustworthiness of the 
research. I have followed the guidance of consolidated criteria for reporting 
qualitative research (COREQ) to build rigour in this section of my thesis (Tong, 
Sainsbury & Craig, 2007). 
 
3.6.1 Selection of Research Participants  
 
This study focuses on YP who had been newly diagnosed and had lived with MM 
for less than five years. I wanted to capture the YP’s experience in this time rather 
than living after the treatment and surviving this disease. The family/significant 
other were also included as they play an essential role within the age group I was 
considering, and this group had been a notable exclusion from previous research. 
The proposed small sample size of the study was appropriate to a qualitative IPA 
methodology to capture and illuminate the lived MM experience. 
 
In Scotland, there are approximately 14 YP between 16 to 24 years of age 
diagnosed with MM each year. Although this disease is more common in females 
than males, it was hoped that recruitment of both genders would have been 
possible comprising three men (n=3) and three (n=3) women (ISD, 2019), six 
(n=6) family members/significant other. However, as the number of YP diagnosed 
with this disease is relatively small compared to other cancers, and once they are 
treated, it is often difficult to follow them through the journey. 
 
3.6.2 Population  
 
The researcher and the Clinical Nurse Specialists (CNSs) confirmed the 
participant inclusion/exclusion criteria before obtaining consent. The 
inclusion/exclusion criteria for all participants are outlined in Table 3.3, stating the 
inclusion/exclusion criteria. 
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Table 3.3: Inclusion and Exclusion Criteria 
Inclusion Criteria: Exclusion Criteria: 
• Aged 16 to 26 years.  
• Family members aged 16 to 80 
years.  
• Male or Female. 
• Malignant Melanoma, Stages 1 to 
4.  
• Live within Scotland.  
• English speaking. 
• <16 years and >26 years. 
• Young people with severe cognitive 
impairment.  
• All other cancers. 
• Non-resident in Scotland.  
• Non-English speaking. 
 
 
3.6.3 Population Size 
 
The original intention was to recruit twelve (n=12) participants, six YP (n=6) and 
six family/significant other (n=6). However, two (n=2 female) withdrew on the day 
I was scheduled to meet and interview them at very short notice. It was not the 
intention to interview each young participant at each specific stage of their cancer 
journey but rather understand individual experiences at different stages of the 
journey for the YP and their family/significant other. Table 3.4 illustrates the 
participant representation across Scotland, presented anonymously. 
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Table 3.4: NHS Scotland Health Board Participant Representation 
NHS Scotland Health Board Participant Representation 
 
 
NHS Greater Glasgow & Clyde 
 
2 
NHS Grampian 
 
4 
NHS Lothian 
 
4 
Total 
 
10 
Participant 
Numbers 
Male Female Total 
Young 
People 
 
4 1 5 
Family 
Members 
 
2 2 4 
Significant 
Others 
 
1 0 1 
Total  10 
 
3.6.4 Sampling 
 
Convenience sampling was considered to provide the researcher with the most 
accessible participants, for example, all within the one geographical area, which 
would have been practical (Polit & Beck, 2010). However, this is not the most 
rigorous sampling types and would not gather the data required to answer the 
research aim and questions fully. Given the relatively small number of YP 
diagnosed with MM in Scotland each year, recruitment across the country was an 
important consideration. As a specialist nurse, I often cared for YP from the North 
of Scotland who had a different treatment experience through their cancer journey 
compared to those who lived in the densely populated 'central belt' of the country. 
I wanted to explore these different experiences from across Scotland rather within 
one specific region.  
 
A purposive sample of participants identified by the CNSs ensured the sample 
was experiencing the phenomenon (Silverman, 2006). Also, it would have been a 
challenge to have recruited ten (n=10) YP with MM from one centre when there 
are only approximately 14 YP diagnosed per year with this disease across 
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Scotland (CRUK, 2019b; ISD, 2019). Purposive sampling allows the researcher to 
be selective in the choice of participants for the study and to ensure transparency 
(Bryman, 2008). Concerning purposive sampling, the size and the individuals 
selected are decided upon at the beginning of the study. In some forms of 
qualitative research, one should continue data collection until saturation has been 
reached, however in IPA it is not the quantity but the quality of the data that is 
important and the richness of the individual cases (Bryman, 2008; Smith et al., 
2009). Typically, the number of interviews in IPA studies tends to be around 10-
15 although as a PhD student Smith et al. (2009) suggest three to eight is sufficient 
given the volumes of data to analyse, categorise and interpret.  
 
3.6.5 Access to Participants 
 
Access to the Primary Treatment Centres (PTCs) in this study was granted via the 
research passport process with full compliance with the necessary Disclosure 
Scotland procedures, as shown in Appendix 1. Professional indemnity insurance 
for the research was arranged through ENU and the Royal College of Nursing 
(RCN).  
  
3.6.6 Ethical Considerations 
 
Ethical considerations are important within the context of healthcare research 
because any exploration which has an impact upon the lives of people can 
generate ethical problems (Beauchamp & Childress, 2001). Ethical considerations 
were an initial concern in the planning phase of this study, particularly around the 
restricted size of the potential sample population spread across the three centres 
and the possible concerns around maintaining participant anonymity. These 
ethical issues were considered throughout the development, implementation and 
execution of this study and in particular around the IPA methodology employed. 
The adoption of the IPA methodology presented several ethical challenges 
including avoiding any risk of harm when talking about sensitive and personal 
issues, and the need to ensure informed participant consent at every stage in the 
research process. 
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3.6.7 Ethical Approval  
 
As a registered Child Health Nurse, the researcher is professionally accountable 
for ensuring that the ethical principles such as autonomy, non-maleficence and 
beneficence are integral to professional practice (Nursing and Midwifery Council, 
2018) and was aware of this when considering the age of the participants that 
would be included within the study.  
 
Ethically it would have meant gaining access to the children’s hospital centres 
along with TYA units and adult centres. After careful consideration of the ethical 
issues, and the need to recruit participants within a realistic timeframe, the age 
range for participants was increased from 13 to 24 years of age to include those 
aged 16 to 26 years old for both practical and ethical reasons. This change was 
endorsed by the researcher's own Higher Education Institution (HEI), ENU and 
the NHS Integrated Research Application System. Increasing the age range 
meant that recruitment could be commenced quickly within the agreed research 
timescale, and there were fewer administrative requirements as the number of 
specialist centres reduced from six to three. 
 
The first step in the ethical approval process was to obtain the consent of the ENU 
Ethics Committee. In tandem, the researcher applied to the NHS Integrated 
Research Application System to attend the next appropriate Standards and Ethics 
Committee (SEC) meeting. The researcher, along with the Director of Studies, 
attended the SEC meeting on 28th September 2016 in Edinburgh, to obtain the 
committee’s approval and support for the proposed research. The 18-month 
ethical approval process is summarised in Figure 3.3.  
 
  
 __________________________________________________________________________ 
86 
 
Figure 3.3: Timeline 
 
 
 
During December 2016, both in-house HEI ethics committees (FHLSS/1787 
Version no.2) and NHS Lothian consented to the proposed research programme 
and approved access to the required research participants (2016/0319). This 
access to the individual participants was valid until 12th December 2017. 
Subsequent to NHS Lothian approving the research, a formal Research Passport 
was required to obtain multicentre approval from three NHS Boards across central 
Scotland. Formal approval for the Research Passport was obtained in January 
and February 2017 for each of the three sites, after several review meetings, 
including attending the Clinical Trials Executive Committee (CTEC) at the Beatson 
West of Scotland Cancer Centre in Glasgow. Data collection in each of the 
individual sites commenced shortly after formal approval was received. Copies of 
the relevant ethical approval communications are included in Appendix 2, 3, 4 and 
5. It was clear that there would be challenges in gaining access to the patient 
group and this was recognised by both the SEC committee and the researcher. 
Within the agreed timeframe, the required numbers of participants were recruited 
to the study. I intended to recruit six YP (n=6) and six family/significant other (n=6), 
however ten (n=10) YP and family/significant other were recruited. 
 
3.6.8 Recruitment of Participants 
 
The key to the successful recruitment of the participants in this study was the 
supportive relationship and rapport established with the CNSs at each individual 
site. The CNSs were aware of the inclusion/exclusion criteria before the 
February 
2017
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Disclosure Scotland 
Approval Granted
September 
2016
Standards and 
Ethics (SEC) 
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December 
2016
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recruitment of the participants, and they were responsible for ensuring the criterion 
was followed. Without them, recruitment would not have been so swift. This part 
of the study was undertaken from January to November 2017. Due to the relatively 
small numbers of YP diagnosed with MM in Scotland, five (n=5) YP and five (n=5) 
family/significant other were recruited to the study. There were four individuals (n= 
4) and three dyads (n=6).  
 
Participants were recruited from three NHS Boards across Scotland. These were 
the three PTCs for Adults and did not include CYPs services. Recruitment was 
from the adult PTC's depending on where the young person was receiving care at 
the time of the research. Young people and their families/significant other from 
remote and rural areas were identified through the PTCs to ensure that YP with 
this disease from remote areas were included within the research. Young people 
were given the choice of an individual interview, or with the person, they chose as 
being paramount within their cancer journey. As discussed previously in Chapter 
1, recruitment was facilitated and supported by the Scottish Skin Cancer Nurse 
Specialist Group (SSCNG), who acted as gatekeepers to the research population. 
The SSCNG invited the researcher to discuss the proposed research before the 
study commencing. 
 
Table 3.5 summarises the main characteristics of the research population included 
in the study. All names are pseudonyms to protect individual privacy and 
confidentiality. There were a larger number of males to females, and most of the 
YP choose their mother or father to be included within the study as opposed to 
significant other as friend or partner. Helen chose her partner as her family lived 
in southern Europe. 
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Table 3.5: Research Sample Population Characteristics 
Participant  Age at 
Diagnosis 
(Years) 
Age at 
Interview 
(Years) 
Stage 
of 
Disease 
Occupation 
at Interview 
Family / 
Significant 
Other 
Age at 
Interview 
(Years) 
John 
Male 
16 19 2B University 
Student 
Eve 
Mother 
521 
Paul 
Male 
21 23 3A Health 
Administrator 
Anna 
Mother 
521 
George 
Male 
21 23 3A Mechanic Richard 
Father 
722 
Patrick 
Male 
11 16 3B Starting 
College  
Terry 
Father 
382 
 
Helen 
Female 
25 26 3B Hotel 
Manager 
Stuart 
Partner 
262 
(1= single interview). (2 = dyad). 
 
Table 3.6 summarises the biographical narrative of each the anonymized 
individual participants. 
 
Table 3.6: Research Population Biographical Narrative. 
Participant Research Population Biographical Narrative. 
John 
Dyad: No 
John, a young male, was 16 years of age when he was diagnosed with 
Stage 2 MM on his neck. The mole and part of the lymph were surgically 
removed, and no further treatment given aside from routine follow-up 
check-ups. The surgery has left a scar. They are a close family with 
support from extended family and friends. 
Eve 
Dyad: No 
Eve, John's mother, was 52 years of age and a registered adult nurse. 
Both mother and son had a close bond. Since the time of diagnosis Eve 
had been blaming herself for the disease. John's father suffers from 
anxiety and depression, which prevents him from working. 
Paul 
Dyad: No 
Paul, a young male, was 21 when he was first diagnosed with Stage 1 
MM. The mole was surgically removed, but the MM reoccurred six 
months as a Stage 3 MM. Further surgery was required and followed 
with regular check-ups. Paul has widespread scarring on his neck as a 
result of the surgery. Growing up, he suffered from bad acne and was 
on medication which contributed to his severe depression.  
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Anna 
Dyad: No 
Paul's mother, Anna, is 52 years of age and worked in insurance. Anna 
was separated from Paul's father and had one son, Paul. Although 
mother and father were separated, they remained a close family.  
George 
Dyad: Yes 
George was first diagnosed with Stage 3 MM at the age of 21. The 
surgery left a scar to his head. Regular follow-ups continued. George 
lived at home with his parent's, twin sister and two other older sisters. 
The family lived in the country far from the specialist hospital but had 
easy access to private transport.  
Richard 
Dyad: Yes 
George’s father, Richard, is in his 70’s had cared for George and his twin 
since birth. They were a close family unit and lived in the country. 
Patrick 
Dyad: Yes 
Patrick was a young child of 11 when first diagnosed with Stage 3 MM 
in his leg. He was first diagnosed in 2011 then again in 2015. He lived at 
home with his father and younger brother. He had missed a lot of school 
from being in hospital.  
Terry 
Dyad: Yes 
Patrick’s father, Terry, cared for his two sons. Patrick’s mother did not 
live with them. Terry lived some distance from the hospital but was able 
to drive. 
Helen 
Dyad: Yes 
Helen, a young woman, lived with her partner, Stuart. At the age of 25, 
she was diagnosed with Stage 3 MM on her abdomen. The mole was 
removed, followed by surgery to remove those lymph nodes that were 
affected. The surgery resulted in extensive scarring to Helen's arms and 
abdomen, and she was waiting to receive immunotherapy at a Specialist 
Centre. 
Stuart 
Dyad: Yes 
Stuart and Helen had been together for two years and lived together. He 
had been a great support since the initial diagnosis. Stuart had family 
close to where they lived. 
 
3.6.9 Informed Consent 
 
The principle of informed consent is enshrined in research practice, and mandates 
that prospective research participants should be given as much information as 
they require in order to make a voluntary informed decision about whether or not 
they wish to participate in the study (Bryman, 2008). As the CNSs were the 
clinicians who had access to the patients, they were able to identify those patients 
suitable for inclusion within the research. This allowed the YP not to feel coerced 
into being part of the study and could say no freely to their CNS, the person whom 
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they trusted. It was essential that informed consent was given and that they felt 
safe and confident during their participation. The researcher had to trust and rely 
on the CNSs who were the gatekeepers to support the recruitment phase of the 
study, which they enthusiastically supported. Within this process, gatekeepers had 
a key role in ensuring that researchers gain access to potential participants and 
sites for their research. Positive influences from the gatekeepers can be invaluable 
to the research process by facilitating the smooth running of research activity to 
completion (Miller, Birch, Mauthner & Jessop, 2012) and is favoured by the ethics 
committees. However, gatekeeping is not always a positive experience and can 
be challenging for some researchers, an example being where the gatekeeper 
may not want the patient to be involved in the research as a way of protecting 
them (Polit & Beck, 2010). 
 
The CNSs reviewed the Participant Information Sheet (PIS) and provided 
feedback before the PIS was discussed with potential participants. This was to 
ensure that the language within the PIS would be understandable for the 
participants to read. The CNSs were responsible for ensuring they understood the 
study before obtaining informed consent. The young person then chose a family 
member/significant other who was experiencing the cancer journey with them. 
This was explained to them by the CNS when the PIS was issued. The PIS was 
then given to the family/significant other by the young person before the 
researcher gaining consent from them. The PIS stresses the voluntary, 
anonymous and confidential nature of the research and Appendix 6 and 7 shows 
the PIS utilised for the YP and the family/significant other. 
 
Under Scottish Law, young people between 16 and over can make decisions 
about their own treatment and care and were able to give informed consent to their 
participation in the research (Scottish Government, 2014). Although the young 
person was able to provide informed consent, it is seen as good practice to involve 
the family where/when necessary. Appendix 8 shows the Informed Consent 
documentation for the YP and Appendix 9 contains the family/significant other 
document. It was not always possible for both to be given out together as the 
young person often attended the outpatient clinic appointment without their 
family/significant other.  
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3.6.10 Risk to Participants 
 
A diagnosis of cancer for the YP and their family can be devastating in many ways 
(Grinyer, 2007). The YP and family require a great deal of support, especially if 
the disease is incurable, and the researcher must be sensitive to this. The 
researcher has worked for over 30 years within this area of care, although mainly 
with children (Paediatric Oncology Nurse) and was very mindful of how upsetting 
it can be for the patient and their family. I was also mindful of being the 
independent researcher and not the professional nurse caring for the YP and their 
family.  
 
Due to the nature and timing of the study, YP may have unwell at the time of the 
interview, especially if undergoing treatment or were receiving palliative care. 
Participants may also be anxious or distressed when being interviewed. If this 
occurred before and/or during the interview, then it would be abandoned. If the 
young person or family member did become upset, the CNS would be notified and 
advice sought after the interview. It was agreed with the CNSs at the outset that 
information regarding the patient and family would be discussed before the 
interview and after gaining consent. It was also discussed with the participants, 
that if I was unduly worried that the interview had uncovered any challenges, I 
would inform their CNS. These risks were therefore managed by ensuring the 
participants were fully briefed and debriefed before and after their interview and 
advised if any distress arose. I was also mindful not to disclose any information 
that I had gathered from the YP that the family member was not privy to and 
therefore had to ensure confidentiality throughout. Appendix 10 shows the Risk 
Pro-Forma for the participants. 
 
For the reasons discussed above, the YP themselves decided when and where 
the interview should take place within the hospital and if they chose to be included 
in the study or not. This was discussed in detail with the YP and the CNS before I 
was contacted. They were assured that withdrawal at any point would not affect 
their care delivery in any way and that the researcher fully understood if this should 
happen. No one was coerced into participating in this study, and this was agreed 
with the CNS from when recruitment began. As a CNS for many years and as the 
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researcher of this study, I was fully aware that YP and others should be given this 
option in a non-threatening and non-judgemental way. As discussed previously in 
this Chapter, two young female participants withdrew from the study, on the day I 
went to interview them. Both participants came from the same geographical area, 
and a train journey of three hours was required to reach the destination. I had also 
contacted the specialist centre to ensure a quiet room for the interview was 
available. Both withdrew, on different days, and for varying reasons. An alternative 
date was offered, but I did not pursue this as it became clear they did not want to 
continue their participation in the research. Participants were debriefed 
appropriately and provided with a Participant Debriefing Letter by the researcher 
and/or CNS (Debriefing Letter) after the interview, as shown in Appendix 11.  
 
3.6.11 Confidentiality and Data Handling 
 
The Nursing and Midwifery Council, (NMC) (2018) states that nurses are 
professionally accountable for ensuring that confidential patient information is fully 
protected at all times. In this context, confidentiality has two fundamental 
elements. Firstly, the storage and handling of all data which contains personally 
identifiable details is a significant responsibility for the researcher and must be 
subject to robust and secure handling procedures. Secondly, the assurance of 
anonymity is based on these underlying procedures and intricately linked to 
maintaining the confidential nature of all patient information.  
  
In order to maintain participant anonymity, all publications and reports supporting 
this study, including this document, do not contain any identifiable individual 
information. All participants were allocated pseudonyms to protect their anonymity 
(Gerrish & Lacy, 2010) but it may be possible that some individual participants 
could be able to identify themselves through the inclusion of specific interview 
quotes and excerpts. However, individual confidentiality is assured as these alone 
should not be identifiable to others. 
 
To protect anonymity, the recordings and interview transcripts, audio files and field 
notes were stored in a secure computer and cabinet in ENU, which only the 
researcher could access. These materials are scheduled for destruction after 
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completion of the study and participants will be informed of this in writing. 
Destroying of all the research materials associated with this thesis complies with 
the General Data Protection Regulations 2018, a regulation in EU law on data 
protection and privacy for all individuals within the European Union and the 
European Economic Area. 
 
The data from the interviews are presented in an anonymised format which is in 
keeping with ethical guidelines for qualitative research. A random participant name 
was used to anonymise the participants in the data files and to bring the 
participants stories to life. This approach was in keeping with the idiographic 
underpinnings of IPA and the use of codes depersonalised the data. 
 
3.7 Data Collection  
 
When considering how to engage YP and their family/significant other, multi-
modal methods were considered and discussed with my supervisory team 
(Glasscoe & Smith, 2011). Multi-modal methods involve the gathering of data from 
different perspectives, such as through an interview and use of visuals. In the 
beginning, I was keen to use a multi-modal method to collect data which would 
include using images and emotional touchpoints to encourage the participants to 
talk (Dewar, MacKay, Smith, Pullin & Tocher, 2010). As the study would involve 
YP, I was concerned that they would not wish to communicate their story with me. 
However, I decided against using emotional touchpoints as they risked distracting 
the focus away from the questions I was seeking to answer. I also discussed 
carrying out the data collection at the well-known annual conference in the UK – 
Find Your Sense of Tumour.  
 
Focus groups over the last ten years have gained acceptance within nursing 
research and are popular in qualitative studies as they are designed to obtain in-
depth information in a non-threatening way (Polit & Beck, 2010; Parahoo, 2014). 
However, due to the nature of the IPA and that the participants are from different 
parts of Scotland, this would have been problematic and costly to have a group at 
one particular place and time and therefore was disregarded. In addition, through 
observational techniques, the researcher observes and records behaviour, but 
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does not interact with the participants. This method provides data collected within 
the natural setting of the participants but is often complex and time-consuming. 
Although all the above were considered, after discussion with supervisors, these 
were disregarded, as they would not yield the data required concerning the IPA 
approach.  
 
From the IPA perspective, understanding becomes possible through language, 
and therefore dialogue is essential. After much deliberation and considering the 
nature of the questions, I decided that the individual semi-structured interview 
would meet the requirements of this thesis and answer the research questions 
(Parahoo, 2014; Smith et al., 2009). However, as the YP were offered a choice 
about being interviewed individually or as a dyad, with their family/significant other, 
recent literature suggests that within IPA this is concerned with exploring a shared 
and distinctive experience which is important to two people. Larkin et al. (2019 
p186,) refer to this as a multi-perspective design, or “two sides to every coin”.  
 
3.7.1 Semi-structured Interview 
 
As discussed in the above section, in-depth semi-structured interviews were 
conducted with the participants from across Scotland. I intended to interview the 
young person first, but due to practical reasons and the need for some of the YP 
to be interviewed with their family/significant other, some were interviewed as a 
dyad. The first four (n=4) were individual interviews with six (n=6) being completed 
as a dyad. YP and their fathers and YP and their significant other. 
 
A social phenomenological perspective demands an emphasis on understanding 
the participant's experience of the world from their situation, and then interpreting 
how that understanding is inter-subjectively constructed (Eatough & Shaw, 2019; 
Eatough & Smith, 2008; Willig, 2011). In-depth interviews, therefore, offered an 
appropriate and compelling method to generate data which permitted such 
insights and reflections, allowing participants to reconstruct their understandings 
of a phenomenon (Smith et al., 2009) verbally. Conducting interviews face-to-face 
as opposed to over the telephone or via email also allowed the establishment of 
rapport, an important consideration when discussing sensitive topics such as 
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cancer and life experiences. The semi-structured interview enabled all participants 
to be asked the same core questions. Unlike the structured interviews, this design 
also allows for flexibility in the phrasing and the order of the questions being asked 
(Parahoo, 2006). This was an important feature as the participants all had various 
experiences, such as the ages and family dynamics of the individual YP.  
 
When planning the study, the Ethics Committee recommended that participants 
should not be interviewed at ‘home’ or in a ‘cafe’ but be approached when 
attending a suitable outpatient clinic appointment. This would minimise any 
disruption to the participants’ daily schedule and was included within the final 
research methodology. Interviews took place within the hospital environment in a 
private, quiet and comfortable area on the day of appointment or hospital visit to 
avoid any further personal disruption. All travel and subsistence costs were paid 
by the researcher if required. Using a familiar environment, specific to situated 
experiences of phenomena is suggested to enhance recall and solicit rich 
descriptions (Bloomberg & Volpe, 2008). The interviews lasted between 60 to 145 
minutes depending on if they were a dyad or individual and the length of the 
contributions made by the participants. It is suggested that participants may 
become tired and lose concentration after this time (Kvale, 2007). This can be said 
for the researcher also. A research interview does not merely ‘collect’ data, but 
instead generates accounts of lived experience and its meaning through an 
exchange of views and dialogue between the participant and the researcher 
(Kvale, 2007). The data is collaboratively produced within the relational context of 
the interview, with the researcher helping the participants to reach beyond the 
superficial layers of their experience in order to generate rich, novel and 
informative insights (DiCicco-Bloom & Crabtree, 2006). This was achieved 
through my own professional knowledge and experience as a nurse and 
academic. The interview schedule for the YP is presented within Appendix 12 and 
for the family/ significant other in Appendix 13. This provides a flavour for the types 
of questions that were asked of the YP and the family/significant other. 
 
The researcher was also able to probe the respondents where clarification was 
necessary (Bryman, 2008) by asking subtle questions so they could follow through 
with their experience. Although the telephone interview was a consideration due 
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to the geographical distance between the researcher and the participants, the 
telephone interview is less personal and generates different data. It would have 
been impossible to gauge the participant's body language and other non-verbal 
communication in order to accurately describe their feelings and experiences, 
without actually talking to them while observing them at the same time (Bryman, 
2008). The main limitation of the semi-structured interview was the time constraint, 
as the participants were from across Scotland and all were interviewed 
after/before their clinic appointment. The researcher required to be strict as there 
may be a tendency to exceed the time allocated for each interview. The researcher 
gave careful consideration when switching off the digital recorder, as vital data is 
often lost if the recorder is deactivated too soon (Bryman, 2008). As part of the 
interview planning process, interruptions were prepared for and in most cases did 
not occur. The semi-structured interview was an appropriate method of data 
collection as participants were very keen to talk, except one young participant who 
found it difficult to enter into the conversation and often left this to his parent. 
Perhaps the use of an audio-diary (Polit & Beck, 2010) for this young person would 
have been more appropriate, and they could have completed this at home and 
then returned it to me.  
 
Qualitative studies require consistency in the way in which data is collected so that 
there is fairness for each participant. An awareness of personal characteristics 
and how the questions were asked was identified, as there may have been a 
tendency for the participants to respond in a fashion that would please the 
researcher (Fossey, Harvey, McDermott & Davidson, 2002). The researcher, 
therefore, strived to facilitate a naturalistic and responsive interview as described 
by Bryman (2008). This includes the use of conversational language, incorporating 
terms used by the participants with attention to non-verbal communication, to 
convey an open, respectful and non-judgemental attitude. As paediatric oncology 
is the researcher’s specialist area, supervision was vital throughout the whole 
process to reduce subjectivity and guard against the possibility of coercion and 
bias (Polit & Beck, 2010). 
 
The researcher was also aware of what Roethlisberger & Dickson (1939) highlight 
as the 'Hawthorne Effect', where the observer's presence (researcher) cannot be 
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fully eliminated, which may lead the participants to behave in ways that are not 
'normal' for them (as cited in Parahoo, 2006). In considering this theory, although 
not observing the participant’s behaviour, the researcher was aware of the 
participants' non-verbal communication in the answering of the questions. The 
nature of the questions was sensitive, and the participants were assured that the 
content of the interview would be treated with the strictest confidence with all 
personal identities disguised by pseudonyms to ensure the anonymity of 
individuals and their place of employment (RCN, 2004; Orb, Eisenhauer & 
Wynaden, 2001). The participant's confidentiality was highlighted verbally and in 
writing and hopefully enabled the participants to share information in a non-
threatening way. 
 
In carrying out the interview, it was clear that I had to ask the participants what 
was important to them. The first interview was the ‘pilot’ or trial run, which allows 
the researcher time to gain confidence in their study and prepare them for the 
remainder of the interviews (Polit & Beck, 2010). This was important in moving 
through the data collection as I strived to be the ‘researcher’ and not the ‘nurse’.  
 
3.7.2 Recordings 
All interviews were digitally recorded with the participant's permission and 
transcribed verbatim. The recording is regarded as being best practice and 
ensures the rigour of the data collection process, but it is recognised that it may 
also be intimidating for people to have their conversations recorded (Silverman, 
2006). Before the interview and as part of the PIS, this was explained so that 
participants were fully prepared. The device I used was small, so did not seem to 
intimidate any of the participants. In practice, all the participants consented to the 
recording of the interviews prior to the interview commencing.  
 
The interviews were recorded digitally and then uploaded onto the researcher's 
computer and then shared with an external transcription service via a secure 
website to be transcribed. No notes were taken during the interviews as there was 
a requirement for the researcher to be fully immersed in the topics being discussed 
and to give the individual participants full attention. I felt to take notes would have 
been intrusive to the interview process. I did, however, make extensive field notes 
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following each interview, noting aspects such as how I was welcomed, what the 
dynamics felt like and key issues that were immediately apparent. Sometimes this 
was done on the digital recorder and others I wrote directly into the research diary. 
After the first four individual interviews, the CNS within one of the PTCs was 
present to speak to after. This was a great help in processing what had been 
discussed. I was also able to relay any worries I may have had about the 
participants, which had been agreed as part of my ethics approval. This was to 
prevent any risk occurring to the YP or their family/significant other. This approach 
was not repeated in all the other PTCs as the CNS was unavailable. During the 
data collection, the recorder was always kept in a securely locked drawer when 
not in use. 
 
3.8 Data Analysis 
 
Using a systematic approach, and with the respondents' consent, interview data 
were analysed using an inductive interpretative approach (Smith et al., 2009). 
Transcription of the data can be arduous, but as the literature suggests it is 
advisable to transcribe some if not all, in order to capture the actual essence of 
the material (Bloomberg & Volpe, 2008). Nevertheless, some researchers prefer 
to use other methods to immerse themselves in the data and have secretarial 
companies complete the transcription, however, this can be costly. For this study, 
the researcher opted to transcribe a small number personally and sent the 
remainder to a professional secretarial company. Once data transcription was 
complete, the researcher had the choice of manual data analysis and/or support 
from a computer-assisted qualitative data software called QSR NVivo. Each 
transcript was analysed separately both for the YP and then the family /significant 
other, whether as an individual or dyad. This was important as I was not sure at 
this stage whether the findings for the YP would be different from that of the 
family/significant other at this stage of the process. 
 
3.8.1 Processing of the Data 
 
QSR NVivo was used to facilitate the analytic process with the option of moving 
to a traditional ‘pen-and-paper’ approach with specific attention paid to the 
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transparency and consistency to ensure its dependability (Bryman, 2008). The 
QSR NVivo software was of great assistance initially in classifying, sorting, filing 
and retrieving data (Bloomberg & Volpe, 2008). Although the software is designed 
to support and assist in the management of the data analysis, as Bloomberg & 
Volpe (2008) suggest, it does not suit all researchers. In utilising this tool, I found 
that ultimately the software did not fully ‘open up’ and reveal the experiences of 
the participant’s as various ‘individual parts’ and then as a ‘whole’ population as I 
did not feel fully immersed in the data through this tool. As a result, and in keeping 
with IPA, I moved to a more traditional manual analysis methodology, utilising the 
tools available through the Microsoft Office 365 suite. Appendix 14 illustrates how 
each sentence and section of the transcription was subsequently examined to 
expose meaning and identify the experiences of each participant in keeping with 
IPA. 
 
The Microsoft tools meant that I could listen to the transcript and code at the same 
time. Data analysis is a continuous, reflexive process, with initial data analysis 
guiding subsequent data collection until no new findings are identified and is vital 
to the success of any research study (Rolfe, 2006). Utilising the software tools, 
individual interviews were analysed and coded, and then emerging sub-themes 
were systematically refined into a smaller number of super-ordinate themes 
(Bryman, 2008). Each sentence and section of the transcription was subsequently 
examined to expose meaning and identify the experiences of each participant. 
 
As discussed earlier in this Chapter, a branch of phenomenology was used to 
interpret the data. Through IPA, I had to strive to find meaning from the 
participant's experiences and to interpret this through an understanding of what 
they were telling me. Larkin & Thompson (2012) discuss the level of flexibility 
within IPA, describing the “considerable room for manoeuvre” within analytical 
strategies, which are influenced by the research itself and the interaction between 
the researcher and the participant. Nonetheless, Smith et al. (2009) provide 
guidance within the analytical process which ensures a systematic approach to 
help the researcher focus on the level of interpretative analysis that is required 
within IPA. The seven-step approach by Smith et al. (2009) was adopted, as seen 
in Figure 3.4. Further insight and guidance was provided through an IPA 
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workshop, ‘Thinking Qualitatively’, delivered by Dr Chris Darbyshire (2019) during 
May 2019. This section provides an overview of the structure and in relation to the 
theory for the first six steps. The thesis as a whole is presented as step seven in 
the process. 
 
Figure 3.4: Key Steps 
 
Adapted from: Smith et al. (2009) 
 
3.8.2 Seven-Step Approach 
 
Step 1 in the IPA analysis is reading and re-reading the data transcripts. This step 
is congruent with immersing oneself in the data and to ensure that the participants' 
account is the focus of the analysis. As already explained, the researcher 
transcribed some of the interviews personally, and the remaining were sent for 
external transcribing. However, re-listening to the interviews can also help 
familiarize the researcher with the flow of the interviews. Hale, Treharne & Kitas 
(2007) identified reading and re-listening to interviews as being helpful in 
‘recapturing emotion and intonation’. It was useful to repeat this step as there had 
been some considerable time lapse between collecting the data and analysing it, 
apart from some initial rudimentary analysis undertaken through field notes and 
my reflective diary. Whilst it could be argued that the time-lapse was not ideal, as 
Step 7: Writing up
Step 6: Looking for patterns across cases
Step 5: Moving into the next case
Step 4: Searching for connections across emergent themes
Step 3: Developing emergent themes
Step 2: Initial noting
Step 1: Reading and re-reading
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many qualitative researchers suggest data analysis should occur concurrently with 
data collection, this was borne out of necessity and in fact, proved to be useful as 
I found returning to the data provided me with a fresh approach, which allowed a 
more analytical stance.  
 
Step 2 involved initial noting, which was challenging but also creative as there are 
no rules to what to comment on (Smith et al., 2009). Following the IPA framework, 
I was able to explore and comment on including the descriptive keywords and 
phrases, linguistic and conceptual comments. This step of the initial level of 
analysis was the most detailed and time-consuming. As I moved through the 
analysis process, I became more familiar with the process and the data. I found 
that Steps 1 and 2 often merged. During this stage of the analysis, I also had the 
opportunity to attend an IPA programme/series of workshops facilitated by 
Professors Paul Flowers and Michael Larkin; two of IPA's founding authors. This 
opportunity provided me with a valuable learning opportunity which gave me 
confidence in my own analytic ability, as well as the procedural elements of doing 
IPA. While at the IPA workshops, the class were able to discuss and share notes. 
In this step, initial noting includes making different types of comments on each 
transcript including descriptive comments which help explain interpretative 
processes and provide a body of comments from which to draw upon when making 
the interpretative account of the experience. This approach was instrumental in 
aiding the interrogative process of analysing the data. Smith et al. (2009) also 
suggest examining the narratives from a linguistic perspective to analyse the 
meaning of the situation for the participant further. An example of Step 1 and 2 
can be seen in Appendix 15. In order to understand these codes more fully and 
identify any similarities between each of the participant responses, it was helpful 
to analyse the responses using a series of colour categorisations.  
 
The development of the themes is Step 3 and is also part of the conceptual 
process, where the descriptive notes can be used as source data for this process. 
After initial coding, the next stage is to identify emergent themes. In this stage of 
analysis, there is a shift from engaging with a focus on the transcript to engaging 
with the initial notes, which Smith et al. (2009) propose, if completed 
comprehensively should be closely related to the original transcript itself. This shift 
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to coding should maintain complexity and depth, which was created through 
exploratory coding while also reducing the amount of data. Smith & Osborn (2007) 
identified that when identifying emerging themes, the researcher should use 
concise phrases to capture the essence of what was found within the narrative. 
Emergent themes should be both grounded in participant’s accounts while moving 
to a high level of abstraction, whereby psychological terminology may become 
more apparent, for example 'life was put on hold', 'frightened and afraid'. This is 
where subthemes emerge, and the researcher then requires to sort these into 
themes to illuminate the experiences of the narrative as told to them. This part of 
the process can be described as almost like a tree with lots of branches, but the 
branches need to be attached to a stronger branch. Smith et al. (2009) stress the 
importance of the interplay between the participants and the researcher here, 
suggesting the researcher is actively engaged with the lived experience of the 
participant so that the resultant interpretation is based on the perspective of both. 
Themes become statements which explain the connection between the 
participant's transcript and the researcher's interpretation which captures an 
understanding of the experience. Appendix 16 contains an example of Step 3. 
 
After identifying all emergent themes, Step 4 is to search for connections across 
emergent theme titles and all corresponding extracts. This step is particularly 
helpful in practical terms as a data management tool. In essence, Step 4 involved 
mapping emergent themes across the data set looking for similarities, connections 
and relationships within the data sets. This can be seen in Appendix 17. To assist 
in the analysis process, I produced a mind-map to illustrate the main themes of 
interpretation that appeared to be emerging from the data. This mind-map, shown 
in Appendix 18, was used to discuss these main themes with my supervisory team. 
 
Smith et al. (2009) propose that remembering the importance of both the 
Interpretative and Phenomenology in IPA is essential for a comprehensive 
analysis, and emergent themes should move beyond mere description and 
instead mirror both the participant’s words and the researcher’s interpretation. The 
aim of identifying emergent themes is to engage with a more in-depth level of 
abstraction, which is reliant on the researcher taking a central role in the analysis. 
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Reflective journals, field notes in addition to transcript analysis, helped create 
deeper understanding related to the data. 
 
The process described above is repeated for each transcript. As IPA maintains an 
idiographic ontological perspective, Smith et al. (2009) suggest that the researcher 
must epoché or ‘bracket’ their assumptions in an attempt to reduce any researcher 
bias that could influence the data collection and data analysis processes. As 
discussed earlier in the methodology interpretation is very much via the 
researcher’s unique lens, informed by knowledge, experience, alongside 
reflexivity. Gadamerian hermeneutics approach rejects the notion of bracketing, 
instead embracing the active engagement of the researcher and their developing 
understanding as part of the process. I also believe that to truly bracket one's 
experiences is not possible within IPA and engaging with the participants and their 
life stories (Peat et al., 2019; Wilson, 2018). Therefore, I consistently followed the 
double hermeneutic circle, framework and steps by Smith et al. (2009). To ensure 
all the voices and narrative were heard, I required a visual in order to ensure all 
participants were represented and the experiences shared. The thematic mind 
map, as seen in Appendix 18 this and my ability to articulate to some of my 
colleagues to support me in finding reassurance in my findings. This was when 
the realisation of the sequential journey arrived and therefore, has been 
showcased in this way. 
 
Step 5 involved moving into the next case. After completing steps 1 to 4 of the 
analytical process, Step 5 involved repeating the same process for each 
participant/dyad to bracket assumptions and ideas which have been revealed 
earlier. Following guidance from Smith et al. (2009) the goal is to treat every 
transcript with fresh eyes with the aim to bracket assumptions and ideas which 
have become illuminated through previous analysis. Although this is not always 
entirely possible, following a systematically analytical procedure can help to 
minimise any priming which has been created through previous data analysis to 
ensure that new themes emerge. As expected, similarities between participants 
emerged as the analytic process continues, and emergent themes began to repeat 
through the transcripts.  
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Following the completion of the individual-level analysis, the next stage of the 
analytical process was Step 6. Once key themes were identified, Step 6 was to 
look for patterns across each case and involved abstraction and moving away 
from the idiographic underpinning of IPA. This meant searching for meaning in 
each of the cases presented and developing a new identity for the theme that 
encapsulated the shared experience. This was resolved by identifying the shared 
experience common across the themes and extracting the super-ordinate and 
sub-themes for each participant (Larkin & Thompson, 2012). At this stage, the 
researcher is seeking patterns and connections across the cases, recurrent 
themes, and exploring the possibility of themes in one case being able to solidify 
or illuminate themes in another. At this stage, I reorganised, edited and modified 
the themes, highlighting the iterative analysis processes within IPA. In this process 
of moving to group-level analysis, the researcher can engage with ideas of the 
hermeneutic circle looking for similarities to deepen the level of interpretation. 
Emergent themes naturally cluster together and from this main 
themes/superordinate themes and subthemes arose from across the whole data 
set. 
 
As the participants were young people with MM and their family/significant other, 
the IPA method allowed me to examine the data for similarities and differences in 
how MM is experienced from each of the participant’s perspectives. Since I had 
given the participants the choice of being interviewed individually or together, the 
different combinations of data sources presented challenges for the analysis 
process but also had advantages as the multiple perspectives of the experience 
were exposed. The difference in interviews was also interesting as the dyads who 
were interviewed together prompted each other at times during the interview, 
arguably revealing more and different information than they would have if 
interviewed separately. However, those who chose to be interviewed apart also 
reported telling me more than they would have about the effect of living with MM 
either form the young person's perspective or the parent/partner. The writing-up 
of the findings is discussed in Chapter 4 following a process of iterative and 
reflexive consideration. 
 
 __________________________________________________________________________ 
105 
 
3.8.3 Quality Assurance  
 
There are many frameworks available for assessing the quality and robustness of 
qualitative research (Elliott, Fischer & Rennie, 1999; Yardley, 2000). Rolfe (2006) 
suggests that there should be no rigid generic framework to establish rigour, as 
this has the potential to thwart the authenticity and creativity of the individual study. 
While IPA is firmly established as a rigorous qualitative approach (Eatough & 
Shaw, 2019; Wilson, 2018), some continue to try and challenge the scientific 
quality of IPA (Smith, 2010; Paley, 2014).  
 
The concerns relating to the level of freedom and creativity researchers appear to 
have regarding how IPA is performed, make it challenging to ensure the findings 
are credible and trustworthy (Smith, 2010). From the phenomenological 
perspective, IPA is more aligned to the philosophy of Heidegger than Husserl, with 
a strong focus on interpretation (Finlay & Ballinger, 2006). Furthermore, Smith et 
al. (2009) vigorously defend IPA, arguing that while qualitative methodologies are 
prescribed distinctly from quantitative methodologies, the strength of IPA lies in 
the intellectual and intuitive work performed at each stage (Smith, 2010).  
 
Interpretative Phenomenological Analysis is based on guidelines for good practice 
rather than strict adherence to specific frameworks, thus high-quality IPA research 
relies on the researcher’s professional and personal abilities and their proficiency 
in managing the complex demands at each stage of the process (Smith, 2010) for 
which training and education are essential (Smith et al. 2009). Yardley (2000) 
presents four broad principles for assessing the quality of qualitative research and 
in particular within IPA; (1) sensitivity to context; (2) commitment and rigour; (3) 
transparency and coherence (4) impact and importance (Smith et al., 2009). 
 
Yardley’s (2000) first principle is sensitivity to context, which begins in the early 
stages of the research process, and this was evident when considering the patient 
group and the ethical approval requirements. As my study concerned YP and their 
family/significant other living with MM, sensitivity was requested within the ethical 
approval process, mainly around the topic and where the interviews would take 
place. Yardley's second broad principle is commitment and rigour, which was 
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demonstrated in a number of ways and can be synonymous with the first broad 
principle. Commitment to the study was shown through my dedication and passion 
for this research and my commitment from the beginning of the PhD journey to the 
end. Throughout, I have strived to be reflexive and be aware of any personal bias 
resulting from the experiences I discussed earlier in the Chapter. According to the 
literature, reflexivity enhances the rigour and credibility of the IPA study, and this 
was also achieved through the multiperspective design I adopted (Larkin et al., 
2019). During the process, triangulation of data collection and analysis was 
utilised as a quality indicator to ensure credibility and achieve a rounded 
multiperspective understanding of the research topic (Elliott et al., 1999). The use 
of triangulation also built upon the rigour of searching and identifying the shared 
experiences, common in IPA. Convincing transparency and coherence in the 
presentation of the analysis and empirical data, Yardley’s third principle, was 
achieved by detailing every aspect of the data collection process and the 
framework used to code the data. Throughout the data analysis section, I 
presented the six steps of the data analysis to support the rigour, transparency 
and coherence of the findings. In addition, transparency refers to the degree to 
which all relevant aspects of the research process are disclosed, and my research 
has followed this throughout. 
 
The IPA approach is inherently idiographic and does not seek to find one single 
truth (Wilson, 2018; Yardley, 2000). Yet, it recognises the possibility of drawing 
single cases together for further analysis and moves towards more general claims 
based on exploring the particular more closely, and in essence the individual 
experience becoming part of the whole (Smith, 2019; Eatough & Shaw, 2019). 
Rather than empirical generalisability, it is more appropriate to consider IPA in 
terms of impact and importance, Yardley’s principle four, (Yardley, 2000; Smith et 
al., 2009) or as theoretical transferability which is consistent with other qualitative 
paradigms. Widespread dissemination through the CNS network, broader nursing 
education and practice along with further detailed exploration, will extend the 
impact, reach and importance of my research findings.  
 
The principles outlined above supported and maintained an interrogative and 
interpretative stance when reviewing and analysing the research narratives (Smith 
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et al., 2009). I aligned myself within the social constructivist/interpretive approach 
that is aligned to the work of Heidegger and Gadamer as this in close alignment 
with my personal and professional interests, the IPA approach and my 
experiences as an academic, researcher and a nurse.  
 
3.9 Summary 
 
This Chapter has provided a comprehensive overview of the methodology that 
underpins my selection of an IPA approach to answer the stated research aim and 
questions. It has illustrated how the theoretical perspective of IPA has guided the 
applied research practice, alongside the practical methods for this study. 
Engaging in this methodology of qualitative enquiry allowed constructive and 
insightful interpretative accounts of experiences that enrich understanding and 
reveal prominent matters within healthcare. Interpretative Phenomenological 
Analysis (IPA), offers a rigorous, somewhat structured, yet open and flexible way 
to perform research into specific lived experience (Larkin & Thompson, 2012). The 
robust theoretical foundation of IPA locates the research directly to participant's 
experiences, while meeting the framework described by Flowers, Smith & Larkin 
(2009). Larkin & Thompson (2012) clearly outline the theory and processes of IPA, 
which, when new to this qualitative approach, was helpful, building upon my own 
interest in philosophical theories and approaches within healthcare. Growing 
support exists for the use and recognition of IPA as a rigorous qualitative 
methodology, which yields value in healthcare research (Smith et al., 2009). IPA 
allows more room for creativity and freedom than other approaches (Willig, 2011) 
and provides an element of 'giving voice’ (capturing and reflecting upon the 
principal claims and concerns of the research participants) and ‘making sense’ 
(offering an interpretation of this material, which is grounded in the narrative 
accounts of the individual participants (Eatough & Shaw, 2019).  
 
The following Chapter 4 presents the findings, meticulously drawing upon the 
three philosophical perspectives; phenomenology (examining the lived 
experience), hermeneutics (interpretation of the lived experience and idiography 
(attention to particulars of individual stories). The researcher has attempted to 
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elucidate the participant’s experiences of the phenomenon through the final 
emerging four super-ordinate themes, and 12 sub-themes. 
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Chapter 4: Research Findings 
 
4.1 Introduction  
 
This Chapter aims to provide a rich insight into the experiences of YP living with 
MM and that of their family/significant other. Smith et al. (2009) suggest that as a 
novice IPA researcher, the discussion Chapter should be written separately from 
the findings. This allowed the researcher to be fully immersed in the interpretation 
of the narratives and findings without reference to the literature. Throughout the 
iterative analysis process, I strived to explore the essence of what the participants 
felt was real, true and important to them at this time. This reflected the 
epistemological and ontological foundation of IPA, which was fully discussed in 
Chapter 3 (Smith et al., 2009). In understanding that experience is subjective, and 
that IPA is concerned with the meaning of what people experience as a 
phenomenon rather than a direct reality, this was achieved through continuous 
adherence to the hermeneutic and idiographic nature of the IPA approach. 
Working within the hermeneutic circle, constantly and dynamically moving 
between the individual experiences along with the data set as a whole, I have 
carefully selected individual comments and stories from specific participants to 
illuminate each of the super-ordinate and sub-themes while being mindful of the 
idiographic nature of the study. This section of the thesis presents the findings 
from the multi-perspective design, through the individual or dyad interviews (Larkin 
et al., 2019). This was necessary as I worked through each of the interviews 
aiming to bring meaning to this thesis and its findings. 
 
In order to present a consistent analysis of the participants’ lived experience, a 
multi-perspective design supported by regular supervision supported my 
interpretation of the dataset was rigorous, credible and trustworthy (Larkin et al., 
2019). This approach was consistent with the IPA framework suggested by Smith 
et al. (2009). The detailed analysis of the lived experiences identified four super-
ordinate themes and 12 sub-themes, which encapsulate the experience of YP 
living with MM and that of the family/significant other. These super-ordinate 
themes are presented in Table 4.1. 
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Table 4.1: Super-ordinate and Sub-themes 
 
Super-ordinate Sub-theme Sub-theme Summary Theme Summary 
Is it Serious? Suspicious 
findings…what is it?  
Wondering about the 
change to their mole 
Finding and seeking 
support for the 
change in their 
moles, then worrying 
about the result and 
diagnosis  
The waiting game  Waiting to be taken 
seriously and worrying 
about the mole 
Being diagnosed How this diagnosis is 
reached and 
communicated 
Too Much  
too Young 
In-between Being young and 
having cancer 
Being young and 
being diagnosed 
with MM and what 
this means  
Uncertainty and fear 
about the future 
Life on hold and fear of 
the unknown 
A sense of guilt and 
helplessness 
Feeling guilty and not 
fully understanding why 
this had happened to 
them 
Not the Same A life less ordinary  Trying to adjust and 
cope with their new  
life circumstances 
Living with MM and 
the treatment 
experience which is 
different from other 
cancers 
The treatment 
experience  
Where, when, how and 
from whom they 
received care 
Feeling a fraud Not like other patients 
with cancer 
Time to Live  The scars tell a story The physical and 
emotional scars tell 
their story of MM 
Realising not on the 
same path as they 
were but with new 
meanings to their 
lives  
Supportive 
relationships 
Supportive family and 
friends being important 
within the journey 
New meanings Being positive, even 
when worry prevails 
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At the outset, I recognised that the experiences of many YP and their 
family/significant other could not be neatly separated and therefore decided to 
offer the YP the option of being interviewed separately or together. This was a 
practical solution as both the young person and their family/significant other often 
attended the clinic appointments together. This was an interesting finding in itself, 
as it was clear from the data that YP and their family/significant other were 
experiencing the MM journey jointly, and their experiences were interconnected. 
Due to these close interconnections, I opted to present the findings together and 
are not categorised by YP or the family/significant other. Young people in the 16 
to 26 age group may often find themselves experiencing a ‘boundary-crossing' 
(Valentine, 2003) where they are adults physically and chronologically but 
emotionally still firmly bound to their immediate family for emotional and 
psychological support. Their experiences could not be reported without reference 
to the impact on and support of the family/significant other. A visual representation 
of the four super-ordinate and 12 sub-themes can be seen in Figure 4.1 and these 
are discussed in more detail as the Chapter progresses.  
 
Figure 4.1: Super-ordinate and Sub-themes – A Visual Representation 
 
 
 
Table 4.2 illustrates the recurring themes and indicates whether the super-
ordinate theme is present for each participant. Although negative case analysis 
was considered for Helen and Stuart, as they were the only ‘couple’ in the study, 
Young 
Person & 
Family / 
Significant 
Other
Not the Same Too Much too Young
Time to Live Is it Serious?
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it is not commonly seen within IPA as the sample is ordinarily homogenous with 
the objective of finding a shared thematic understanding from the participants 
(Smith et al., 2009; Willig, 2011). Negative case analysis involves searching for 
and discussing elements of the data that did not support or contradicted patterns 
that emerged from data analysis (Polit & Beck, 2010). However, following the 
rigorous double hermeneutic circle approach and searching for the shared 
experience, it became apparent that this was not what I had uncovered. During 
data analysis, similarities in their experiences of living with MM were interpreted 
as being shared with other participants, and therefore this was ruled out.  
 
Table 4.2: Identifying Recurrent Themes 
 
Superordinate Themes 
 
Participants 
Is It Serious? Too Much 
Too Young 
Not the Same A Time 
to Live 
John ü ü ü ü 
Eve ü ü ü ü 
Paul ü ü ü ü 
Anna ü ü ü ü 
George ü ü û ü 
Richard ü ü û ü 
Patrick ü ü û ü 
Terry ü ü ü ü 
Helen ü û ü ü 
Stuart ü û ü ü 
 
 
4.2 Key Findings – Telling Their Story 
  
For the purposes of this Chapter, the super-ordinate and the sub-themes are 
discussed along the continuum order of the cancer journey to provide 
transparency and natural flow to each journey. The exact sequence and timing of 
each individual cancer journey may vary, but all follow their inherent logic, with a 
beginning, middle and end. I have opted to illustrate the experiences of YP against 
the continuum of their MM to aid the reader in understanding the journey and the 
perceived lifeworld of each individual. Within the study, the findings were reported 
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utilising the idiographic and the double hermeneutic approach as required by an 
IPA methodology and a reliable co-creation of their stories.  
 
To begin, I revisit the first step of their journeys, when each participant was living 
their everyday life and going through their mundane daily routine when they or 
others came across a change in their mole. Recognising that the mole had 
changed and required attention, waiting for this diagnosis through to the impact of 
the diagnosis was a significant part of living with MM and beyond. I have chosen 
to present individual participants and/or dyad per sub-theme, keeping to the 
idiographic nature of IPA, which in turn presents something unique to the particular 
participant and overall experience. By limiting the number of quotes to illustrate 
the themes, it ensures that the researcher is fully immersed in the data analysis 
while at the same time being interpretive of the participant's stories. 
 
To assist in the identification of the individual participants and their specific 
narrative, Table 4.3 highlights the colour coding approach that has been adopted: 
 
Table 4.3: Participant Colour Coding 
 
Young Person Family/Significant Other 
• John • Eve 
• Paul • Anna 
• Patrick • Terry 
• George • Richard 
• Helen • Stuart 
 
This colour coding allowed for the individual voices to be heard throughout the 
detailed analysis, which is a critical component of the IPA approach. 
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4.3 Is it Serious? 
 
 The title of this Super-
ordinate theme reflects the 
beginning of a journey from 
discovering the mole or 
seeing a change in their 
existing mole(s) through 
their regular daily routines 
such as bathing or going to the hairdressers. This discovery caused initial 
bewilderment, with the YP wondering whether the mole was serious or not, 
followed by the worry in waiting for further information to finally being shocked 
when the confirmatory diagnosis finally arrived. This experience for most was long 
and traumatic. Many of the participants were uncertain and not sure what this 
change in their mole meant, but continued to worry. It was difficult for them to find 
support from either their GP or Dermatology clinic. However, when the mole was 
removed, and the diagnosis received, they felt shocked and frightened about how 
they were going to cope with the disease. Although the YP all had family/significant 
others to support them and protect each other, they also felt alone and isolated.   
 
The question ‘is it serious’ was asked by all the participants at an early stage, and 
represented the beginning of their emotional journey through MM. This theme had 
three interrelated sub-themes that were common throughout most of the 
participant’s narratives: ‘Suspicious findings…what is it’, refers to the YP and their 
family/significant other noticing the change in their mole; ‘The waiting game’ refers 
to their numerous GP and other appointments before being taken seriously; and 
‘Being diagnosed’ which refers to being told that they have skin cancer. It became 
clear why the participants have referred to the mole as ‘it’ as we move through this 
Chapter, and the participants’ stories unfold to illuminate each of the themes. 
 
4.3.1 Suspicious Findings…. What is it? 
 
Feelings of bewilderment and confusion about the symptoms which they or others 
had found were present in all the participants’ experiences. Most of the YP had 
Young 
Person & 
Family / 
Significant 
Other
Not the Same Too Much too Young
Time to Live Is it Serious?
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either noticed their mole had changed in shape and size while bathing or going to 
the hairdresser. This was the beginning of their journey of noticing worrying 
symptoms and wondering whether it was serious or not. This was common across 
all of the participants, and most were able to provide vivid descriptions of the 
changes in their mole but were unsure about its seriousness or potential impact. 
These participants were going about their daily lives when they came across a 
change in the mole. This initial discovery for most of the YP was relayed to their 
family/significant other and action was taken by arranging to go to see their GP or 
be seen at a Dermatology clinic.  
 
Paul was 23 years of age when he described his experience, although he was first 
diagnosed with MM at the age of 21. He had lived with two reoccurrences of MM 
up to this time. He was an only child and lived at home with his mother, Anna, who 
was separated from Paul’s father. Paul’s experience was different from the other 
participants as he had lived with severe acne all his teenage years. He had grown 
a beard to hide his acne and therefore had not noticed the mole growing 
underneath. Paul's acne was being treated with medication which had serious side 
effects, most notably depression and he often felt suicidal. He was not sure why 
the Dermatology clinic had not noticed the changes in the mole first, before anyone 
else. While shaving one day, he had come across the mole under his beard and 
had recognised that something was not quite right as the mole was red and 
appeared to be growing. 
 
"well I normally had a beard, so it was covering up the mole that was 
red and growing, so I'd never really noticed it before, but I'd notice 
while having a shave, so I was like 'what am I meant to do with this?" 
(Paul) 
 
Despite his beard, Paul had noticed that the mole had become inflamed and was 
larger than usual, but he was not quite sure what to do. His bewilderment and 
recognition that these symptoms were worrying/out of the ordinary are seen in his 
comment “what am I meant to do with this?” This was his first time noticing the 
changes to his mole. Paul went on to describe what he did next: 
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“I've been coming to this building (Dermatology) since I was 12 or 
something, so you would think they would have noticed, well I 
normally had a beard, so it was covering up the mole that was 
growing.’ I had an appointment coming up with Dermatology, so I 
waited” (Paul). 
 
There were three telling aspects of this experience. Firstly, Paul was receiving 
long-term dermatology treatment for his acne and expected that the specialists 
should have noticed the change in his mole at an earlier stage. Secondly, finding 
the mole while shaving had prompted him to remove his entire beard to take a 
closer look. On closer inspection, it became clear that something was wrong with 
the mole. Thirdly, despite his initial concern about the mole, Paul opted to wait 
until his next routine dermatology appointment, some two weeks later, before 
raising his concerns with any of the specialists. 
 
Anna, Paul's mother, also recalls the first time her son noticed the mole and 
related this to his long-term acne. What Anna remembers is that Paul was not sure 
if this was anything to worry about, and again, she thought it might be related to 
his ongoing acne. The uncertainty and ambivalence about whether or not there 
was something to worry about are reinforced here by Anna, and this seems a 
common part of the related experiences for both mother and son.  
 
"At first, I thought it was his acne because he had got bad skin, he 
thought it was just his skin, an old spot, you know, but when the 
beard was off you could tell it wasn't quite right" (Anna). 
 
It also appears that Anna was uncertain as initially, she had associated this with 
everyday acne spots. Similar to Paul, Anna also realised that the mole did look 
suspicious, especially once the beard was removed and they both could clearly 
see the mole. Again, there was an emphasis on uncertainty and ambiguity of 
whether or not there was something of concern. From Paul and Anna's accounts, 
there was a growing concern and worry, although they are still not sure what they 
had found. Two weeks passed, and they both describe what happens next after 
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the initial visit to the Dermatology clinic. Here Paul sees the specialist by himself, 
while Anna sits outside.  
 
"So, they had a look at it and then cut it out, so by that time I was 
very, I was down a lot, and then cancer came along and I was like, I 
just kind of felt like initially, like I don't know what I am going to do, it 
just made everything a lot worse. But then, that one was just Stage 
I. So, after that, it was fine" (Paul).  
 
Paul’s first encounter with his Stage I happened when he was already emotionally 
depressed and at a low point in his life. The acne medication he was receiving had 
contributed to his depression, which made the MM experience far worse. 
However, the mole was excised, and life went on as usual, and his mother's 
comments confirm Paul's recollection:  
 
“Anyway they removed that and we got over that quite quickly and 
life went on and then next minute he’s going ‘I think I got a lump' and 
I felt it and I can't feel anything and then it came up and then again, 
we knew exactly, I looked at the Internet, everything was pointing at 
it coming back again” (Anna). 
 
The shared first experience between Paul and Anna was significant in that they 
seemed not to be very worried. From Anna's account above the mole was excised 
and all appeared to be well, it was over and "life went on”. This experience 
continued for a further six months until another episode arose when shaving, Paul 
found a lump in his neck, but this time it was more sinister. Worry set in for them 
both. This experience was building up to a significant interruption to both their 
lives. They both knew exactly what it was, and they allude to this here. Underneath 
the veneer of a positive outlook, there was a foreboding feeling building. Anna's 
worry prompted her to search the internet for answers to what she was suspecting. 
The lump seemed to protrude from his neck when he swallowed, and Paul 
descried this lump as being “massive”. Here Paul talks about the lump rather than 
the description of the mole itself: 
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"I had a shave one day, and my mum hears ‘oh shit’ and then she 
says 'what's wrong with you?' ‘This lump is pretty big mum!' That 
was a little bit of a shock, seeing how big it was, it wasn't that large, 
but when I swallowed it popped right out'… so by this time, it was 
growing massively; I was like 'it's obviously back” (Paul).  
 
Paul was experiencing shock and concern over the size of the lump he had found. 
By calling out “Oh shit," he was describing his sudden shock and calling for his 
mother to come and see what he has found. His mother hears this and rushes to 
the bathroom. They are both now aware that the disease had returned, but this 
time it was different as it was a “huge lump” in his neck. Once again, feelings of 
foreboding are coming through, that something was seriously wrong, but they are 
not sure what. What was apparent at this stage is that neither Paul or Anna are 
using the words MM or cancer, and this was common throughout all the 
experiences and is highlighted here through Paul’s story.  
 
Paul and Anna initially describe that they were not so worried about the mole, nor 
were they sure if the mole was cancerous. However, when the disease spread to 
the neck, they became distraught. This was where all the participants highlighted 
that there was a gradual transition to growing concern. The change from mole to 
lump was common in most participants. All had a second or third reoccurrence 
and went on to find a lump rather than a change in their mole (i.e. MM had 
infiltrated into the lymph system, and the disease had spread). This was a 
collective experience for most apart from one young man, John, who had one 
occurrence and was treated for this. Along with feelings of suspicion, there were 
similar emotional and physical changes described by Paul and Anna, which 
shaped the journey of living with this disease.  
 
George and his father Richard, who shared their experience as a dyad, had a 
similar story to Paul and Anna. George was 21 years of age when first diagnosed 
with Stage III MM. He was 23 years of age when interviewed. George, like Paul, 
had not initially noticed the mole as it was at the back of his head, hidden by his 
hair. He had lived most of his life with moles and had not noticed any changes. 
For George, going to his hairdresser for his routine haircut was how the mole was 
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found. The hairdresser was worried by the mole’s colour and the fact that it did not 
look quite right. Because the hairdresser was worried and had mentioned the mole 
to him, George was prompted to make an appointment with his local Doctor 
straight away. George and Richard did not delay and immediately contacted their 
GP for an urgent appointment. This was a similar reaction for all the other 
participants, apart from Paul. 
 
"I was off getting my haircut, and my hairdresser went 'that mole 
doesn't look right'. So, I made a Doctor's appointment just to get 
checked, but it had got bigger, it had gone black and was all horrible, 
and they weren't happy with it, they weren't sure about it because 
it’s only just a little local Doctor.' I would say, if it wasn't for my 
hairdresser spotting it, I wouldn't have noticed it, because it was 
round at the side there and I don't see it" (George).  
 
Knowing that the hairdresser was worried, although vague in her description, it 
was enough to concern George. He was so grateful that his hairdresser had 
spotted a change to his mole as it was impossible for him to check the back of his 
head. He had been worried enough to make an appointment straight away. 
Although George’s local Doctor was unsure and did not appear to be experienced 
in skin cancer, he decided to remove the mole and send George for further 
investigation. Initially, neither George or Richard expected the GP to take their 
concerns seriously, but the rapid removal of the mole instilled confidence in the 
Doctor and his skills. Both were relieved that the Doctor had removed the mole so 
quickly. Being listened to, and taken seriously, was a positive outcome for them 
both which was not shared across most of the other participants who had 
numerous visits to their GP before the mole was eventually removed.  
 
“The GP kicked it off, and I would say, was exceptionally good. Well, 
we made the initial appointment for him, who's from the same part 
of the country as myself, he said 'aye, just send him up and we'll take 
it off and send it for analysis' and by the end of the appointment, he 
suddenly had four doctors standing about him saying 'we're no 
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touching that' and at that time, it was downhill all the way after that" 
(Richard).  
 
The father shares his worries with the local Doctor about the mole. This was similar 
to Paul and Anna's experience, although in this case, it was the father alone 
discussing his concerns and worries with the Doctor. The father feels he was 
listened to, and that action was taken. It was apparent that even the local Doctor 
knew that the mole required attention and that they would need to be referred 
urgently to the skin specialist. This local Doctor was not an expert in skin cancer, 
nor was he sure it was cancerous, but as it looked very suspicious, he removed 
the mole. Once again, this ambiguity and feelings of foreboding were building.  
 
In following the interviews through, I was keen to know if the moles had been 
painful or had caused some discomfort and wanted to know if this part of their 
experience prompted them to examine their mole? I also wondered whether this 
had delayed finding the change in their mole. I asked George: 
 
“Was the mole causing you discomfort, was it sore?” (Interviewer). 
“No, it wasn't sore; it never bothered me or anything. And they 
weren’t sure what it was, so that same day they said 'oh, we'll cut it 
off' because they can do that down there. So, they took photos of it, 
and they asked if they could use it for teaching students. Because 
they didn't know what it was, I said 'aye, that's OK. Everybody's got 
to learn'. So, they took it off, got a couple of stitches, and I was back 
to work the same day. And, I think it was a week later, I got, well, I 
was getting checked up after that, and they phoned me, and they 
said, 'we'd like to see you” (George). 
 
There were no painful symptoms from the mole itself, which was familiar to all the 
other young male participants, but there were changes to the colour and size of 
the mole. Professional uncertainty and ambiguity about the mole were also 
present throughout the participant’s accounts, which mirrored the initial 
uncertainty and ambiguity experienced by participants on first noticing their 
symptoms. George was very matter of fact and was able to return to work the 
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following day, resuming his normal life, until he received the urgent phone call that 
changed his experience as Dermatology wanted to see him straight away. From 
this point, he was monitored closely as the disease can spread rapidly throughout 
the body. 
 
At one appointment, the specialists felt a lump in his neck, and a biopsy was taken 
to determine the nature of the lump. This was George's second recurrence, and 
again, like many of the other participants, the disease has infiltrated into his neck. 
The disease had spread into the lymph, which is a common consequence of a 
delay in diagnosis. The second sub-theme, ‘The waiting game,’ explores the 
emotional and psychological impact of waiting for a diagnosis.  
 
4.3.2 The Waiting Game 
 
This sub-theme, ‘the waiting game’, summarises the numerous and repetitive 
visits back and forth to the GP and the Dermatology unit. This captures the 
experiences of waiting for an appointment, being seen and then the feelings of 
anxiety while the GP or Dermatology specialists delivered the biopsy results. 
Although the young participants reported that they did not feel ill, unlike many other 
patients with cancer, waiting for the GP to take their concerns seriously or to see 
the specialist seemed like an eternity. The waiting magnified the uncertainty and 
worry, which started at the point of discovery and was now prolonged until the 
point of diagnosis. This waiting for the initial diagnosis ranged from one to ten 
weeks. Apart from George, who had his mole excised immediately, all the 
participants had to wait before their moles were investigated. In the minds of each 
participant, the time taken for the initial diagnosis to be made seemed to be 
unending. However, after the diagnosis was made, the subsequent treatment 
seemed far speedier. 
 
During the waiting for a referral and for a diagnosis to be reached, each participant 
felt helpless and fearful. There were two telling aspects about this sub-theme 
which are highlighted through John and Eve’s experience. Firstly, ‘not being taken 
seriously initially’, and secondly ‘feelings of relief and their suspicions being 
validated’ before being referred to a specialist. John was 16 years of age when 
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his mother, Eve, first noticed the raised red spot on his neck. John was in his sixth 
(and final) year at school and looking forward to his future. John was the only 
participant who was diagnosed with Stage 2B, as defined in Chapter 1 and had 
no reoccurrence. Eve, his mother, was a nurse, and she was the one who spotted 
the change initially. John, like Paul and Anna, had presumed the initial symptoms 
were due to age-related acne/spots although his mother was worried about it: 
 
“My mum was a bit more sceptical about it. But, throughout, when 
the mole came up on my neck, I, stupidly, just thought it was a spot, 
I thought I was at that age and I just thought, oh no, I am starting to 
get spots, so I was putting things like Sudocream on it, it was a tiny 
bit raised and the circumference of it started to increase slowly and 
we’d been back and forwards to the Doctor and they had assured us 
it was OK and that was down at my local GP.” (John). 
 
As acne is more common in teenage boys, John had thought the change in the 
mole was typical of his age and was applying a cream to clear it up. In describing 
this initial finding, John describes how he ‘stupidly’ continued to apply a cream as 
if nothing was wrong. Eve, John's mother, was correct in her more pessimistic 
view of the situation, perhaps because of her professional training as an adult 
nurse. They had attended the GP on numerous occasions, and although John 
initially was not as worried as his mother, they were eventually referred to the 
Dermatology clinic. After a few visits to the GP, they were told that all was fine. As 
the Doctor suggested that all was fine, they decided to go on holiday, although 
growing worries about the changes to John’s mole continued to nag his mother:  
 
“So, we went to Tenerife, I kept worrying about it, and I kept staring 
at it while we were on holiday. And I kept thinking 'that's getting 
bigger'. And I thought 'oh, I'm not happy'. So, the whole holiday I was 
like, 'when can we go home?' And the day we got home, we flew in 
really early in the morning, and I had stayed up to call the Doctor at 
8:30 in the morning, but I had to be somewhere that day, and so I 
said to my husband would you take him to Doctor. But I don't want 
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you to leave the GP's without an appointment, an emergency 
appointment for Dermatology” (Eve).  
 
Eve was unhappy for the duration of the whole holiday and knew deep down that 
something was wrong. Experience had taught her to keep an eye on the mole (as 
a nurse). Eve was desperate to get home and seek professional advice as the 
mole continued to grow and change throughout the holiday, suggesting that 
something sinister and frightening was afoot. On returning home, an urgent 
appointment was made to try and resolve her fears. A sense of urgency was 
present here and desperation to get help. This time when they attended the GP, 
they saw a different Doctor who again was not worried, but as John and the father 
insisted, they were referred that day to Dermatology: 
 
“So, I was like 'six weeks, that's actually not very urgent!' So anyway, 
six weeks came and went, and we came up here, and we saw one 
of the consultants here, (Dermatology) who again said he didn't think 
it was anything serious, they thought it was a basal cell melanoma 
or whatever. So, they said 'we'll take it off, anyway', but patted him 
on the head and said don't worry, they were not really taking the 
mole seriously but took it off anyway. So within about four days, we 
got a phone call saying you need to come up, and I just knew then 
that there was something wrong" (Eve).  
 
John had to wait six weeks for his appointment with a specialist. For Eve, the wait 
for the appointment was particularly slow and arduous and compounded her 
feelings of inadequacy through her perception that the doctor was not taking her 
seriously. There was also a growing realisation within the family that their concerns 
for John's health were not seen as urgent by the specialists. When they were 
eventually seen again, this sense of not being taken seriously was confirmed in 
Eve’s mind. The dermatologist claimed not to be worried about the mole and 
suggested that it could be a melanoma but not the sinister type (MM).  
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In Eve's account, the specialist was presented as being quite dismissive and 
patronising through patting John on the head as if he was a child with unrealistic 
and unfounded worries. In reality, John was worried as he described: 
 
“Because I had been assured by others, who I saw as professionals 
and I thought, and you trust your Doctors. So, at my GP I think that 
was the thing from the start, prior to any diagnosis I was pretty chilled 
about it, and then when I came up here (Dermatology) to get the 
results, they do a small excision to take out the mole, and I was fine 
up till then, and then we got the phone call, which it was a bit early, 
so we had been waiting ages and then it was like we need to see 
you" (John).  
 
Before his MM diagnosis experience, generally, John had a high degree of trust 
and respect for the GP and the healthcare profession. This, however, was 
shattered by the urgency of the call after waiting such a long time for an 
appointment.   
 
The key message from this analysis was John and Eve’s disappointment at the 
lack of respect for their concerns about the mole and the time taken to achieve 
anything. This apparent indifference exacerbated their worries when the urgent 
and ‘sinister’ call was received requesting their immediate attendance at the 
hospital. This experience may have shaped subsequent experiences which follow 
in this journey.  
 
Recognising early changes in the mole was seen as crucial to their lived 
experience, but for some of the participants like John and Eve, it resulted in a long 
and anxious waiting game. The journey quickly became very intense for both the 
young person and their family/significant other with the sudden change from being 
reassured by health professionals/doctors to receiving pressing phone calls and 
needing to be seen as a matter of urgency. What was suspected and significant 
here although not yet spoken – that this was a serious situation.   
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Helen was diagnosed with Stage 3 MM on her abdomen at the age of 25 years of 
age and was 26 at the time of interview. Helen was the only female participant in 
this study, and she was the oldest YP who had lived in southern Europe most of 
her life. Helen had grown up in the sun, with moles all over her body and had been 
vigilant in checking them daily, throughout her life. It was evident that Helen was 
fully self-aware about her life and the moles on her skin. Helen was interviewed 
as a dyad with Stuart, her significant other. Helen – similar to George, but not 
Paul or John – had grown up with many moles all over her body but had checked 
herself every day. When she noticed that one of the moles on her abdomen was 
causing her discomfort and had changed, she knew that something was wrong. 
Up until this point, they had not changed, but she had always tried to avoid over-
exposure to the sun. This was seen as a way of life for Helen and her family. When 
she identified that the mole had become red and tender, she immediately knew 
there was something wrong. Stuart, her partner, was aware of the change and 
knew Helen had gone to her local Doctor who then referred her to Dermatology. 
Helen and Stuart waited the longest time for a diagnosis to be reached, some ten 
weeks. Stuart, her partner, was not mentioned here as he initially was not part of 
this first experience for Helen. Although he knew she had concerns, she did not 
elaborate on these or want to worry him. Helen was protecting Stuart, which was 
another critical aspect of this waiting phase. Many participants seemed to be 
fearing the worst but also trying to protect others from thinking about it. To highlight 
Helen's experience, there were three key aspects to her journey to reaching the 
diagnosis; ‘recognising something was wrong’, ‘protecting others’ and ‘waiting a 
long time to be told.’ To start, Helen described the mole on her stomach, which 
seemed to have been bothering her for a few months:  
 
"It had become sticky and bleeding, and sometimes it was painful. 
This has never happened in my life before. Last year I started to 
have a problem with the one on my stomach, I was born with moles, 
and it was already big and always flat. It was not any problem, never 
bleeding, never itchy. But it was one year and a half ago it was sticky 
and bleeding sometimes, and it was painful, which has never 
happened in my life. So, I went to the Doctor, to say it was bleeding 
and I knew that was not a good sign when a mole is bleeding. So, I 
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came to the Doctor she gave me the first out-patient appointment to 
the Dermatology" (Helen). 
 
Helen's mole had begun to change and cause her discomfort. Within this extract, 
she vividly describes how her mole has changed and the discomfort she 
experienced. Helen knew this was unusual and required immediate attention. The 
mole was not how it should be, and she was worried, as seen in the narrative 
above. This prompted her to go to her Doctor. The Doctor also realised that the 
mole had changed and that a specialist should see her. This follow-on 
appointment with the specialist seemed to be made quickly, and Helen was then 
seen straight away.  
 
“What were your thoughts about the change in your mole and having 
to wait for the results?” (Interviewer) 
"After I spoke to the Doctor and she said 'OK, we'll just remove it 
because I'm not sure what it is so, you don't need it so we will just 
remove'. I removed after I came back from holiday in November, it 
was the 26th of November, and everything was fine, those stitches 
were most painful because it was just a local anaesthetic, the scar 
was just quite big. I had to wait, they took the biopsy, and they would 
call me. And actually, two and half months passed and then they 
called because they weren't sure what it was" (Helen).  
 
Helen was reassured when the mole was removed, although it left her with a large 
scar. However, they had to wait ten weeks before they received a call from the 
specialist, as mentioned earlier. This was particularly long as others waited 
between days and a few weeks. Again, this brought about uncertainty and worry. 
For Helen and Stuart, the waiting for the biopsy results seemed exceptionally long. 
This waiting was draining for both Helen and Stuart, and although they got on with 
their daily lives, it was continually at the back of their minds. 
 
“And actually, two and half months passed and then they called 
because they weren't sure what it was. And they were asking 'we 
need to check, or we need to wait and see how it grows' I don't know 
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how they do it. I had a couple of examinations, and they identified 
two lymph nodes, one here and one here (groin and axilla). And they 
would remove when I had the first surgery, so I just waited. The first 
surgery was in March (2018)" (Helen). 
 
Initially, it would appear that the Dermatologists were unsure of Helen’s diagnosis. 
They had removed the abnormal mole but had decided to wait and check her 
regularly, which is a similar situation to that faced by George, who was also being 
regularly checked. However, the delay between removing the mole and further 
surgery was lengthy, for Helen, and it is not clear why she had waited so long. 
This time-lapse brings this uncertainty and worry about what they might find in the 
minds of the YP. Similar to all the other young participants, the disease had 
infiltrated into their lymph system, and surgery was now required. For some who 
experienced a second and third relapse, more surgery and treatment 
(immunotherapy) was also a requirement for them. 
 
The hidden “it” as described by participants becomes the present threat in their 
lives, building upon the uncertainty and the worry until their suspicious symptoms 
are finally identified as Cancer. How the diagnosis was communicated and 
received is discussed next. The issues of trust and respect for the healthcare 
professionals by the participants was described, which builds upon the period of 
uncertainty and prolonged worry. This was the next part of the journey which left 
them in disarray, uncertainty and fear. They were left feeling unprepared although 
they had suspected that there was something wrong with their mole.   
 
4.3.3 Being Diagnosed 
 
The initial MM diagnosis involved a delay for the majority of the participants. Time 
spent waiting for a diagnosis ranged from one to 10 weeks, depending on where 
the participants were located. The treatment to remove the initial mole was either 
by a small excision carried out in the GP Surgery or Dermatology department with 
further excision of the disease, if it had spread, following hospital admission. At 
this point in their journey, participants could recall being told that their ‘suspicions’ 
were related to ‘melanoma’ or ‘skin cancer.’ How this news was communicated to 
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the participants was also relevant, as most were left confused and required more 
information. The majority of the YP had never really heard about this disease and 
most did not associate it with ‘cancer.’ Many believed that cancer carried a stigma, 
but this was a perspective riddled with many misconceptions. Most of the 
participants had to live through the experience of receiving bad news more than 
once. An aura of normality that had paved the road ahead for these YP had 
instantly vanished when they entered the room to receive the news. As they left 
the room, they could recall the realisation that their world would never be the same 
again, and their lives had changed forever. It appeared that the emotional suffering 
did not stem from the diagnosis itself, but the impact on those around them, such 
as their mother or partner, and the profound effect cancer was going to have their 
lives going forward.    
 
Many of the participants felt disappointed by how the diagnosis was 
communicated to them. The environment and the way the ‘news’ was given was 
troublesome for the YP. Most had gone into the room with their parent/partner. 
John described how he was informed that he had MM: 
 
"I came into the room, and they said, it’s a melanoma and I didn’t 
know what a melanoma was at the time. So, when I said ‘what’s a 
melanoma?’, they said ‘you’ve got skin cancer’ and then that, I think 
as soon as I heard the word cancer, because it had such a stigma 
to it, it hit me like a ton of bricks at first” (John).  
 
Despite his disbelief in the diagnosis, John was shocked when the word cancer 
was mentioned. He had never heard of melanoma, but he was aware of cancer. 
The impact of the word cancer so eloquently described by John as “hit me like a 
ton of bricks” effectively communicates the scale of the impact on John and his 
extreme emotional and negative reaction to the word cancer. This was 
compounded by the stigma John associated with cancer.  
 
The evident suffering worsened John's emotional reaction, which was revealed on 
Eve's face at the time of the diagnosis. Eve was in the room with him as he had 
only recently turned 16, and he needed his mother with him.  
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 “As soon as we walked in, I knew because there was nobody 
around, the place was dead quiet, it was like everybody had gone 
home, kind of thing. It was just us two, and then when we walked 
into the office, there was the consultant and the CNS, and I thought 
'oh God'. And then I suppose our whole day just collapsed there. 
And then the consultant said 'I'm really sorry, but it's cancer' and of 
course and I just went 'Oh my God' and then burst into tears “(Eve). 
 
Eve's experience was notable for several reasons. Eve had long suspected that 
something was wrong with her son, and even the atmosphere when she entered 
the room seemed ominous. Her instinct had told her something was wrong. After 
the diagnosis was given to John, Eve's world just "collapsed" in on itself. For Eve, 
her worst fears and suspicions had been confirmed in the harsh clinical light of the 
dermatology clinic and this released feelings of profound shock and distress within 
her. Both mother and son experienced these feelings in different and very personal 
ways, but the physical and emotional impact was profound for them both.  
 
Helen and Stuart recounted a similar experience. During this part of the journey, 
they were together at the Dermatology clinic receiving the diagnosis: 
 
"Well, I was actually kind of shocked, he was with me (Stuart) 
because we just entered, so there were these two doctors and they 
just 'OK, sit down', and I think 'OK, this is nothing too good if they 
are telling me to sit down'. So, we just sit, and she just gives me this 
book with Melanoma Cancer, so I was like 'we're talking about 
cancer!' and after she started to explain that it was a Melanoma, for 
the biopsy they just waited to see how it evolved and was a very 
aggressive stage" (Helen).  
 
Entering the room with Stuart, Helen experienced a profound sense of unease that 
seemed to be originating from the two specialists waiting for her. Despite the 
detailed clinical description of her aggressive Stage 3B MM, the seriousness of 
the disease only became apparent to Helen when the word 'cancer' was first 
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spoken. It was this word that alerted Helen to the seriousness of her situation, 
rather than the description from the specialists.  
 
"So, it was a bit of a shock when we were told that she had cancer' 
it was strange because you know, there was one doctor, that was 
very serious, and she was looking at us, like sad. And the other was 
like more upbeat'. For me, it was a bit of a shock, of course. 
Especially for me, because when we were told in January, that was 
the second person for me who I was close to who was diagnosed 
with cancer. So, it was a shock to me because I had lost the other 
person” (Stuart). 
 
This extract seems to indicate that the specialist Doctors felt uncomfortable in 
giving Helen and Stuart the diagnosis and that there was safety in numbers by 
having two doctors present. It also suggests they knew that the true seriousness 
of Helen’s disease at this time. 
 
There was more devastating news to follow later that day when it was confirmed 
that cancer had spread to the lymph nodes within her abdominal area. This meant 
additional surgery for Helen along with immunotherapy. This treatment was unlike 
any other previous treatment, and as a result, Helen was required to attend a 
specialist centre some distance from her home. 
 
Stuart was shocked and fearful for Helen. He had previous experience of a close 
friend dying from cancer. This experience had been quite recent and to learn that 
his partner had cancer seemed unreal to him, resulting in feelings of fear and 
shock. He had been looking at the Doctors for reassurance, but no such 
reassurance was offered. He was trying to read the signs before the news was 
broken, but this only caused him confusion. He felt total despair.  
 
The narrative below illustrates how the young participants began to see the 
seriousness of MM and its treatment. Although Helen and Stuart, both 26 years of 
age, and the oldest participants in this study, their experiences of shock and 
disbelief were similar to the other participants. 
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“Yes, actually the last time I spoke to my Doctor he told me, because 
I'm high risk, they told me it was a very aggressive type of Melanoma 
which I had, and because there was already a cancerous cell in one 
of my lymph nodes, they just told me to do a kind of, it not a proper 
chemotherapy because they told me I not going to lose my hair or 
stuff like that, I actually don't remember the name” (Helen). 
 
Helen's immediate reaction was to question in her mind whether she had a ‘proper' 
kind of cancer. This reaction seemed to be based on the proposed treatment that 
did not involve chemotherapy. In Helen's mind, there was an association between 
the word ‘cancer' and ‘chemotherapy' as the only available treatment option.  
 
Once the diagnosis was confirmed for all the participants, the subsequent weeks 
were just as challenging and emotionally fraught. However, although it was 
relatively normal for most people to think about having cancer and its impact, it 
was near impossible to articulate it to family and friends.  
 
Participants described the disease as being different from other cancers as they 
did not feel ill. Most continued to refer to the cancer as ‘it’ even when they recalled 
their experiences through the interview process. They rarely talked about MM or 
cancer. Saying the words “I have cancer” or “my son has cancer” was extremely 
difficult for them. The possibility of death from the disease, in the near or more 
distant future, brought deeply rooted fears and uncertainty to the surface. This is 
explored further in the following ‘Too Much Too Young’ theme.  
 
"Those days had gone. We went about accepting our new, redefined 
normality, and when we met in the hallways of my house, we all 
maintained the "I'm okay" mantra' (John). 
 
Day to day the YP and their families/significant others accepted this new re-
defined normality. In this new reality, John's quote clearly shows the emotional 
need to retain the status quo of everyday life and trying to be positive.  
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4.3.4 Summary 
 
This super-ordinate theme, ‘Is it Serious,’ explored the participants’ experience of 
finding the mole and feeling bewildered and confused with what they had found. 
Irrespective of how the changing state of the mole was noticed, either through 
personal vigilance in the case of Helen or through the observation of others as 
with George's hairdresser, the delays encountered during the road to a confirmed 
diagnosis was long and arduous. These experiences emphasise the need for 
greater public awareness and knowledge about skin cancer. All the participants in 
this study confirmed that their understanding of the risks of skin cancer was 
minimal. This lack of awareness combined with the belief that 'it will never happen 
to me' can lead to even more significant delays in MM in YP being diagnosed and 
treated.  
 
Even when the young person has decided to act and seek professional advice, 
there was a real concern that they would not be taken seriously. For many of the 
participants, this concern appeared to be well-founded with delays experienced in 
obtaining a referral to a suitable specialist, disjointed approaches to treatment, 
which resulted in feelings of fear, loneliness and frustration. Throughout the first 
and second theme, the YP referred to the cancer as ‘it,’ and avoided calling ‘it’ by 
any name. This first part of the journey was a fraught and difficult experience, 
although it was not always clear whether they had taken ‘it’ seriously. 
 
4.4 Too Much too Young  
 
 The second super-ordinate 
theme is ‘Too Much too 
Young’ and brings a deep 
understanding around the 
next part of the journey of 
how an MM diagnosis 
impacts on young lives, 
physically, emotionally and psychologically and on their family/significant other. 
This theme is divided into three sub-themes. Firstly, ‘In-between’, which refers to 
not being a child or an adult. Secondly, ‘Why – uncertainty and fear’ which refers 
Young 
Person & 
Family / 
Significant 
Other
Not the Same Too Much too Young
Time to Live Is it Serious?
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to young people’s lives changing through having MM, which also causes fear of 
the unknown. Thirdly, ‘A sense of guilt and helplessness' where the family, in 
particular, feel they have not protected their child and are at a loss of how to 
support them in their time of need.  
 
As discussed in Chapter 1, young adulthood is characterised by the creation of 
fluid power dynamics within the family unit. The young person frequently asserts 
some independence while continuing to rely heavily on the support of parents and 
family/significant other. When an MM diagnosis is added to this dynamic, some 
families reported that their child was not equipped emotionally or socially to deal 
with such profound news. 
 
4.4.1 In-between  
 
Attempting to understand and normalise their MM diagnosis while trying to live 
their lives was a complex challenge for the YP. Many found it challenging to move 
beyond the disease, and the younger participants began to realise that some 
aspects of life were no longer available to them. For example, being unable to 
complete a school career with the expected academic results and failing to 
achieve their full potential. Several participants reported a loss of innocence as 
the disease robbed them of their youth. For the family/significant other, their 
child/loved one required their love and care to protect them during these tough 
times.  
 
Two telling key aspects were underlying this theme. Firstly, the sense of being 'In-
between,’ with the participant being neither a child nor an adult. Secondly, all of 
those affected by the MM diagnosis wanted to help protect one another from 
whatever life was about to throw at them.  
 
Patrick was 16 years old when interviewed with his father Terry as a dyad. Patrick 
was 11 when first diagnosed with MM, and by the time of the interview, Patrick 
was enduring his third relapse (cancer has reoccurred). Patrick had missed much 
of his secondary education due to extended periods of hospitalisation. This was 
an unusual situation when treating MM, and as a result, his future academic 
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options were limited. The family unit had broken down, and the father, Terry, was 
the primary carer. Terry had lost his job when caring for and supporting his son 
through periods of hospitalisation. Simultaneously, Terry was struggling to care 
for Patrick’s younger sibling. As they recounted their experiences, it was clear that 
Patrick and Terry’s journey was unique in some aspects, but there was some 
commonality that related to all the participants, such as the tensions around 
independence versus dependence.   
 
In the interview, Patrick found it difficult to share his experiences. He was only 11 
years of age at the time of his original MM diagnosis and was not fully aware of 
the fact that he had cancer. He relied on his father to recall these events, and it 
was unclear if he could remember or if he chose not to, leaving his father to tell 
the story. Patrick seemed withdrawn but willing to share what story he could 
remember. During the interview, it became evident that Terry, in trying to protect 
his son, had never disclosed to Patrick his initial diagnosis of cancer.  
 
The father began the story by explaining he had not informed Patrick of the cancer 
diagnosis because he was frightened that Patrick would be unable to cope with 
such a serious event. Although made aware of his cancer diagnosis during his 
second relapse at the age of 15, he was now experiencing his third relapse.  
 
Patrick commented that he was grateful to his father for trying to protect him and 
recalled how his father knew about the diagnosis before him. It was unclear 
whether Terry understood the seriousness of this initial diagnosis. This is the only 
example in this study of the truth being withheld from the young person, albeit 
Patrick was a child at the time.  
 
“He was a child, I told him he was only going in for a wee operation, 
to get something off his leg. And that was my decision to do that, 
and I've stuck by that to this day” (Terry). 
 
Terry described the operation that was required to remove the ‘wart’ as “nothing 
to worry about.” Terry maintained that withholding the truth about the diagnosis 
was the right decision and in the best interests of Patrick. He believed this to be 
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true even while the interview was taking place. Terry had no regrets over his 
actions. All the other participants were old enough to be informed about the 
diagnosis and accept responsibility for their treatment.  
 
Patrick's mole had started on his upper thigh, and like all the other YP, apart from 
John, the disease had travelled in the lymph system. During the interview, 
Patrick's father, Terry, spoke the most, but Patrick didn’t seem to mind this and 
looked to his father throughout for constant reassurance. When asked: 
 
‘How did you notice the mole?’ (Interviewer). 
‘I have had that since I was a wee boy. It was like a big wart on that 
bit of my leg (points to his left thigh)’ (Patrick). 
 
Patrick described the mole vividly. He could point to the exact location on his leg 
and the fact that it resembled a “wart.” He could also point to the scarring that 
resulted from the removal of his lymph nodes in his groin area. Patrick described 
that it had been there for a long time as if it had become part of him. Terry, his 
father, had noticed it also, and they both wanted to seek confirmation from their 
GP to find out what it was.  
 
“We went to the GP, he was only 11 years old, well, we'd already 
been to the GP three or four times, about this. The first time we went 
back, it had got bigger, and the second time, we got knocked back, 
and it had come back bigger again. So, we went up to this same GP 
three times, got told ' oh, no, just a skin lesion, nothing to worry 
about. The fourth time we went up, the GP was on holiday and saw 
someone else; they want that seen to straight away and get that 
tested and that's when we found out" (Terry).  
 
The father explains that the Doctor was often dismissive and failed to address their 
concerns and worries about the mole. Patrick, a boy of 11, was caught ‘In-
between' on many fronts. Firstly, he relied on his father to initiate and arrange the 
visits to the GP as Patrick merely thought that he had a harmless wart on his leg. 
His emotional and intellectual immaturity prevented him from seeing the more 
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serious potential. Secondly, the healthcare system did not adequately cater to 
their needs and Patrick was dependent upon his father and his persistence to 
ensure that their concerns were acknowledged. Thirdly, this ‘In-between’ status 
revealed itself when the results from the skin biopsy were relayed to Terry, rather 
than him. Patrick described how the news was given to his father and not to him: 
 
“He told my dad, but my dad didn't want to tell me because he 
thought it would worry me, and if my dad thinks it was the right 
decision, then it was” (Patrick). 
 
Sometime after the mole had been removed in an adult hospital, that had no 
specific provision for children and young people, Patrick then noticed a lump in his 
groin area and told his father.  
 
"It was only a wee lump, and again we were told, don't worry about 
it, it's his age, and then the next thing is we are going back up six 
months later" (Terry). 
 
Terry was now angry that once again his concerns around Patrick’s health were 
being downplayed and disregarded. Terry recalled how his concerns were not 
heard the first time around, and he felt powerless to stop the same situation arising 
again.  
 
Patrick and Terry had a strong connection with one another and a mutual 
dependence that was obvious and visible. It was unclear whether the healthcare 
professionals initially believed that the lump was due to his age and stage of 
development or whether they did not know. Six months later, Patrick was seen 
again at a specialist children's hospital, and further treatment was required. It was 
this episode that represents the significant interruption in family life for Patrick and 
Terry. This was the point when Patrick started to miss school on a regular and 
frequent basis. Travelling to and from the specialist hospital for treatment was 
often lengthy, expensive and complicated for the family.  
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During their experience of MM father and son had become inseparable, with 
Patrick dependent upon his father. Consequently, his father had become the most 
important person in Patrick’s world. For Terry, he went on to describe:  
 
“I needed to watch him, and that's why I lost my job’ and ‘it’s hard to 
remember this, in order. You’ve got to remember, when he went 
through all of this, he lived with us for one month out of six. So, my 
memories are all over the place with these times and places (Terry). 
 
Terry's primary role as a father, carer and friend to Patrick was putting extreme 
pressure on the family unit in a serious way. Terry was present with his son in the 
hospital where they spent the next five months as Patrick had become seriously 
ill from the treatment. This placed a considerable strain on the family and his 
father. As Patrick was under 16, Terry was responsible for caring for his son with 
only limited support from extended family and friends. As Terry was devoting such 
time to caring for Patrick, he could no longer manage his full-time job. Trying to 
remember these events was stressful for Terry and his memories are blurred and 
confused.  
 
4.4.2 Uncertainty and Fear About the Future 
 
After diagnosis, trying to accept that they had the disease and move forward with 
their lives, participants were able to describe the uncertainty and fear that the 
diagnosis brought. The true scale of the MM had been revealed, all their 
suspicions and worries unhidden but now turned into the unsaid with internal fears 
and worries about the future never fully or directly expressed.  
 
Part of this theme concerned the uncertainty and fear of dying from the disease, 
like other patients with cancer, they had become aware that death was a 
possibility. The stark change to their previous thoughts about MM had now 
become a reality that could possibly happen. This was where the ambiguity and 
worry became real and true for some of the participants and trying to comprehend 
what this meant moving forward with their lives was very scary. 
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There were two key telling aspects to this theme, ‘uncertain futures’, which refers 
to their lives being turned upside down, and ‘fear of the unknown’ which refers to 
being frightened of what might happen. John had previously experienced one 
occurrence of the disease, and in contrast to all the others, he still felt his future 
had become uncertain.  
 
“who wrote this into my life plan. I was diagnosed when I was 16, so 
that was the start of my sixth year at school, so I took a bit of time 
off from school, then I think I was diagnosed on the 21st of October 
and I think I got the all-clear towards the start of December, so it was 
a pretty short period of time although it didn't feel that way " (John).  
 
This account highlights the significance of John’s life being interrupted by the 
disease at this period in his life. John was fully engaged with his school and 
academic life and dealing with the ordinary emotional journey of being a teenager. 
John can clearly recall his story from the time he was initially diagnosed to the 
specific month when he received the ‘all clear.’ The disease had caused significant 
emotional turmoil in his life, creating considerable uncertainty about his future. He 
further explains;  
 
"When you are 16, people say to you all the time, and I don't even 
like saying it myself, but you think you're a bit invincible and I didn't 
think that I was invincible but to an extent I did, I thought really bad 
things like cancer don't really happen, they don't happen here" 
(John). 
 
Within this narrative, John described how he was only 16 years of age when 
cancer came along, and he was surprised that this had happened to him. Being 
young often brings a belief of immunity to such illnesses and that cancer does not 
happen to YP who are looking forward to their futures. At this age and stage, YP 
believe they are unbeatable and can conquer anything life throws at them. This 
was precisely what this young man and most of the other participants felt and 
experienced. Adverse life events happen to other people; it was often difficult to 
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accept that this can happen to anyone. For John’s mother Eve, this was also a 
surprise. 
 
“At 16 they are making choices about subjects and University. I had 
hopes and dreams of what he would go off to do at University and 
study, and suddenly your life is sort of on hold” (Eve).  
 
The pervading feelings of uncertainty and fear also affected the family in the 
present and their possible futures as this mother illustrated through her narrative. 
While Eve was sad for her son, she too had hopes and dreams that were suddenly 
changed, and her life became dependent upon their MM journey. 
 
In addition, this mother, like many of the other families, believed that their child 
had been robbed of their youth. The disease had taken their child down a different 
path from the one they had envisioned. The cancer arrived at a fundamental 
crossroad in the lives of the YP when they and their families were in the process 
of developing and supporting early adult life plans. This was the point where the 
participants now realise the seriousness of this disease and what this could mean 
for their lives. For some, the future was difficult and frightening to imagine.  
 
"It was like being on an emotional roller coaster the whole time, and 
I could not get off” (Eve). 
 
Eve’s experience described through the roller coaster metaphor evokes the sense 
of emotional turmoil and lack of control that she was struggling to cope with. The 
highs and lows of coping with John's MM and the unpredictability of how the 
disease would manifest itself over the next few months were very draining for Eve. 
Often, she would find herself in despair over the fear, uncertainty and 
unpredictability around John’s future. At other times, she would be filled with an 
optimistic view of John’s life prospects. Underlying Eve’s comments was a 
powerful sense of resentment at the loss of control over her life and its 
circumstances. Ever since John's MM diagnosis, she had found herself on a track 
not of her choosing and with no real influence over what would happen next.  
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Being able to articulate their fears about the cancer and discuss them with family 
and friends was cathartic for the YP and their family/significant other, although 
some reported that they found it difficult to say the word ‘cancer’. For all, these 
early conversations were the most emotionally challenging and uttering the phrase 
‘I have cancer’ would ultimately end in tears. For the YP to know and accept that 
they had an aggressive form of skin cancer was an integral part of their journey, 
especially for those who had metastases (MM which had spread to other parts of 
the body).  
 
The YP all reached out to the available specialist support services at a time that 
was right for them as individuals. In many cases, the first and most immediate 
support came from the Clinical Nurse Specialist (CNS).  
 
“At the time, it was relatively easy to think about it but near 
impossible to articulate it. Saying the words “I have cancer,” but Mary 
(CNS) was fantastic from day one, absolutely unbelievable; I 
couldn’t say a bad word about her. She just said you are a very 
sensible young man, fit and strong. I joke with her sometimes, 
because she was like a second mum. Whenever there were, 
questions that either I didn’t want to say to my mum or maybe I had 
a fear that she would take it the wrong way, I knew that she was right 
there. And she was always very good at easing any queries that I 
had or any, even things that I couldn’t say myself, she would make 
it clear and that would sort of ease the pain for me. Because at the 
time I was very physically fit, but skin cancer is one of those mental 
battles where you think I got cancer, but you can't really feel it, 
especially if you catch it early" (John).  
 
John, like the majority of the YP, expressed their admiration and gratitude for the 
CNS, who was a source of support during this time of uncertainty and fear. They 
all had experience of the Skin CNS for MM, and this was the healthcare 
professional who provided the most support and advice. For some, the CNS 
became a surrogate family member and would predict what kind of support or 
advice was required without the young person having to say it. The CNS lifted the 
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family’s burden and supported them in maintaining a balanced but positive 
outlook. John, who was physically fit at the time of his diagnosis, found the 
challenges to his mental health presented by the MM far more significant than he 
anticipated. This experience was quite different from other cancers such as 
Lymphoma, which can be a ravaging physical and mental experience for patients.  
 
In addition to the information provided by the CNS, some family members and 
friends wanted to know as much as possible about the disease and used the 
internet as a resource, but with mixed results. 
 
"I just, I stupidly, started reading about melanoma online, and I'd 
been told not to do it, but I did, and that made me worse. I thought 
'oh my God, he's going to die, and he is not going to survive five 
years, he going to be dead by the time he is 20’" (Eve) 
 
Attempting to understand and find out more about MM was a necessary coping 
strategy for families. However, the scope of information available via the internet 
merely confused and added to the fear and uncertainty being experienced by the 
family members. Without anyone to explain or interpret the information, or how it 
could apply to their child or partner, the unfiltered information heightened their 
sense of panic and caused them to worry uncontrollably.  
 
4.4.3 A Sense of Guilt and Helplessness 
 
Following on from the ‘uncertainty and fear’ of living with MM was an overwhelming 
sense of ‘guilt and helplessness’ on the part of the YP and their family/significant 
other. The YP felt guilty as they were not ill unlike other cancer patients, but they 
had started to realise the seriousness of the disease. In contrast to the 
family/significant other, the YP expressed guilt around having to rely on their 
parents or loved one to support them. Young people described how this 
interruption to their lives had placed heavy emotional strain on their immediate 
family and friends. In contrast, the families felt guilty because, in their minds, they 
had failed to protect their child from the sun and blamed themselves for the 
disease. The feelings of guilt and helplessness were helped by the support 
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available from the CNS. However, the support available from other healthcare 
professionals was not always available or consistent. Some families commented 
that they felt alone with almost no support to help them make sense of the situation 
they found themselves in. For some, the existential questions of “why has this 
happened”, and “how will we cope?” were common, but the answers were not 
always readily available.  
 
 "I could not make sense of why he had skin cancer, he was never 
in the sun, and he never got burnt as a child 'why should this happen 
to him he has done nothing wrong" (Anna)  
 
Anna expressed her disbelief in the fact that her son, Paul, had this disease. She 
questioned why this should be as he was never over-exposed to the sun, never 
went to a tanning studio and looked after himself. In trying to understand her 
situation, Anna was seeking answers to why her son should have this disease. 
Anna felt helpless. 
 
Another mother, Eve, described the situation differently: 
 
"I just felt so guilty, more than that I felt guilty, that I had been a bad 
mother, and I'd allowed my child to get skin cancer. If you know what 
I mean, I was beating myself up about it every day, and I kept saying 
to everybody, 'it should've me' and I kept saying 'why is it him, it 
should've been me.’ But I'm sure a lot of mothers, with a lot of 
teenagers or children say that” (Eve). 
 
Eve's experience was different from Anna as she believed that it was her fault and 
blamed herself. Eve believed that she had not done enough to protect her child in 
his early years from this disease. Indeed, Eve went as far as to wish that the MM 
had happened to her rather than her child. She was aware that many mothers 
would feel this way, but that did not offer any comfort. Eve was traumatised by this 
experience and expressed overwhelming guilt and self-blame, making her feel 
helpless with no influence over the likely outcome.  
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The majority of the participants believed that this disease was related to exposure 
from the sun or sunbeds. Like the parents, the YP had tried to recall any 
overexposure to the likely causes of the MM. As John described: 
 
“At the time I didn't do anything to abuse my skin, I didn't go on 
sunbeds or anything, and it can be just as simple as that, it can crop 
up. My mum always covered us in sun cream, I just want to take that 
shock away from some people, if ever did happen to them, because 
that's where I think my worry came from, we had done nothing 
wrong” (John) 
 
Unlike his mother, John knew that his skin had not been abused and specifically 
did not blame his mother for any action or inaction that could have resulted in the 
disease. John’s attitude seemed to be very phlegmatic and pragmatic about the 
disease compared to Eve’s reaction. This was best illustrated in John's previous 
description under 'The waiting game' sub-theme, where he was very relaxed and 
at ease with his situation. This attitude was demonstrated as John tried to 
understand what had caused the disease within him. In this narrative, John 
appears to be saying that greater public awareness and knowledge about the 
causes of skin cancer could help people understand how this type of disease 
occurs. In some situations, the occurrence of MM can be almost random, with no 
visible link to UV light. As John further explained: 
 
“When we went abroad, I covered up, and mum and dad were a bit 
paranoid about getting sun cream on us in the early days. So, I think 
that was, that didn't shock me, but it shocked mum, I think. I think 
she feels quite responsible still, and when she comes in to speak to 
you, she'll probably address that herself. But that's something that 
my dad's come to terms with; I think he's come to the point where he 
thinks 'this was pretty random, we did everything we could to help in 
the best way'. But I think being a mum she thought ' I've tried my 
whole life to try to help in every way, and this blip in the road is my 
fault' and it's not and to pin that blame on herself is stupid because 
we can't pinpoint where it came from, and personally I think it just 
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quite a random thing. Like I didn't expose myself to the sun any more 
than the person next to me" (John). 
 
In direct contrast to John’s experience was George. George could recall when he 
had exposed his skin to the sun and had been ‘burnt.’ He was 23 years of age 
but could recall this experience as a small boy: 
 
“I’ll admit when I was young, I was always outside my house always 
out on my bike and I never wore sunscreen, and it was always my 
neck that burnt first, and it still is, so that probably didn't help when I 
was growing up" (George). 
 
George has never worn sunscreen even now he is a young man. His skin has 
been overexposed to the sun and has been damaged on several occasions. He 
understands that this may have contributed to his MM. 
 
4.4.4 Summary  
 
This super-ordinate theme, ‘Too Much too Young’ illuminated three subthemes ‘In-
between,’ ‘Uncertainty and fear about the future’ and ‘Sense of guilt and 
helplessness.’ The concept of ‘In-between’ represents that time when the young 
person was neither a child nor an adult. Living with an MM diagnosis reinforced 
the YP’s dependencies on their family/significant other just as they were 
attempting to assert some independence from the family unit. This dependence 
on support from the family/significant other extended across a range of different 
life situations.  
 
The confirmation of the MM diagnosis also brought an overwhelming sense of the 
unknown into their lives. Earlier plans and ambitions had to be rearranged and 
postponed, replaced with the immediate priority of dealing with the emotional, 
social and physical impact of the disease. In looking for guidance, advice and 
support to see them through this challenging time, many participants reported a 
significant lack of support from the healthcare system. The notable exception to 
this was the references to the value provided by the CNS role, where available.  
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The YP were not physically ill and demonstrated a range of modest symptoms and 
as such, felt quite different from other people with cancer. Families/significant 
others blamed themselves for the disease and sought reassurance from other 
sources to understand why their child/loved one had to suffer in this way.  
 
For many of the participants in this research, the term ‘cancer’ was pre-loaded 
with a social stigma and was commonly seen as synonymous with death. Fear of 
death was the rational and expected response in these circumstances for the YP 
and their family/significant other. For many, the stark reality of their MM diagnosis, 
contrary to their initial symptoms, had still to be entirely accepted and internalised, 
even though for some, this was their second or third recurrence.  
 
4.5 Not the Same  
 
Following on from ‘Is it 
Serious’ and ‘Too Much 
too Young’ is the ‘Not the 
Same’ super-ordinate 
theme. This third super-
ordinate theme has been 
further categorised into 
three sub-themes: ‘A life less ordinary’ which refers to adjustment and coping to 
the diagnosis? 'The treatment experience, which describes where, how, and by 
whom they were treated, and 'Feeling a fraud', which explores why YP with MM 
feel different from other patients with cancer.  
 
The term cancer does have a social stigma, as discussed earlier in this Chapter 
and generates intense feelings of fear and dread. Receiving an MM diagnosis, at 
least initially, appeared to be different. At the early stages, there was no real sense 
of foreboding as the physical symptoms were minimal as discussed earlier in the 
first theme. However, after the second or third reoccurrence of MM in the form of 
a lump, the YP and their family/significant other began to experience acute 
Young 
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feelings of fear and uncertainty. The timeline of these emotional reactions is quite 
different from that experienced by other cancer patients.  
 
4.5.1 A Life Less Ordinary  
 
For most of the participants, the disease had altered their life plans, and they 
required to try and adjust and cope with this. All the participants were forced to 
adjust in several ways. For Helen and Stuart, a young couple striving to build a life 
for themselves, coping with MM brought unexpected lifestyle and financial 
precariousness. Although Helen and Stuart are the only couple, there were 
recurring patterns and connections similar to some of the other participants within 
the study. Helen’s mother had come from abroad to support and care for her 
daughter after the first surgery. However, as she could not speak English, her 
ability to support Helen at hospital appointments was severely limited, and Helen 
often had to attend on her own. Stuart’s Italian family lived nearby but again were 
not fluent in English.  
 
Helen, who had been unwell from her extensive surgery, required extended sick 
leave from her employment but without the benefit of any employer’s sick pay. 
Stuart, her partner, had continued to work, but felt the pressure from one salary 
coming into the home. This was difficult for them both. Helen’s mother provided 
some additional financial support, but this was infrequent, and Stuart’s salary 
remained the only reliable income. Their experience of coping with such a steep 
decline in their financial position was a difficult adjustment for the young couple. 
There were two telling aspects of this theme. Firstly, adjusting to a change in life 
circumstances. Secondly, coping with and then living with the disease over an 
extended period. As Helen described below; 
 
“Well, except for my mum and of course he (Stuart) paid for most of 
the things because for the last three months I didn't work. I spoke 
with a social worker and they said 'the least amount of time I can 
claim is six months' so I was off for just two and a half, I tried to do 
the same in March last year, but they said 'they don't want to accept 
your request because it is less than six months'. Even at work, I had 
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a good salary, and they move the salary to basically nothing because 
I cannot even pay for my part of the rent which is very stressful" 
(Helen) 
 
This financial insecurity resulted in them both being worried for their future, 
another source of stress, adding to the already hefty burden of daily life and living 
with skin cancer. Although Helen seemed to take the actual treatment experience 
in her stride, the time off work and not receiving sick pay was a real worry. Stuart 
did not mind working, but it was a physical and emotional challenge to work and 
then visit Helen when she was in the hospital for her surgery. This overall 
responsibility appeared to add additional strain to their relationship. Helen added:  
 
“My doctor has just made me a feel in a good place, in a good way, 
it's been very clearly explained, everything that is going to happen, 
if you’re feeling unwell what you have to do, so I'm kind of happy to 
see him so he can explain and because I will have to go by myself 
as you (Stuart) can’t take 3 weeks off” (Helen). 
 
Helen felt well-informed regards the further treatment she required and believed 
that this had been communicated well. She felt able to travel this new part of the 
journey on her own and to continue fighting the disease.  
 
Patrick and his father, Terry, endured similar lifestyle and financial challenges to 
those faced by Helen and Stuart. Terry also faced financial insecurity from losing 
his full-time job but received state benefits, which helped support the family. 
Patrick's treatment, immunotherapy, made him so unwell that he had to spend 
considerable periods in hospital. Without this treatment, the MM would have likely 
taken his life. Terry was the primary carer for the family, which included Patrick's 
younger brother. Terry had to juggle these responsibilities carefully when Patrick 
was so gravely ill and struggled to stay with him when he was in the hospital. This 
disrupted the family as Terry opted to stay with Patrick for the duration of each 
treatment. During this time Patrick's younger brother was cared for by Terry's 
sister. Terry described the experience as difficult and trying to cope was 
particularly challenging at times: 
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“Probably, close to a mental breakdown right at the end, right 
enough. If anything, I struggled when we were given the good news, 
it was hard. Trying to cope with everything and not being able to 
sleep, I'd not been sleeping for like a month when he was in the 
hospital, just constantly, waking up and eventually, it calms you 
down” (Terry). 
 
The narrative above highlights how emotionally and physically exhausted Terry 
was from caring for his son on a long-term basis. This had seriously impacted on 
the lives of the family and Terry was close to a mental breakdown. Without any 
apparent support, he had lost all hope and was struggling to cope with daily life as 
well as Patrick's treatment regime. Even when there was good news available 
about Patrick’s disease, Terry was almost unable to process this due to his mental 
exhaustion. As Terry described: 
 
“And then we were told 'oh, by the way, what we told you, there is 
no hope, well forget all about that’, that was brilliant, but it was hard 
to kind of go from one and straight to another. So, we went from 
incurable was the word. Aye, we went from one extreme to what we 
went through to the next extreme a couple of weeks later and a 
phone call telling you everything’s all right “(Terry). 
 
This unexpected change in the forecast outcome brought a new challenge for 
Terry as he went through the extremes from 'a death' to an 'all right’ situation. He 
experienced difficulties in accepting the new positive, good news about Patrick's 
disease and outlook. After preparing himself mentally over several weeks for 
Patrick's expected death, Terry had to quickly re-orientate himself to this new 
scenario and had to appear positive and happy for his son immediately. Internally, 
Terry was wrestling with his feelings and reaction to the change. 
 
Another aspect of this theme was the inability of the family/significant other to 
adjust to the emotional demands of coping with the MM. This is best illustrated 
through John’s narrative where he outlines how Eve struggled to retain a positive 
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outlook and was never able to escape the MM diagnosis and lived each day with 
the corrosive feelings of uncertainty gnawing at her. As John explained: 
 
"I think even now to this day she struggles with it; I've been able to 
come to terms with what happened and talk openly about it, but for 
her, it’s much more. I think it will always be because, for her, her son 
got cancer when he was 16, and that's not any mum's plan, all mums 
will have a sort of plan for their kids, but they will never tell the kids, 
and I think she thought at the time 'this is not what should be 
happening'. So, I quite quickly was able to think it through and think 
how am I going to move on from this thing, but I don't think she ever 
has been able to" (John) 
 
John seemed to be able to rationalise this change in his future plans and 
prospects. However, for Eve, this disease had a profound effect on her. There was 
an utter sense of devastation of living through this and watching her child struggle 
to overcome the disease and then rebuild a life for himself. John recognised that 
Eve was riddled with guilt and had fallen into deep despair. John understood that 
this change in his mother might never alter, no matter how hard she tried.  
 
4.5.2 The Treatment Experience  
 
The treatment experienced by each young person and their families/significant 
other was the next step in this journey. Participants living with MM experienced a 
wide disparity in the range and type of hospital-based care and support. There is 
a widespread belief through evidence-based practice that the ideal treatment 
experience is delivered from specialist service centres that are age-appropriate. 
However, access to specialist centres was not readily available for all YP with this 
type of cancer, and distance was often problematic. This scarcity of specialist 
centres was evident through the narratives concerning the various treatment 
experiences, and these are illustrated below.  
 
All the participants had various experiences to recall. Some were either treated 
within a surgical Ear Nose and Throat (ENT) ward for adults, an adult breast 
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cancer ward or a surgical adult ward. Only Patrick experienced his treatment 
through both children’s and adult services. None of the other participants were 
treated in the TCT units, although two of the participants did receive psychosocial 
support from this charity. 
 
Although John had waited six weeks for an urgent appointment to have the mole 
excised, he received a phone call within four days arranging for his admission to 
hospital. John was admitted to a specialist unit for women being treated for breast 
cancer. John and Eve had not known what to expect, but Eve did wonder why he 
received his treatment within a ward for women with breast cancer. John and his 
mother had initially expressed some disquiet around being treated in a female 
ward. However, the experience turned out to be positive in the most unexpected 
way, as Eve described: 
 
“he ended up actually in the breast clinic, for his surgery, which in a 
way was lovely, in a way because it was all women, and all the 
nurses were fawning over him and looking after him because he was 
the only guy in there” (Eve). 
 
For Eve, it was not about her son receiving care within a teenage environment. It 
was about the treatment and care he received. Although treated in a female ward 
for breast cancer, he was fussed over, and the nurses were very attentive to his 
care. At the time of admission, Eve had felt unable to accompany her son, so 
John’s father had gone instead. 
 
"His father went with him for that, because I was just a mess. By this 
point I was just like, I can't do this. And then, because he was 
brilliant, he was actually so strong, he never worried one bit, he said, 
about the whole thing. And, we would go for a walk and things, I 
would be like a zombie, and he would be wandering around trying to 
crack jokes and make me laugh, but I just couldn't get out of it. I was 
so, so, so worried. And then, so he had his surgery, and that was it 
all over. And they took quite a big excision, obviously at the time. So 
I kind of looked after him when he got home because he went into 
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spasm, his neck went into spasm and he couldn't, he was in agony, 
so I ended up having to massage his neck, and he suddenly went 
'oh my God, it fine, it's fine'.  But it was from lying like that for hours 
on the surgery table" (Eve). 
 
Eve's experience was similar to the other family members/partner who described 
how well their child/partner had coped with the diagnosis and taking the next step 
towards the treatment. Nevertheless, Eve's worry continued, and there were days 
when she felt her life had no purpose. John and his father had adjusted to the 
need for surgery and were focused on dealing with the practical matters before 
and after. In contrast, Eve freely admitted to feeling “like a zombie” and felt she 
was failing to provide any meaningful support for John at this critical time.  
 
Echoing his mother’s comments, John described how his father accompanied him 
to the hospital as Eve was unable to do so. John's father had suffered from mental 
health issues for many years and Eve had taken on the role of breadwinner and 
acted as head of the family. However, in an apparent reversal of these traditional 
family roles, both mother and son came to rely on the father/husband, despite his 
struggle with everyday life. As John described: 
 
“He doesn't work; he doesn't work at all. He suffers from mental 
health issues, so he's been not working for years now. Before I went 
into theatre, my dad accompanied me into a room to get all the wires 
and things attached, I'm assuming that it was a heart monitor, but 
I'm not really sure. I was scared; I had succumbed to genuine fear. I 
looked at my dad, and he held my hand. It was just nice to know that 
he was there, but we were helpless" (John). 
 
Not having a full understanding of the procedures and treatments for MM can add 
to the burden of a negative experience, and this was evident in this family’s case. 
John’s father had gone with him as Eve had felt unable to do so. As described 
previously under the theme ‘sense of guilt and helplessness,’ Eve felt responsible 
for her son’s disease. Going to the theatre to have the cancer removed was 
particularly frightening for John as no one had fully explained the procedure. His 
 __________________________________________________________________________ 
152 
 
father, on the other hand, was a great comfort, and it was reassuring to have the 
human touch and connection, which seemed to relieve some of John's fears and 
feelings of helplessness. 
 
During the treatment experience, John and Eve had no contact with anyone facing 
a similar MM diagnosis and were unable to share their experiences. Both Eve and 
John were reassured by the fact that they received high-quality treatment and 
care. However, Eve commented that teenagers should be treated differently: 
 
“I think there should be a designated area for teenagers, so they’re 
not just shoved in with people having their breast removed or having 
plastic surgery done for whatever reason. I just don't think that was 
right, but, at the same time, it was what it was. Sitting waiting to be 
seen by the doctor in the Cancer Centre with all the adults was a bit, 
you know, 'God he is so young, so it made it worse almost, it was 
like all these older people with cancer, sitting there with. You know, 
I think you have to have the appropriate places, for an appropriate 
age” (Eve). 
 
Eve believed that a dedicated unit for teenagers would have been a more suitable 
environment for her son. Being treated in an adult environment with older people 
did not seem right for her son. This experience of age-inappropriate environments 
was shared with some other participants who had no access to a specialist 
teenage unit. For those who did, for example, as a day patient, they found the 
specialist unit supportive, although there was no one else with MM being treated.  
 
Patrick’s treatment experience was different. He had received treatment at 
numerous adult and child centres, but healthcare professionals were undecided 
on the best place for Patrick’s care to be delivered. Because he was 15 years of 
age when treated for his third MM reoccurrence, he was cared for in the adult 
Intensive Care Unit (ICU) as the treatment had made him very unwell. As Patrick 
remarked: 
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"When I first woke up, I looked around, and I was with older folk 
because I was in intensive care, and there weren't any kids in 
intensive care. And then I got moved into a sort of children's hospital, 
and I think I was the oldest in the ward" (Patrick). 
 
This narrative describes how Patrick could sense where he was. It was not clear 
why he was in the adult ICU and not within an age-appropriate environment, and 
Patrick was quite confused by this. Patrick was aware that no ‘kids’ were present 
and when he did get moved, he was the oldest (at this time 15)  
 
Terry suggested that there should be more consistency in the care for YP who fall 
between child and adult service age definitions. As Terry commented:  
 
“He got caught between adult, yeah. If this (interviewer’s research) 
is going to help anybody out, make sure that this never happens 
again. Because they are stuck between a rock and a hard place. 
There are maybe other kids his age, but they have to decide whether 
they are adult or child, one way or another, they shouldn't be passing 
them about” (Terry). 
 
It was clear that there was confusion over where a 15-year-old boy should be 
treated. Patrick fell between the standard age definitions for each of the services 
involved in his treatment, and as such, there was confusion over where best to 
treat him and his family. There was no attempt to involve an experienced 
healthcare professional with the relevant knowledge and understanding of the 
specific requirements of Patrick’s age group and his disease. This experience was 
important to Terry, not so much Patrick as he was too unwell at the time. As Terry 
described below: 
 
“At the end of the day, he needed to be with doctors and nurses who 
care for kids and know about his cancer” (Terry). 
 
Patrick was young and required to be cared for by knowledgeable healthcare 
professionals, experienced in caring for YP with MM. This was important to Terry, 
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even more so than the treatment environment, and he was adamant that Patrick 
should receive the ‘best’ possible care and treatment from specialist healthcare 
professionals who were educated in this disease and patient group, irrespective 
of the environment. This was evident for most of the YP, as George described: 
 
“It’s fine if you stay in X, you can hop on a bus and get to it, but for 
the likes of us they do have a local hospital, but they’re useless. I 
mean utterly useless and to get to X takes over two hours” (George). 
 
It was revealing to read George’s experience of the local hospital and his lack of 
faith in the healthcare professionals who worked there. This was interesting as 
earlier in the Chapter, George and Richard had been suitably impressed by the 
local doctor who had acted without delay in removing the suspected mole. Like 
Terry and Patrick, and Helen, having to travel to the nearest PTC outweighed the 
risks of receiving care that was not appropriate for their disease or age group.  
 
4.5.3 Feeling a Fraud  
 
Malignant Melanoma is a cancer that in its preliminary stages offers no visible 
signs and symptoms to the casual observer; for example, the mole may be hidden. 
Other cancers such as Leukaemia can affect YP and bruising, paleness and 
lethargy being the most common signs and symptoms of the disease. For the 
participants, this generated a self-perception and associated feelings that they 
were different in some way from other cancer suffers. 'Feeling a fraud' was a 
typical summation of the participants' experience as they compared themselves to 
other people, whether friends, family or acquaintances, who had suffered through 
other forms of cancer and the associated side effects. For those YP who 
experienced these feelings, they saw themselves as different from other patients 
with cancer and believed that they were deceiving people in some way about their 
illness and its severity and worried about what other people would think of them.  
 
The mental anguish resulting from ‘feeling a fraud’ was very different from the 
‘guilt’ some YP felt about having MM. This internal ‘sense of guilt’ stemmed from 
the profound impact their MM and treatment was having on their loved ones. The 
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young person could see the physical and mental toll the disease was taking on 
parents and life partners. Combined with the absence of any noticeable treatment 
side-effects, many of the YP in this study felt guilty for a long time. As a result, 
many of the YP lived in a constant state of anxiety. 
 
Another telling aspect of the theme was that the participants' felt that they were 
treated in a distinct way and did not have the same support. The young 
participants discussed MM as being different, as seen below: 
 
"You know you were saying about it being surgery, after that one it 
felt like I've had cancer but I've not had cancer and then this one, it 
feels like it's getting there, but I've not had chemo or radiotherapy, 
so it was like, I feel like a fraud, in some ways that, you know, when 
people think cancer they think chemo line (Central Venous Catheter) 
or whatever, in bed, looking like you think of like TV-type stuff, you 
know it's not really like that but it feels like you're saying you've had 
cancer, and ‘I never thought I'd actually feel like this, but cancer guilt, 
survivors' guilt or whatever' - friends of friends have died and other 
people I have known with cancer" (Paul). 
 
In the above narrative from Paul, there are two telling aspects; ‘feeling different’ 
and survivors’ guilt.’ Paul described feeling different from other people diagnosed 
with cancer. His individual experiences are drawn from friends and TV dramas 
and associated cancer being attached to someone who requires a Central Venous 
Catheter for the chemotherapy and other treatments. This is not the experience of 
MM; it is different from other cancers. The second telling aspect from the narrative 
is how Paul struggled with the death of a friend from cancer and the emotions 
around his mortality. Paul felt like a fraud and was guilty that his experience had 
been different and that he had survived his cancer when others he felt to be more 
deserving had not.  
 
This was similar to what his mother Anna expressed: 
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“Actually, he said he felt a bit of a fraud because he had no illness 
whatsoever ’It just because he didn’t have any pain or anything. I 
suppose he just felt lucky, not lucky to have cancer, but it can be 
operated on and not having to have the chemotherapy or the 
radiotherapy. Because my friend’s daughter, who had Leukaemia, 
she’ll have problems all her life and she probably never be able to 
have kids” (Anna). 
 
Anna, Paul’s mother, did not fully realise the seriousness of the MM. Previous 
personal experience, similar to Paul’s, told her that Leukaemia was far more 
severe than Paul's MM diagnosis. Both believed that the MM was not as serious 
as Leukaemia and the treatment not as arduous as chemotherapy or radiotherapy. 
The side effects from these treatments endured by her friend’s daughter had 
affected her thinking about cancer and its side effects. It is interesting to note that 
Anna could vividly recall the experience of her friend’s daughter and still believed 
that Leukaemia was more serious than MM, even though her son was living 
through his third recurrence.  
 
Paul described a boy from his school who had died from bowel cancer. In some 
strange way, it was as though he felt he was deceiving people who cared for him 
by telling them he had cancer. Paul explained below: 
 
“He graduated with a first-class honours degree and then got bowel 
cancer. Don't know where else, liver, kidney, he died about three 
weeks afterwards. On paper, he was better than me at everything, 
but he died, and I survived, so it was for a while it was like, how does 
that work out?" (Paul) 
 
In trying to make sense of his friend’s untimely and unexpected death, Paul was 
confused, expressing feelings of low self-worth and asking why he survived, and 
others did not. Paul believed that his friend had achieved far more in his short life 
than he had. In his deliberations, Paul never once mentioned the ‘lottery of life' 
concept but was trying to figure out why his friend had died, and he had not. This, 
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in a way, had confirmed in his mind that MM was not as serious as other cancers, 
and not as dangerous as his friend’s bowel cancer.  
 
The participants' experience of living with MM was consistently different from other 
patients with cancer, and this made them feel unusual and apart from the other 
patients. The feelings of being different grew from the perception that MM was 
treated in a distinct way from the outset of their MM journey. Some of the younger 
participants felt alone, but mostly, it was the families who felt isolated with no one 
to share their experiences. Families longed to be in a ward where there were 
others in a similar predicament to their child. Eve, John's mother, described this:   
 
“I seemed to be the only one, at that time and I just wanted to speak 
to another parent that had had a child that had gone through it, 
exactly the same as me, I didn't want to go and talk to parents' who 
had had a child going through Leukaemia, because that was not the 
same for me” (Eve).  
 
Eve is expressing how desperate, alone and isolated, she feels with no one to talk 
to. Her son seemed to be coping, but she felt the need to find support from others 
who were experiencing what she was going through. Having trained as a nurse, 
Eve was aware that patients with cancer, such as Leukaemia, have other families 
to talk with. Eve was asking ‘why could this not be the same for MM?’ It appeared 
that participants were treated separately, and therefore they felt different. 
 
4.5.4 Summary 
 
This super-ordinate theme, ‘Not The Same,’ revealed that living with an MM 
diagnosis changed their path in life and significantly altered their future life plan. 
Irrespective of the outcome, the MM diagnosis and associated treatment journey 
caused all the participants to re-evaluate their life and what was important to them. 
Nearly all the participants' confirmed that at some point, they all went through a 
period of self-reflection to try and cope with this disease. 
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A big part of the change to their life circumstances from MM came in unexpected 
ways. For many, the acute financial burden and associated worries meant that the 
fears around the MM treatment were compounded by the fear of financial 
uncertainty and loss. For many, the financial impact alone could change their lives 
beyond recognition.  
 
The treatment experience was unique for each participant for many reasons. Not 
one participant was treated within an age-appropriate unit, and consequently, 
some felt that the healthcare system was not designed to meet their particular 
requirements. However, it was evident that they often felt isolated and alone and 
that their care was not seamless, apart from the CNS (not always a TYA CNS, 
but, a Skin Cancer CNS), who offered support. There was also the casual TCT 
psychosocial input for some who were treated as a day patient. In particular, there 
no support available for the families/significant other. Due to the public's 
widespread perception of conventional cancer treatments, patients with MM who 
presented with no initial symptoms or treatment side effects reported that they felt 
different from other patients with cancer. Besides, having had personal experience 
of knowing someone who had died from cancer added to this perception and the 
feelings of being different. This emotional response was based on the different 
treatment protocols for MM, different services and the lack of support services in 
distinct locations. 
 
4.6 Time to Live  
 
 The super-ordinate 
theme, ‘Time to Live,' 
represents the final part of 
the MM journey. It was 
important for the YP to 
remain positive about the 
next part of their MM and 
life journey. It seemed they had adopted a range of emotional coping strategies 
early in the journey and had accepted the need to live with their cancer diagnosis. 
This positive thinking allowed them to redefine their goals and focus on the 
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meaningful aspects of their lives. For the family/significant other, this was 
described as “we’ll all just beat it again” (Terry) alongside the uncertain futures 
and having to live with MM through recurrent times. 
 
This final theme was categorised into three sub-themes. Firstly, ‘The scars tell a 
story,’ which refers to the YPs physical and emotional scarring as a consequence 
of having MM and being ‘marked’ by the disease. Secondly, ‘Supportive 
relationships’ which outlines the importance of support from family and friends and 
the interconnection of these relationships. Finally, ‘New meanings’ which revealed 
the importance of being positive and moving forward with their lives alongside an 
uncertain future. Although for some, especially the parents, there were days when 
fear and worry would consume them. Fear that the cancer would return meant 
continually checking their child’s skin for any sign of abnormal moles.  
 
4.6.1 The Scars Tell a Story  
 
Physical and emotional scarring was present for all the YP in this research. Severe 
physical scarring, had ‘marked’ them and was present for all, with most of the 
scarring visible around the head and neck area, upper leg, groin, abdomen and 
arms and told the story of their cancer journey. Some scars could be hidden or 
disguised, while others could not. This hiding seemed important for some, but on 
the whole, did not appear to affect them. Several YP reported that members of the 
public were inquisitive about their scarring while others felt that they were entitled 
to make uninvited comments and remarks about the physical scarring. As George 
explained:  
 
"Some days it’s like I’ve been in a bar fight with Chuck Norris. I was 
at a breakdown with my job, a couple of weeks ago, and I was sitting 
in the van, and a boy saw my scar and went ‘oh, what happened 
there?’ and I said to him I had cancer and he goes ‘oh, Melanoma 
cancer?’ I was like ‘aye’, and I said ‘have you had it?’ He says ‘no, I 
know folk that have’. So that's the first time I've ever heard anybody 
speak about it. So, it's not well known, whereas I think it should be” 
(George). 
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George felt defined by his scarring and although pretended to his father that the 
physical scarring did not bother him he was consciously aware that it was 
extensive. He was going about his daily life when questioned for the first time 
about his physical scarring. George was surprised that the young boy knew about 
melanoma and was astonished as no one else had ever commented or questioned 
George. It seemed that George’s surprise was genuine, and he was pleased that, 
at last, someone else had encountered MM and understood what it was.  
 
Richard, his father, described how his son preferred to keep the scarring covered. 
He had a different perspective on the physical scarring from George and believed 
that his son deliberately kept it covered and ‘hidden.’  
 
 “If he takes his beanie off, then you'll see it then, he says it doesn’t 
bother him, but he has that hat on all the time” (Richard). 
 
Richard explained that his son never removed his hat in order to keep the scarring 
hidden. George concealed his scarring to keep it hidden from the fear of people 
asking difficult or awkward questions. Richard believed his son George wore his 
beanie hat all the time as he was self-conscious of the scars the surgery had left. 
 
The other male participants faced similar issues. Paul described his physical 
scarring as though he had been physically attacked:  
 
 “I don't really think that the scarring bothered me that much. I've got 
scaring all over my neck and back, so if my hair is short, you can see 
scaring on my neck. It's two things, the acne, you feel people judge 
you for that because they think ‘oh you're unclean' I went out to a 
barbeque with my mum shortly after I had the staples removed and 
it was like someone had hit me with an axe. But I don't really think it 
has affected me. If anything, it's the acne that's done that” (Paul). 
 
Paul was trying to convey that the scarring had not affected him but simultaneously 
expressed very clearly how traumatic it was for him by comparing the scarring to 
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a physical injury resulting from an attack. This experience has commonality with 
Richard and the tensions the scarring brought to their lives.  
 
The physical scarring seemed to be just as arduous as the emotional scarring. 
This was the constant reminder of the cancer when they looked in a mirror or when 
people commented felt the need to comment or ask questions. The physical 
scarring would always be a part of them, as John described below:  
 
 " For me, the days with cancer will never end, and I will always be 
attached to it in some way, or another. I don't think I'll ever accept 
that it happened." (John). 
 
John was a young man with a fearless and dauntless character, but similar to the 
other YP, he was affected by the physical scarring. Being ‘attached to it’ was 
evidence that they had experienced and survived this type of cancer, as it was 
always there. The evidence was visible to all and would be present for the 
remainder of their life, however long or short. This scarring, and what it represents, 
would be part of his normal daily life and John had accepted that his life was now 
different from before the MM diagnosis. 
 
 “I think at first, just being young, I thought I can’t have a scar on my 
neck, people are going to stare at me and think who is this big scary 
guy. Mum was laughing because I think of it, a bit like my tattoo, and 
it's a good talking point if anyone asks me about my scar" (John). 
 
It was suggested that the physical scarring had become part of his identity and 
sense of self, which is similar to the other YPs experiences of their scarring. They 
were conscious of having this had altered their body image, important to them, 
when young. The physical scars, in particular, were focal points for conversation 
as the YP were aware that their physical body had changed, altered by the 
scarring from the disease.  
 
On top of the scarring from the MM, Paul was still traumatised from his earlier 
acne scarring, as discussed earlier in this Chapter. The combination of the MM 
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and acne scarring had a profound psychological impact on Paul, and also it was 
visible on his neck. He felt that strangers judged him as not caring for his skin 
correctly.  
 
“I wanted home but (because of) the cut and the clips (part of the 
surgery) I just was in a lot of pain. I had to sit up to go to bed, which 
was painful, I was out of breath constantly, so it was horrible, horrible 
at night. Then, of course, depression came back that night. But the 
worst part was the drain and getting the drain removed, that went, it 
was that length, and it was all the way up around the back of me. 
They were pulling it out, the pressure hadn't come off completely, so 
they were fairly yanking it.” (Paul). 
 
Post-surgery, the impact for all YP was immense, and this was the first time in the 
MM journey they felt ‘unwell’ and in discomfort from the surgery. The emotional 
scarring was evident as they recalled their experiences of after being in the 
hospital and being left to suffer from their post-surgery wounds. Paul was 
discharged early from the hospital, as he wanted to be at home. He was suffering 
physically and emotionally, both of which worsened at night when his mother was 
asleep, and he was alone with his thoughts. The post-surgery period appeared to 
be the agonising part of the MM journey as Paul described so vividly. Months after 
this, his discomfort, 'emotional scarring' was apparent, which was a similar 
experience for other YP and the family/significant other who were trying to support 
them.  
 
For Helen, her experiences of physical scarring were minimal, in direct contrast to 
the experiences of other participants. For Helen it was likely that the physical and 
emotional scars run deeper than would first appear, given the comments about 
changes to her lifestyle. Both were concerned with moving on with their lives, as 
Helen expressed blow:  
 
 "When I see all my scars, I don't see them as a big problem, I maybe 
can't wear a bikini anymore, but it's fine. I can't even go to the beach 
yet" (Helen). 
 __________________________________________________________________________ 
163 
 
 
Helen realises that her body had changed, and she knows the consequences of 
having endured many surgical procedures to remove the cancer. Previously it was 
‘normal’ for Helen to go to the beach as she comes from a small seaside town in 
southern Europe where the beach is where she went most weekends with her 
family.  
 
For Stuart however each time going to see the Doctor brought emotional turmoil 
and fear. In his mind, each visit seemed to bring more bad news; 
 
“We’re going to see him tomorrow to find out the results of the scan, 
which I hope, is ok” (Stuart).  
 
 
4.6.2 Supportive Relationships 
 
Cancer is a disease that affects the whole family/significant other as well as 
friends. The role of families/significant other is important within the MM journey, 
often more so than friends, due to the relatively young age and immaturity of some 
of the participants. Family/significant other were asked for advice, guidance and 
emotional support. This role was often difficult for the family/significant other as 
they grappled with their fears and worries for their child/loved one. Being ‘at hand’ 
for positive, optimistic and cheerful advice was a challenge for many of the 
families/significant other despite all recognising the importance of trying to hold 
the family/partnership together. The retention of the family unit provided everyone 
with support and reassurance through the solace they found in laughter, shared 
experiences and in-depth discussions about the disease. 
 
"I take each day as it comes, as long as he's here and he's hearty 
and as long as he's happy. Then we'll just soldier on. When he'd 
been told he had cancer at that time, I said look, he sat down beside 
me, I said 'it doesn't matter, whatever happens, I will be with you 
every step of the way,' and that's the way it is to be. I go with him to 
all appointments. As a parent, that's one of my roles in life to see 
him through these times” (Richard). 
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Richard always accompanied his son, even though he was 23 years of age, to 
every appointment. Richard was taking control and caring for George as best he 
could based on his firm belief that this was his role as a father. Describing the 
journey as “we’ll just soldier” on suggests fighting another battle, should it arrive. 
No matter what, Richard would be there for him. Richard was trying to be realistic 
and provide his son with comfort and security. This narrative shows the 
interconnection between father and son and that they were experiencing the 
journey together.  
 
"My dad comes with me; I am able to go myself, but as the hospital 
is a bit away, he comes with me for the drive. He has always been 
there for me (George). 
 
The importance of supportive relationships is clear and extremely important within 
the MM journey: 
 
"We've all worked really hard together, to pull each other up, I 
suppose. So yeah, to pull each other out of everything and sort of 
support each other I suppose. And it's been really supportive, it 
actually brought us closer, the whole experience, I suppose, we've 
all said that as a family it brought us closer than we could ever be. 
And more, we're so grateful to have each other, if you know what I 
mean" (Eve). 
 
MM was not only affecting John; it was also impacting on his family, emphasising 
the interconnection rather than the ‘individual’,  and they were all suffering in their 
way. It was all-consuming. The family were close before the MM journey began, 
but now, they were even closer than before with each member of the family 
supporting the others. They craved support and reassurance, especially when the 
days were at their darkest and they were plagued with worry and fear. It was the 
intensity of this support that made the MM journey bearable.   
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Supportive peer-to-peer relationships with friends was an essential consideration 
for some of the YP. Some friendships would prove to be durable throughout the 
MM journey, but others would wither away under the relentless emotional pressure 
of the disease, with the enforced absences diluting existing relationships. For 
George, his family and friends were vitally important: 
 
“Apart from the family, my friends were there for me as well. So, they 
held tight, after my second operation, I was still in bandages and 
everything, my friend picked me up we went to a car show. So, it's 
not like I was stuck in the house or anything. They were there helping 
me as well, through the whole thing. My mum and dad have also 
been there through the whole thing" (George). 
 
George described how fortunate he was to have such good friends. They had seen 
him through the good and the tough times, throughout his MM journey. His friends 
had been reliable and had stuck with him throughout. George’s friends were 
reliable and supportive, along with his family, and this was evident in all parts of 
his life. Their support kept him moving through his MM journey. They were his 
strength. 
 
For John, the journey was bearable with having such strong friendships 
throughout; 
 
“They were great... they are such a good bunch, and that was 
another huge thing of my cancer, as soon as I'd been diagnosed we 
were meant to be going on a trip with school, so, I had to text them 
and I said 'look guys, you got to come round to mine tonight because 
I've got to have a chat with you all' So they all came round, and I told 
them on the night I had been diagnosed and I broke into tears, 
because that was the thing as soon as I tried to tell someone, it was 
like that's real now. So I told them and just about straight away, we 
just about started making jokes, and that was a big thing, I think 
being able to laugh, I was able to sort of make it this sort of small 
thing instead of being like' wow, this is cancer'. I was able to take a 
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step back and think 'look, just think about this rationally and don't 
overthink it'. So that was the big thing for me, I found laughter and 
being able to joke quite therapeutic. Because I felt myself, I didn't 
feel like I was pinned to having cancer” (John). 
 
John, although on the surface phlegmatic for most of his MM journey, also 
expressed how fortunate he was to have such good friends, with close personal 
relationships having been built over several years. John found it difficult to tell his 
friends about the cancer initially, but once broached, the discussion brought a 
cathartic emotional release. It helped that the friends could laugh with John and 
distract each other from the seriousness of the disease. The shared sense of 
humour, often very dark, brought strength to John and helped him feel 'normal' 
again. John had found himself as a person again, not defined by the cancer. This 
was different from his laid-back attitude, as described earlier in the Chapter. 
 
John, however, was aware of how the disease had impacted on his mother, Eve. 
This experience had taken its toll on her and John was acutely aware of this: 
 
 “My mum was there throughout, and I think my journey with cancer, 
well I quickly came to terms with it and didn’t really think about the 
magnitude of what was going on until watching other people. Like 
my mum, we have always been close, and with my family and to 
watch them not know what was going on inside of me was probably 
the scariest thing. It was never really like, oh no I got cancer, this is 
really bad on me, it was more like this is not good for anyone around 
me’” (John).  
 
In this context, John has a strong connection to his family but mainly his mother. 
This disease has had an enormous effect on the whole family. John could accept 
having the cancer, but it was difficult to observe how this had impacted on his 
family and those close to him rather than himself. They had all embarked on this 
journey together.  
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For Patrick, in sharp contrast to John’s experience, prolonged absences from 
school and associated social events disrupted existing friendships, and they would 
never to return to ‘normal’ again. As Patrick expressed his feelings of social 
isolation: 
 
“Dad’s always had to take care of me and pals don't like me just now 
because I have cancer and they feel sorry for me. That's not a pal” 
(Patrick). 
 
Patrick's comments above reveal the deep state of his social isolation from his 
immediate peer group and the emotional disruption associated with this. He was 
also describing the most important relationship with his father, where his trust was 
implicit and never falters. Patrick relies on him for everything. The social stigma 
and possible fear of cancer had changed Patrick's friendships in a negative way 
which was not common to all YP in this study. Some friends wanted to pity Patrick 
and make a point of supporting the ‘cancer victim.’ Other friends have been driven 
away by the fear that cancer was contagious, and they did not want to be 
associated with the “pal” with the disease. 
 
4.6.3 New Meanings  
 
Malignant Melanoma impacted on the daily and future lives of all the participants. 
Many expressed having developed a more profound sense of meaning in their 
lives that derived from the experience of dealing with MM. By the end of the MM 
journey, many felt a strong motivation to embrace life and all its opportunities and 
reported an increase in their confidence and strengthened relationships with 
family, friends and loved ones. This, however, was not a universal experience for 
all participants as some continued to worry about the cancer returning. 
 
Helen, who has found her deep levels of resilience through dealing with profound 
adversity such as a third relapse and unexpected financial stress, commented: 
 
“OK, I’m going to die. I never thought this. We always tried to be 
positive, I think this is why I am normal when speaking about my 
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story. I will never be able to go back to my normal. I am not feeling 
fully healed, still in some pain, but I just feel I need to restart my 
normal life.” (Helen). 
 
Helen was determined and positive right from the outset of her MM journey, which 
was in tandem with some of the families' stories, as discussed earlier in the 
Chapter. Despite the seriousness of her cancer, Helen refused to be ‘beaten’ and 
did not let the cancer destroy her life or life she was trying to build with Stuart. She 
was fully aware that her health will never return to the pre-cancer days but was 
determined to restart her life. Helen and Stuart's life before the MM had 
disappeared and they now had other more important parts of their life to consider. 
It did appear that Stuart worried about the future, perhaps without Helen, as he 
now knows the gravity of Helen’s MM. Helen wants to restart her life where Stuart 
was pausing which illustrates the uncertainties.  
 
"We will not get married yet. First of all, it's more the money situation, 
because obviously, we don't have a lot of money, I mean she's 
(Helen) not been working for a long time this year, and she still has 
to have more treatment, we will know about this soon and she will 
need to be there on her own" (Stuart). 
 
Helen and Stuart plan to marry once the treatment has finished, and they can 
continue with their life. Helen and Stuart, similar to Terry, have had to face financial 
precariousness. Prolonged absences from work or periods of unemployment have 
led them to experience financial difficulties which in turn had affected their lives. 
Helen and Stuart’s life was interrupted, but they also had to live with the constant 
fear and worry about the cancer recurring. The MM had affected their life plans 
significantly, and at some points, it seemed as if their future life together was 
hanging in the balance. 
 
Most of the participants had found some positive meaning in their lives. Even 
though four out of the five YP who were interviewed had a recurrence of the 
disease, they all stayed positive. Yet, it was for some of the parents who found 
this hard. As Eve, John’s mother describes below; 
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"Because it was a different cancer. But I think cancer is just cancer, 
you know. I still think sometimes, I still worry about him all the time. 
I mean, I check his moles every month. I am the ‘mole mapper’ of 
the whole family. I've become more anxious because of it. I've 
changed, I know I've changed” (Eve). 
 
For Eve, the term cancer was serious, no matter the specifics of the disease. Since 
diagnosis, Eve’s self-imposed role was now to be the mole checker and mapper 
for the whole family, a role she has taken very seriously. The MM experience has 
changed Eve, which was parallel to the experiences of other family members and 
loved ones. Eve described how anxious she had become because the MM had 
afflicted her child. Although wanting to move on for the health and benefit of her 
family, Eve remains trapped in the mole checking cycle and was continually 
checking for early indicative signs of MM in other members of the family. 
 
Although on a new path, with new meanings for most, there was still the worry and 
fear that the MM could return at any point in their life. The YP knew they would be 
required to continually monitor their skin for any signs of the disease returning. 
The daily routine of checking the condition of existing moles, and looking for new 
ones, would need to continue for the rest of their lives. Terry explained: 
 
“He is just so worried, he is going to always have to check, it’s as 
simple as that, and he does check every day in the shower, and I 
keep an eye, but if or when the bad times come, if anything happens 
again, we’ll all just beat it again as simple as that (Terry). 
 
Many of the YP had to adjust their daily routine in response to the MM. For some, 
this was a practical change to their lifestyles. Fear, anxiety and worry over the 
possible reoccurrence of MM was the main driver for this change in behaviour. For 
many, this change was seen as a positive, proactive step in protecting their future 
health and well-being. Paul seemed to be coping well with this new regime in his 
life:  
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“Well, I’m content. I don't think I've been happy for a very long time. 
Well happy, happy. I not sad or anything anymore, really, but I'm 
content. I'm happy with where I am and just not outwardly” (Paul). 
 
Paul’s feelings of contentment sprung from his acceptance that the worst was 
behind him and that his life could move forward, but he would remain vigilant in 
looking for signs of the MM returning. This is something that would stay with him 
and was present in all the participants with the notable exception of one mother, 
Eve, Johns mother, who was stuck. Eve would worry for the rest of her life and 
found it difficult to move on.  
 
“it will always be on my mind, it will still always be there, thinking it 
could come back, and hopefully they'll keep on top of checking. He'll 
check himself obviously” (Eve). 
 
No matter what journey this disease had taken them on, the YP, for the most part, 
were optimistic and could see a future for themselves. Most had plans for the 
future, and like Patrick, would be positive while looking ahead and considering the 
future: 
 
“I will be 17 in August, so I’ll be starting my driving lessons and going 
to college” (Patrick). 
 
Patrick had turned 17 and had been on the journey of living with MM since he was 
11 years of age. He was optimistic and excited about learning to drive, and when 
accomplished in his driving would have transport back and forth to college. At the 
college he would receive an education, the education he had missed out on from 
being unwell with his MM. 
 
4.6.4 Summary 
 
The 'Time to Live' super-ordinate theme described how all the participants' journey 
with MM had brought new and different meanings to their lives and forged a 
different path for them. In moving forward, they had not been defeated by the 
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disease. All continued to make plans for the future, despite the uncertainty and 
interruption to their lives that the MM diagnosis had delivered.  
 
The YP’s scars, both physical and emotional, were a constant reminder that they 
had experienced and successfully endured all the trials that the MM had presented 
to them. These scars now represented a key part of their present and future 
identity, and most of the YP had come to terms with this.  
 
Supportive relationships were critical to the YP’s MM journey. They all viewed their 
MM experience as a shared journey with family/significant other and friends. As 
most of the YP lived at home with their family/partner, it was their parents/loved 
one who became their primary carer, supporter, adviser, advocate and friend 
along this journey. In addition to the immediate family member others were also 
affected, for example, the siblings. This disease had impacted significantly on all 
their lives in many different ways, although there were shared experiences for 
most of the journey.  
 
The participants were mainly positive and optimistic, with a newfound meaning to 
their lives. The worry of reoccurrence would remain as an almost permanent 
presence in the lives of some YP and their family/significant other, but they were 
still able to move forward with their lives.  
 
4.7 Conclusion 
 
This Chapter has documented that living with MM was an emotional journey for all 
the participants who described their lives as being interrupted. The data suggested 
that being diagnosed with MM was a significant life event and, in some 
circumstances, can trigger emotional responses that compel the individual to find 
new and additional meaning. Also evident was that living with MM was a family 
disease and support was required for both the YP and the family/ significant other. 
 
The core ‘Life Interrupted’ conceptual thread is introduced in Chapter 5 to capture 
the fluid and interactive nature of the processes and experiences of living with MM 
Further discussion follows to illustrate the unique journey for YP and their 
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family/significant other living with MM and the dynamic and multifaceted 
interrelationships that exist.  
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Chapter 5: Discussion and Conclusions 
 
5.1 Introduction  
 
This Chapter presents the research aim and questions. It then discusses the core 
conceptual thread, the ‘Life Interrupted’ metanarrative, which illustrates the 
thematic structure and interconnections between the YP and their 
family/significant other in living with MM. A fundamental part of the MM journey for 
all hinges around the unique and often complex factors that interplay between the 
YP and their family/significant other and I present a conceptual representation of 
this journey. This maps the sequential stages in their MM journey, the multifaceted 
and dynamic relational interplay between the YP and their family/significant during 
the journey alongside the individual and shared experiences of living with MM. 
The main findings embedded within the four superordinate themes are then 
critically discussed and evaluated, exploring the meaning, importance and 
relevance of my research to theory and practice. Finally, I present my overall 
conclusions.  
 
At the time of writing, this study was unique in exploring the experiences of YP, in 
the 16 to 26 years age bracket, and their family/significant other living with MM. 
The earlier narrative reviews in Chapter 2 identified that there was no current 
qualitative literature exploring the experiences of YP and their families/significant 
other living with MM. During the 1970s MM in YP was rare (Bader et al., 1985; 
McNally et al., 2014), but over the intervening decades, there has been a marked 
increase in the reported incidence of MM in YP around the world. According to the 
ISD (2019), the most common diagnoses reported in YP across Scotland were 
carcinomas (21%), lymphomas (18%); and melanomas and skin cancers (16%).  
 
Research into YP with cancer has focused on the more common forms of cancers, 
such as Leukaemia and Hodgkin’s (Taylor et al., 2018; Fern et al., 2013b; Zebrack 
et al., 2014). These studies have recognised shortcomings and were discussed in 
my second literature review in Chapter 2. Specifically, I identified that the 
methodological approaches used were not always appropriate to provide an in-
depth analysis of the YP experiences alongside the family/significant other. 
Additionally, the focus in previous literature has been on all cancers rather than 
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one specific disease and has been on the individual young person to the exclusion 
of the family/significant other. In concluding this Chapter, I discuss my study’s 
original contributions to the broader body of knowledge, the strengths and 
limitations of the research, before highlighting and summarising my 
recommendations for future research, practice and policy. Finally, I present my 
overall conclusions from this research.  
 
5.2 Research Aim and Questions 
 
At this point, it is relevant to re-state the research aim and questions in Table 5.1 
and confirm that these have been answered through the IPA approach and 
associated research methods. It was clear that each young person and the 
family/significant other had established dynamic interconnections built around pre-
existing inter-relationships. My research findings in Chapter 4, have been 
presented to reflect the nuances of these dynamic connections and relationships. 
Consequently, the research questions were addressed through the four 
superordinate themes and the key discussion points critically analysed and 
synthesised within the available cancer literature that included MM in other age 
brackets and seminal work specific to this patient group. 
 
Table 5.1: Research Aim and Questions 
Research Aim and Questions 
Explore the experiences of YP and their family / significant other living with MM 
within Scotland. 
1. What are the experiences of YP and family / significant other living with a 
malignant melanoma? 
2. What are YP and family / significant other experiences of the support and care 
they require or need? 
3. What further support or improvements in care do YP and family / significant other 
identify? 
 
Through a rigorous IPA based analysis of MM in the 16 to 26 age group and their 
family/significant other, this section is grounded in the data gathered during this 
research and is contextualised within existing theoretical understandings. It is also 
important to acknowledge that the experience of cancer takes the form of a 
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trajectory or ‘journey’. This involved a series of events along the way, including 
recurrence for some. In my study, four out of five YP experienced a recurrence as 
part of their journey, and these were explored within the narratives recounted in 
Chapter 4. Willig (2011) explains that through her own experience of living with 
cancer, individual understanding changes as patients move along their cancer 
trajectory and each point on the journey involves a shift in their epistemological 
stance towards the disease.  
 
5.3 The Metanarrative – Life Interrupted  
 
The metanarrative of a ‘Life Interrupted' represents the interconnections and inter-
relationships between the identified super-ordinate and sub-themes and acts as 
the core conceptual thread throughout the findings. This study also captured the 
uniqueness of the multiple voices as opposed to the individual voice (Larkin et al., 
2019), which is a novel addition to the IPA approach. Multiperspectival IPA retains 
a commitment to idiography in data collection and analysis but broadens this by 
combining two or more focal perspectives, allowing for the relational and 
intersubjective to be captured. This was a critical finding within my study, where 
the multiple voices contributed to the overall MM experience. The concept of a 
metanarrative is that recurring hermeneutic (meaning constructing) practices 
constitute a familiar ‘lifeworld’ (Wilson, 2018). From this perspective ‘Life 
Interrupted’ is an appropriate metanarrative in respect of which more particular 
themes in my research are situated (Eatough & Shaw, 2019; Carel, 2016; Smith 
et al., 2009).  
 
Throughout my study, I have endeavoured to capture the ‘connectedness of 
meaning’ established during the hermeneutical exploration of the experiences of 
living with MM while integrating the findings into this overarching metanarrative 
(Eatough & Shaw, 2019; Gilstrap, 2007; Osborn & Smith, 2006; Somers, 1994, 
p619). The ‘Life Interrupted’ metanarrative was evident in the experience of every 
participant living with MM, irrespective of the patient and family background, 
circumstances or outcome. The data collected from this study was organised 
hierarchically into themes, and following the iterative process of analysis, the 'Life 
Interrupted' metanarrative was identified from the participant's lives. ‘Life 
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interrupted’ speaks to the various ways that participant’s lives were interrupted 
due to the cancer diagnosis, and the journey this disease took them on as well as 
the unsettling emotions that were experienced during this journey.  
 
Based on my findings, a thematic structure of the ‘Life Interrupted’ metanarrative 
is shown in Figure 5.1 to illustrate the core conceptual thread and the 
interconnection between YP and the family/significant other. The interconnection 
between the four super-ordinate and the 12 sub-themes is also shown. Some 
participants repeated parts of the journey for a second or third time, due to 
recurrence of the disease. The central concern of IPA is with the individual lived 
experience, which we understand to be a form of “concernful involvement” 
(Yancher, 2015, p109) which considered the shared experiences that were 
present throughout the entire journey. Concernful involvement allows for the 
disclosure of truth about aspects of the world, but truth, from this perspective, must 
be understood as unfolding, multifaceted, and inexhaustible. Events, objects, 
places and people within the world matter to the individual and in order to make 
sense of the lived experience the researcher required personal reflection in order 
to reach an understanding as was discussed in Chapter 3. 
 
Figure 5.1: Life Interrupted – A Thematic Structure  
 
  
Young 
Person & 
Family / 
Significant 
Other
Not the Same Too Much too Young
Time to Live Is it Serious?
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Interpretative Phenomenology Analysis (IPA) is 'underwritten' by hermeneutic 
philosophy or fundamental informing and from a hermeneutic perspective, a 
'characteristic of the lifeworld' (Eatough & Shaw, 2019) or where the participants 
recurring events occur. The metanarrative provides an overarching interpretation 
of the participants’ experiences of living with MM and is concerned with describing 
the whole story, specifically one which integrates to the other narratives. In living 
with MM, YP and their family/significant other experienced interruptions and 
setbacks to their customarily familiar or anticipated lifeworld’s (Eatough & Shaw, 
2019). Eatough & Shaw (2019) offer an understanding of the lived experience of 
a particular person with Parkinson's disease. Through an IPA case study 
approach, they recognised that the experience is indivisibly woven into the 
person's lifeworld. Lifeworld describes how each of us inhabits a subjective 
situated world and one in which we share "ever-present characteristics" within the 
situated worlds of others (Eatough & Shaw, 2019, p51; Smith, 2019). This was 
evident throughout the participant’s experience in my study, where the participants 
were all experiencing the same disease, which brought about similar emotional 
and physical changes.  
 
Virginia Eatough writes: “IPA seeks to retain the rich and personal detail of the 
particular while pointing to ways in which the particular illuminates (and is 
illuminated by) characteristics of the lifeworld that are common to us all. These 
lifeworld features provide a useful lens through which to examine the concrete 
particulars of an individual situation and say something about its more universal 
features” (Eatough & Shaw, 2019, p51). The phenomenon of lifeworld or ‘lived 
world’ is situated within the accounts of other people who are also sharing the 
same experience, such as the family/significant other (Larkin et al., 2019). By 
lifeworld Eatough & Smith (2006) discuss the world in which we experience, that 
is filled with meaning, attempting to capture what matters within an individual life 
(Smith, 2019; Wilson, 2018). 
 
During the YPs' lives, the MM experience arrived at a time when they were in the 
process of developing their early adult life plans and were at a fundamental 
crossroad in their lives. Despite the varying individual personalities and personal 
circumstances, my in-depth research acknowledged that these participants were 
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experiencing a significant interruption to their typical 'day-to-day' routine and 
plans. School and career plans along with life and prospects for adulthood were 
affected by the disease and its treatment. Prolonged periods of hospitalisation for 
this disease were rare, for most, and many YP at the beginning of their journey 
did not recognise that they were unwell or living with cancer, unlike other forms of 
cancer affecting YP. The family/significant other also felt that their lives had 
changed, with their hopes and dreams for their child’s future altered by the 
disease.  
 
5.4 Living with Malignant Melanoma – The Journey 
 
Although the MM journey can be similar in some respects to other recorded cancer 
experiences, such as the conceptual model proposed by Taylor et al. (2013), in 
my study the MM journey varied for each participant, but they shared a similar 
experience which was different from other forms of cancer in YP. In particular, the 
impact of MM can only be fully understood when viewed through the prism of the 
dynamic and complex family/significant other relationships. The ebb and flow of 
these intense relationships can, in some situations, magnify the impact of the 
physical disease, with the emotional turmoil often rivalling the physical 
manifestation of the disease. Equally, different relationships may help the YP and 
the family/significant other cope with the disease in a more positive and supportive 
way. The importance of these unique and changing relationships in living with MM 
should not be underestimated.  
 
To capture the unique and complex factors at play in the MM journey for each 
young person and the family/significant other, Figure 5.2 illustrates three core 
interlocking parts of the journey that was revealed through this research: (1) the 
sequential stages of the MM journey from pre-diagnosis to living with MM; (2) the 
multifaceted and dynamic inter-relationships between the young person and their 
family/significant other that sit at the core of the journey; and (3) the individual and 
shared physical, emotional and social experience of ‘Life Interrupted’. 
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Figure 5.2: The Malignant Melanoma Journey – A Conceptual 
Representation  
 
 
 
Part 1 charts “the MM sequential journey” and illustrates the typical cancer 
trajectory for most YP living with cancer with vertical arrows showing the flow 
between each stage. For some, the journey also involved a return to treatment 
when a recurrence was experienced. Horizontal arrows from each stage of this 
journey, intersecting with the core of the diagram, reveal that each individual step 
was taken in tandem with the family/significant other and was influenced by the 
existing complex and dynamic family/significant other interpersonal relationships. 
This meant that each young person experienced a unique journey in terms of the 
manifestation of the physical disease and its emotional and social impact. 
  
Part 2 centres the complex and dynamic family/significant other relationships 
throughout each MM journey. It was these emotional and social interrelationships 
and interconnections that provided the resilience to cope with the true impact of 
the disease and shaped the ways that lives were interrupted as the MM journey 
progressed.  
 
Part 3 captures the experience of having life interrupted illustrated in the four 
super-ordinate themes revealed by this study: ‘Is it Serious’, ‘Too Much too 
Young’, ‘Not the Same’ and ‘Time to Live’. 
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The complexity of these multifaceted interrelationships and interconnections 
between the YP and their family/significant other are encapsulated in four shared 
responses shown at the bottom of the diagram. These shared feelings and 
experiences are dynamic, ebbing and flowing, intensifying and receding, as the 
MM journey progresses, yet each played a vital part in the overall lived experience. 
Presentation of the core threads and themes of the thesis in this visual way helps 
to conceptualisation “what lies between” (Larkin et al., 2019) and shows how the 
experiences YP and their family/significant other were inseparable. 
 
The following critical analysis and synthesis discusses the profound life impact an 
MM diagnosis, and the subsequent treatment experience can have on the young 
person and their family/significant other at a significant period of their lives. The 
core conceptual thread alongside each of the four superordinate themes and 
findings are now discussed in more detail.  
 
5.4.1 Is it Serious? 
 
For YP and their family/significant other participating in this study, the MM journey 
commonly started with encountering unexpected physical changes in the condition 
of their skin or pre-existing mole. There was a general lack of awareness of this 
disease and most did not associate melanoma as being cancerous. Personal 
awareness of cancer, in general, was from their own experiences of a friend or a 
relative who had lived or died with other cancers, such as Leukaemia or Bowel 
Cancer, but for most, there was limited specific knowledge, understanding or 
awareness of skin cancer. This lack of awareness, and wondering whether it was 
serious or not, impacted later on in their journey in living with this disease. Apart 
from Helen, who had lived all her life in the ‘sun’ and had grown up protecting her 
skin, and Eve, who was an adult nurse, had some knowledge of skin cancer. None 
of the other YP or family/significant other had any awareness of melanoma. This 
bewilderment and lack of awareness were present from the beginning of their MM 
journey. 
 
Apart from these physical changes, there were often no other symptoms which 
are different from other common cancers in YP. These changes, when noticed, 
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promoted action to visit their GP or health professional to investigate and diagnose 
their suspicions. For many, the time of diagnosis involved new environments, 
unfamiliar language, unsatisfactory communication and inadequate healthcare 
processes. Treatment protocols for MM are stage-dependent and typically 
delivered through outpatient appointments at non-specialist cancer treatment 
centres, and hospitalisation is usually for surgical procedures only. Malignant 
Melanoma is not a disease that is often associated with children and YP, and 
generally is un-noticeable to the general population and indeed often to 
themselves (Ferrari et al., 2019; McNally et al., 2014). As was evident within my 
findings, the changing moles were often ‘hidden’ or unnoticed by YP and their 
family/significant other. This was a challenge for some. In addition, they did not 
experience any abnormal symptoms from the mole site, apart from Helen. 
Whether it was ‘out of sight out of mind’, the participants tried not to worry and to 
carry on as ‘normal’. For one participant, Helen, it was the discomfort and bleeding 
which prompted her to act. Each individual young person and family/significant 
other described in great detail the events that led them to seek medical advice. 
 
Often changes to the mole can be perceived as trivial and not signifying possible 
skin cancer (Bird et al., 2015; Kyle et al., 2012; Walter et al., 2010). Ensuring that 
the YP and the healthcare professionals have an awareness and are 
knowledgeable about melanoma, would support a positive life experience in living 
with this disease. Changes to the mole, being identified earlier, would present a 
more favourable outcome for the YP and their family/significant other preventing 
unnecessary worry and fear (Kyle et al., 2012: Hajdarevic et al., 2014; Walter et 
al., 2010). Epidemiological research has found that early diagnosis of melanoma 
prevents the disease from infiltrating into the lymph system and other organs of 
the human body (Ferrari et al., 2019) and preventing the spread of the disease. 
 
As highlighted above, the experience of finding the mole, being bewildered and 
surprised was a common reaction amongst all the YP and their family/significant 
other. Apart from Patrick, all the other participant’s abnormal mole was detected 
by the YP themselves or through daily life routine. Research by Smith et al., (2007) 
reported that YP may attribute physical signs and symptoms of other types of 
cancer to more usual problems such as stress and injuries. It was also suggested 
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that YP have an inbuilt sense of immortality combined with a lack of self-
awareness and a belief that cancer would never happen to them (Smith et al., 
2007; Gibson et al., 2013; Pearce, 2009). Similarly, the YP in my study shared 
these feelings, and this added to their initial bewilderment and surprise in finding 
the suspicious mole.  
 
The challenges associated with early recognition of MM and seeking prompt, 
professional advice within the YP population needs careful consideration and 
should not be underestimated within the actual cancer trajectory. Several studies 
have shown the importance of education around the signs and symptoms of 
cancer and emphasise the importance of seeking appropriate medical guidance 
and support without delay (Albritton & Bleyer, 2003; Kyle et al., 2014; Smith et al., 
2007). In my study, YP, the family/significant other were also experiencing similar 
feelings of surprise, tinged with a degree of suspicion – ‘was this serious or not,’ 
and denying that this disease could be affecting their child/loved one. As seen in 
Figure 5.2, this is the first step for many in the MM journey. 
 
The emotional bewilderment associated with the changes to the mole was never 
static, and worry began to erupt as they progressed through the journey to 
diagnosis. The difficulties participants described were documented throughout 
Chapter 4 and the first super-ordinate theme. Although the young participants 
reported that they did not feel unwell, unlike many other patients with cancer who 
experience many unwanted symptoms, they did begin to worry about what they 
had found. Waiting for an appointment, and the results of the biopsy were 
emotionally draining for many and contributed to the strain of wanting to be 
believed and their symptoms accepted. However, as they progressed to the 
diagnosis, early signs and symptoms of changes to their mole were not always 
fully recognised or accepted by the GP.  
 
Being fully aware and able to recognise the signs and symptoms of cancer is, 
however, an essential factor for YP and has been investigated further within recent 
studies (Hajdarevic et al., 2014; Hubbard et al., 2018; Kyle et al., 2014; Meyer, 
Christensen, Tolstrup, Dalum & Køster, 2019; Rouhani et al., 2009; Walter et al., 
2010). According to these studies, skin cancer awareness in this age group is 
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extremely low, and self-awareness, knowledge and understanding are critical to 
early diagnosis and preventing the disease from spreading and increasing the 
threat to their future lives.  
 
Although all the participants acted on the changes to the mole, without delay, none 
of the YP and their family/significant other had knowledge and understanding of 
skin cancer, apart from Helen and Eve as discussed earlier in the Chapter. Most 
of the participants reported within their narratives the lack of awareness about the 
dangers and risks of melanoma and the fact that there was no available 
information within the healthcare centres, compared to other cancers such as lung 
cancer and smoking. A cross-sectional study by Kyle et al. (2014) undertaken in 
Scotland, with 2,173 adolescent secondary school pupils, highlighted the 
influential role awareness and education play in understanding skin cancer, the 
risks associated with UV exposure and encouraging safe sun-protective practices. 
Similarly, Horsley, Charlton & Waterman (2002) carried out a study in England 
where school pupils’ aged between 10 and 16 years were included in a survey 
questionnaire regarding their behaviour in the sun, opinions and experiences of 
sunburn. Horsley et al. (2002) found that the young participants believed that 
having a ‘tan’ made them beautiful and therefore exposed themselves to the sun 
whenever they could. They found that education was needed to challenge the 
notion that a ‘tan is beautiful’ and proposed using social teaching methods to 
empower pupils to carry out sun protection in real life. However, as reported within 
their narratives, sun-related behaviours or tanning were not typical for most of the 
YP in my study. 
 
Much of the literature found on MM focuses on the epidemiology and sun-related 
behaviours or tanning (Hubbard et al., 2018; Murray & Turner, 2004; Tripp et al., 
2016; McInally, 2018). The evidence suggests that MM could be entirely avoidable 
by heeding the warnings about exposure to UV light, irrespective of its source 
(Murray & Turner, 2004). Murray & Turner (2004), through a mixed methodology 
study, found that more self-awareness was required around the risks of 
overexposure to the sun or sunbeds. This study gathered information from people 
aged between 18 to 32 years living in Merseyside and through an IPA approach 
that having a tan made them feel better about themselves and was essential for 
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their body image. However, for many, this behaviour became addictive, similar in 
many ways to the social pressures experienced around smoking and alcohol 
consumption in some parts of society (WHO, 2019). Early awareness and the 
associated changes in behaviour and attitudes have the potential to reduce the 
burden of melanoma in adolescence and early adulthood, as well as in later life 
through the establishment of self-awareness and for some other protective health-
related behaviours (Kyle et al., 2014). Most of the YP, from what they could recall, 
had not participated in any form of unprotected sun or UV light exposure or sought 
to have a tan, which contrasts with the Murray & Turner (2004) study. The families 
also reported that they had always tried to protect their child’s skin from 
overexposure to the sun.  
 
Nevertheless, most followed up on their suspicions with either their GP or 
dermatology clinic. As discussed earlier in this Chapter, this is unusual in this 
patient group as most YP can be ambivalent about illness, but it may have been 
that alerting their family/significant other to their findings prompted them to seek 
medical attention, without delay. Congruent with a small number of qualitative 
studies, it is common for YP to postpone seeking medical attention after they have 
had specific or non-specific symptoms (Gibson et al., 2013; Fern et al., 2013b; 
Miedema et al., 2006), and most keep these ‘worries’ hidden from their 
family/significant other.  
 
The majority of the participants in my study reported that their GP initially 
dismissed the concerns. Reflecting on their experiences, many described the false 
sense of security they received from the GP at the initial consultation. However, 
continuing symptoms meant that despite these initial reassurances, they found 
themselves going ‘back and forth’ to consult with their GP multiple times. Their 
worries and concerns were only taken seriously once the mole had been 
eventually biopsied or excised. Time spent waiting for a diagnosis ranged from 
one to 10 weeks, depending on where the participants were located. This part of 
the MM journey was reliant on the time taken from primary excision of the mole to 
the histopathology results being relayed to the healthcare professional and further 
action taken. This waiting time allowed the participants the opportunity to research 
their disease through the internet and fuelled the belief that the delay in diagnosis 
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may have allowed the disease to spread within their bodies. This experience 
added to the stress already being felt by the participants. 
 
Although the incidence of melanoma is rising in the YP population globally, it is 
still relatively rare for an individual GP to experience a young person with cancer 
such as MM (Miedema et al., 2006; Scottish Government, 2019a). A study by TCT 
(2015) found that close to a third (29%) of young patients with cancer were only 
diagnosed when their health deteriorated to the point of admission to an 
Emergency Department (ED). Nearly a third of young patients (32%) had a poor 
diagnosis experience indicated by three or more visits to a GP before referral. 
Almost a quarter (24%) had been to a GP with symptoms but attended ED when 
symptoms worsened. Melanoma can be difficult for the GP to diagnose, but 
patients should be referred to appropriate specialist services if the lesions are 
suspicious (Marsden et al., 2010; Melanoma UK, 2019; Scottish Government, 
2019a; TCT, 2015). Early detection, clearly defined referral pathways and 
equitable access to specialist services, minimises unnecessary delays and 
enables treatment to start as promptly as possible (Murray & Edgar, 2012).  
 
Government policy in the UK stipulates that patients, including YP, with suspected 
malignant skin lesions, should be seen by a specialist who has knowledge and 
experience of this disease (Marsden et al., 2010; Macbeth, Newton-Bishop, 
O’Connell & Hawkins, 2015; NICE, 2005; 2015). In addition to this, CYP in 
Scotland who present three or more times with symptoms that do not appear to 
be resolving, or following an expected pattern, should be considered for referral 
for a second opinion regarding the concerns (Scottish Government, 2019a). The 
difficulties of supporting YP with this disease also extends to where the journey 
begins, how the diagnosis is made and communicated to the YP and their 
family/significant other.  
 
For many, the journey started with an undiagnosed, and often minor, skin 
complaint that had transformed into a life-changing and threatening condition once 
the word ‘cancer' was mentioned. Despite seeking medical attention for their 
suspicions about the mole, the participants were not prepared for the diagnosis. 
The sudden onset of the disease was not expected, and it was alarming that it had 
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occurred at this critical stage in their life. Healthcare professionals relayed this 
diagnosis as 'melanoma' and only when prompted by the YP or family/significant 
other did they confirm the diagnosis as ‘skin cancer’. This first part of the journey 
was an emotionally fraught and challenging experience, although it was not 
always clear whether some of the YP and the family/significant other had taken ‘it’ 
as seriously as other types of cancers. Young people, in particular, referred to the 
'cancer' as 'it’, opting to avoid naming the cancer as a way of detaching themselves 
from the MM, which may have served as an effective coping strategy for some. 
 
Most of the YP had limited knowledge about melanoma, but as discussed in the 
previous section, they did have experience and knowledge of other cancers. This 
illustrated how vitally important appropriate and compassionate communication 
was from the healthcare professionals when delivering such news to YP with or 
without their family/significant other in attendance. There is a rich seam of 
literature around communication for YP with cancer, but this does not always 
include the family/significant other (Fern et al., 2013b; Gibson et al., 2013; Grinyer, 
2009). The literature also reports on the accuracy of the information they receive 
(Lea et al., 2018; Mulhall, Kelly & Pearce, 2004) and whether this is helpful or not.  
 
Many of the participants felt as though they had not been provided with sufficient 
information during the diagnosis. Additionally, the environment in which the news 
was delivered did not make them feel at ease. Openness, honesty, transparency 
and communication are the essential key skills that all healthcare professionals 
should possess to ensure that YP and family/significant others have enough 
support when the diagnosis is relayed (Al Omari & Wynaden, 2014; Hølge-
Hazelton & Olsen, 2018; NMC, 2018). This was an essential part of the MM 
journey and one that was missing for all the participants in my research. Apart 
from the information and support given from the CNS, which was inconsistent, 
there was no information or support available.  
 
Provision of accurate and timely information would have supported and assisted 
the participants in understanding the diagnosis, which would have helped them 
understand and comprehend what lay ahead. Most YP requested involvement in 
their care and treatment, although they also indicated that they wanted their 
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family/significant other to be present alongside them. Consequently, participants 
sought out this information for themselves, using the internet as a go-to, easily 
accessible and convenient resource. The information sourced from the internet 
inevitably added to their worry and concern as they had no one to support, 
interpret and filter the information in the correct way. Information around statistics, 
survival rates and the probability of spread throughout the body all intensified their 
worries and fears. Often, this information was not shared as they attempted to 
protect one another from the harsh reality of what may lie ahead. One mother, 
Eve, described how she had contacted the Melanoma Support Scotland charity, 
out of desperation, but did not find this useful as there were no YP or families in a 
similar situation to discuss their experiences.  
 
Lea et al. (2018) discussed the importance of online resources for YP with cancer. 
This study interviewed 21 young people, aged 13 to 24 years based in England 
and sought to determine and understand how YP with a cancer diagnosis use the 
internet to source information and support their needs. The internet is a fully 
integrated part of our everyday lives, and online resources must be developed to 
maximize the potential support available. However, caution is advised in the use 
of these resources as the participants in my study discovered more about MM than 
they had initially wanted or needed. Having a professional to explain these findings 
was expressed by my participants as imperative to prevent unnecessary worry 
and confusion.  
 
There are a few studies in the adult population that concern MM and healthcare 
delay (Gajda & Kaminska-Winciorek, 2014; Hajdarevic et al., 2014; Walter et al,. 
2010). The Hajdarevic et al. (2014) study was carried out in Sweden with 71 
patients aged between 18 to 80 years of age. This study sought to describe 
patients diagnosed with MM depending on their initial medical contact, MM stage, 
sex and age between initial diagnosis through to treatment. Sweden has a similar 
population and statistical profile to that of Scotland, and again, the incidence of 
MM is rising each year. This study found that one reason for delayed diagnosis 
was related to a lack of medical attention for suspected change in the condition of 
existing moles. Although the participants in this research were older, the findings 
are similar to the YP in my study, where inaction on the part of the GP was evident. 
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Miedema et al. (2006) support these findings and suggest that delay was a cause 
for distress in young adults with suspected skin cancer. There is some limited 
literature around YP with cancer in general which considered the impact and 
consequences of delay in diagnosis (Gibson et al., 2013). It cannot be ignored that 
in many cases, a significant cause of the delay results from the inaction of the YP 
themselves or the medical professional (Miedema et al., 2006). This was not seen 
in any of the participants in my study apart from one young male, Paul, who waited 
(two weeks) until a routine dermatology appointment for his acne before 
mentioning the change to his mole. However, there was a significant delay from 
the GP for some of the participants and Miedema et al. (2006) highlight how the 
inaction of both parties could exacerbate the MM.  
 
Gajda & Kaminska-Winciorek (2014) literature review suggests that the GP needs 
to be aware of how to detect suspected melanoma and how to use a dermoscopy 
(examination of the skin using a microscope) for the screening of skin cancer. The 
inability to recognise early changes can have severe implications for patients and 
is detrimental to future lives (Ali et al., 2013). This cannot be proven empirically 
from my study but was a significant concern for the families/significant other, 
especially as four out of five of the YP were diagnosed with stage 2 or 3 and 
subsequently went on to have recurrence. Most reflected on this waiting and the 
GP to take them seriously as a negative experience and one that could have been 
avoided. Delays in diagnosis can cause distress and unnecessary worry, and for 
this disease, in particular, early recognition is vital to prevent metastasis (infiltrated 
disease to the lymph system and organs) (Ali et al., 2013).  
 
In summary, the YP and the family/significant other had minimal experience of 
melanoma prior to diagnosis. They did not see this disease as serious and it was 
not a cancer that they associated with themselves or their child/loved one. Being 
self-aware, having knowledge and an understanding of melanoma was 
fundamental to the process and sequential journey . Unique to this study was the 
family/significant other who were a vital part of the journey and one that was 
shared. Most experienced a false sense of security in their GP but identified that 
obtaining an early diagnosis was crucial, especially from the healthcare 
professional. Consideration of how this was communicated, and associated 
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information provided also needs to be reviewed as part of improving the overall 
experience for YP and their family/significant other living with MM. 
 
5.4.2 Too Much too Young 
 
Being young and receiving an MM diagnosis, at a transitional life stage on the 
threshold of young adulthood, did impact on their life trajectories. All the YP, apart 
from Helen, lived at home with their family. All had experience of being in the 
hospital for a short period, apart from Helen and Patrick. Most had experienced a 
recurrence apart from John, and all were at University or in employment apart from 
Patrick. The young participants were undergoing many forms of developmental 
transitions such as developing from a child to a teenager or teenager to young 
adult and being conscious of their sense of identity and increasing independence, 
autonomy and responsibility. The young people were at a stage where their lives 
were filled with life-affirming potential. The critical role of these emotional 
transitions in dealing with the MM diagnosis and its impact was illustrated in Figure 
5.2 under ‘Life on hold’. Young people’s developmental pathway was interrupted 
in different and lasting ways; however, the YP did not want this disease to define 
them. 
 
Young people with cancer face unexpected life-changing and extraordinary 
challenges to accept, manage and overcome their diagnosis during these 
transformative years of their lives (Grinyer, 2007; Soanes & Gibson, 2018; 
Woodgate, 2006; Zebrack et al., 2014). Similar to my findings, through a grounded 
theory approach, the theory of establishing and protecting an adult identity 
suggests that YP may interpret cancer as an interruption to their life events 
(Soanes & Gibson, 2018). This study was one of the few that included one young 
participant with MM in the 19 to 24 age bracket and established that interrupted 
biography was resumed through re-establishing their sense of identity by focusing 
on internal and external support resources. In addition, Bury’s (1982) work focused 
on the person living with a chronic or long-term illness such as cancer. His work 
draws attention to the way illness interrupts the expectations and plans that 
individuals hold for the future, requiring “a fundamental rethinking of the person’s 
biography and self-concept” (Bury, 1982,  p169). He further suggests that living 
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with a chronic illness, for some people, does not necessarily amount to a 
fundamental and profound biographical disruption but can be experienced as 
biographical continuity and normality. Bury (1982) and Soanes & Gibson (2018) 
highlight that being diagnosed with a chronic illness, such as cancer, often leads 
to loss of self and identity as YP struggle to keep their independence and hopes 
for their futures alive. Although most of the YP did not regard MM as ‘chronic’ or 
indeed that they were unwell, they did experience altered life plans but managed 
to continue with their lives. All of the YP participating in my study were adamant 
that they did not want their lives to be defined by the MM as it was generally seen 
as a “mere bump in the road”. 
 
Within my study, Bury's theory can be related to some of the YP, for example, 
Patrick who appeared to have experienced an altered biography, mainly during 
spells of hospitalisation or being unwell from the treatment. Similarly, John and 
Paul experienced this altered biography, especially when while preparing 
themselves for their futures. My research findings suggest a critical, more 
profound impact on the young person resulting from an interrupted biography at a 
crucial transitional moment in their life trajectory. Another experienced interruption 
was where YP reported the loss of friends, school and the life they had known 
before their MM. This altered sense of their lives was also present for the 
family/significant other.  
 
The theory of loss and their sense of self was seen in most of the YP as they 
struggled to find a new way of being within their lifeworld (Charmaz, 1983). Both 
Bury (1982) and Charmaz (1983) discuss loss and uncertainty that arrive with a 
chronic illness and how people adjust to this within their new lifeworld. However, 
although most of the participants expressed this sense of loss, they all reported 
how they progressed with their lives, albeit on a different path. The core 
conceptual thread once again aligns itself to this interruption as opposed to 
disruption.  
 
Being young and having cancer challenged the YPs’ life trajectory at this crucial 
stage in their lives when feelings of loss of control and gaining autonomy are 
pivotal to normal growth and development. Coyne, Holmström, & Söderbäck 
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(2018) discussed these concepts and referred to situations where YP refrain from 
being the sole decision-maker and actively seek the participation of their family. 
However, recent literature has advocated empowering YP to make their own 
decisions where and when possible, but this should be negotiated between the 
YP and their family/significant other (Davies et al., 2015). Davies et al. (2015) 
discussed the limited evidence available regarding YP being involved in decision 
making about their cancer treatment. This study suggested that this involvement 
was crucial, and there can be several tensions between YP and family members 
which stem from paternalistic approaches to care. Yet these paternalistic 
approaches can be viewed as being in the best interests of their child or young 
person. Within my study, the YP were happy to include their family/significant other 
and found this support beneficial to their overall experience of living with MM. It 
was not always easy for YP to make these decisions on their own, especially when 
they were still living at home. Cancer is inherently a family disease, impacting on 
each individual and all facets of the young person’s lifeworld and that of the 
family/significant other. At the time of diagnosis, and throughout their MM journey, 
support from their family/significant other was crucial to each young person as 
illustrated in Figure 5.2 earlier in the Chapter.  
 
Family-centred care (FCC) has for many years been the pillar of children and 
young people’s nursing in the UK and some parts of Europe (Franck & Callery, 
2004; Nethercott, 1993; Smith & Coleman, 2010, Whyte, 1997), and person-
centred care (PCC) within adult nursing practice (Coyne et al., 2018). My study 
would suggest that both FCC and PCC are important concepts and present 
themselves within different parts of the MM journey. The majority of the YP in my 
study made the decisions together as a family/couple, aside from Patrick where 
his father, Terry, who had withheld the truth when initially diagnosed at the age of 
11 years, to protect his son. This approach to the care delivery may have been 
influenced by the fact that four of the YP lived at home with their family, while 
Helen was living independently with her partner. Research suggests that YP with 
cancer need autonomy and support, yet they also require protection and their 
family/significant other to support them through the cancer journey (Kelly & 
Gibson, 2008; Hokkanen et al., 2004; Kyngäs et al., 2001; Davies, Hannigan & 
Kelly 2019).  
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During the adolescent years, YP are moving from dependence to independence, 
sexually maturing and developing their own identity and their view on the world 
with themselves in it (Grinyer, 2009; Soanes & Gibson, 2018). It is well 
documented in the literature that during this stage of growth and development, YP 
tend to present with an increased self-consciousness and sense of self, and when 
family and peer relationships can be complicated. This is also a period where, as 
Erikson (1972) proposed, identity formation is the critical developmental task of 
adolescence. Young people need to form their own identity at this stage and is a 
significant step towards gaining self-confidence in order to stride forward and take 
control of their own lives. Being diagnosed with cancer can add to this complicated 
and challenging stage of their lives, as was seen in my study and discussed earlier 
in Chapter 1. Biography is not an objective, detached record of life. Instead, it is 
the life as constructed by the person in the present (Soanes & Gibson, 2018). It 
was particularly pertinent for Patrick, for example, to emphasise the continuity of 
himself between the present and the past. In doing so, he was helping to preserve 
his sense of self against the impact of the disease. It was important for all the YP 
not to be identified solely by the disease, however, because of the extensive 
scarring, some were unable to separate themselves from the disease.  
 
Living with an MM diagnosis reinforced the YP’s dependencies on their 
family/significant other just as they were attempting to assert some independence 
from the family unit. This dependence on support from the family/significant other 
extended across a range of different life situations. As discussed in earlier 
Chapters, the YP during this period were trying to be independent and assert 
themselves within the world before the MM arrived. Healthcare professionals 
require to work with both the YP and their family/significant other to ensure the 
needs of the whole family are met adequately.  
 
Woven into my research findings was an underlying sense of 'uncertainty and fear 
about their future’ which was a sub-theme of ‘Too Much too Young’ as seen in 
Chapter 4. Uncertainty is not static or restricted to a single event that occurs in 
one's lifetime. According to an Australian study by Levy et al. (2018), uncertainty 
shifts along a trajectory according to how people deal with their diagnosis, the 
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information they receive, and how they respond to treatment. For many of the 
young participants in my study, their disease was progressive, and therefore they 
had varying experiences of uncertainty, which erupted at different intervals along 
their journey. This also had a profound impact on the family/significant other. 
However, for most of the time, they had the necessary treatment and continued 
with their lives, which is different from other forms of cancer within this population. 
 
In Chapter 4, I presented data which suggested that the participants' experience 
of uncertainty and fear were subjective and a socially constructed experience 
which was often uncomfortable and led individuals to develop coping strategies to 
minimise this uncertainty. For the participants, having known people who had 
endured cancer and subsequently died added to their emotional state of being. 
Their journey seemed to resonate with the unknown, the uncertainty and fear of 
dying from the disease, like other patients with cancer, had become a possibility. 
At this point, the awareness, fear and worry became almost tangible as each tried 
to comprehend what the future might hold. Earlier plans and ambitions had to be 
rearranged and postponed, replaced with the immediate priority of dealing with 
the emotional, social and physical impact of the disease. When seeking guidance, 
advice and support to see them through this challenging time, many participants 
reported a significant lack of support from the healthcare system. The notable 
exception to this was the references to the value provided by the CNS role, where 
available. However, the CNS was not always a specialist within YP or skin cancer. 
Ongoing support, in terms of emotional, informational and practical, would have 
been welcomed by all throughout the MM journey. 
 
Although most of the participants were not faced with the possibility of death at 
the time of being interviewed, in reality, they had considered this possible 
outcome. For example, Patrick and Terry were initially given ‘bad’ news about the 
expected outcome only for the specialist to retract this prognosis weeks later. 
Searching for solid ground was evident in the form of hope and striving to 
understand what lay ahead through balancing hope and despair. Participants 
could recall relatives and friends who had died from cancer, and until searching 
the internet, they had no real association with MM and the possibility of death. 
Power, Bell, Kyle & Andrews (2019) focused on a collection of empirical papers 
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from social and health geographers that explored the way people seek to sustain 
a sense of health and well-being despite a myriad of challenges associated with 
life. This paper explored these challenges often around the non-linear way of how 
people seek to find ways of living with ill health and trying to adapt to new ways of 
being that can allow them to move through their lives, often with hope and 
expectation for their futures. Power et al. (2019) considered many dichotomies to 
gain an understanding of adversity which could then be applied to the participants 
in my study who had defined their lives before MM by planning their future lives. 
All of the participants in my study adapted to this adversity by finding meaning and 
purpose, mainly through carrying on with their lives and regarding the MM as an 
interruption. For most support from family/significant other and friends helped 
them find the strength and ability to move forward and remain hopeful.  
 
The YP and the family/significant other wanted the opportunity to discuss the 
disease and to share their experiences with others. This was recognised as an 
essential source of support and an effective coping strategy. The challenges of 
coping with the disease were magnified along the journey for each participant, 
especially for those who had to deal with a recurrence. A study by Juvakka & 
Kylma (2009) who interviewed six YP aged 16 to 21 years in Finland found that 
there were two dimensions to how YP coped with cancer. The study highlighted 
YP having hope, intentional hope and inner hope, which was similar to the Power 
et al. (2019) paper that sought to explore hopeful adaptation strategies to cope 
with adversity as discussed above. All participants in my research were able to 
find hope, internally and externally, from coping strategies that included 
family/significant other and friends. The Juvakka & Kylma (2009) research on inner 
hope found that YPs religious beliefs allowed them the strength to cope which was 
similar to research carried out by Al Omari et al. (2017) and Al Omari & Wynaden 
(2014). Both these studies used IPA to explore coping strategies for YP in Jordan. 
The findings from Al Omari et al. (2017) were similar to Juvakka & Kylma (2009) 
in that the participants, all Muslim, had strong religious beliefs and believed that 
Allah would protect them. It is interesting to note that in my research that none of 
the participants mentioned their religious belief, but all discussed other coping 
strategies to support them along their journey, which mainly included the belief 
that they would get better. The greatest coping strategy was from not having to 
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face this MM journey alone; they all needed support from their family/significant 
other and their friends. This interconnection and inter-relationship highlighted the 
uniqueness of this study and how the MM disease had impacted on the whole 
family/relationship and people who were important to the young person.  
 
Research from Engvall et al. (2011) described the value of adopting emotional 
coping strategies such as hope, positive thinking and seeking support from others. 
Alongside the family/significant other support came from the CNS. Knowledge and 
information provided by the CNS gave the YP and their family/significant other the 
strength and confidence to consider the practicalities of living with MM and how to 
move forward with their lives. In addition, there was support available from TCT, 
but this was not consistent for all. In adopting these coping strategies, most of the 
participants were able to reach a level of acceptance regarding their life with MM, 
past, present and future allowing them to redefine their goals and focus on 
meaningful aspects of their lives. Emotional and social support were absent from 
their journey apart from when some of the participants met with the CNS. This 
experience, however, was not common across all the participants, and some felt 
isolated and alone. The Hughes, Williams & Shaw (2017) literature review 
suggests that YP require psychological support during their cancer trajectory to 
deal with the issue of personal mortality. The family/significant other also required 
support yet there is very little research around this need. A recent study by Kenten 
et al. (2018) sought to understand the experiences of YP with cancer for whom a 
cure was unlikely. This study, carried out in England, included young adults aged 
16 to 40 years, of which four had melanoma. However, the age of the YP with 
melanoma is not made clear. Through a multi-method realist evaluation, this study 
found that current care towards the end of life was challenging when curative 
treatment options had been exhausted for the YP. This had severe consequences 
for the families and the healthcare professionals involved in the care delivery. This 
study has some similarities to my research, with appropriate support for YP and 
their family was identified as missing from the journey. 
 
Participants wrestled with the uncertainty and fear, sometimes unspoken, that the 
disease would end their life before maturity. For those who had endured an earlier 
episode of MM and now faced a second or third recurrence, the uncertainty and 
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fear intensified and added more turmoil to their lives. Although the YP had MM, 
they did not express that they were in any pain from the disease but did discuss 
the resulting discomfort from the surgery. The sub-theme ‘A sense of guilt and 
helplessness’, illustrated how guilty some YP felt for having caused this 
interruption to the family unit and for having this disease. The family/significant 
other were also feeling guilty and blamed themselves wondered why this had 
happened to their child/loved one. Guilt was well described in the narratives from 
most of the participants, with many YP feeling guilty about having a form of cancer, 
that to them was not as severe as other cancers. The family, especially the 
mothers, felt guilty that their child had to endure this disease and blamed 
themselves. Listening to the participants reconstruct meaning and coherence 
about their journey was a crucial part of the caring and healing for all participants 
and one in which they shared as part of their interview. Despite the growing 
recognition of the distinct needs of YP with cancer, studies on the subjective 
experiences of cancer in young adulthood still indicate that there are unmet needs. 
These include particular sensitive issues such as living with serious life-limiting 
conditions and the fear of death or loss of life (Grinyer, 2007, 2009; Kim, White & 
Patterson, 2016). 
 
Many of the YP and their families/significant other were fearful about death and 
mortality but found it difficult to discuss. Many had previous experience of 
family/friends who had not survived cancer, which added to their guilt and 
helplessness. Although most of the participants believed that MM was not as 
serious as other cancers, the thought of death still loomed, especially when 
experiencing a recurrence as this meant that the disease had spread within their 
bodies.  
 
To conclude, the confirmation of the MM diagnosis brought an overwhelming 
sense of the unknown into all the participants' lives, especially the YP who were 
looking forward to their life plans and ambitions. During the journey of living with 
MM, they often felt alone and isolated with no other young person or 
family/significant other in the same situation. This impacted on how they 
recalibrated and restructured their existing lives and future plans. Emotional and 
social support was mostly absent, but they had support from their family/significant 
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other and for some, their friends. Within this part of the journey, the emotional and 
social impact on the YP and the family/significant other was profound. Young 
people felt guilty that they were well but had to deal with the social stigma that is 
attached to cancer. In addition to the natural worry for their welfare of their child, 
many family members felt guilty and blamed themselves for the disease even 
though they reported that they had not exposed their child to the sun.  
Following both an FCC and PCC approach was essential as the YP fluctuated 
between independence and dependence. 
 
5.4.3 Not the Same 
 
Fundamentally, the majority of the participants in my study felt they were not like 
other participants living with other forms of cancer and therefore felt different, 
alone and isolated. ‘A life less ordinary’, a sub-theme of the third superordinate 
theme, captured the challenges of adjusting and coping with their new lives 
including changes to their physical well-being, financial worries, changing 
relationships and an altered future. For some, the acute financial burden and 
associated worries meant that the fears around the MM treatment were 
compounded by the fear of financial uncertainty and loss. Within my study, there 
were a few participants for whom financial worry was a recurring concern. Terry, 
Patrick's father, had been made redundant, and he struggled financially as he was 
the sole provider for his family and could not work while caring for his son. Helen 
was too unwell to work and received no sick pay from her employer. This financial 
worry was a burden and affected day-to-day life decisions and added further stress 
to their relationships.  
 
As patients with melanoma are diagnosed through a different route and do not 
always see the specialist in cancer care until much later in their journey (CRUK, 
2019b), this may have contributed to their overall perception of having no 
specialist support. Accessing specialist support, similar to other YP and their 
families with other types of cancer, may have helped ease their feelings of not 
being the same as others with cancer and feeling alone without any support. 
However, the participants all reported that the care received was to a high 
standard and within a safe environment, albeit not specialist care or age 
appropriate.  
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Participants also expressed their concerns that they were not supported or cared 
for in the same way as others they had known with a different type of cancer. This 
experience left the YP and their family/significant other feeling as though they were 
‘Out on a Limb’ which is illustrated in Figure 5.2 and not part of the same journey 
as others living with cancer. The treatment and care were not specific to the YPs’ 
age nor their cancer, although there were links with the specialist cancer services 
for those experiencing a second or third recurrence and required systemic 
treatment. Feelings of being different from other patients with cancer were 
common in all the young participants and for some of the families, which in turn 
brought about the feeling of being a fraud.  
 
The majority of the participants in my study had not spoken to other YP or 
families/significant other with MM. This support was something they longed for. 
They all spoke about this lack of support and not being with others who were 
experiencing the same disease. This would have eased their burden and feelings 
of not being the same as other YP with cancer or being different. Although most 
acknowledged the support from the CNS, as indicated previously, and contact was 
mostly through the outpatient clinic appointments. Research by Lea et al. (2018) 
supported the use of online groups as a support mechanism and concluded that 
they would be a useful addition to YP and their family/significant other living with 
cancer. 
 
The feeling of being different was expressed in the participant narratives and was 
connected to their lives with MM and the treatment experience. This feeling was 
reinforced by the participant’s personal experience of seeing others cope with a 
cancer diagnosis. These findings were similar to those identified in a study by Bird 
et al. (2015) who explored patient experiences and the supportive needs of adults 
with MM, the youngest being 31 to the oldest aged 70 years. Through a grounded 
theory approach Bird et al. (2015) found that patients living with melanoma saw 
the disease as being different from other cancers and resulted in feelings of 
isolation with no one to share the heavy burden. This study also found that 
significant support from healthcare professionals was required to help ease their 
fears and worries.  
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In terms of service provision, YP with cancer were once depicted as the “lost tribe” 
(Michelagnoli, Prichard & Phillips, 2003, p2571) and “on the margins of medical 
care” (Whelan, 2003, p2573). Although most of the YP in my study were not 
treated within a TYA specialist unit, most were satisfied with their hospital care 
and being with older adults. Apart from Patrick, none of the YP wanted to be within 
a children’s ward, and although some of the family members did mention that the 
care environment was inappropriate, a children’s ward was not discussed as an 
alternative.  
 
There is increasing recognition in the UK for healthcare for YP to be different from 
the approaches in place for children and adults (Lea et al., 2018). Approximately 
2,400 YP aged 15 to 24 years are diagnosed with a malignancy each year in the 
UK (CRUK, 2019) and cancer is the leading cause of death from disease amongst 
this age group (O'Hara et al., 2015). Being diagnosed with cancer, such as 
melanoma, generally has a worse prognosis when compared to children or older 
adults (O'Hara et al., 2015; Stark et al., 2015). As discussed in Chapter 1, the 
Cancer Plan for Children and Young People in Scotland aimed to ensure that CYP 
aged between 0 to 25 years diagnosed with cancer have equal access to the best 
possible care and treatment as early as possible (Scottish Government, 2016; 
McInally & Willis, 2017). As expressed in my study, a number of the participants 
felt that they or their child were ‘In-between’, not a child and not yet an adult. Some 
of the YP in my study were hovering between childhood and adulthood, while 
others were considered as a young adult. Yet, all apart from one were still relying 
on their family to provide guidance and support across a range of life situations 
and choices.  
 
As discussed in Chapter 1, this age group are within the liminal space, 
transitioning from childhood to adulthood (James 1986) or as it has been 
described “at the edge of no man’s land” (Hollis & Morgan, 2001 p45). Liminality 
designates a situation of ‘betwixt and between’ that traditionally occurs in transition 
rituals designed to transfer an individual from one social position to another 
(Arnett, 2006, Jaskulska & Mickiewicz,  2015; Janusz & Walkiewicz, 2018). This 
was evident for all the young male participants, although Helen – the only female 
and the oldest participant in the study – had reached maturity through developing 
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from being a teenager to a young independent woman and was in the process of 
building a life for herself and her partner, Stuart.  
 
Consistent with other studies (Hajdarevic, Hörnsten, Sundbom, Isaksson & 
Schmitt-Egenolf, 2013; Lea, Gibson & Taylor, 2019; Gibson et al., 2013), many 
YP and their family/significant other in my study expressed dissatisfaction with 
some parts of their MM journey. Overall most participants in my study were 
satisfied with the hospital care delivery and treatment experience, albeit for some 
very brief. The main areas of dissatisfaction included insufficient information, the 
use of elaborate terminology which they did not fully understand and 
arrangements for aftercare, which is similar to previous literature (Farjou et al., 
2013; Fern et al., 2013b; Gibson et al., 2013; Hedström, et al., 2004; Hokkanen, 
et al., 2004; Kelly et al., 2004; Kyngäs et al., 2001; Miedema et al., 2006; Olsson 
et al., 2015; Stegenga & Ward-Smith, 2009; Wicks & Mitchell, 2010).   
 
In my study care delivery for YP with MM seemed to be disjointed and although 
some had contact with the TCT unit, which for one participant was adjacent to the 
specialist adult hospital, others had no access to these units until a further ‘lump’ 
or recurrence was diagnosed. No YP were treated within a TCT unit nor had any 
contact with other patients with MM who were going through the same experience 
as them, aside from Patrick and Helen when they suffered a second recurrence. 
The families also wanted some form of support and felt isolated in their 
psychological burden of trying to deal with MM and the waves of emotion that 
arrived when they thought of their child or loved one dying from this disease. 
 
One young man Patrick, and his father Terry, appeared to be ‘orphaned’ within 
the healthcare system with no one prepared to decide on the optimal place of care 
for this patient. Patrick’s place of care was dependent on his age as he was under 
16 years of age at the time of his first and second diagnosis. He was still classified 
as a child and therefore had to be treated in a specialist children's hospital. The 
complexities of defining this age group can have an impact on the treatment 
pathway, defined by biological age, and sets the location of care as discussed 
earlier in Chapter 1. However, as Patrick was initially admitted to an adult ITU, as 
there were no beds within the TCT unit or children’s ITU, this period of treatment 
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was confined to the adult setting. Families reported that the hospital environment 
was unsuitable for their child, with one mother, Eve, commenting on her son’s 
treatment in a women’s cancer breast unit. Another parent, Richard, commented 
about being in a busy surgical ward with older patients and all types of conditions. 
There were other concerns, such as travel and distance, to the specialist hospital, 
but most were prepared to travel for the ‘specialist’ cancer care. This was evident 
in Helen and Stuart's narrative, and although willing to travel, this meant Helen 
would spend a few weeks solely on her own as the specialist hospital was a 
significant distance from her home. 
 
The treatment experience for those participants living with MM was different 
compared to the national guidelines for YP with cancer (NICE 2015; 2005; Scottish 
Government, 2016). Cancer care for TYA in the UK is consistently described as 
age-appropriate care, a concept that is said to underpin the culture of healthcare 
delivery specific for this population (Lea et al., 2018; Marris et al., 2011; Smith et 
al.,  2016). Growing consensus describes it as inappropriate to deliver care to TYA 
in either child or adult environments of care (Kelly et al., 2004) or in settings not 
equipped to meet their psychosocial needs (McDonagh & Viner, 2006), yet these 
recommendations did not reach the YP and their family/significant other living with 
MM.  
 
In December 2016, the Blueprint for Care was published in England, which 
provided a detailed account regarding the care requirements for the TYA 
population (Smith, et al., (2016). One of the key messages from this report was 
that all healthcare professionals caring for TYA with cancer should be 
knowledgeable regarding the developmental stages including social, emotional, 
psychological and physical development and all the needs of each individual 
should be assessed according to their developmental stage. Within my research, 
the treatment experience for MM appeared to be mainly provided by the CNS’s, 
but once again, this was not consistent and was dependent on the personal 
attributes of the nurse. All other support was minimal and absent from their day-
to-day lives. Models of care for YP with cancer in the UK have developed over the 
last 30 years to improve survival rates and provide an environment supportive to 
the unique needs of YP (Fern et al., 2013b; Lea et al., 2018; Pearce, 2009; Taylor 
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et al., 2013). However, two-thirds of YP with cancer in the UK do not have access 
to these ‘specialist’, ‘age-appropriate’ units and are treated either at their local 
hospital or a regional cancer centre alongside adults of all ages (Birch et al., 2013). 
This lack of access to specialist units was common to the YP and their 
family/significant other within my study. 
 
Many studies have been carried out over the last twenty years where the TYA 
group is seen as unique with specific needs and place of care is an important issue 
(Fern et al., 2013b; Gibson et al., 2013; Hedström et al., 2004; Hokkanen et al., 
2004; Kelly et al., 2004; Smith et al., 2007; Olsson et al., 2015; Wicks & Mitchell, 
2010; Zebrack et al., 2014). More recent studies have focused on conceptualising 
age-appropriate care for TYA with cancer (Fern et al., 2013b; Lea et al., 2018). A 
mixed methodology study reporting on age-appropriate care reports on the 
complexities of defining age-appropriate care and suggest that there are seven 
core elements to their proposed model. This study was part of the BRIGHTLIGHT 
research study and was carried out by the research team. The types of YPs’ 
cancer is not stated, but there were 17 YP and 29 healthcare professionals 
included in the semi-structured interviews from specialist and non-specialist 
hospitals. This study highlights that there was wide variation within the UK as to 
how we define age-appropriate care and where these YP have access to the 
specialist centres. Most YP who have MM are not cared for within this age-
appropriate environment as their journey typically begins with the skin or plastic 
surgery outpatient departments. There was a lack of continuity and seamless care, 
with no one to share their experiences with. 
 
A further finding related to the treatment experience was that for all the 
participants, the MM journey depended upon the knowledge, skills and 
competence of the healthcare professionals charged with delivering their care. 
Healthcare professionals in the UK are educated and trained to deliver high-
quality, evidence-based care and to be able to listen and communicate with 
compassion (NMC, 2018). These are complex skills that can be lost in a 
pressurised, task-oriented environment with little time or energy available for 
emotional investment (Lavender et al., 2019). Research by Lavender et al. (2019), 
through a narrative inquiry with health professionals caring for AYA with bone 
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cancer, identified the importance of expertise and development for health 
professionals caring for this specific group of patients. The study explored one 
specific cancer and how AYA were prepared for inclusion within clinical trials. 
Once again, this study highlighted the importance of well-educated and well-
trained healthcare professionals caring for the TYA cancer population, irrespective 
of the cancer they may have.  
 
The participants in my study expressed concerns around the lack of any 
supportive care and the absence of healthcare professionals who knew about 
melanoma in YP, apart from some of the CNSs. Caring for YP with cancer and 
their family/significant other has unique challenges that attract healthcare 
professionals to work within this speciality (Gibson, Fletcher & Casey 2003; 
Gibson et al., 2012; Hedström et al., 2004; Kyngäs et al., 2001; McInally, Pouso-
Lista, McLaren & Willis, 2017). Without education, training and a broader 
awareness of YP with cancer, healthcare professionals may not fully understand 
or be aware of the age-specific nuances that profoundly influence the YPs’ 
experiences and that of the family/significant other. Some of these nuances 
include identity formation, gaining independence and being empowered to care 
for themselves (Soanes & Gibson, 2018). The participants within my study were 
desperate to have healthcare professionals who could support them through their 
journey, appreciating their age and stage in life as well as understanding MM.  
 
Recent literature suggests that cancer education and training within the UK is 
inconsistent and is often embedded and delivered within HEIs and individual 
clinical services (Edwards, Kelly & Hopkinson, 2016; McInally et al., 2012). In the 
UK, education is mainly delivered through postgraduate education, predominately 
online, and is often seen as a specialist area of care (Jestico & Finlay, 2017). 
However, this type of learning does not suit all healthcare professionals, while 
others are seeking ‘non-specialist’ education and training, requiring this to enable 
them to care for YP out with the specialist areas of care. Evidence-based practice 
can transform and provide patients and their family/significant other with high-
quality care (Smith et al., 2016; Gibson et al., 2012). A key priority identified by 
the Children and Young People’s Health Outcomes Forum (DoH, 2007) is the 
need for a national approach to achieving a competent nursing workforce. 
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Collectively these recommendations have provided the platform for changes to 
nursing care and delivery. Recent literature has highlighted a drive to embed high-
quality nursing care into specialist YPs cancer care (Scottish Government, 2016; 
Smith et al., 2016; NICE, 2005). There needs to be a continued effort to enhance 
the knowledge and competence of nurses who work with TYA with cancer in all 
types of services where they are cared for (Gibson et al., 2012; Smith et al., 2016; 
Taylor et al., 2016). Educational programmes need to facilitate professional’s 
progression from novice to expert and provide for all levels of nursing alongside 
the interprofessional teams that also care for YP and their family/significant other 
(Benner, 1984; 2001; McInally, et al., 2017). The participants in my research fell 
through the 'specialist' care gap and therefore, like other YP with cancer may not 
have access to what is believed to be the best approach to their care.  
 
Young people’s cancer care has seen rapid advances in treatment and as survival 
rates continue to grow the need for expert specialist care and support increases 
(Lea et al., 2018; Gibson et al., 2012, Taylor et al., 2011). Although the number of 
YP with cancer in the UK is relatively small in comparison with the number of 
adults with cancer (Bleyer, Ferrari, Whelan & Barr, 2017; Fern et al., 2013a), it is 
recognised that cancer education and training for healthcare professionals is 
required to ensure patients and their family/significant other receive care from 
knowledgeable and expert healthcare professionals (NICE, 2005; Scottish 
Government, 2016; Taylor et al., 2016). Currently, in Scotland cancer education 
and training provision is varied and fragmented, and there is a need to establish 
TYA care within professional curriculums (McInally et al., 2017). A systematic 
review of the literature between 1996 and 2008 by Marris et al. (2011) examined 
how the experiences of young adults support or refute current policy during this 
time (NICE 2005). This review revealed that YP aged 13 to 24 years valued an 
age-appropriate environment along with support from others in their age group. 
The expertise of healthcare professionals caring for them was also seen as an 
essential aspect of their care.  
 
The treatment experience of living with MM was unique for each participant in my 
study for many reasons. One young participant, Patrick, was treated with 
immunotherapy for his second recurrence and required more extended periods in 
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hospital than any of the other YP as the treatment had severe side-effects. There 
is little known about the lived experience of patients with MM undergoing 
immunotherapy and no literature concerning YP. Levy et al. (2018) conducted a 
feasibility study with 28 adult patients aged 41 to 84 years being treated with 
immunotherapy for advanced melanoma. This study found that patients with MM 
live within uncertain spaces, especially around the time of treatment. These 
patients attempt to normalise their lives after this event, engaging with family and 
other usual activities. This was similar to the findings in my study, even with a 
younger group of patients. Not one participant was treated within a specialist, age-
appropriate environment, and as a result, many felt that the system was not 
designed to meet their needs. However, this was not the case for all, and in some 
situations, the care delivery was reported as excellent. As most were not 
hospitalised for prolonged periods, apart from Patrick and Helen, being with others 
of a similar age or with the same disease did not seem to matter to these YP.  
 
Part of the treatment for YP focuses on transitioning of care between services. 
Transitioning from child to adult services or from hospital to home is recognised 
as a challenge for TYA care (Weston et al., 2018; McInally & Cruickshank, 2013). 
Although most were treated in an adult ward, apart from Patrick, who eventually 
transitioned to a TCT unit, the move from hospital to home was problematic for 
some. There did not appear to be any follow-up regarding pain or their wounds 
once they were discharged home. My research focused on this aspect of their 
journey, as some appeared traumatised from their surgical wounds. Paul, for 
example, expressed that overall, this was the worst part of his MM journey.  
 
There are many models of transition in place across the UK, both within cancer 
and other chronic disease settings, and the age range varies according to local 
and government policy. There is, however, no clear evidence whether one of these 
transition models is superior to the others and there is wide variability across the 
country in the models used (DoH, 2007, NHS Improvement, 2011). Furthermore, 
healthcare professionals sharing their experiences of transition through different 
practice systems are invaluable and highlight the differences in the care delivery 
regionally and nationally (Weston et al., 2018). Within the specialist cancer 
services across Scotland, the transition models used appear to depend on the 
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diagnosis and where the YP are treated (Royal College of Physicians of Edinburgh 
2008; McInally, 2013).  
 
A cancer diagnosis and the associated treatment during this critical transitional 
stage of normal adolescent development adds extra complexity to illness-related 
challenges. The Improving Outcomes Guidance (IOG) for Children and Young 
People with Cancer suggests YP with cancer should benefit from the expertise of 
specific cancers and supportive healthcare professionals (NICE, 2005). To 
support YP with MM, specialist healthcare professionals, and approaches to care 
delivery are required. Care should be age-appropriate, flexible, and individual to 
meet their specific needs. Following their cancer treatment, YP can feel 
disempowered, vulnerable, and experience a loss of personal confidence. 
Interventions that facilitate empowerment can help improve health-related quality 
of life and their ability to cope (Kyngäs et al., 2001; Wu et al., 2009).  
 
This part of the journey provides strong evidence that the MM journey had 
interrupted the lives of the YP and their family/significant other. During the journey, 
the specific treatment experience differed for each young person and was 
dependent on their age at the time of initial diagnosis. Two YP were aged under 
19 while three were over 20 years old and this may have contributed to the 
different experiences. The delivery of high-quality care, and the associated 
treatment experience, required competent healthcare professionals who are 
knowledgeable about the immediate and long-term implications of MM treatment 
journey. As YP with this disease begin their journey out with specialist cancer 
services, the care delivery for this patient group and their families/significant other 
requires to be seamless, ensuring there are links between services, working better 
together than apart. Healthcare services need to ensure that clearly defined care 
pathways and guidelines that are specific to the needs of YP are accessible. 
Remarkably, although MM is a serious life-threatening disease, the YP and their 
family/significant other all felt as though they were different from other patients 
with cancer and therefore did not always fully comprehend the seriousness of the 
disease.  
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5.4.4 Time to Live 
 
The YP’s scars, both physical and emotional, were a constant reminder of what 
they had experienced and endured, along with the other trials and tribulations that 
the MM had presented to them. These scars now represented a crucial part of 
their present and future identity, and most of the YP had come to terms with this, 
as had their family/significant other. Both physical and emotional scarring were 
present and were associated with the long-term side effects from the treatment 
and mirrored by the participant stories of how they survived and lived with MM. 
The YP described this scarring by referring to them as ‘battle scars’ and has much 
in common with post-traumatic stress disorder (PTSD) symptoms (Al Omari 
Wynaden et al., 2017; Al Omari & Wynaden 2014; Madan-Swain et al., 2012).  
 
The YPs physical and emotional scarring reminded them constantly about the 
disease, its seriousness and their fragility. Although the YP could recall having 
hope and the ability to move forward after having the mole excised and surgery to 
remove the infiltrated disease, the procedures had left severe scarring. These 
scars represented a key part of their present and future identity, although most of 
the YP had tried to come to terms with them. For the family/significant other, they 
were aware of how uncomfortable these scars were for their loved ones and tried 
hard to distract their attention from the physical scaring. 
 
In common with Soanes & Gibson (2018), my study found that YP reported a 
desire to maintain their sense of self and protect their identity. It was difficult for 
the YP, in particular, to detach themselves from the scarring. A systematic review 
of the psychosocial outcomes for adult patients with advanced melanoma carried 
out in Brisbane, Australia, found that altered body image had left the patients 
feeling unprepared for the impact of the surgery and distressed by their 
appearance (Dunn, Watson, Aitken and Hyde, 2016). Although this qualitative 
literature review concerned the older patient with MM, the mean age ranged from 
41.2 to 69.6 years. The findings are relevant to the YPs experiences within my 
study. The YP reported that although satisfied that the mole had been removed, 
they were conscious that the scarring had disfigured them as a result of the 
surgery.  
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Young people and some of the family/significant other required psychological 
support to improve their overall well-being, social functioning and mental health 
during and after their MM experience. Most of the participants had strong 
supportive networks through families and friends, but further support from expert 
professionals would have been beneficial. Aldiss et al. (2019) reported on a UK 
wide study where YP aged 13 to 24 years, along with families, friends, partners 
and professionals were asked through a survey design to identify and rank the key 
priorities for YP with cancer. Ten key priorities identified, with the main priority 
identified being psychological support during and after treatment (Aldiss et al., 
2019). This is an area of care that is underdeveloped and one that is often 
forgotten about in comparison to the delivery of physical care. Recently within 
Scotland, YPs mental health has been raised as a critical priority, and more needs 
to be done for YP who are experiencing cancer along with mental health illness 
(Scottish Government, 2018). These needs must be considered for this patient 
group when they are at a junction in their lives, and where mental illness may have 
been a challenge for them prior to MM (Marshall, Grinyer & Limmer 2018; Wicks 
& Mitchell, 2010). In my study, two the YP had lived with a mental health illness 
before the cancer arrived. For the family/significant other living with MM was like 
being on an emotional rollercoaster simply because their experience of MM 
changed all the time, combined with having no professional help to ease them 
through the difficult parts of their journey. Young people and their 
families/significant other need support with all aspects of the MM diagnosis, with 
a greater focus on psychological care.  
 
Supportive relationships were critical to the YP’s MM journey. They all viewed their 
MM experience as a shared journey with family/significant other and friends. As 
most of the YP lived at home with their family/partner, it was their parents/loved 
one who became their primary carer, supporter, adviser, advocate and friend 
along this journey. This journey with MM had brought new and different meanings 
to their lives and forged a different path for them. In moving forward, they had not 
been defeated by the disease and continued to make plans for the future, despite 
the interruption from the MM diagnosis. 
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The YP expressed that they had acquired a greater awareness of themselves, and 
they were checking their bodies frequently to try and avoid any worry about future 
recurrences. The worry of recurrence would remain as an almost permanent 
presence in the lives of some YP and their family/significant other, but they were 
still able to move forward with their lives. Given the untimely interruption in their 
lives, a critical point in the journey was to regain a sense of control over their lives 
as a means of attaining long-term adjustment and well-being. Psychosocial 
support for patients with MM would assist individuals in retaining or returning to 
function in significant social roles, such as a spouse, student, worker, or friend. 
Successful interventions would enable YP to overcome the detrimental impact of 
a health crisis and strengthen the internal and external coping resources available 
to them. However, despite the successes in medical treatment over the past 40 
years, a full range of psychosocial services is not readily available to all patients 
diagnosed with MM and living with this disease.  
 
Although most of the participants would have welcomed support from others who 
were “in the same boat” as found in a study by Kelly et al. (2004, p847), support 
did come from various other places including family and close friends. This was 
similar to the findings in the research carried out by Al Omari & Wynaden (2014), 
Wu et al. (2009) and Wicks & Mitchell (2010), where support from family and 
friends was a fundamental coping mechanism. Friends were a vital source of 
support for the participants. The nature of friends' responses to the MM helped the 
YP through the disease, the YP were grateful they had stayed the course of the 
journey with them (Davies et al., 2018; 2015; Wu et al., 2009). Families were also 
relieved that their friends had not deserted them. This, however, was not the case 
for all and for Patrick, his friends had disappeared. He found solace in the 
father/son bond and through his small extended family. Adolescence is a critical 
period in psychosocial development and autonomy; peer group acceptance and 
bonding are fundamental in the transition period from adolescence to adulthood 
(Grinyer, 2007). A lack of peer support during this time may prevent the young 
person attaining a sense of belonging (Mulhall et al., 2004). The need for peer 
support was clearly articulated in this study, but for some (Patrick and Helen) they 
found this from their family/significant other. 
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Participants in my study were mainly positive and optimistic throughout and looked 
forward to their future, albeit on a different path and living within the shadow of 
MM. 
 
The notion of trying to achieve ‘normality’ has been identified as necessary to TYA 
during the cancer experience (Taylor et al,. 2013; Stegenga & Ward-Smith, 2009) 
but it is not clear what this ‘normality’ is for the YP and their family/significant other. 
Within my research, they all recognised that their life had changed but remained 
aware of what was important to them. Although all strived to achieve some 
normalcy, for some, the disease and treatment had a continuing impact on their 
lives. Most had completed treatment but were still receiving regular follow-up 
checks, and there was a constant worry that the MM would return. Many saw this 
as a time to re-align and move forward as life was more than cancer, and thoughts 
of the future turned to their career, setting up a home or going to University. The 
life they had once known had gone, and they were experiencing a new and 
unexpected journey. All the participants felt stronger both as a family/partnership 
and that this experience had drawn them even closer. For some, close friends also 
played a crucial role in providing emotional support while for others, it was their 
family/significant other. When reflecting on their MM experience, it was clear from 
the YP and their family/significant other that improvements to certain aspects of 
the care delivery would have alleviated many of the stresses and fears in their MM 
journey. 
 
Findings from my study reinforce previous studies (Hokkanen et al., 2004; 
Salantera 2004; Kumar & Schapira, 2013; Stenenga & Ward-Smith, 2009; 
Woodgate, 2006) that stress the importance of having strong supportive 
relationships. These relationships helped the YP cope with their cancer (Davies et 
al., 2018; Smith et al., 2007; Taylor et al., 2018; Woodgate, 2006) and move 
through their journey. These supportive relationships included family, friends and 
the CNS. Family-centred care has, for many years, been central to the nursing 
practice for CYP across the UK and some parts of Europe (McInally & Cruikshank 
2013). Reflecting the intense emotions experienced with MM, many YP worried 
about how the disease had impacted on the emotional and psychological 
wellbeing of their siblings. Previous literature around YP with cancer have taken 
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into account how this impacts on siblings (Eiser, 1993; Grinyer, 2007; McDonald, 
Patterson, White, Butow & Bell, 2015). Parents provide the most important social 
support, but as the disease had an impact on the whole family, it was clear that 
they all needed support (Grinyer, 2007, 2009).  
 
While the importance of strong family relationships was a crucial part of the MM 
experience, these individual relationships were unique, sophisticated and 
fluctuated over time. During my research, one young man, Patrick, who was 
discussed previously in Chapter 4, was the only participant who was a child at the 
time of his initial diagnosis. At such a young age, Patrick lacked the maturity, 
knowledge or emotional stability to deal with the disease and was content with his 
father making all the decisions for him. The other YP within the study had all 
reached a level of maturity that allowed them to make their own decisions in 
consultation with their family/significant other.  
 
A further study by Davies et al. (2018) suggests that the family and those close to 
the YP during their cancer journey, are undeniably important in their lives during 
this time. Through a longitudinal multiple exploratory case study design, utilising 
observation and documentary analysis, five YP aged 16 to 24 years were 
interviewed three times during their journey along with parents, carers and 
healthcare professionals. The experience of the significant other/loved one was 
essential and seemed to play the same role as the family, although they had an 
additional element to their relationship as they were romantically involved. More 
research is required into these dynamic relationships and their impact on the YPs 
experiences and their treatment/care-related decisions along the cancer journey 
(Kyngäs et al., 2001; Davies et al., 2018; Drew, Kable & van der Riet, 2019).  
 
This study provides evidence to support that living with MM involved the whole 
family/significant other and the relationships had a positive impact on living with 
the disease for  all the participants who could recall the closeness and emotional 
bonds that were now stronger than they had ever been before. These relationships 
provided encouragement, positivity and strength to continue in living with MM. 
From the evidence gathered sharing the burden of melanoma-related worry 
lessens the worry and fear associated with the disease.  
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5.5 Strengths and Limitations  
 
The findings of this study have been drawn from in-depth qualitative interviews 
with five YP (n=5) and five family/significant other (n=5) living with MM in Scotland 
and offers a unique perspective from the participants. The findings were not 
intended to be generalisable beyond this setting, but have relevance and 
significance to other researchers, healthcare professionals and services who care 
for YP with MM and their family/significant other. As such, at the time of writing, 
this was the first in-depth study to describe the experiences of YP and their 
family/significant other living with MM using an IPA approach and makes a unique 
contribution to knowledge.  
 
This study and the underlying IPA approach has many inherent strengths. Firstly, 
the individual interview and dyad approach added a multi-perspective design, 
allowing for the shared experience and the phenomena to be fully captured and 
understood (Larkin et al., 2019). This design allowed for the YP to select their 
family/significant other, who were involved in living with MM, and whether they 
opted for an individual or shared interview. However, in carrying out the dyad, I 
was mindful to ensure that no individual was more dominant or influential than the 
other. Although small, the sample size of ten fully complied with the IPA 
methodology recommended by Smith et al. (2009). Through following the step-by-
step IPA approach, I maintained a rigorous approach to the data to ensure I had 
captured the voices of all my participants.  
 
Secondly, my study was the first to explore the experiences of one specific type 
of cancer, MM, and to consider the impact of this disease on the patient group and 
their family/significant other in great depth. This detailed analysis has produced 
rich results and allowed the researcher to trace the ebb and flow of the cancer 
journey through the experiences and words of the individual participants. 
 
Thirdly, this thesis has made a strong and unique contribution to existing 
knowledge, highlighting the understanding required to care for YP with MM and 
their family/significant other in the most effective and holistic ways. 
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However, my study does have limitations. Firstly, obtaining ethical approval at the 
beginning of the study for my preferred age bracket was the immediate challenge. 
At the outset, I wanted to include YP in the 13 to 24 years of age bracket, although 
the number of children under the age of 15 years diagnosed with MM in Scotland 
per year was exceedingly low, with only one child being diagnosed with this 
disease in 2015 (ISD, 2019). The challenge was related to the actual ethical 
approval process involving both ENU and NHS Scotland. The documentation from 
each organisation was arduous and complex (NHS Research Scotland, 2020). In 
Scotland, YP under 16 years of age are considered children, and from the outset, 
it proved difficult to obtain informed consent within the available timeframe 
(Scottish Government, 2014). Nevertheless, focusing on the lower age bracket 
would have been an addition to this study as it was important to capture the 
younger voice. Ultimately, after careful consideration, and discussion with my 
supervisory team, it was decided that the age bracket range would be increased 
to include those aged 16 to 26 years. This change in the inclusion criteria  allowed 
ethical approval to be sought and granted relatively quickly and allowed data 
collection to begin.  
 
Secondly, although the sample size of ten was appropriate to an IPA approach, 
only one young female and one significant other (her male partner) participated in 
the study. With the reported incidence of MM in young females greater than among 
the male population (CRUK, 2019b; ISD, 2019), it would have been beneficial to 
have captured a broader female perspective on the disease. Despite recruiting an 
additional two female participants into the study, neither attended their scheduled 
interview and although alternative telephone interview options were offered, these 
were also declined. As part of the ethical approval, it was recommended that the 
interviews take place during the outpatient appointment to minimise the disruption 
to the participants' lives. However, if another venue and time, more suitable to the 
young females, had been offered, this may have supported and encouraged them 
to participate in the study. The experience of the significant other in the MM 
journey was also under-represented in my study. All the young participants in the 
study had the option of selecting a family member or their significant other to join 
them in the interviews. To my surprise, the vast majority of YP opted to select a 
parent to participate in the interview process. As I wanted to reflect the voice of all 
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the participants truly and accurately, there was no obvious way to mitigate these 
circumstances. Any future research that seeks to build on the results of this study 
should endeavour to make the recruitment of children, females and significant 
others a priority. 
 
Other limitations associated with my study mainly lie within the integral limitations 
of IPA as a research approach. The role of language and emphasis in collecting 
data cannot be underestimated. Deriving meaning from the research depends 
upon the interpretation of individual narratives, stories, metaphors and nuances. 
The primary purpose of IPA is to gain insight into the lived experience, but that 
insight is always intertwined with language and the researcher's understanding of 
the language used by the participants to convey meaning. To assist with capturing 
the voice of the YP and interpreting their true meaning, alternative data collection 
methods could have been used (Larkin et al., 2019, Polit & Beck, 2010). For 
example, allowing participants to keep an audio diary over a suitable period may 
have reduced their anxiety or stress associated with the interview process. This 
may have also helped provide deeper recollections of their experience recorded 
in their natural, day-to-day language. This, however, does depend on the ability of 
the individual to clearly articulate their experiences and emotions. This is a 
dependence common to all qualitative forms of enquiry, including IPA (Smith et 
al., 2009).  
 
Questions can also be asked whether the IPA methodology can accurately 
capture the experienced reality and the associated meanings rather than just 
opinions, memories and reflections of it. As IPA is a philosophy associated with 
introspection allowing the researcher to explore his or her experiences through 
‘phenomenological meditation’, IPA as a research approach relies on the accounts 
of participants and the experiences of researchers (Smith et al., 2009). This 
depends on both the participants and researcher possessing the requisite 
communication skills to communicate the nuances of experiences successfully. 
Consequently, phenomenological research relies on the most eloquent individuals 
and this may be particularly true in my study, reflecting those individuals who were 
best able to elucidate their experiences. Indeed, concerns over their ability or 
confidence to clearly express their experiences orally may explain why two 
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participants withdrew from the study after initially agreeing to take part. As noted 
earlier, alternative data collection methods such as an audio diary may have 
helped minimise this concern and should be used in future studies with YP and 
their families/significant other in this context.  
 
Finally, the sample population of ten (n=10) generated copious amounts of rich 
data which needed to be organised, collated, analysed and then interpreted. 
Indeed, the sample size exceeded that recommended by Smith et al. (2009). At 
the outset, this presented challenges for an initially novice IPA researcher. 
However, following the Smith et al. (2009) step-by-step approach provided the 
necessary guidance, structure and support to complete the data analysis and 
ensure its integrity and coherence. 
 
5.6 Implications for Research, Practice and Policy 
 
Based on the findings presented in Chapter 4, I now make several suggestions for 
research, practice and future policy.  
 
5.6.1 Research  
 
The main aim of my study was to establish what it meant to live with MM and to 
record the experiences of the YP and their family/significant other. The IPA 
approach has allowed rich data to be collected and analysed to answer the original 
research aim and questions in great depth.  
  
As a direct progression from my study, new research would further expand the 
understanding of this specific participant group living with MM. My plan for further 
research includes exploring the following questions:  
 
1. Are the findings presented within the thematic structure an accurate 
representation of the participants’ journey with MM?  
This research will gauge the relevance of the thematic structure, presented in 
Chapter 5, in relation to the YP’s actual lived experience. This question will be 
fully answered through the planned public engagement event scheduled for 
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March 2020. Additional data will be collected from the participants on their 
journey since 2017.  
 
2. Do YP under the age of 16 years and females diagnosed with MM have any 
additional or different experiences and expectations over and above those 
identified in this study?  
Children and young people under the age of 16 years and young females were 
underrepresented in my original study, and their specific, unique experiences 
have been missed. Owing to the small number of children diagnosed with MM 
in Scotland each year, any future research would be expanded across the four 
nations of the UK to ensure a representative sample size of younger 
participants, with specific attention paid to the experiences and voices of young 
females. The exact research protocol to be adopted would require careful 
consideration but is likely to feature a combination of survey, audio diaries and 
semi-structured interviews as an effective way of collecting data on this scale. 
 
3. How do the family/significant other inter-relationships change when the YP 
experience a recurrence of MM with a poor life outcome?  
The family/significant other cannot be separated from the YP’s MM experience. 
The research would explore the emotional and social impact of an MM 
recurrence within the family/significant other and include the impact on siblings 
and close friends. With no available literature, this research would add to the 
body of knowledge specific to this disease. 
 
4. What are the healthcare professional’s perspectives on the findings? 
During ethical approval with the NHS Boards, I was asked to return and relay 
my findings and plan to complete this in Summer 2020. I plan to explore the 
healthcare professional’s perspectives on the core conceptual thread, ‘Life 
Interrupted’ metanarrative, and the key findings. Alongside the NHS healthcare 
professionals, it would also be beneficial to explore these findings with the GP 
and to capture their experiences on dealing with YP who come to their surgery 
with suspicious moles. 
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5.6.2 Practice 
 
It is only by focusing on the experiences of YP, and their family/significant other, 
living with MM that should see improvements to healthcare services designed to 
meet the needs of this patient group. Anecdotal evidence suggests and is 
confirmed within my study, that YP with MM experienced fragmented service 
delivery and insufficient support, potentially leading to poorer patient outcomes. 
Obtaining an early diagnosis is crucial to identifying the stage of this disease and 
enabling swift treatment to help prevent metastases (Ali et al., 2013). How YP and 
their family/significant other receive this diagnosis and the supporting information 
provided, also needs to be reviewed in light of the evidence within my study. 
Improvements in communication and information sharing would help introduce an 
improved overall experience, given how profound this experience is for YP and 
their family/significant other.  
 
As YP with this disease begin their journey outside specialist cancer services, the 
care delivery for this patient group and their families/significant other require links 
between services, working better together than apart. For example, stronger links 
between the TCT units and health and social care professionals and Skin Cancer 
Services. Being able to recognise and deal with the disease can be challenging, 
and mechanisms need to be in place to support YP and their family/significant 
other psychologically including, for example, support groups and online spaces 
specifically for the YP with MM. Currently education programmes for young people 
in schools are been reviewed with the the face to face contact being replaced with 
digital earning (TCT 2020).  A series podcasts would support YP and their family 
increasing their awareness, knowledge and support for melanoma. This would 
support the lack of physical, emotional and social support for this patient group 
and this disease, often resulting in feelings of isolation.  
 
5.6.3 Policy 
 
This study emphasises the need for greater awareness, knowledge and 
understanding about skin cancer, especially for CYP. The Scottish Government 
are in the process of updating their existing policy for CYP with cancer and are 
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inviting contributions from leading clinicians and nursing professionals. Part of my 
dissemination strategy will involve the creation and circulation of a short key 
findings paper to prominent policymakers, senior clinicians and nursing 
professionals. This approach will include sharing the key findings with the MSN 
National Clinical Director, Professor Hamish Wallace. Education must continue 
within schools, colleges, and the media to increase awareness of skin cancer and 
prevention, for both the YP and their families. This may help ensure that prompt 
medical attention is sought at the appropriate time. Other countries, such as 
Australia, have already led the way with the effective public and media campaigns 
such as ‘Slip, Slap, Slop’ (Montague, Borland and Sinclair, 2001). Society also 
needs to reassess its common definitions of beauty in this age group so that in 
time the demand for tanning studios may reduce making these as culturally 
unacceptable as smoking or drink-driving (Murray & Turner, 2004).  
 
Young people with this type of cancer do not necessarily feel unwell. Therefore, 
education regarding the full symptom spectrum associated with MM must be 
mandatory for all healthcare services and professionals, especially in primary care 
settings which are the first port of call for YP with suspicious symptoms. This 
broader understanding of the disease, wherever it presents within the health 
service, can help signpost the individual to the most appropriate care provider. 
 
5.7 Conclusions 
 
The lives of YP matter; their experiences matter; their futures matter; and that of 
their families/significant other matter. As a nurse, academic and researcher, this 
study confirmed five significant contributions to knowledge and understanding 
about YP living with MM: 
 
1. The study has addressed the gap in the existing literature around the 
experience of YP living with MM. 
 
2. No other studies have explored one type of cancer experienced by YP, such 
as MM, in this level of detail.  
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3. This study included the critical role played by the family/significant other in 
supporting the YP in their MM journey and the interconnection and inter-
relationships that exist.  
 
4. This is the only study (at this time of writing) that has used IPA to understand 
YP and their family/significant other living with MM and to illustrate the depth 
of experiences.  
 
5. The use of a novel multi-perspective design within the IPA approach that 
builds on the recurring hermeneutic practice. 
 
From these five significant contributions, my thesis makes a claim to originality on 
two grounds: (1) empirical; (2) methodological. Development of theory cannot be 
claimed as this is not an accepted feature of an IPA approach.  
 
There have been no other studies, utilising an IPA approach, that have explored 
the experiences of YP living with MM or that of their family/significant other. 
Perhaps, as a paediatric nurse first and foremost, the needs of the family have 
always been of significant interest to me as part of the YP's life journey. The 
conceptual representation shown earlier in Figure 5.2 will help healthcare 
professionals improve their understanding of the multifaceted and dynamic 
physical, emotional and social needs of YP and their families/significant other in 
living with MM. The importance of the complex interplays between the YP and 
their family/significant other and the underlying emotional bonds is clearly 
illustrated within the visual representation. Ultimately this enriched understanding 
will contribute to improving the care pathways and management for this patient 
group. It will also drive the improvement of care delivery for this specific disease 
in order that this patient group is provided with the same access to service delivery 
as other YP with cancer.  
 
The YP and the family/significant others experience of MM before diagnosis was 
limited and not a disease that they associated with themselves or their child/loved 
one. The general public and healthcare professionals require greater awareness, 
knowledge and understanding about skin cancer and in particular melanoma. 
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From this study, it cannot be concluded that a diagnosis of MM in the YP group 
was a direct result of overexposure to UV light. Apart from one young person who 
had been 'sunburnt' as a child, all others had protected their skin. The literature 
highlights that sunburn as a child increases the risk of melanoma and safety 
interventions are recommended throughout life (McNally et al., 2014; Tripp et al., 
2016; Ali et al., 2013). Most of the YP were ambivalent and bewildered with their 
changing mole, and although had sought medical advice straight away, delay in 
diagnosis was evident from the inaction of the GP. All participants in my study 
would have valued contact with other patients with the same disease and care that 
was similar to other YP who are experiencing cancer. The perception of MM, and 
its severity, is different from other cancers and did impact on the experience of YP 
and their family/significant. This may relate to a lack of knowledge and 
understanding from healthcare professionals and the general public.  
 
At the beginning of their MM journey, all the participants experienced an 
overwhelming sense of their lives being interrupted. Most were looking forward to 
their lives, studying hard to accomplish good grades and building their futures. 
This interruption, however, fluctuated along the life continuum and on some days 
their lifeworld flowed as smoothly as before, but other days were consumed with 
uncertainty and fear. This insight into the actual lived experience of the YP and 
their family/significant other substantiates Eatough & Shaw’s (2019) lifeworld 
research.  
 
The increase in TCT units across the UK and in particular Scotland has not 
necessarily improved the experience of everyone in the YP age group or 
eradicated the ‘lost tribe’ described by Michelagnoli et al. (2003). Indeed, for the 
YP in this study, there was limited access to these units or the supportive care 
element that they provide. However, for the participants in this study, the treatment 
environment was not the primary concern. It was the lack of specialist support 
from other healthcare professionals and other families “like them” who understood 
the impact of the disease. It is vital that YP and their families/significant other have 
someone to communicate with and share their concerns. In order for healthcare 
professionals to better understand how to support YP and their families/significant 
other at the time of discovery, diagnosis, treatment and adjusting to living with MM, 
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requires a change in attitude and approach within the broader healthcare 
profession and the patient group themselves. 
 
This study has revealed that the diagnostic process for investigation of a 
'suspicious' mole, was a stressful experience for many YP and their 
family/significant other. While a Skin CNS provided emotional support for the 
participants during the diagnosis of MM, they were not always a specialist for YP. 
The findings of this study suggest that all patients might benefit from increased 
psychological support and information provision at the initial clinic attendance and 
throughout the treatment journey.  
 
Melanoma, in common with other cancers, has a significant psychological effect 
on YP and their families/significant other. This study also found that this disease 
has a profound effect on siblings and close friends, although this is an area of the 
experience that this study was not able to capture but is an area that requires 
further exploration. The visible nature of cancer, in general, seems to be 
necessary with participants expressing frustration and anger that the ‘skin 
lesion/mole' was not recognised sooner. Prognosis and individual factors were all 
essential aspects in their ability to cope with the diagnosis, and all reiterated that 
support, information and a clear treatment plan, would support the overall journey 
in living with MM.  
 
As seen throughout this thesis, MM remains one of the most prevalent cancers in 
YP worldwide, and the reported incidence continues to rise, despite global 
advances in cancer treatments, management and public awareness over the last 
50 years. With the incidence also accelerating across the world, including Scotland 
and the rest of the UK,  there is a pressing demand to improve the experience, 
diagnosis, treatment and understanding of this patient group. This study has 
illuminated the experiences of the YP and their family/significant other and should 
have a positive impact on future research, practice and policy. The results seen 
here should be regarded as the beginning rather than the end of this change in 
approach to dealing with MM.  
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For the YP and their family/significant other, the MM experience interrupted their 
expected life journey in many ways, resulting in a series of negative and, for some, 
positive life-affirming experiences. This overall experience is best summarised in 
the words of C.S. Lewis which opened this thesis, “The truth is of course that what 
one calls the interruptions are precisely one’s real-life” (Lewis, 2008 p.97). 
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Epilogue 
 
"There are far, far better things ahead than any we leave behind”. 
C. S. Lewis, in a letter to his friend Mary Shelburne on 17th June 1963  
as she was dying, five months before his own death 
on 22nd November 1963 (Hooper, 2006 p.90). 
 
I began this thesis by relating my professional and personal interest in, and 
experience of, living with MM in the Prologue. My primary motivation has been to 
hear and honour the voice of the individual participants and provide a scholarly 
platform for their stories. Throughout this journey, I have searched for answers to 
existential questions and human experiences which prompted my original 
research questions of “What are the experiences of YP and their family/significant 
other living with MM?” While the preceding Chapters have provided me with 
innumerable personal and professional opportunities for learning and reflection, I 
aimed to gain an understanding of YP and their family/significant other living with 
MM. 
 
Conducting an IPA study was time and labour intensive, but it was also creative 
and thought-provoking (Smith et al., 2009). This involved focused concentration in 
listening and reading the transcripts, ensuring I was interpreting the participants' 
experiences in a way that captured the whole while preserving the individual 
voices. During the data collection process, I had to continually remind myself that 
I was not the ‘nurse’ but the ‘researcher’. For this to be successful, I had to anchor 
myself firmly within the research role and be guided by my supervisory team 
throughout this part of the PhD journey. Often, this was a lonely and emotional 
experience, especially days where I had to immerse myself within the data and 
determine the meanings of what the individual participants had conveyed. The 
continuum of research skills set out by Smith et al. (2009) have clear guidelines 
which offer useful information at all levels to learn and develop the craft of IPA, 
and I followed this protocol.  
 
Throughout this research, I kept a reflexive journal and audio diary which have 
helped me to explore the experiences and understandings in more depth. Initially, 
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my data analysis was descriptive, particularly in the early stages of data collection, 
however later, when I became absorbed in analysing the data rigorously and 
following the key steps by Smith et al. (2009), these notes became much more 
detailed. I consider that using IPA helped to deepen my knowledge and skills of 
analysis as this encouraged free associations to develop my creativity in the early 
stages of analysis, and I found this to be particularly liberating. 
 
In addition to the above, I became a member of the IPA Scottish Interpretative 
Phenomenological Analysis Interest Group (SIPAIG) who meet from January to 
April each year. This group offers a relaxed, informal, supportive environment for 
those engaging in IPA research. Each meeting comprised a combination of 
workshops designed to support students in each step of the IPA process coupled 
with an open forum for advice, guidance and discussion on our work. Several 
keynote presentations allowed me to meet experienced IPA researchers, such as 
Michael Larkin and Paul Flowers, and learn about their work. These workshops 
have supported my grounding of the IPA approach, which is distinct from other 
qualitative approaches due to the combination of its inductive, idiographic, 
interpretative and reflexive nature. 
 
Strategic dissemination of my work has taken place throughout the PhD journey. 
I have continuously presented my work to a range of audiences, including 
colleagues within ENU, CNSs, nursing students and researchers as well as health 
and social care specialists working within CYP and TYA. The primary purpose of 
this approach was to share the key learnings as the PhD progressed and that 
ensure my work was appropriately considered and recognised, allowing the 
participants in my study to voice their experiences.  
 
Dissemination of my work involved several conferences, public engagement 
events and publications over the last three years and this approach to sharing my 
research will continue. This strategy is summarised in Appendix 19. My approach 
to the dissemination of my research has been strategic and focused on sharing 
key knowledge to drive forward the design and implementation of research, 
practice and policy for this important patient group and their family/significant 
other. 
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Dissemination began with the presentation of my preliminary results at the TYAC 
Conference in June 2017, where I received an award for runner-up ‘best 
infographic poster’. In November 2017, I was instrumental in leading the 
collaboration with Macmillan Cancer Support, Youth Theatre Arts Scotland, ENU 
School of Health and Social Care (Cancer Collaborative Theme) to deliver a high-
profile public engagement event with an original performance inspired by the 
findings of the BRIGHTLIGHT research. This event was held over three nights at 
the famous Traverse Theatre in central Edinburgh. As an organiser for this event, 
I was able to invite the participants from my study to attend. Making contact 
through their CNSs (who were also invited) the study participants, along with the 
various CNSs, took part in the roundtable discussion immediately after the final 
performance. Afterwards, they informed me that that had found the performance 
emotional, believable and true-to-life and found great solace and comfort from 
being able to network with other YP with cancer and discuss shared experiences. 
As part of sharing the knowledge and understanding gained from the 
BRIGHTLIGHT research, critical policymakers from the Scottish Government, the 
NHS in Scotland and MSN, including the First Minister and Health Minister, were 
invited to attend and hear first-hand about the experiences of YP with cancer. 
Examples of this work can be seen in Appendix 20. The receipt of a Stephen 
Sutton Award allowed me to attend the Adolescent and Young Adults Global 
Accord International Cancer Conference in Atlanta on 5th December 2017, where 
I presented my updated preliminary findings. Both conferences helped with the 
early dissemination of my work across international audiences of health and social 
care professionals, researchers and service users. 
 
In early 2018 as part of the Post Graduate Research (PGR) conference, I gave an 
oral presentation on my research to other PhD students, researchers, colleagues 
and nursing students. The feedback received was very complimentary and 
encouraged me to continue on my PhD journey. Examples can be seen in 
Appendix 21. During the year I was approached by Professor Alan Glasper, Chief 
Editor of the journal Comprehensive Child and Adolescent Nursing, to submit a 
position paper around YP with MM in Scotland which was published later in 2018. 
This can be seen in Appendix 22.  
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In March 2020, following on from the positive experience of the BRIGHTLIGHT 
public engagement event in November 2017, I invited all my study participants 
and their siblings to a second public engagement event. Additional funding and 
ethical permission were sought and approved prior to the event. This event was a 
participatory workshop where I presented my PhD findings and gathered 
additional data around the findings through a series of moderated and facilitated 
discussions. The discussions explored the credibility and relevance of my findings 
and to establish how their own journeys had progressed in the intervening three 
years since I first began collecting data. More details about the workshop can be 
seen in Appendix 23. 
 
I have continued to submit abstracts to showcase my work through national and 
international conferences such as the British Psychosocial Oncology Society 
event in Edinburgh in February 2020, The Society of International Paediatric 
Oncology conference in Ottawa, Canada in October 2020. I am the lead for the 
EONS Education working group, and a teaching session is being arranged 
through the European School of Oncology (ESO) as an e-session to take place in 
August 2020. Part of this role is to develop and deliver a series of podcasts for 
health and social care professionals caring for children and young people with 
MM.  
 
I also plan to build upon my research portfolio by submitting three empirical papers 
from my thesis. My first literature review was registered through Prospero 
(CRD42017084148) and will be part of the dissemination for my second literature 
review in Enfermeria-Clinica, a Spanish peer-reviewed journal. Recently the 
Enfermeria-Clinica editor has approached me to contribute to a special edition 
focusing on Teenagers and Young People with Cancer. This is scheduled for 
publication in June 2020. In addition, a review paper on the methodology and 
novel perspectives (individual and dyads) used within the IPA methodology will be 
submitted to Frontiers in Psychology in mid-July 2020. Lastly, I will be preparing a 
paper on my findings for the European Journal of Oncology Nursing in September 
2020. Going forward, I will continue to build upon my practice NHS links and 
collaborative membership working with cancer charities around the UK and 
internationally to disseminate my research findings further. 
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Each step in this PhD journey has presented me with new personal challenges, 
from exploring theoretical debates into the nature of reality to the more practical 
development of effective interviewing and analytical skills. Significantly, my five-
year immersion in the research process has also compelled a timely re-
examination of my professional practice as a nurse, academic and researcher. 
During my PhD journey, I stumbled across the following song by Paul Weller. The 
song, True Meanings – Aspects, is fitting for IPA and how we try to make sense 
of our life and our world. However, the true meaning for its use within my thesis is 
that this artist was my brother Keith’s favourite growing up as a young teenager in 
the early 1980s. At this time Paul Weller was the lead singer of The Jam and left 
a lasting impression on his young adult life. This song played a vital role in my 
PhD journey. Its lyrics shared below as the final words of this thesis, spoke to me 
on a personal, emotional level. I listened to this song frequently. 
 
Increasing my knowledge around evidence-based practice and research has 
developed my critical thinking, especially around the care for children and young 
people with cancer, and in particular YP and their families/significant other living 
with MM. For now, this is the end of this story. This thesis is the first step in 
understanding the meanings and patterns in YP’s and their family/significant 
others’ experiences of living with MM. From here, through the dissemination of 
my findings and future research building on the foundation I have laid, my hope 
is that a new wave of research can be carried forward to ensure that healthcare 
is appropriate and accessible from the moment YP ask ‘Is it Serious? 
 
“True Meanings – Aspects” by Paul Weller.  
 
It's not in the way it's not in your hair 
You won't find it under your chair 
  
It's not in a hollow or pieces of wood 
I don't see it anywhere no more 
  
And as long as 
The wind blows 
The tides flow along 
And as long as the wind blows 
The tides flow along 
  
Under a blue sky on a new wave 
In a new world today 
  
Crippling aspects 
Of life with no rhyme 
Nor that of reason or that of time 
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Under a blue sky 
On a new wave 
In a new world 
Today 
  
It's not in a holler 
Not in a scream 
You won't find it under your feet 
  
It's always inside you 
As old as the sun 
It's holding the answers as new as the young 
  
To find true meanings 
And patterns in things 
Symbols in making 
These moments exist 
  
And as long as 
The wind blows 
The tides flow along 
  
Under a blue sky 
On a new wave 
In a new world today 
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Appendix 4: Research Access – NHS Greater Glasgow & Clyde 
 
 
  
 LetterOfAccess_McInallyWendy Page 1 of 2 
 
Administrator: MUV ElaiQe O·Neill Research & Development 
Telephone Number:0141 232 1815 West Glasgow ACH 
E-Mail:elaiQe.R·Qeill2@ggc.VcRW.QhV.Xk   Dalnair Street 
Website: www.nhsggc.org.uk/r&d Glasgow G3 8SW 
   
  
      
09 February 2017 
 
 
Mrs Wendy M McInally 
Edinburgh Napier University 
9 Sighthill Court 
Edinburgh 
EH11 4BN 
 
 
Dear Mrs W McInally, 
 
 
Letter of Access for Research 
 
This letter confirms your right of access to conduct research through NHS Greater Glasgow and Clyde for 
the purpose and on the terms and conditions set out below. This right of access commences on 09/02/2017 
and ends on 09/04/2018 unless terminated earlier in accordance with the clauses below. 
 
You have a right of access to conduct such research as confirmed in writing in the letter of permission for 
research from this NHS organisation. Please note that you cannot start the research until the Principal 
Investigator for the research project has received a letter from us giving permission to conduct the project. 
 
The information supplied about your role in research at NHS Greater Glasgow and Clyde has been 
reviewed and you do not require an honorary research contract with this NHS organisation. We are 
satisfied that such pre-engagement checks as we consider necessary have been carried out.  
 
You are considered to be a legal visitor to NHS Greater Glasgow and Clyde premises. You are not 
entitled to any form of payment or access to other benefits provided by this NHS organisation to employees 
and this letter does not give rise to any other relationship between you and this NHS organisation, in 
particular that of an employee.  
 
While undertaking research through NHS Greater Glasgow and Clyde, you will remain accountable to 
your employer Edinburgh Napier University but you are required to follow the reasonable instructions of 
Dr David Dodds in this NHS organisation or those given on her/his behalf in relation to the terms of this 
right of access. 
 
Where any third party claim is made, whether or not legal proceedings are issued, arising out of or in 
connection with your right of access, you are required to co-operate fully with any investigation by this NHS 
organisation in connection with any such claim and to give all such assistance as may reasonably be 
required regarding the conduct of any legal proceedings. 
 
You must act in accordance with NHS Greater Glasgow and Clyde policies and procedures, which are 
available to you upon request, and the Research Governance Framework.  
 
You are required to co-operate with NHS Greater Glasgow and Clyde in discharging its duties under the 
Health and Safety at Work etc Act 1974 and other health and safety legislation and to take reasonable care 
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for the health and safety of yourself and others while on NHS Greater Glasgow and Clyde premises. You 
must observe the same standards of care and propriety in dealing with patients, staff, visitors, equipment 
and premises as is expected of any other contract holder and you must act appropriately, responsibly and 
professionally at all times.  
 
If you have a physical or mental health condition or disability which may affect your research role and which 
might require special adjustments to your role, if you have not already done so, you must notify your 
employer and the heaOWh bRaUd¶V HR deSaUWPeQW prior to commencing your research role at the Health 
board.  
 
You are required to ensure that all information regarding patients or staff remains secure and strictly 
confidential at all times. You must ensure that you understand and comply with the requirements of the 
NHS Confidentiality Code of Practice (http://www.dh.gov.uk/assetRoot/04/06/92/54/04069254.pdf) and the 
Data Protection Act 1998. Furthermore you should be aware that under the Act, unauthorised disclosure of 
information is an offence and such disclosures may lead to prosecution.  
 
You should ensure that, where you are issued with an identity or security card, a bleep number, email or 
library account, keys or protective clothing, these are returned upon termination of this arrangement. 
Please also ensure that while on the premises you wear your ID badge at all times, or are able to prove 
your identity if challenged. Please note that this NHS organisation accepts no responsibility for damage to 
or loss of personal property. 
 
We Pa\ WeUPiQaWe \RXU UighW WR aWWeQd aW aQ\ WiPe eiWheU b\ giYiQg VeYeQ da\V¶ ZUiWWeQ QRWice WR \RX RU 
immediately without any notice if you are in breach of any of the terms or conditions described in this letter 
or if you commit any act that we reasonably consider to amount to serious misconduct or to be disruptive 
and/or prejudicial to the interests and/or business of this NHS organisation or if you are convicted of any 
criminal offence.   You must not undertake regulated activity if you are barred from such work. If you are 
barred from working with adults or children this letter of access is immediately terminated. Your employer 
will immediately withdraw you from undertaking this or any other regulated activity and you MUST stop 
undertaking any regulated activity immediately. 
 
Your substantive employer is responsible for your conduct during this research project and may in the 
circumstances described above instigate disciplinary action against you.  
 
NHS Greater Glasgow and Clyde will not indemnify you against any liability incurred as a result of any 
breach of confidentiality or breach of the Data Protection Act 1998. Any breach of the Data Protection Act 
1998 may result in legal action against you and/or your substantive employer. 
 
If your current role or involvement in research changes, or any of the information provided in your Research 
Passport changes, you must inform your employer through their normal procedures. You must also inform 
your nominated manager in this NHS organisation.  
 
Yours sincerely 
 
MUV EOaiQe O¶NeiOO 
Senior Research Administrator 
 
cc: Shona Fitzpatrick (Napier University) 
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Appendix 5: Edinburgh Napier University Ethics Approval 
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Appendix 6: Patient Information Sheet – Young Person 
 
 
 
Participant Information Sheet: Young Person 
 
Version 4 21/10/16 
 
 
Participant Information Sheet: Young Person V4 – October  2016 
Participant Information Sheet – Young Person  
 
Title: Exploring the Experiences of Young People Living with Malignant 
Melanoma within a Relational Context. 
 
Participant Code:  
 
What is the purpose of the study? 
This research study aims to explore young people’s experiences of living with malignant 
melanoma and will include a family member who is fundamental to the overall cancer 
journey. You will be asked by the Clinical Nurse Specialist who will provide you with this a 
Participant Information Letter to identify one key family member.  This is your choice. The 
family member needs to be identified at this time or when giving consent. Please take the 
time to read the information in this sheet about this study and feel free to ask if you have any 
questions. 
 
Why have I been asked to take part? 
You have been chosen to take part in this study as you have been diagnosed with malignant 
melanoma. Your experiences are important in helping us to understand your needs.  The 
study will aim to recruit from three NHS hospital treatment centres in Scotland. 
 
Do I have to take part? 
No, you do not have to take part in this study. It is entirely up to you whether or not to take 
part. If you do so, you will be given this information letter to keep. Also if you decide to 
participate you are free to withdraw at any time and without giving a reason. If you decide to 
withdraw, any data you have provided will be safely destroyed and will not be used in any 
publication. 
 
What will happen if I take part? 
You will be contacted by the Clinical Nurse Specialist who will provide you with this 
Participant Information Letter. This will be given to you a week before so you have time to 
think about being part of the study.  If you agree to take part, the CNS will let the researcher 
know and they will be responsible for ensuring you sign a consent form before being 
interviewed. There will be no right or wrong answers. Your responses will be confidential and 
anonymous. You will then take part in one interview. The interview will be at any part of the 
cancer journey. The interview will last no longer than 1 hour. The interview will take place at 
a time and place that is convenient to you within the hospital environment.  You may wish to 
be interviewed with your family member present or on your own, it is entirely your choice. At 
the interview you will be asked how malignant melanoma has affected your life; what, if 
anything, has changed, and what has stayed the same. There will be some 
prompts/guidance given to help you think about this. For example, you will basked about 
what sources of support you have used and what has been helpful or unhelpful. This is an 
example of what may be asked. If you agree, the interview will be tape recorded and then 
typed. If you wish you can read through the typed interview to make sure it is accurate. 
 
What are the possible benefits of taking part? 
The results of this study will be used to inform and develop services locally, nationally and 
internationally for young people with malignant melanoma and their family.  This study is to 
improve the services for young people with this type cancer in the future. 
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Participant Information Sheet: Young Person 
 
Version 4 21/10/16 
 
 
Participant Information Sheet: Young Person V4 – October  2016 
What are the possible disadvantages and risks of taking part? 
I know that this may be a stressful time for you. It is possible that by discussing your 
experiences you may become upset. If this happens I will offer to stop the interview 
immediately. I will offer to provide additional support to you at this time either by talking 
things through with you or by contacting someone you feel comfortable with. This may be 
your CNS or Doctor. 
 
Will my decision to take part or to decline have any effect on the care I receive? 
Your decision to take part or to decline will not affect the standard of care you receive in any 
way. If you agree to take part now, you can withdraw from the study at any time without 
explanation. 
 
Will my taking part in the study be kept confidential? 
If you are willing to take part in the study, all information about you and the responses that 
you give will be confidential. No personal information will be used. Your responses will be 
collated with other participant’s responses. All data will be stored on a password protected 
computer with no personal identifiable information. Your name will be replaced with a 
participant code and it will not be possible for you to be identified in any reporting of the data 
gathered. You can see your unique participant code at the top of all the documents within 
this project pack. If you wish to leave the project at any time, you do not need to identify 
yourself to the Research Team; you just need to give them your participant code. All data 
collected will be kept in a secure place (paper copies of questionnaires will be kept locked 
cabinet in locked room/electronic data will be stored in a password protected computer). 
Access to data will be strictly limited to the research team. All transcripts will be destroyed 
following 5 years of completion of the project. The study has been given a favourable ethical 
opinion by the Research Ethics Committee of the Edinburgh Napier University. The results 
may be published in a scientific journal or presented in a report and at scientific conferences. 
You will not be identified in these publications by any of the information provided. The 
sponsor of the study, Edinburgh Napier University, may ask to see anonymised data. You 
will not be identified by any information provided in these data. 
 
What will happen to the results of the study? 
A full report of this study will be submitted to Edinburgh Napier University for assessment for 
the award of Doctor of Philosophy. Some results will be submitted for publication in 
professional journals and presented at conferences. Participants will not be identifiable in 
any of these reports. 
 
Who has reviewed this study? 
 This study has been reviewed by Edinburgh Napier University Research Ethics committee 
for ethical approval. 
All research in the NHS is looked at by an independent group of people, called a Research Ethics 
Committee. A favourable ethical opinion has been obtained from South East Scotland REC 2. NHS 
management approval has also been obtained. 
 
What happens when the study is finished? 
A full report of this study will be submitted to Edinburgh Napier University for assessment for 
the award of Doctor of Philosophy. 
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Participant Information Sheet: Young Person 
 
Version 4 21/10/16 
 
 
Participant Information Sheet: Young Person V4 – October  2016 
What if there is a problem?  
If you have any questions and / or concerns about any aspect of this project, you should ask 
to speak with the, Wendy McInally, who will do her best to answer your questions. If you 
would like to contact an independent person, who knows about this project but is not 
involved in it, you are welcome to contact Janyne Afseth, Lecturer Edinburgh Napier 
University (j.afseth@napier.ac.uk). 
 
Who is organising the research and why? 
If you are interested in being interviewed, your will be contacted by the researcher who will 
arrange a meeting at a convenient location and time. After the interview you will be provided 
by a Participant Debrief.  The debrief letter is for you to keep and contains further information 
regarding sources for support. You can also keep this information letter, if you wish. Your 
participation in this study is a one–off and you will not be contacted again in relation to this 
study. Many thanks for your consideration. 
 
 
Wendy McInally SFHEA MSc BSc (Hons) RSCN. 
Chief Investigator. 
Edinburgh Napier University 
9 Sighthill Court 
Edinburgh EH11 4BN 
Email: w.mcinally@napier.ac.uk.  
Telephone: 0131-455-5343. 
 
 
 
 __________________________________________________________________________ 
271 
 
Appendix 7: Patient Information Sheet – Family/Significant Other 
 
 
 
Participant Information Sheet: Family 
 
Version 3 17/10/16 
 
 
Participant Information Sheet: Family V3 October 2016 
Title: Exploring the Experiences of Young People Living with Malignant 
Melanoma within a Relational Context. 
 
Participant Code:  
 
What is the purpose of the study? 
You are being invited to take part in a research study.  You are a family member of a young 
person who has malignant melanoma. Before you take part, it is important for you to 
understand why the research is being done and what it will involve. Ask the researcher if 
there is anything that is not clear or if you would like more information. Take time to decide 
whether or not you wish to take part. Thank you for reading this.  
 
Why have I been asked to take part? 
You are a family member of a young person who has been diagnosed with malignant 
melanoma. This may be your child, a sibling, or partner for example at diagnosis, mid 
treatment or at the end of their treatment .The study will aim to recruit from three NHS 
hospital treatment centres in Scotland. 
 
What will happen if I take part? 
This research study aims to explore the young person’s experiences of living with malignant 
melanoma and will include the family who are fundamental to their overall cancer journey.  
Please take the time to read the information in this sheet about this study and feel free to ask 
if you have any questions. 
 
What does the project entail? 
You will be contacted by the Clinical Nurse Specialist who will provide you with this 
Participant Information Letter. If you agree to take part, you will have to sign a consent form 
before being interviewed. There will be no right or wrong answers. Your responses will be 
confidential and anonymous. The interview will last no longer than 1 hour. The interviews will 
take place at a time and place that is convenient to you within the hospital environment. If 
you agree, the interview will be tape recorded and then typed. If you wish you can read 
through the typed interview to make sure it is accurate. 
 
Do I have to take part? 
No, you do not have to take part in this study. It is entirely up to you whether or not to take 
part. If you do so, you will be given this information letter to keep. Also if you decide to 
participate you are free to withdraw at any time and without giving a reason. If you decide to 
withdraw, any data you have provided will be safely destroyed and will not be used in any 
publication.  
 
Will my taking part in the study be kept confidential? 
If you are willing to take part in the study, all information about you and the responses that 
you give will be confidential. No personal information will be used. Your responses will be 
collated with other participant’s responses. All data will be stored on a password protected 
computer with no personal identifiable information. Your name will be replaced with a 
participant code and it will not be possible for you to be identified in any reporting of the data 
gathered. You can see your unique participant code at the top of all the documents within 
this project pack. If you wish to leave the project at any time, you do not need to identify 
yourself to the Research Team; you just need to give them your participant code. All data 
collected will be kept in a secure place (paper copies of questionnaires will be kept locked 
cabinet in locked room/electronic data will be stored in a password protected computer). 
Access to data will be strictly limited to the research team. All transcripts will be destroyed 
 __________________________________________________________________________ 
272 
 
  
Participant Information Sheet: Family 
 
Version 3 17/10/16 
 
 
Participant Information Sheet: Family V3 October 2016 
following 5 years of completion of the project. The study has been given a favourable ethical 
opinion by the Research Ethics Committee of the Edinburgh Napier University. The results 
may be published in a scientific journal or presented in a report and at scientific conferences. 
You will not be identified in these publications by any of the information provided. The 
sponsor of the study, Edinburgh Napier University, may ask to see anonymised data. You 
will not be identified by any information provided in these data. 
 
What are your rights? 
Participation in the project is entirely voluntary and you are free to refuse to take part or to 
withdraw from the project at any point without having to provide a reason and without any 
consequences. If you wish to withdraw, you can contact the research team, give them the 
participant code printed on this letter and on your debriefing letter and the researchers will 
withdraw your data. You do not need to provide your name. Your decision about whether to 
participate in the project will have no influence on your current employment. Your responses 
to the interview questions will be confidential. You need to be aware that if you disclose 
information regarding criminal activity or serious breach of professional code of conduct, the 
researchers will have to break confidentiality and take appropriate action.  
 
What are the possible benefits of taking part? 
There are no direct benefits to you from taking part in this study. However, many people find 
it interesting and helpful to take part in similar studies and reflect on how they feel. Your 
participation may benefit young people with malignant melanoma and their families/carers by 
increasing our understanding of the cancer journey and best practice.  
 
What are the possible disadvantages and risks of taking part? 
I know that this may be a stressful time for you. It is possible that by discussing your 
experiences you may become upset. If this happens I will offer to stop the interview 
immediately. I will offer to provide additional support to you at this time either by talking 
things through with you or by contacting someone you feel comfortable with. This may be the 
CNS or Doctor. You can take breaks if you are tired or concerned and even re-schedule the 
meeting for another date, if you wish. You will be given time to ask any questions before you 
give your consent and at any point during or even after your participation in the study. 
 
What if there is a problem?  
If you have any questions and / or concerns about any aspect of this project, you should ask 
to speak with, Wendy McInally, who will do her best to answer your questions. If you would 
like to contact an independent person, who knows about this project but is not involved in it, 
you are welcome to contact Janyne Afseth, Lecturer Edinburgh Napier University 
(j.afseth@napier.ac.uk). 
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What happens when the study is finished? 
A full report of this study will be submitted to Edinburgh Napier University for assessment for 
the award of Doctor of Philosophy.  
 
What will happen to the results of the study? 
Some results will be submitted for publication in professional journals and presented at 
conferences. Participants will not be identifiable in any of these reports. 
 
Who has reviewed the study? 
This study has been reviewed by Edinburgh Napier University Research Ethics committee 
for ethical approval. Approval for a research passport is also required for each of the three 
NHS boards. 
 
Who is organising the research and why? 
If you are interested in being interviewed, your will be contacted by the researcher who will 
arrange a meeting at a convenient location and time. After the interview you will be provided 
by a Participant Debrief.  The debrief letter is for you to keep and contains further information 
regarding sources for support. You can also keep this information letter, if you wish. Your 
participation in this study is a one–off and you will not be contacted again in relation to this 
study. Many thanks for your consideration. 
 
Wendy McInally SFHEA MSc BSc (Hons) RSCN. 
Chief Investigator. 
Edinburgh Napier University 
9 Sighthill Court 
Edinburgh EH11 4BN 
Email: w.mcinally@napier.ac.uk.  
Telephone: 0131-455-5343. 
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Appendix 8: Consent Form – Young Person 
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Appendix 9: Consent Form – Family/Significant Other 
 
 
Consent Form: Family 
 
Version 4 21/10/16  
 
 
Consent Form: Family V4  October 2016 
Title: Exploring the Experiences of Young People Living with Malignant 
Melanoma within a Relational Context. 
 
Participant ID:  
 
Chief Investigator: Wendy McInally 
Contact Details: Email: w.mcinally@napier.ac.uk.  
Telephone: 0131-455-5343. 
 
Questions (Please initial the appropriate box): YES NO 
1. I have read and understood the Participant Information Letter.   
2. I have been given an opportunity to ask questions and further discuss this 
project. 
  
3. I agree to participate in the study by being interviewed.   
4. I understand that any information provided will be kept confidential.   
5. I understand the limitations of confidentiality, i.e. that the researcher will have 
to take appropriate action if in danger of harm to yourself and others. 
  
6. I understand that I am under no obligation to take part in this study.   
7. I understand that participation is entirely voluntary and that I am free to 
withdraw from the study at any time without giving a reason. 
  
8. I understand that anonymised data will be analysed and the anonymised 
results and/or anonymised quotes maybe be used in scientific reports and 
publications. 
  
9. I understand that the sponsor of the study, i.e. Edinburgh Napier University, 
might have access to anonymised data. 
  
10. I agree to take part in the above study.   
 
If your answer is YES to all the above, please sign the consent form and hand it 
back to the researcher BEFORE your interview. 
 
 Participant Researcher 
Name:  
 
 
 
Signature:  
 
 
 
Date:  
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Appendix 10: Risk Assessment Proforma 
 
  
Risk Assessment Proforma 
 
Student Name: Wendy McInally 
 
 
Risk Assessment Proforma  Version 2 5th September 2016 
Title: Exploring the Experiences of Young People Living with 
Malignant Melanoma within a Relational Context. 
 
Date(s) to be carried out:  
August – March 2017 although this will be dependent on patients at this particular time 
and ethical permission. 
 
List here any potential risks you (as researcher) may face in carrying out this 
research; 
Potential risks to the researcher;  
Possible bias as the researcher was a specialist children's oncology nurse and have read 
widely as an academic around young people living with and beyond a cancer diagnosis. 
Being subjective as opposed to listening carefully to what they are communicating. 
Due to the sensitive nature of the study there is a risk of becoming emotionally involved. 
Dealing with experiences that affect the overall patients care. 
 
Outline the measures/steps you are putting in place to minimise these risks: 
Training, preparation, and supervision will be taken into account so that the risk to the 
researcher can be minimized. Due to the nature and sensitivity of this research this will be 
sought throughout the whole process. 
 
Students carrying out research off-campus should complete the following:  
 
Where I am going?* 
Aberdeen, Glasgow and Edinburgh NHS Hospital/clinic environment.  
 
How I am getting there (including travel route)?  
By bus/car/train 
 
What to do should I not return at the specified time? 
I will be in contact at all times through mobile phone. 
 
This person will be my Line Manager:  
Karen Campbell. 
 
Ensuring to maintain participant confidentiality  
I am bound by this through my registration as a nurse. 
 
Outline here the procedure you will be using to do this:  
At all time and as a registered nurse the researcher will adhere to participant 
confidentiality (NMC 2015). All information gathered will be kept confidential unless 
participants discuss their dissatisfaction with the health care system the researcher will 
seek participants permission to disclose the information from the interview to the relevant 
authority. This is in keeping with Nursing and Midwifery Council (NMC) (2015) guidance 
on the code of professional practice for nurses and midwives.   
 
All participant involvement will be anonymous. Only the researcher and supervisors will 
have access to the audio files and transcripts which will be password protected through 
the computer. These materials will be destroyed after completion of the study and 
participants will be informed of this. Destroying of all the materials is in accordance with 
the Data Protection Act (1998).   
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Risk Assessment Proforma 
 
Student Name: Wendy McInally 
 
 
Risk Assessment Proforma  Version 2 5th September 2016 
 Supervisor Student 
Name:  
 
 
Signature:  
 
 
Date:  
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Appendix 11: Research Debrief – Young Person and Family/Significant 
Other 
 
  
Proposed Interview Schedule: Family 
 
 
 
 
 
Proposed Interview Schedule: Family Version 2 5th September 2016 
Title: Exploring the Experiences of Young People Living with Melanoma 
within a Relational Context. 
 
Research Summary: 
 
Thank you for agreeing to participate in the interview.   
 
As this study seeks to find out the process young people go through following a diagnosis of 
melanoma and what their experiences are of the support and care during this time, your 
views and experiences are important. There are no right or wrong answers; it is your 
perceptions and experiences that are important here.  
 
To begin with I’d like to ask you a bit about your role around the time the young person with 
melanoma was diagnosed and thereafter treated for melanoma depending on the stage of 
diagnosis. The young person has chosen the family member who is most important in their 
care and journey. 
 
• What is your experience of caring for your family member with melanoma? How has 
it been for you? 
• Has your life changed/been affected in any way and how? (In a positive/negative 
way)? 
• What are the challenges you have been faced with during this time as a family 
member? 
• What has gone well and what has not gone so well during this experience? (Probes: 
care, treatment, support) Could you give me an example? 
• How has your relationship with the young person changed or not during this 
experience? (Probes: impact, family, social) 
• Is there anything else you would like to talk about in relation to your experience of 
living with young person with melanoma that we haven’t covered? 
• How was your experience of being interviewed for this project? 
 
Chief Investigator: 
 
Wendy McInally SFHEA MSc BSc (Hons) RSCN. 
Chief Investigator. 
Edinburgh Napier University 
9 Sighthill Court 
Edinburgh EH11 4BN 
Email: w.mcinally@napier.ac.uk.  
Telephone: 0131-455-5343. 
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Appendix 12: Interview Schedule – Young Person 
 
  
Proposed Interview Schedule: Young Person 
 
 
 
 
 
Proposed Interview Schedule: Young Person Version 2 5th September 2016 
Title: Exploring the Experiences of Young People Living with Malignant 
Melanoma within a Relational Context. 
 
Research Summary: 
 
You have been asked to take part in this study as you have been diagnosed with malignant 
melanoma.  For this study I would like to find out how this particular cancer has affected 
young people and how they are learning to live with it. I will also be asking for you to choose 
a significant family member that is experiencing this journey with you. There are no right or 
wrong answers; it is your experiences that are important here. Probes will be used to 
facilitate discussion of personal experiences, aids memory recall and taps into and uncovers 
a range of both negative and positive thoughts. I will have semi-structured questions to 
encourage the flow of discussion.  
 
• To begin with I’d like to learn a bit about your journey to being diagnosed with 
malignant melanoma. 
• What things stick in your mind about the time leading up to diagnosis?  
• What stands out for you from your experience through this journey from diagnosis, to 
treatment or after treatment? (Probes: diagnosis, treatment, after treatment) 
• How has this cancer affected your life? (Probes: Self, daily life, work, social, 
relationships….) 
• How has your life changed as a result of your cancer? (Probes: negative and positive 
changes?) 
• What are your main concerns at this time? 
• How do you feel about the support you have at the moment? What support do you 
need just now? (Probes: family, nurse specialist etc?) 
• Is there anything else you would like to talk about in relation to your experience of 
living with malignant melanoma that we haven’t covered? 
 
Chief Investigator: 
 
Wendy McInally SFHEA MSc BSc (Hons) RSCN. 
Chief Investigator. 
Edinburgh Napier University 
9 Sighthill Court 
Edinburgh EH11 4BN 
Email: w.mcinally@napier.ac.uk.  
Telephone: 0131-455-5343. 
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Appendix 13: Interview Schedule – Family/Significant Other 
 
  
Proposed Interview Schedule: Family 
 
 
 
 
 
Proposed Interview Schedule: Family Version 2 5th September 2016 
Title: Exploring the Experiences of Young People Living with Melanoma 
within a Relational Context. 
 
Research Summary: 
 
Thank you for agreeing to participate in the interview.   
 
As this study seeks to find out the process young people go through following a diagnosis of 
melanoma and what their experiences are of the support and care during this time, your 
views and experiences are important. There are no right or wrong answers; it is your 
perceptions and experiences that are important here.  
 
To begin with I’d like to ask you a bit about your role around the time the young person with 
melanoma was diagnosed and thereafter treated for melanoma depending on the stage of 
diagnosis. The young person has chosen the family member who is most important in their 
care and journey. 
 
• What is your experience of caring for your family member with melanoma? How has 
it been for you? 
• Has your life changed/been affected in any way and how? (In a positive/negative 
way)? 
• What are the challenges you have been faced with during this time as a family 
member? 
• What has gone well and what has not gone so well during this experience? (Probes: 
care, treatment, support) Could you give me an example? 
• How has your relationship with the young person changed or not during this 
experience? (Probes: impact, family, social) 
• Is there anything else you would like to talk about in relation to your experience of 
living with young person with melanoma that we haven’t covered? 
• How was your experience of being interviewed for this project? 
 
Chief Investigator: 
 
Wendy McInally SFHEA MSc BSc (Hons) RSCN. 
Chief Investigator. 
Edinburgh Napier University 
9 Sighthill Court 
Edinburgh EH11 4BN 
Email: w.mcinally@napier.ac.uk.  
Telephone: 0131-455-5343. 
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Appendix 14: Using The Microsoft Software Suite 
 
Content Participant Comment Making Initial 
Noting 
First of all, just to let you understand this is study 
as part of my PhD, and we are going to be using 
IPA which is interpretive phenomenological 
analysis. It is really about your experience of your 
journey so far, right from when you were 
diagnosed with melanoma. So, what might be a 
good place to start is that you tell me a bit about 
yourself? 
 
Interviewer  Icebreaker 
I was born in Edinburgh, lived here my whole life 
and went to school down in Leith and went to the 
high school at Leith academy. I was diagnosed 
when I was 16, so that was the start of my sixth 
year at school, so I took out a bit of time off from 
school then, I think I was diagnosed on the 21st 
of October and I think I got the all clear towards 
the start of December, so it was a pretty short 
period of time. But it didn’t feel short, it felt quiet 
long. After that, post cancer, I took a bit more time 
off school, the school were great, the school were 
really good at easing me back into it and not 
forcing me into anything that I wasn’t will to do at 
the time. After that I had my interview at university 
to go to study journalism and he had said that I 
needed to get one more B because I was 
currently sitting on 3 Highers and they were 
looking for four. I explained my situation and he 
said it would be great if I could get one higher 
which happily I did and I got my B in Biology which 
meant I could go to university straight out of 
school. 
  
1a Short time – felt long 
for the YP. 
 
Uncertainty about his 
exams 
 
Pressure of exams 
and staying on top of 
his school work 
Life on hold 
 
 
 
Trying to normalise 
his life 
 
Worried about 
exams 
 
Worried about his 
future 
 
 
Thank you. I am just going to take you back a bit 
to the experience at that time when you were 16, 
looking forward to your life after school, going 
onto university and things. What were thoughts at 
this time about having this disease and moving 
on with your life?  
 
Interviewer  Trying to probe, to 
recall his journey at 
this time and how 
he made sense of 
his world. 
Yeah, 100%. When I look back at it now it seems 
like a different part of my life, it seems like it was 
sort of taken out of it and I look at it as a different 
space. Because I have now had time now to 
reflect on it and reflection has been a big thing for 
me looking back, I’ve been able to look back at it 
as a different chunk and be able to comprehend 
what had happened and to think about it quite 
clearly. But at the time it did feel like this wasn’t in 
the schedule. Because when you’re in Sixth year 
you do get a map off your teachers, and they say 
you do this, you’ll revise for your exams and then 
you’ll start getting in contact with the college or 
university. So, it did feel like where did this, who 
wrote this into my plan. 
 
1a Not happening to 
me? 
 
Different journey than 
one on. 
 
 
Looking forward to 
life then bang 
cancer. 
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Appendix 15: Six-Step Development of Emerging Themes – Steps 1 & 2 
Step 1 and 2 – Reading, Re-reading and Initial Noting 
 
Transcript Participant Comments 
 
Themes 
Emerging 
No, I think my mum who is a nurse; she was a bit 
more sceptical about it. But, throughout, when the 
mole came up on my neck, I, stupidly, just thought it 
was a spot, I thought I was at that age and I just 
thought, oh no, I am starting to get spots, so I was putting 
things like Sudocream on it. And then... 
 
1a - John Not sure what it 
was 
 
Relying on 
mother’s 
knowledge  
 
Not really 
bothered by it 
 
Just his age, so 
apply cream to the 
‘spot’ 
Being bewildered  
 
Ambiguity of not 
really knowing or 
understanding 
what he had 
found 
 
 
Is it serious, not 
really sure? 
Was it sore, did you have any discomfort form the 
mole? 
Interviewer   
no, it wasn’t it was a tiny bit raised and the 
circumference of it started to increase slowly and we 
been back and forwards to the doctor and they had 
assured us it was OK and that was down at my local 
GP. 
1a Mole changing 
 
Back and forward 
to G. P.  
Delay in 
diagnosis 
 Yeah, I don’t go very often but if something does crop 
up, I just go in there. I must have been twice, I went the 
first time and she said ‘no, it not a problem’ and then 
we went again because I was going on holiday to 
Tenerife and Mum was conscience that maybe this was 
something looking in to. And she said, ‘I don’t think this 
is anything to be worried about but go away on your 
holiday and if there are any problems when you come 
back, come back in and speak to me.’ So then to take it 
back to what your question was and was I surprised? 
That was, I think that was the biggest shock, because 
I had been assured by other, who I saw as 
professionals and I thought … and you trust your 
doctors. So, at my GP … I think that was the thing from 
the start, prior to any diagnosis I was pretty chilled 
about it and then when I came up here to get the, they 
do a small excision to take out the mole and I was fine 
up till then, and then we got the phone call, which it was 
a bit early but I talk to my dad about it and we had come 
to the idea that it was just to check on my scar, because 
I had a tiny little scar at the time and I came in here and 
they said ‘it’s a melanoma’. And I didn’t know what a 
melanoma was at the time, so, I stopped and when I 
said, ‘what’s a melanoma?’ and they said, ‘you got 
skin cancer’ And then that… I think as soon as I heard 
the word cancer, because it had such a stigma to it, 
it did, it hit me like a ton of bricks at first. And I was 
in, it’s in just like any other GP’s room, it was in a very 
small room but that felt even smaller.  
1a Shock 
Cancer- hit me 
like a ton of bricks 
 
Had put his faith 
in his local doctor. 
 
Went on holiday 
as all ok 
 
Came back and 
all was surreal  
No self-
awareness 
 
Not serious 
 
Emotional impact 
and disbelief 
 
Recognises the 
word cancer not 
melanoma 
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Appendix 16: Six-Step Development of Emerging Themes – Step 3 
 
Step 3 – Developing Emergent Themes 
 
Participant Transcript: George Participant Transcript: Paul 
Yes. Well I’ve got quite a lot of moles all over and 
never really paid attention to them because I 
knew they were there. So, I was off getting my 
haircut, and my hairdresser went 'that mole 
doesn't look right'. So, I made a doctor’s 
appointment just to get checked, and they 
weren't happy with it, they weren’t sure about it 
because it only just a little local doctor. 
 
Well we made the initial appointment for him and 
we saw a local man, who’s from the same part of 
the country as myself, highlands 
understanding. He said ‘aye’ just send him up and 
we’ll take it off . 
I was absolutely shattered and in a lot of pain. I 
had to sit up in bed which was painful, I was out of 
breath constantly so it was a horrible night, 
horrible night, then of course, depression came 
back that night, so I was not suicidal but it would 
have been easier if I never woke up. I had strong 
painkillers but made me constipated. It was just 
the one night, mostly on my own, didn’t want to 
wake my mum, I was a total shambles.  
Interpretation Review:  Interpretation Review: 
Description / 
Content:  
Language 
Use: 
Interrogative 
coding: 
Description / 
Content:  
Language Use: Interrogative 
coding: 
Tell me about 
when you first 
noticed a 
change in your 
mole? 
 
 
 
‘never really 
paid much 
attention’, 
 
‘off getting 
haircut’ 
 
No real signs 
or symptoms 
that there was 
something 
wrong with his 
mole, has may 
all over his 
body, never 
bothered him 
before, why 
now? 
Going about 
his daily 
routine 
Slightly 
worried but 
really not sure 
What was it 
like for you 
when you 
went home, 
after 
discharging 
yourself early? 
 
 
‘absolutely 
shattered and 
in a lot of pain’ 
 
‘out of breath 
constantly, 
horrible, 
horrible night’ 
Worry setting 
in, reality of the 
surgery and 
what had 
happened to 
him.  
Anxiety causing 
breathlessness 
in addition to 
the surgery. 
Community 
care from 
hospital 
discharge to 
home. 
What 
prompted 
George to go 
to the Doctor? 
 
‘hairdresser, 
that mole 
doesn’t look 
right’ 
No self-
awareness or 
knowledge of 
moles 
Worried 
enough as 
hairdresser 
was worried 
Wanted to get 
it checked 
Were you able 
to take 
medication to 
help with your 
pain? 
‘had strong 
painkillers but 
made me 
constipated’.  
Treatment was 
followed 
through with 
medication 
Treatment and 
follow up care 
not satisfactory 
  
Why did he 
trust the 
hairdresser? 
 
Richard, 
Georges father 
discussed how 
the mole was 
identified and 
taken seriously 
Worried about 
the mole, 
uncertain of 
what it was 
 
Father made 
the initial 
appointment 
with a local GP 
whom he knew 
from where he 
came from 
 
Trusting 
relationship 
with 
hairdresser 
Seeking 
reassurance 
Trusted the 
local doctor 
The doctor 
acted straight 
away, had an 
awareness 
that that 
something was 
not right from 
the father’s 
phone call.  
Did you have 
a community 
nurse to visit 
you? 
‘depression 
came back 
and it would 
have been 
easier if I 
never woke 
up’.  
No 
psychological 
support 
Alone and 
afraid 
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Definition of terms used: 
Description/content: What the interviewer was asking from the participant  
 
Language Use: Data from the original transcript 
 
Interrogative coding: asking questions of the data to facilitate a deeper coding and 
inquisitive attitude towards the data. 
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Appendix 17: Six-Step Development of Emerging Themes – Step 4 
 
Step 4 – Searching for patterns across themes 
 
Colour Coding Key: 
Green Normal mundane routine 
Orange Bewildered 
Red Unprepared/unexpected 
Violet Followed up with GP 
Purple Reassured 
Yellow Post-surgery unwell 
Brown Anxious, worried 
Teal No psychological support 
Grey Treatment experience 
Dark Blue Feeling alone, helpless 
Light Blue Loss of independence 
Brown Worry and fear 
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Appendix 18: A Thematic Map Mind-Map Representation of the 
Metanarrative, the Super-Ordinate and Sub-Themes 
 
Mindmap: 
 
 
Thematic Analysis: 
 
 
  
Life 
Interrupted
Is it 
serious?
Suspicious 
findings…what is it?
The waiting
game
Being
diagnosed
Too much 
too young
In-between
Uncertainty and 
fear for the future
A sense of guilt and
helplessness
Time to
live
The scars tell a 
story
Supportive 
relationships
New meanings
Not the 
same
A life less 
ordinary
The treatment 
experience
Feeling a fraud
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Appendix 19: Dissemination Strategy 
 
 
  
• Infographic posters
• Oral presentations
• Public engagement 
events
• Publications
• Podcasts
• e-learning sessions
• 2017 & 2020: TYAC,   
AYA, BPSO & SIOP 
conferences.
• 2017 & 2020: PE Events
• 2020 Publications:  
enfermeria-clinica, 
Frontiers in Psychology, 
EJON
• Share findings
• Add to the body of 
knowledge
• Give YP and 
family/significant other a 
voice
• Improve overall MM 
experience
• Policymakers
• Researchers and 
educators
• Health and social care 
professionals
• Nursing students
• YP and family/significant 
other living with MM
Target
Audiences
Dissemination 
Objectives
Dissemination 
Content
Dissemination
Channels
PhD 
Dissemination 
Strategy
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Appendix 20: Public Engagement Examples – BRIGHTLIGHT, TYAC Award 
and AYA 
 
 
 
 
THERE IS A LIGHT: BRIGHTLIGHT
An original performance inspired by the findings of BRIGHTLIGHT, the first 
major study of its kind, There is a Light: BRIGHTLIGHT presents young 
patients’ perspectives on specialist cancer care in England. 
The event is being held from the 17th to 19th November 2017 in Edinburgh 
by The Youth Theatre Arts Scotland and the Cancer Collaborative Theme, 
Edinburgh Napier University. There will be a special matinee performance on 
the 18th for colleagues and students.   
Contact w.mcinally@napier.ac.uk for further information. 
THERE IS A LIGHT: BRIGHTLIGHT
An original performance inspired by the findings of BRIGHTLIGHT, the first 
major study of its kind, There is a Light: BRIGHTLIGHT presents young 
patients’ perspectives on specialist cancer care in England. 
The event is being held from the 17th to 19th November 2017 in Edinburgh 
by The Youth Theatre Arts Scotland and the Cancer Collaborative Theme, 
Edinburgh Napier University. There will be a special matinee performance on 
the 18th for colleagues and students.   
Contact w.mcinally@napier.ac.uk for further information. 
THERE IS A LIGHT: BRIGHTLIGHT
An original performance inspired by the findings of BRIGHTLIGHT, the first 
major study of its kind, There is a Light: BRIGHTLIGHT presents young 
patients’ perspectives on specialist cancer care in England. 
The event is being held from the 17th to 19th November 2017 in Edinburgh 
by The Youth Theatre Arts Scotland and the Cancer Collaborative Theme, 
Edinburgh Napier University. There will be a special matinee performance on 
the 18th for colleagues and students.   
Contact w.mcinally@napier.ac.uk for further information. 
THERE IS A LIGHT: BRIGHTLIGHT
An original performance inspired by the findings of BRIGHTLIGHT, the first 
major study of its kind, There is a Light: BRIGHTLIGHT presents young 
patients’ perspectives on specialist cancer care in England. 
The event is being held from the 17th to 19th November 2017 in Edinburgh 
by The Youth Theatre Arts Scotland and the Cancer Collaborative Theme, 
Edinburgh Napier University. There will be a special matinee performance on 
the 18th for colleagues and students.   
Contact w.mcinally@napier.ac.uk for further information. 
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Life on hold – future uncertain
Edinburgh Napier University PhD Supervisory Team: Dr Z Chouliara | Dr R G Kyle | Dr C Gray-Brunton |
Worked as a specialist nurse 
(children & young people with 
cancer) for over 25 years.
Began PhD 1st February 2015.
Beginnings
5th common cancer.
Approximately 14 young 
people diagnosed per year    
in Scotland.
Prognosis can be poor if the 
initial diagnosis is delayed.
Why Malignant Melanoma?
It is evident there are NO
studies regarding young 
peoples experiences of 
this disease.
The Literature review
Obtained through ENU Ethics 
& through SEC NRES.
Research Passport & multi-
centre approval December 
2016.
Ethical  approval
The study 
To explore the experiences of 
young people living with the 
disease & their family / 
significant other within the 
cancer pathway. Five young people were 
purposively sampled from 
three PTC’s across Scotland’s 
National Health Service 
Boards (Aberdeen, Glasgow 
& Edinburgh).
Gender ratio: Male (n=4). 
Female (n=1).
Family / Significant other: 
Fathers (n=2), Mothers (n=2), 
Partner (n=1).
Each young person and a 
family member / significant 
other nominated by them 
were interviewed either 
individually (n=6) or as a dyad 
(n=4).
Semi-structured interviews 
were conducted with the 
participant’s consent.
Interview data was audio 
recorded and transcribed 
verbatim. 
Data collection (n=10)
Qualitative using IPA to 
capture the lived experience. 
The hermeneutic approach 
will be used to interpret and 
understand.
Data analysis
‘Life on hold’: the disruption 
or halting of future life plans 
after cancer diagnosis.
‘Out on a limb’: the lack of 
access to specialist cancer 
services available to young 
people with other cancer types.
‘Feeling a fraud’: not had 
chemotherapy or radiotherapy.”
‘Loneliness and fear’: trying to 
protect others.
Findings so far …….
Understanding young 
people’s experiences, and 
that of their family / 
significant other, during the 
cancer pathway is 
fundamental to care delivery.
Way forward
Despite the seriousness of the 
disease and growing numbers 
there are reasons to suggest 
that young people and their 
family / significant other(s) may 
be experiencing fragmented 
services, insufficient support, 
leading to poorer outcomes. 
There is a lack of empirical 
evidence available upon 
which to highlight:
a) key problems and, 
b) generate solutions.
Discussion
“right diagnosis, right 
treatment, right team, right 
place…service delivery”
Cancer Research UK 2017, 
Scottish Government 2016
Challenges
The young 
person
Family & 
significant 
other(s)
The 
cancer 
pathway
Young people’s experiences of 
living with malignant 
melanoma and their family
Wendy McInally
Lecturer in Child Health & Cancer Nursing 
w.mcinally@napier.ac.uk | www.napier.ac.uk
Worldwide malignant melanoma is a cancer that has steadily increased over the
past 50 years and is predominately seen in fair-skinned populations.
Across the United Kingdom this type of cancer is rapidly increasing in the
population. Although it is more often diagnosed in older people, it is increasingly
affecting younger people - it is the fifth most common cancer among young
people. In Scotland 14 young people aged 15 to 24 years are diagnosed with
the disease each year. Despite improvements in survival rates prognosis is known
to be poor if diagnosis is delayed.
There is little international evidence around the experiences of young people
living with malignant melanoma.
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Appendix 21: PGR Conference 
 
  
  
  
  
  
 
Wendy McInally
Lecturer in Child Health
& Cancer Nursing
PhD Supervisory Team: 
Dr Zoe Chouliara
Dr Rickard Kyle
Dr Carol Gray-Brunton
A Life Interrupted – Future Uncertain
Young people's experiences of living with malignant melanoma: 
an interpretive phenomenological analysis 
2Malignant Melanoma
A Global Concern
Worldwide malignant melanoma is a cancer that has steadily increased over the past 50 years.
It is predominately seen in fair skinned populations.
3Malignant Melanoma
United Kingdom
In the United Kingdom it is the fifth most common cancer among young 
people.
In Scotland 14 young people are diagnosed with the disease each year, 
more common in male than female.
Despite improvements in survival rates prognosis is known to be poor if 
diagnosis is delayed.
The United Kingdom
England & Wales
Scotland
Northern Ireland
1
2
3
4Young People
Challenging Patient Group
A challenging 
patient group
Different models of care. 
Sufficient amount of literature around experiences of cancer in general.
No literature around experiences of young people with Malignant 
Melanoma.
Caring for young people with cancer
5Beginnings
Wendy McInally
Wendy McInally
Worked as a specialist nurse for over 25 years
Began PhD Feb 2015
Ethics granted in the Dec 2016/17, challenging as multi-centred
6Research
Methodology
A qualitative exploratory study underpinned by Interpretive 
Phenomenological Analysis. Each participant at a different 
part of the cancer journey.
1
Five young people were purposively sampled from three 
National Health Service Boards (16 to 26 years) based on 
where they were receiving treatment. Four male and one 
female. Two mothers, two fathers and one partner.  Stages 
2 to 4.
2
Each young person and a significant other nominated by 
them were interviewed (n=10) either individually (n= 4) or 
as a dyad (n=6). Semi-structured interviews with the 
participant’s consent interview data was audio recorded 
and transcribed verbatim. 
3
7Research Methodology
Design
Developed in 1995 by Johnathan Smith
Double hermeneutics 
Idiographic
Epistemological and ontological position
Concerned with narratives around lived experiences
Telling their story … not mine, giving the narrative meaning.
8Data Analysis
Hermeneutic Approach
9Data Analysis
Key Steps 
1. Reading & re-reading
2. Initial noting 
3. Developing emergent themes 
4. Searching for connections across emergent themes 
5. Moving to the next case 
6. Looking for patterns across cases 
7. Writing up (not completed yet)
(Smith, Flowers & Larkin, 2009) 
Key Steps Used
1
4
3
5
2
6
7
10Research Methodology
Data Analysis
1. Life interrupted
2. Out on a limb
3. Feeling a fraud
4. Feeling alone and afraid
The main themes emerging
Life 
Interrupted
Out on 
a Limb
Feeling a 
Fraud
Feeling Alone 
& Afraid
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11In their own words
“I was 16 years old 
following the mundane 
Monday to Friday school 
routine and trying to make 
my sixth and final year of 
school some sort of 
success” 
P1
Life Interrupted
“I was in a ward where 
there were women with 
breast cancer – no access 
to the TYA unit” 
P2
Out on a Limb
“I felt different from other 
people with cancer as I had 
my hair and didn’t look like 
a cancer patient” 
P3
Feeling a Fraud
“There was no step by step 
guide on how to deal with 
it. And the suffering did not 
stem from my diagnosis 
but from those around me” 
P1
Alone and Afraid
12Research Methodology
Findings So Far ……
Despite the seriousness of the disease there are reasons to suggest that young 
people and significant others may be experiencing a disruption to their world when a 
cancer diagnosis is given. 
Young people with this disease experience fragmented services, insufficient support, 
leading to poorer outcomes. 
Feeling not like other patients with cancer was evident as the treatment does not 
have the same side effects. 
Although the young people have a significant other they often feel alone as they 
struggled to be independent and live their life to the full. 
Impact on the young people
13Moving Forward
1. Complete data analysis, feedback to CNSs (gatekeepers to study)
2. Continue to write Chapters
3. Present and publish
4. FINISH on time!
Timeline
14References
1. Murray and Edgar (2012) Providing optimal care pathways for young 
people with skin cancer, Clinical and Experimental Dermatology (31) 
77–80 
2. National Institute for Health and Clinical Excellence (2005) Guidance on 
cancer services: improving outcomes in children and young people with 
cancer NICE London 
3. Smith J A, Flowers P & Larkin M (2009) Interpretative Phenomenological 
Analysis: Theory Method and Research. London: Sage 
4. The Scottish Government (2016) Cancer Plan for Children and Young 
People in Scotland 2016-19: Managed Service Network for Children and 
Young People with Cancer in Scotland, The Scottish Government, 
Edinburgh
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Appendix 22: Publication 
 
 
 
,-".*/ $$ $ / 
	

((( /$"
 $
% 0/" 1% *2$
	




	
 !"#	$%&"'
$(	

))***+,
+)) 
--
.*/0
-





,1#

2
	3
4
0
5-5
2
	
	
	


 !
"#$%&'( )*+%' ,+- #' *.*/*0
12.34.4511...
26	
	




	 
!"# $% 
&$'(	
)(*" +  
 __________________________________________________________________________ 
294 
 
  
COMMENT
Malignant Melanoma: How Do We Meet the Needs of
Young People and Their Families?
Wendy McInally
Department of Nursing, School of Health and Social Care, Edinburgh Napier University, Edinburgh,
Scotland, United Kingdom
Malignant melanoma is a type of skin cancer that affects around 132,000
people across the globe every year (World Health Organization, 2017). If
diagnosed early, prognosis is good. Yet, despite improvements in treatment
that have driven improved survival, the incidence of malignant melanoma
continues to increase in some countries, due to a combination of factors such
as lack of awareness, light skin color, blonde or red hair, number of moles,
family history, and excess exposure to ultraviolet (UV) radiation, particularly
in childhood. Although malignant melanoma is more often diagnosed in
older people, it increasingly affects adolescents and young adults (AYAs). In
the United Kingdom (UK) for example, it is the fifth most common cancer in
AYAs (Cancer Research UK, 2017; Information Services Department [ISD],
2017), and in Scotland, of the 180 young people between ages 15 to 24 years
diagnosed with cancer every year, on average 14 will be diagnosed with
malignant melanoma. In particular young females are more at risk than
young males.
A study by Kyle et al. (2014) highlights the importance of awareness of
skin cancer risk associated with UV exposure and encouraging sun protective
practices. Such awareness and the establishment of protective health-related
behaviors may have potential to reduce the burden of malignant melanoma
in adolescence and early adulthood, as well as in later life. Malignant mela-
noma is an important disease within this age group and awareness of
prevention and UV exposure is essential, as are early diagnosis and care
management within age appropriate specialist services (Murray & Edgar,
2012).
Curative treatment is dependent on early diagnosis and the stage of the
disease at diagnosis. The treatment for malignant melanoma varies depend-
ing on the stage of the disease. For all cases, treatment is usually surgical
followed by immunotherapy which may be used as an additional treatment
for high risk patients (Cancer Research UK, 2017). Clinical trials using
immunotherapy are currently taking place, but optimal timing for this type
of intervention has not been determined. Systemic treatment is used in
CONTACT Wendy McInally w.mcinally@napier.ac.uk Department of Nursing, School of Health and Social
Care, Edinburgh Napier University, Sighthill Court, Edinburgh EH11 4BN, Scotland, United Kingdom.
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palliative and end of life care along with radiotherapy, especially for patients
with metastatic disease. However, the recognition of early symptoms, in
order that prompt diagnosis and treatment is available throughout the cancer
pathway, is crucial (Zebrack, Kent, Keegan, Kato, & Smith, 2014).
Understanding and meeting the needs
In Scotland, the Cancer Plan for Children and Young People aims to ensure
that children and young people aged between 0 to 25 years diagnosed with
cancer have equal access to the best possible care and treatment as early as
possible. The Managed Service Network (MSN) for Children and Young
People with Cancer has been charged with delivering this vision (The
Scottish Government, 2016). It is important that, as young people mature
into adulthood, early diagnosis and defined care pathways are established.
These pathways should consider the individual age, cancer type, and the
future risks of late effects from treatment as well as the personal needs of the
young person and their family.
Caring for young people with cancer requires a range of specific knowl-
edge, skills, and experience to deliver often complex care regimes both within
the hospital or in the community environment (Gibson & Soanes, 2008). A
teenager or young person typically begins their cancer pathway within
children’s services, teenage cancer units, or adult services. In the UK they
are given a choice of where they would prefer to be treated if they are
between the ages of 19 to 24 years (National Institute for Health and
Clinical Excellence [NICE], 2005).
A diagnosis of cancer can often occur at a time when the adolescent or
young person is in the process of developing their early adult life plans and
are at a major crossroads in their life (McInally, 2013). The diagnosis and
subsequent treatment at this juncture may impact significantly on their life
plans and their ability to fulfil their full potential. A diagnosis of cancer at
this time may add to the stressors associated with a normal transition from
young person to adulthood. It may also impact on their relationships, quality
of life, and psychological wellbeing, among other components of their lives.
The needs of the family cannot be separated from those of the individual
with the disease, but both would value information and support offered in a
structured way. Implications for practice suggest that young people wish to
be empowered to take care of themselves.
Care delivery by competent health professionals who are knowledgeable
about the immediate and long term implications of treatment is a funda-
mental requirement in order that young people and their families can be
supported and prepared for what lies ahead. Services need to ensure clearly
defined pathways are developed for the care of AYAs with malignant mela-
noma and review the effectiveness of these pathways on a regular basis.
6 W. MCINALLY
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However, there is a tendency to view the ideal treatment and care experience
as arising out of specialist services that are age appropriate although this is
not readily available for all AYAs with cancer across the globe due to
different health care systems and resources (Carr, Whiteson, Edwards, &
Morgan, 2013). This means that there is a need to ask what actually happens
in practice from their own perspective and what information is given about
services for ongoing care and support.
Next steps for research and practice
Existing literature reveals that there is no national or international research
that focuses on the experiences of AYAs living with malignant melanoma.
This can also be said for the experiences the families share with the adoles-
cent endeavoring to cope with the disease. Previous research has tended to
focus on the experiences of young people living with other types of cancer
such as leukaemia and lymphoma rather than malignant melanoma (Murray
& Edga, 2012). Thus, while models of young people’s cancer experience have
been developed (Taylor, Pearce, Gibson, Fern, & Whelan, 2013) it is not
known whether these hold true for those diagnosed with malignant mela-
noma. Anecdotal evidence suggests that adolescents and young adults living
with malignant melanoma may be experiencing fragmented services and
insufficient support, potentially leading to poorer outcomes. Only by focus-
ing on the experiences of young people living with malignant melanoma will
services be designed that meet the needs of these young people and their
families. The increasing incidence of the disease in Scotland and elsewhere
makes this an even more important pursuit.
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Life Interrupted: Sharing the Journey Public Engagement 
Workshop 
Itinerary  
Purpose:  
The focus of the day will be to gather thoughts about the four key super-
ordinate themes and 12 sub-themes that encapsulate the core conceptual 
thread of ‘Life Interrupted’.  
 
Workshop Itinerary and Timings 
 
1045 – 1100:  
Arrive at Sighthill Campus IPoint (reception on level 1). Wendy to meet you 
there. 
 
1100: - 11:30  
Welcome and introductions. An introductory pack will be provided with the 
PPT, and the findings. Completed consent forms for further research 
applications will be collected from participants. 
 
1130 -1200:   
Wendy will present a PowerPoint on the PhD, mainly focusing on data 
collection through to data analysis and findings. Workshop structured around 
the findings.  
 
1200 – 1300: World Cafe 
A ‘world café’ of four individual areas where the themes will be explored and 
the core conceptual thread, will be displayed on a board for participants to 
visualise and discuss whether this resonates with their journey and 
experiences of living with melanoma. The individual areas will be facilitated by 
the two supervisors and the core conceptual thread by Wendy.  
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The ten participants (young people, family and CNS) will be divided into two 
groups. This workshop will be facilitated by my two supervisors, Dr Richard 
Kyle and Dr Carol Gray-Brunton and Wendy.  
 
There will be two key questions from this ‘world café’, 1) Do these findings 
resonate with your experiences of living with Melanoma at the time (three 
years have passed since the data was collected, 2) Is there any other 
experiences that have been not been included but worth mentioning?  
 
Post it notes and pens will be used and flip chart and Wendy will collect all 
thoughts and sort into common themes.  Anything ‘new’ will be added to the 
second part of the day after lunch.  Wendy will place the flip charts on the 
walls for all to see whilst having lunch. 
 
1300 – 1400: 
Lunch.  
 
1400 – 1445:  
This part of the afternoon will focus on asking the participants about the 
findings and how they would like to see these disseminated?  It will also focus 
on the young people and their family and where they are now…. three years 
on.  
 
What now?    
1445 – 1500: Sum up the day, Tip/Top summary. A evaluation cared with be 
given with a Patient Information sheet and a 
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Participant Evaluation Questionnaire 
 
 
 
 
  
 __________________________________________________________________________ 
302 
 
Images 
 
 
 
 __________________________________________________________________________ 
303 
 
 
 
 
 
